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The economic burden and the health risks of bovine tuberculosis have led to an ongoing 
political and scientific debate on the control of the disease in badgers, perceived to be the 
main carrier, responsible for spreading the infection among cattle. Although culling of badgers 
has already been introduced in some parts of Britain, its efficacy remains unclear.  Moreover, 
the implementation of alternative strategies, such as vaccination illustrate the need for a 
deeper understanding of the badger’s immune system. In addition, there is also a need to 
develop additional models and systems for studying the complexity of the immunological 
response in host organisms: simple organisms, including many flies and beetles are becoming 
increasingly popular in this respect. 
The first aim of this thesis is to obtain the nucleotide sequence of the badger transcriptome 
from peripheral blood cells, and to profile the immunity related genes, through critical 
evaluation of bioinformatics data extracted from public domain databases. In the second part 
of the thesis, the introduction of the yellow mealworm beetle, Tenebrio molitor, is developed 
through initiation of a genome sequencing project. It is hoped that this simple organism will 
provide insight into immune challenge and support the annotation of immune-related genes 
from more complex organisms, including the badger as well as providing an accessible model 
organism that is easy to manipulate in simpler laboratory environment such as schools. 
The sequencing of both the badger transcriptome from peripheral blood cells and the T. 
molitor genome generated large data sets. The transcriptome analysis resulted in the 
identification of 15967 transcripts related to 698 known immunity genes in different 
mammals. 1825 transcripts were found to match genes involved in tuberculosis pathogenesis. 
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It is believed that, these findings will improve our understanding of future attempts to both 
prevent and treat bovine tuberculosis.  
The determination of the T. molitor genome will facilitate and improve its use as a model 
organism to study infections. The genome data have been deposited and assembly of an 
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The British Badger culling programme started in 2013 in several areas of southwest of 
England and Wales, in order to control the spread of bovine tuberculosis (Ares, 2014). 
However, the controversy surrounding the programme itself from an animal rights 
perspective, and the actual benefits of its implementation, became a debate long before 
that. Alternative solutions were suggested, including vaccination of both badgers and 
cattle. However, culling still continues to this day with no clear outcome agreed by both 
sides of the debate. 
Bovine tuberculosis (bTB) infection is endemic in the badger population, which is 
recognized as a reservoir of infection for cattle and domestic animals in the UK and the 
Republic of Ireland (Corner et al., 2011). Establishing the identity of the reservoir of the 
pathogen (Mycobacterium bovis) is essential in order for any plan of eradication to be 
successful (Gormley and Collins, 2000). 
1.1 The economic burden of bTB  
Although bTB is a zoonotic disease with a significant health impact in developing countries 
in particular, the problem of zoonosis seems to be rare in the developed world; even in 
countries with large infected cattle populations such as the UK (Michel et al., 2010). 
Bovine tuberculosis is known for its economic impact on the cattle industry both in the 
UK and globally. According to the UK Department for Environment, Food and Rural affairs 
report on bTB impact assessment (2011), the disease is one of the major challenges facing 
the farming industry today: the cost of such a burden was estimated at £90 million, and 
nearly 25,000 cattle were slaughtered in 2010. Control of the disease in cattle can be 
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particularly challenging when wildlife becomes an integral part of the epidemiological 
system (DEFRA, 2011). 
Internationally, the most significant wildlife reservoirs of bTB for cattle are considered to 
be the white-tailed deer (Odocoileus virginianus) in northern America, the Cape buffalo 
(Syncerus caffer) in South Africa and the brush-tail possum (Trichosurus vulpecula) in New 
Zealand (de Lisle et al., 2002). However, there are many other potential mammalian hosts, 
some of which may be capable of onward transmission (Delahay et al., 2002). 
1.2 Badgers as bTB carriers 
 Badger Biology 
Standard biological classification places the badger (Meles meles) under the family 
“Mustelidae”, which also includes weasels, otters and ferrets (Corner et al., 2011). 
Badgers are social animals that live in groups in underground burrows called setts; and in 
highly populated areas a single sett can host a family of 8-20 animals of both sexes and 
different ages (Delahay et al., 2000). Each sett comprises nesting chambers that are inter-
connected by tunnels that spread over many metres with multiple entrances. These setts 
protect the animals from extreme weather and predators beside their main use for resting 
and breeding (Rogers et al., 2003). Badgers are nocturnal animals that are also territorial 
and territory boundaries are maintained by bodily secretions like urine, faeces and 
secretions from inter-digital glands (Corner et al., 2011). Although the Mustelidae family 
is carnivorous, badgers have diverse dietary preferences with seasonal variation 
depending on food availability (Cleary et al., 2009). Their diet includes invertebrates, 
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insects, amphibians, small mammals and decaying carcasses, as well as fruits, cereals and 
vegetation (Cleary et al., 2009). However, they can show highly specific feeding 
behaviours where diet is composed mainly of one type, such as earthworms in south-west 
England (Kruuk et al., 1979) 
 Tuberculosis in Badgers  
Tuberculosis infected badgers in England and Ireland were first reported in 1971 
(Murhead and Burns, 1974) and since then infected badgers have been found widely. 
Badgers have, since then, been considered to be the main wildlife reservoir that spreads 
M. bovis infection among cattle in the UK (Woodroffe et al., 2005) and Ireland (Griffin et 
al., 2005). 
Badgers are not the only wildlife species that can acquire bTB infection as surveys have 
shown in south-west England (Delahay et al., 2001). Other wild mammals can carry the 
infection as well; however, the prevalence is lower in such cases, with milder lesions (Neal 
and Cheeseman, 1996). 
The Eurasian badger (Meles meles) is one of the main sources of infection. The 
progression of the disease in cattle can cause reduced productivity and premature death, 
which makes disease control particularly challenging in the cattle population. In recent 
years, there has been growing interest in the prospective utilisation of farm husbandry 
and biosecurity measures to reduce the risk of bTB transmission (Krebs et al., 1997). 
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 Routes of bTB transmission 
Despite the fact that the exact processes by which cattle become infected with the 
bacteria has yet to be completely understood and characterised; it is generally assumed 
that inhalation is the main route of infection. Intra-tracheal inoculation with a single 
colony forming unit of M. bovis is sufficient to cause infection (Dean et al., 2005).  
As a consequence, combined with the difficulties associated with laboratory culture of M. 
bovis, positive results from diagnostic methods provide a risk alert, but do not guarantee 
certainty in respect of transmission. 
There is strong evidence that airborne infection is likely to be an important route for 
transmission of bTB amongst badgers. However, clinical samples from live badgers have 
shown that M. bovis bacilli can be isolated from sputum, faeces, urine, bite wounds and 
draining abscesses. This suggests that the increased opportunities for transmission of bTB 
to cattle occur either via direct contact with badgers (aerosols) or through material 
contaminated with badger secretions and excretory products such as urine, saliva and 
blood (Delahay et al., 2005). 
The levels of increased risk of transmission of bTB through various routes, in accordance 




Figure 1.1: Routes of excretion and the risk of transmission of Mycobacterium bovis 
infection from tuberculosis infected badgers (Corner et al., 2011) 
 
 
1.3 An overview of the mammalian immune system: 
 Pathogenesis: Cellular progression of infection 
Pathogenesis is a term that defines a series of interactions between the microbe and the 
host, from the initiation of infection to the development of disease and the appearance 
of signs and symptoms.  bTB is a respiratory and an immuno-pathological disease in which 
M. bovis bacilli enter the host through uptake by alveolar macrophages, and the 
formation of lesions  is a result of cell-mediated immunity to the presence of M. bovis 
bacilli (Corner et al., 2011). Once the bacteria are systemic within the badger, M. bovis 
bacilli are engulfed by macrophages through phagocytosis. The bacilli then acquire 
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protection from extracellular bactericidal factors by the phagosome membrane. 
Mycobacteria have the ability to inhibit the fusion of lysosomes with phagosomes and 
thus protect themselves from intracellular destruction by acidification. The 
immunological response is then initiated through the complex interaction of numerous 
cell types, leading to the development of a cell-mediated immune (CMI) response that in 
turn, leads to the formation of granuloma around infected macrophages. The granuloma 
is a protective response which serves to localise the infection and to prevent further 
dissemination by the interactions of immune cells and cytokines (Robinson et al., 2012). 
The body is constantly exposed to pathogens and in order to defend itself and the immune 
system has evolved to protect it against infection. The first line of defence against 
pathogens is the anatomical and physical barriers, which include the skin, the cilia of the 
lungs and lysozyme in tears, and these prevent the entry of some pathogenic organisms 
into the body. Viruses, bacteria, parasites and fungi must penetrate these shields to cause 
an infection or an infestation (Bradford, 2012). In the human body, the first barrier against 
infection is the skin even though it only stretches up to two square meters only, whereas 
the area covered by other epithelial and mucous membranes that line the digestive, 
respiratory and reproductive systems is two hundred times that of the skin (Sompayrac, 
2012). Many pathogens are able to evade these anatomical and physiological barriers, 
and this is where the adaptive immune system is of a paramount importance. The immune 





Figure 1.2: Levels of immunological response in mammals. Adapted from (Turvey and 
Broide, 2010b) 
 
  Innate immunity 
The innate immune response provides organisms with a rapid means of combating 
pathogens: within minutes of exposure, a protective inflammatory response is generated. 
The innate immune system relies on a limited number of receptors referred to as 
pathogen recognition receptors (PRRs) to detect invading pathogens, but compensates 
for this limited number by targeting conserved microbial components that are shared by 
large numbers of pathogens (Turvey and Broide, 2010a). The innate immune system also 
plays a vital part in activating the adaptive immune response and is composed of both 
cellular and humoral elements. A number of both hematopoietic cells and non-
hematopoietic cells are involved in the innate immune response, including the blood 
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macrophages, dendritic cells, mast cells, neutrophils, natural killer (NK) cell and NK T cells. 
Non-hematopoietic cells also play a role in innate immunity, including the skin and 
epithelial cells lining the respiratory, gastrointestinal, and genitourinary tracts. Innate 
immunity also has a humoral component that consists of well-characterised components, 
such as complement proteins, lipid polysaccharide (LPS) binding protein, C-reactive 
protein and antimicrobial peptides working to enhance the effect of these cellular 
defenses (Turvey and Broide, 2010a).  
The major phagocytic cells of the innate immune system are neutrophils, macrophages 
and monocytes. Neutrophils destroy pathogens by engulfing them in intracellular 
vacuoles, where they are exposed to toxic molecules such as nitric oxide and degradative 
enzymes (Kennedy and DeLeo, 2009). Macrophages and monocytes are also highly 
phagocytic for microbes and particles that have been marked for clearance either through 
opsonisation by antibodies and/or complement (Bradford, 2012). Monocytes and 
macrophages also play vital roles in the adaptive immune response by ingesting microbial 
antigens, processing them into peptide fragments, and presenting them to T cells 
(Chaplin, 2010). 
Dendritic cells are potent antigen-capture and -presenting cells that play a key role in the 
initiation and regulation of the adaptive immune response and they are the most potent 
antigen presenting cells (APCs). Dendritic cells (DCs) are present in most tissues of the 
body and concentrated in the secondary lymphoid organs (Lambrecht and Hammad, 
2009). APCs express class I and II major histocompatibility complex (MHC) molecules that 
are required for recognition of processed antigen by the T cell receptor and accordingly 
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DCs are important in initiating the adaptive immune response by migrating from the site 
of infection to regional lymph nodes where they present pathogen-derived antigen to 
CD4+ T cells. Activated DCs express co-stimulatory molecules essential to T cell activation 
and can instruct the differentiation of naive CD4+ T cells into T helper cells, which can lead 
to clonal expansion and migration of T cells to B cell areas to assist with antibody 
production (Gallucci et al., 1999). 
 Adaptive immunity 
In order to mount an effective immune response and unlike the innate immune response, 
the adaptive immune system is based on antigen exposure by both B cells and T cells 
(Turvey and Broide, 2010a). In contrast to the limited number of pathogen receptors used 
by the innate immune system, the adaptive immune system has an extremely diverse, 
randomly generated repertoire of receptors that are encoded by genetic elements that 
somatically rearrange to assemble antigen-binding molecules with great specificity for 
individual, unique foreign structures (Chaplin, 2010). Although the diversity in receptors 
enables adaptive immunity cells to recognise virtually any foreign antigen, this part of the 
immune system requires a relatively long period of antigen exposure before mounting a 
response due to clonal expansion of antigen-specific T and B cells. However, the benefit 
of this key feature is that it produces long-lived cells that persist as memory cells until a 
second exposure with their specific antigen, where they rapidly re-express effector 
functions and therefore it manifests an immune memory, which contributes to a more 




The major role of the T-cell in the adaptive immune response is to identify and destroy 
infected cells, and is responsible for cell-mediated immunity. T cells can recognise peptide 
fragments of antigens that have been taken up by APCs through phagocytosis. The 
immune system has evolved to enable T cells to recognize foreign antigens through 
recognizing self-components and foreign peptide molecules on the surface of APCs. MHC 
molecules are cell surface glycoproteins that bind peptide fragments of proteins that have 
either been synthesized within the cell i.e. endogenous antigens (class I MHC molecule) 
or ingested by the cell and proteolytically processed i.e. exogenous antigens (class II MHC 
molecules) (Chaplin, 2010). 
 Major histocompatibility complex class I and II 
MHC molecules are cell surface proteins that are involved in adaptive immunity and 
histocompatibility. Class I MHC molecules are cell-surface heterodimers consisting of a 
highly polymorphic transmembrane polypeptide chains (Bradford, 2012). The main 
functions of class I MHC molecules are the presentation of peptide antigens to CD8+ cells 
and serving as inhibitory ligands for NK cell receptors (Li and Jevnikar, 2015). Class II MHC 
molecules are expressed on a number of immune cells, including B cells, DCs, monocytes 
and macrophages. They can bind a large repertoire of antigenic peptides which makes 
them most effective in presenting antigenic proteins of extracellular pathogens, such as 
most bacteria, parasites, and virus particles that have been released from infected cells 
to CD4+ T helper cells (Bradford, 2012). 
Although MHC class I and class II are generally considered to have separate functions, 
these molecules most likely have a common evolutionary history. It is difficult to predict 
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how specificity is achieved in immune recognition because on one hand it is believed that 
only specific peptides from pathogens are recognized by T cells and on the other hand a 
single MHC molecule may in principle bind more than a million different peptides 
(Trowsdale and Knight, 2013). 
 
 Humoral Immune Response 
Many of infectious bacteria multiply in the extracellular spaces of the host body, and most 
intracellular pathogens spread the infection by moving from cell to cell through the 
extracellular fluids. The extracellular spaces are protected by the humoral immune 
response. The humoral response involves the production of antibodies by B cells any 
thereby the destruction of extracellular microorganisms and prevent the spread of 
intracellular infections through extracellular fluids. The activation and differentiation of B 
cells into antibody-secreting plasma cells is initiated by the presence of antigens and 
facilitated by helper T cells. Antibodies can neutralize pathogens by preventing them from 
entering host cells through binding to specific surface molecules. Neutralization by 
antibodies is important in preventing bacterial toxins from entering cells (Janeway, 2005).  
Antibodies also protect against bacteria that multiply in the extracellular fluids mainly by 
facilitating engulfment of the pathogen by macrophages that are dedicated to destroying 
ingested bacteria. The process is called opsonisation and it involves the recognition of the 
antibodies that are bound to the pathogen surface antigens by phagocytic cells. 
Moreover, antibodies binding the surface of a pathogen can activate complement 
proteins that recruit phagocytic cells to the site of infection, and the terminal components 
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of this complement system can lyse certain microorganisms directly by forming pores in 
their membranes (Janeway, 2005). 
 Cellular immune response 
Cellular immune response or cellular-mediated immunity (CMI) is an immune response to 
an antigen that involve phagocytosis, cytotoxic T-lymphocytes and the release of 
cytokines. CMI is mainly triggered by pathogens that survive in phagocytes and pathogens 
that infect non-phagocytic cells. It plays a major role in removing virus-infected cells, and 
contributes in the immune response against fungi, protozoans, and intracellular bacteria. 
It also plays a major in fighting cancer and transplant rejection (Janeway, 2005).  
Mechanism of CMI involves the activation of antigen-specific cytotoxic T-lymphocytes 
that are capable of inducing apoptosis in cells displaying fragments of foreign antigen on 
their surface. Cells that are infected with intracellular bacteria or viruses and tumor 
display such foreign epitopes on their surfaces. Moreover, CMI involves the activation of 
macrophages and natural killer cells, enabling them to destroy intracellular pathogens as 
well as the stimulation of cytokines secretion, which influence the function of other cells 
involved in immune responses. 
Generally, CMI occurs in three common phases: (a) Binding of the cytotoxic cells to the 
target cells, (b) Release of cytokines and (c) Lysis of the target cell. T-lymphocytes bind to 
their target cells that display class I MHC or through specific antibodies and receptors. 
Binding of the cytotoxic T-lymphocytes to the target “abnormal” cells is crucial for the 
induction of cell apoptosis. The union of two types of cells induces the T-lymphocyte to 
secrete cytokines, perforin and other cytolytic enzymes into the target cell. Perforin can 
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induce the formation of pores in the cell membrane which allow the movement of remain 
of cytotoxic components causing cell death and disintegration into small membrane 
bound vesicles (Janeway, 2005).  
1.4 Immune response to TB and bTB 
Although CMI plays a major role in the response to mycobacterial infection, other immune 
responses are also of importance and will be also discussed in terms of the type of 
response according to route of infection and the disease progression. 
 Intradermal route 
The main cells involved in protective CMI are the macrophages and the T-lymphocytes as 
shown by early studies of the response of badgers infected experimentally with M. 
bovis by the intradermal route using the lymphocyte transformation test (LTT) with the M. 
bovis strain bacillus Calmette–Guérin (BCG) as the stimulating antigen, and also using the 
intradermal tuberculin test together with an enzyme-linked immunosorbent assay (ELISA) 
(Corner et al., 2011). There was a spectrum of immunological responses observed through 
different stages of the disease. The main observed pattern in the early stage there was a 
well-developed CMI response with increased LTT responses and a positive skin test, while 
in the late stage had an elevated levels if antibody production and CMI responses were 
depressed (Corner et al., 2011). 
 Endobronchial route 
According to Lesellier et al., (2008) a number of immunological studies of badgers infected 
experimentally with M. bovis by the endobronchial route have demonstrated strong 
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responses starting 3 weeks post-infection to bovine purified protein derivative (PPD-B) M. 
bovis-specific single antigen (CFP-10). However, no CMI or antibody response was 
detected against ESAT-6, a target specific antigen in most other species (Corner et al., 
2011). Moreover, a group of well-known immuno-stimulatory antigens in infected cattle 
(e.g. MPB70, Rv3019c, Rv3873, Rv3878 and Rv3879) were not recognized by 
experimentally-infected badgers (Lesellier et al., 2008) which suggests that infected 
badgers recognize a limited or different repertoire of antigens compared with other 
species (Corner et al., 2011). 
 Response to vaccination 
Intradermal BCG vaccine can elicit lymphocyte proliferative responses in vitro. However, 
such responses were only obtained after repeated injections of BCG (Southey et al., 2001). 
Low CMI responses were also reported in other species including white-tailed deer and 
ferrets vaccinated with subcutaneous BCG injections, which suggests that badgers 
response to vaccination is mainly innate to lower the bacterial load before initiating a T 
lymphocyte mediated response (Corner et al., 2011). An immunological tolerance to 
environmental mycobacterial antigen, which occurs due to repeated exposure in badgers, 
can cause a delay in detecting adaptive immune responses until the bacterial load 
(vaccine doses) reach a minimum threshold level, i.e. a BCG dose dependant CMI 
responses in badgers (Lesellier et al., 2006). 
 Mycobacterium and Macrophages 
Macrophages are the primary targets for mycobacterium infection and the host 
resistance is highly dependent on the macrophages’ capacity to produce reactive nitrogen 
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and oxygen compounds, TNF and interleukins (Cassidy and Martineau, 2014). After being 
ingested by macrophages, mycobacteria have the ability to downregulate the expression 
of cathepsin G, a macrophage lysosomal protease with known antimicrobial properties, 
during early stages of mycobacterial infection (Rivera-Marrero et al., 2004)). This process 
is accompanied by an increase the expression of more acidic cathepsins, such as cathepsin 
B and D, which are weak proteases that can benefit the mycobacteria by contributing in 
tissue liquefaction and cavity formation in process called cathepsin switch (Cassidy and 
Martineau, 2014). Apoptosis plays an important role in the macrophages innate response 
against mycobacteria, and evasion of alveolar macrophage apoptosis is a virulence-
associated phenotype in mycobacteria. Mycobacteria can delay the onset of apoptosis in 
infected macrophages through controlling intracellular prostaglandin E2 synthesis and 
thereby allowing more time for intracellular mycobacterial replication which infect more 
cells once the macrophages death occurs (Behar et al., 2010). 
 Cell-mediated immune response in mycobacterial infection 
Recent studies have demonstrated that the adaptive cell-mediated response of cattle is 
quite similar to that of the human especially at the genomic level where genes encoding 
cytokines are known to play a role in regulating the immune responses in humans are 
present in cattle, including cytokines not found in mice (e.g., IL-26) (Waters et al., 2011). 
Cell-mediated immune responses are predominant in mycobacterial infections. Studies 
have shown that CD4+ T cells produce Th1 cytokines, such as gamma interferon (IFN-γ), in 
response to mycobacterial antigens and that the cytolytic activity of CD8+ cells toward 
infected macrophages is important (Kennedy et al., 2002). The Protective cell mediated 
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immunity against tuberculosis is dependent upon the interaction of T cells with infected 
macrophages. CD4+ T-cell sub-population respond to infection principally through the 
production of cytokines such as gamma interferon (IFN-γ) which are considered to be 
involved in the activation of        macrophages (Kennedy et al., 2002). 
The release of IFN-γ is an important function of the CMI response to mycobacterial 
infection in human and cattle and it is widely used for tuberculosis diagnosis (Vordermeier 
et al., 2002). However, unlike rodents human and bovine immunity to the disease is less 
dependent on antigen specific IFN-γ activation of macrophages and more dependent on 
cytotoxic immune cells. The role of IL-21 and other key regulatory factors for maintenance 
and induction of IFN-γ (IL-12, IL-18, IL-23, and IL-27) and NK cell function in protective 
immunity to TB is an important avenue of investigation in the efforts to develop a vaccine 
for humans and cattle (Waters et al., 2011). 
The sub-population of CD8+ T cells is also involved in the production of IFN-γ in a low level 
during the course of infection (Serbina and Flynn, 1999). The important role of CD8+  cells 
in early stages of infection is their ability to act as cytotoxic T lymphocytes which may not 
only be involved in the lysis of specific target cells, but may also release molecules, such 
as granulysin, which have been shown to directly kill mycobacteria (Stenger et al., 1998). 
1.5 Current control strategies of bTB in badgers 
 Badger culling 
The risk of bTB transmission from badgers to cattle can be reduced locally by culling, 
which has been implemented recently in the UK. Despite the evidence of a beneficial 
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reduction in bTB incidence rate in the neighbouring Republic of Ireland, after a similar 
culling programme was implemented (Olea-Popelka et al., 2009), there is still an ongoing 
debate that culling would not make a significant contribution to bTB control in the UK. 
This is based on a cost benefit analysis carried out by  the Independent Scientific Group 
on Cattle (ISG) after evaluating data from the randomised badger culling trail (RBCT) 
(Robinson et al., 2012). Although the repeated culling across accessible land (Proactive 
badger culling) has reduced bTB incidence in cattle by 23% inside the targeted areas, it 
has also increased the incidence rate by 25% in the surrounding areas due to the 
disturbance in badger colonies and migration. Similarly, Reactive Culling, which involves 
culling in the areas close to farms where recent cases of bTB are reported, has also 
increased the incidence rate by 20% (ISG, 2007). Although badger culling appears to be 
an effective interim approach in reducing transmission of bTB to cattle in the cull area, it 
is unsustainable in the long term from both ethical and economic perspectives (Jenkins et 
al., 2010) as the public and scientific opposition to culling continues to grow. 
 Badger and cattle vaccination 
Current research has provided evidence that vaccination can be used as an additional tool 
in any bTB control programme. However, there are still some areas of uncertainty about 
implementing a vaccination campaign, as more technical information on choosing a 
strategy of whether tackling the disease in high endemic areas should be started before 
low prevalence ones or whether or parenteral versus oral vaccination. There is also a 
limited understanding of the duration of immunity, and whether vaccination reduces M. 
bovis elimination from badgers that are already infected, and the excretion patterns of 
 19 
 
vaccinated badgers that subsequently become infected. The most important point in the 
search for an efficient vaccination strategy, is determining the effects of badger 
vaccination on the incidence of bTB in cattle (Robinson et al., 2012). 
The development of successful strategies to eradicate bovine tuberculosis in cattle and 
badgers requires a comprehensive knowledge of all of the epidemiological factors 
controlling the persistence of the infection in both host species, as well as the mode of 
transmission and a thorough understanding of the obstacles hindering success. The 
implementation of a local control strategy based on culling is limited by the number of 
badgers removed versus the total number of infected, and the proportion of the targeted 
area compared to the whole area affected. Research has yet to be completed in the field 
of vaccine efficiency and delivery. However, it is hoped that this will contribute to a more 
effective eradication of bovine tuberculosis on a national level (Gormley and Corner, 
2013). Current bTB control strategies focus on vaccination of both badgers and cattle to 
achieve control and subsequently eradication of the disease. However, there are 
obstacles in the way of the large-scale use of injectable vaccine in badgers and the delivery 
mechanisms of oral vaccine in both badgers and cattle (Chambers et al., 2014). Although 
computer models have shown that maintaining a regular badger vaccination programme 
can theoretically reduce bTB incidence in cattle (Smith et al., 2012), there is no direct 
experimental evidence of reducing bTB transmission between badgers and cattle and vice 
versa (Chambers et al., 2014) 
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The optimisation of an oral bTB vaccine requires more research on the delivery options 
and exact mechanisms of its interaction with the badger’s immune system.  Without this 
knowledge the timescale and the production of effective and affordable vaccine remains 
uncertain especially when vaccination of cattle is currently prohibited under European 
legislations as the ultimate endpoint of using BCG vaccine in cattle without trade 
restrictions may not be achieved before 2023 (Chambers et al., 2014). 
 
1.6 Contemporary experimental and computational approaches to 
understanding the transmission of TB 
In order to understand disease mechanisms in a comprehensive manner, the combination 
of systems biology and bioinformatics is currently proving to be a very powerful research 
approach. Bovine tuberculosis infection can spread from cattle to humans and some 
domestic animals, which, in addition to the economic burden of the disease, has provided 
the impetus for the development of a new management strategy, as more traditional 
approaches seem to be making relatively slow progress. Understanding the fundamental 
disease mechanism together with the badger’s ability to tolerate the infection on a sub-
cellular and genomic level, might prove accessible to contemporary bioinformatics 
research tools. 
In the last few years, bioinformatics has become fully embedded in the methodology of 
research in Biotechnology, through its focus on biological information management, data 
interpretation and future, including predictive methods. One of the recently developed 
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bioinformatics approaches is transcriptomics, which deals with the study of mRNA and 
non-coding RNAs generated by a cell or population of cells that share specific 
physiological functions. In contemporary, multidisciplinary research projects, global 
transcriptome analysis and profiling is commonly the first technology to be applied 
(McGettigan, 2013). Transcriptomics can generate information about which genes are 
expressed, at what level and can also provide information about different transcript 
isoforms 
 Gene transcription 
“Gene expression, the process necessary to transmit information from genetically 
encoded information into functional processes within a living organism, is where it all 
starts. Basic principles are followed, which have proved so successful that they are used 
by prokaryotes and eukaryotes alike.” (Persson and Mueller, 2015). 
In the central dogma of molecular biology (DNA makes RNA makes protein) transcription 
is the step that precedes protein synthesis (translation), where DNA serves as template 
for the synthesis of RNA, catalysed by the enzyme RNA polymerase. In eukaryotes, the 
newly synthesised mRNA is subsequently released into the cytoplasm to be translated 
into protein by ribosomes (Latchman, 2005). 
Generally, transcription takes place in three steps initiation, elongation and termination. 
Initiation occurs when the enzyme RNA polymerase binds to a promoter region of a gene. 
This binding signals the DNA to unwind allowing the enzyme to read the bases of a single 
DNA strand and create a complementary mRNA strand. Elongation refers to the addition 
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of nucleotides to the mRNA strand directed by the complementary bases with addition of 
Uracil (U) instead of Thymine (T) to the growing RNA strand. Termination of transcription 
occurs when RNA polymerase reaches a termination signal in the gene sequence. The 
mRNA molecule is then detaches from the complex and undergoes further maturation 
before release into the cytoplasm (Latchman, 2005). The stages are shown 




Figure 1.3: (A) “The transcription process is initiated when the enzyme RNA polymerase 
binds to a DNA template at a promoter sequence. (B) During the elongation process, the 
DNA double helix unwinds. RNA polymerase reads the template DNA strand and adds 
nucleotides to the three-prime (3’) end of a growing RNA transcript. (C) When RNA 
polymerase reaches a termination sequence on the DNA template strand, transcription is 
terminated and the mRNA transcript and RNA polymerase are released from the 
complex.” Adapted from Clancy, (2008). 
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 In order for a eukaryotic mRNA molecule to be translated into an amino acid sequence it 
must first undergo additional processing, usually before it can be released into the 
cytoplasm. The processing may include mRNA editing, splicing and polyadenylation 
(Latchman, 2005). These processes allow not only mRNA maturation but also for a single 
gene to be used in the production of more than one protein. mRNA editing allows the 
change of some nucleotides in the sequence which as a consequence lead to the 
production of different forms of the translated protein. An example of this phenomenon 
is given the human APOB protein which has two different forms as a result of a premature 
stop signal during mRNA nucleotide editing (Severi and Conticello, 2015). Polyadenylation 
in a process by which a tail of adenine bases is added to the 3” end of mRNA sequence. 
Polyadenylation signals the end of mRNA, involved in mRNA export from the nucleus and 
protects mRNA from hydrolytic enzymes that might break it down in the cytoplasm. 
Splicing involves the removal of introns which are non-coding short regions of the RNA 
sequence that separate the coding exons from each other (Latchman, 2005). As a result 
of splicing the mature mRNA arises by re-joining the remaining exons (the coding regions) 
to form an mRNA transcript for subsequent translation into a protein.  
1.6.1.1 Alternative mRNA splicing and its impact on protein diversity  
The discovery of the discontinuity of eukaryotic genes with protein coding and non-coding 
segments was one of the most unanticipated findings in molecular biology, and later it 
has become clearer with advances in genome sequencing that splicing often parallels the 
complexity of an organism (Jacquier, 2009).  
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As an example of the complexity that results from the alternative splicing is the similarity 
of human and mouse genomes with almost the same number of genes, however, 
alternative pre-mRNA splicing occurs in more than 95% of human genes, compared with 
63% of mouse genes table 1.1. This diversity significantly expands the form and function 
of the human proteome which can serve many regulatory functions, from sex 
determination and diversity of neuronal wiring in the fruit fly to determination of the 
physiological function of membrane-bound receptors in the mammalian nervous system 
(Lee and Rio, 2015). 
  Human Mouse 
Genome size 3,300 MB 3,300 MB 
Protein-coding genes 22,180 22,740 
Multiexonic genes (percentage with 2+ isoforms) 21,144 (88%) 19,654 (63%) 
Isoforms (average number per gene) 215,170 (3.4) 94,929 (2.4) 
Average number of unique exons per 
gene(median) 
33 (26) 22 (15) 
Average number of unique introns per multiexonic 
gene (median) 
28 (21) 19 (12) 
Genes (all) 63,677 39,179 
Isoforms (all) (average number per gene) 215,170 (3.4) 94,929 (2.4) 
Table 1.1: Comparative genomics of splicing levels in human and mouse adapted from 
(Lee and Rio, 2015). 
 
RNA splicing takes place in a large ribonucleoprotein structure known as the spliceosome 
which is composed of five small nuclear ribonucleoproteins that recognise and assemble 




The human gene contains approximately eight exons and seven introns, producing an 
average of three or more alternatively spliced mRNA isoforms. Recent high-throughput 
sequencing studies indicate that the majority of human genes produce at least two 
alternative mRNA isoforms (Lee and Rio, 2015) (Figure 1.4). Alternative splicing can arise 
as a result of several different mechanisms including RNA–protein interactions of splicing 
factors with regulatory sites termed silencers or enhancers, RNA–RNA base-pairing 
interactions, or chromatin-based effects that can change or determine splicing patterns. 
Errors in splicing and mutations in splice sites and splicing factors however rare may still 
can be linked to a number of diseases including cancer (Severi and Conticello, 2015).  
 





1.6.1.2 Transcriptome complexity 
Until recently, the description of a transcriptome was fundamentally limited to the 
characterization of the transcription products of known annotated genes i.e. mRNA, and 
stable non-coding RNAs such as tRNA and snRNA. However, the sequencing of entire 
eukaryotic genomes had paved the way to the development of more techniques to 
determine and catalogue their transcribed sequences and to study the regulation of 
transcription on a large-scale functional approaches (Jacquier, 2009).  
These technologies have revealed that the transcription landscape in higher eukaryotes 
is more complex than previously had been predicted (table 1.1), with a high proportion 
of transcripts originating from intergenic regions that were previously thought to be silent 
or in antisense to genes. The unanticipated level of complexity has led to the fact that the 
transcripts are not restricted to well-defined functional genes (Jacquier, 2009).  
Unlike the genome, the transcriptome is more dynamic and variable depending on cell 
type and function. It also changes in accordance to physiological states such as growth or 
pathological conditions such as infections. Transcriptome profiling is an indicator of gene 
capability of generating different mRNA and protein isoforms through mRNA maturation 
and splicing and it can also indicate the magnitude of gene expression in terms of number 
of mRNA copies under different conditions. 
 Transcriptome analysis 
The transcriptome is the entire set of transcripts present in a living cell or group of cells 
together with the relative abundance of each transcript at a defined developmental stage 
 28 
 
or under a specific set of physiological conditions (Wang et al., 2009). Understanding the 
transcriptome is crucial for interpreting some of the functional elements of the genome 
and uncovering the molecular components of cells and tissues, and for understanding 
physiological and pathological development processes (Wang et al., 2009).  
Amongst the more common aims of applied transcriptomics are: to classify all different 
groups of transcripts, such as mRNAs and non-coding RNAs in a given cell or tissue; to 
establish the transcriptional structure of genes, in terms of their start sites, 5' and 3' ends, 
splicing patterns and other post-transcriptional modifications and to measure the change 
in expression levels of each gene during physiological development and under different 
stress conditions such as disease (Wang et al., 2009). 
Transcription is the first key regulatory step of gene expression that can fill the gap 
between genome expression and cell function. Furthermore, transcriptome analysis 
mirrors genome expression dynamics, as the transcription patterns are highly specific for 
each type of cells despite the fact that all cells of a given organism, share the same set of 
genes (Dong and Chen, 2013). Transcriptomics studies have widened our view field in 
understanding the structure and function of non-protein-coding RNA (ncRNA) and their 
rule in gene regulation (Mattick, 2005). As an example for the magnitude of ncRNA, over 
93% of the human genome is transcribed into RNA (Carninci et al., 2005) and only 2% is 
from protein coding region (Green and Chakravarti, 2001). The development of next 
generation sequencing technology (NGS) has enhanced our understanding of RNA 
biology, and through that enhancement, the application of transcriptomics has been 
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expanded (Dong and Chen, 2013). Methodology improvement, particularly of the NGS 
technology, has led to a higher throughput and resolution level of transcriptome analysis 
studies, and has produced large amounts of data and correspondingly greater levels of 
biological information (Wang et al., 2009). 
 Advantages of transcriptome analysis 
A variety of technologies have been developed to study and measure the transcriptome, 
including hybridization-based and sequence-based techniques. Hybridization-based 
approaches normally involve hybridizing fluorescently labelled cDNA with customised 
microarrays or commercially synthesized high-density oligo microarrays (Clark et al., 
2002). However, the hybridization approaches have some limitations, which include: 
dependence upon existing knowledge about genomic sequence and a limited dynamic 
range of detection due to both background and saturation of signals. Moreover, 
comparing expression levels across different experiments is often difficult and can require 
complicated normalization methods (Okoniewski and Miller, 2006). 
In contrast to microarray technologies, sequence-based methods can directly determine 
the cDNA sequence. However, most sequencing techniques are based on Sanger 
sequencing technology which is rather expensive, and has a number of limitations with 
short sequences where a significant proportion of the short tags cannot be distinctively 
mapped to the reference genome. Furthermore, only a portion of the transcript is 
analysed and isoforms are usually impossible to differentiate from each other. This 
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disadvantage limits the use of traditional sequencing technology in annotating the 
structure of transcriptomes (Wang et al., 2009). 
In recent years, the development of high-efficiency DNA sequencing technology (NGS) has 
provided novel methods for both transcriptome mapping and quantification. This 
method, known as RNA-Seq (RNA sequencing), has significant advantages over existing 
approaches and is predicted to revolutionize the approach in which eukaryotic 
transcriptomes are analysed, for example, RNA-Seq has generated consistently high value 
data for mammalian transcriptome analysis (Mortazavi et al., 2008). 
Transcriptome sequencing can provide an inexpensive, rapid approach to access gene 
sequences, gene expression patterns and provides a quantitative measure of gene 
expression in different species, regardless of the availability of a reference genome. These 
advantages can be attributed to the smaller size and the reduced complexity of the 
transcriptome compared to the whole genome. The successful application of RNA 
sequencing in combination with de novo transcriptome assembly, has facilitated the 
classification of new genes in a wide range of biochemical pathways. Despite the 
development in sequencing technologies, however, considerable challenges remain in the 
processing and analysis of transcriptome sequence data (Gongora-Castillo and Buell, 




 Limitations of transcriptome analysis 
The achievements in transcriptomics are largely attributed to the high volume of genome 
research and the desire to obtain functional information to add value to genome data. 
This has been matched by phenomenal levels of innovation in omics technologies, 
especially the improvements in NGS technology and its simultaneous reduction in cost. 
However, like other technology, NGS needs improvements to reduce the bias introduced 
by RNA amplification and library construction and also to reduce the cost for low input 
RNA-seq. Further, the optimisation of experimental design and bioinformatics analysis are 
both required for more efficient and accurate transcriptome characterisation (Dong and 
Chen, 2013). 
Despite these limitations NGS techniques have emerged to be the most dominant 
genomics technology due to their cost and uses compared to Sanger sequencing 
(Morozova and Marra, 2008). The applications of RNA-seq techniques in the field of 
genomics have included genome annotation, gene expression profiling and ncRNA 
profiling (Morozova and Marra, 2008). NGS approaches have also been used in 
determining DNA sequences associated with epigenetic modifications of DNA and 
histones to profile DNA methylations, posttranslational modifications of histones, and 
nucleosome positions on a genome-wide scale (Callinan and Feinberg, 2006).  
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  The principles of RNA-Seq technology  
RNA-Seq technology is based on deep-sequencing methods, which generally involve the 
conversion of a population of RNA sequences to a library of cDNA fragments, with 
adaptors attached to one or both ends (Wang et al., 2009). 
 
Figure 1.5: RNA-Sequencing, RNAs are converted into a library of cDNA fragments through 
either RNA fragmentation or DNA fragmentation. Sequencing adaptors (blue) are 
subsequently added to each cDNA fragment and a short sequence is obtained from each 
cDNA using high-throughput sequencing technology. The resulting sequence reads are 
aligned with the reference genome or transcriptome (Wang et al., 2009). 
cDNA molecules are then sequenced (either with or without amplification) in a high-
throughput approach to acquire short sequences from one end (single-end sequencing), 
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or both ends (pair-end sequencing). Depending on the DNA-sequencing technology used, 
the read size is typically in the range of 30-400 bp. After sequencing, the resulting cDNA 
fragments are either aligned to a reference genome or reference transcripts which 
enables characterisation of expression profiles (Figure 1.5). De novo assembly is 
performed when the reference genomic sequence is not known to produce a genome-
scale transcription map which can illustrate both the transcriptional structure and level 
of expression for each gene in the sequence (Wang et al., 2009).  
  Advantages of RNA-Seq technology 
Even though RNA-Seq is an emerging technology that seems to be constantly undergoing 
efficiency and yield related improvement; it already presents a number of advantages 
over contemporary technologies. RNA-Seq technology is particularly suitable to apply in 
non-model organisms that do not have reference genomic sequence. The reason for that 
advantage is that RNA-Seq is not limited to aligning the transcripts to a known DNA 
sequence (Vera et al., 2008).  
RNA-Seq technology can detect variations in the transcribed regions of the genome 
(Morin et al., 2008). The technology also has a wider dynamic range of expression levels 
over which transcripts can be detected, i.e. RNA-Seq has no upper quantification limit 
when compared to DNA microarrays which has a limited sensitivity to gene expressed at 
low or very high levels (Mortazavi et al., 2008). RNA-Seq has also shown a high accuracy 




Further advantages of RNA-Seq include: high technical and biological reproducibility 
levels, very low background signal interference and the technique does not include 
cloning steps and therefore less RNA samples are required (Cloonan et al., 2008) and 
when compared to Sanger EST sequencing or DNA microarrays, RNA-Seq offers better 
single-base resolution and gene expression levels at much lower cost (Wang et al., 2009). 
1.7 Transcriptome assembly and annotation 
In bioinformatics, genome annotation is the term that describes two distinctive 
processes. Structural gene annotation is the process of identifying genes intron–exon 
structures. Whereas, functional genome annotation is the process of attaching meta-data 
such as gene ontology terms to structural annotation. 
 Assembly  
A successful annotation is achieved only after comprehensive transcriptome assembly has 
been completed. There are several statistical summaries that can be used to benchmark 
the contiguity and completeness of an RNA-Seq experiment. The most important statistic 
is Scaffold and Contig N50 but other assembly statistics are useful as well (e.g. the average 
gap size of a scaffold and the average number of gaps per scaffold (Yandell and Ence, 
2012). Generally, the existing genomic data are standard, draft assemblies that meet 
minimum requirements for submission to public databases. However, a high-quality draft 
assembly (which is 90% complete) is still a better aim for annotation (Chain et al., 2009). 
A transcriptome assembly with a N50 scaffold length that is gene-size (half of the 
assembled readings are complete genes) is an accepted annotation target. These 50% of 
the assembled genes together with the remaining fragments will give a decent resource 
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for subsequent analysis (Ye et al., 2011). It is recommended to perform more shotgun 
sequencing when the assembly is incomplete or if the N50 scaffold length is too short as 
achieving high-quality assembly reads became more efficient in recent genome projects 
(Husemann and Stoye, 2010). 
 Annotation 
The “Annotation pipeline” is a general term that is used to refer to the different tools and 
programs that assemble and compute data, and use it to create the primary genome 
annotation. The process is intrinsically complex and it mainly focuses on annotating 
protein-coding genes. Annotation pipelines vary in their working details, magnitude and 
accuracy but still have the common core features. The pipeline is commonly divided into 
two phases. In the first computational phase the expressed sequence tags (ESTs) and 
protein-coding genes are aligned to the reference genome or evidence-based gene 
predictions are generated. In the second annotation phase the collected data are 
organised and combined into gene annotations (Yandell and Ence, 2012). 
1.8 The Mealworm (Tenebrio molitor) as a prospective model organism for 
schools   
 Definition of model organisms 
“Model organisms are usually defined as non-human species that are extensively studied 
in order to understand a range of biological phenomena that might not be easily 
researched in advanced organisms, with the hope that data, models and theories 
generated will be applicable to other organisms, particularly those that are in some way 
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more complex than the original” (Leonelli and Ankeny, 2013). This definition focuses on 
the use of model organisms for the primary purpose of research and development, and 
they play a key role in both drug discovery and testing, in the Pharmaceutical Industry.  
One of the earliest systematic experiments, using a model organism, is the use of Pisum 
sativum, by Gregor Mendel during his pioneering work on the “rules” of inherited 
characteristics (Smýkal et al., 2016). Later, Drosophila species were pivotal in the 
investigation of the harmful effects of radiation at the cellular and genetic level (Lamb 
and Smith, 1969). Famously, the Guinea Pig Latin name, is cited as the proxy for the test 
organism in drug trials in particular. However, guinea pigs are used much less frequently 
today compared with mice and zebra fish, for example. A particular model organism is 
chosen for experimental work when it closely matches the system under investigation, 
often in man. However, in Mendel’s case, pea plants provided him with a phenotype 
(plant height) that would unequivocally “report” on the relationship between genotype 
and phenotype, which is a relationship that he believed would apply across all eukaryotes. 
Today, plant biologists generally use Arabidopsis thaliana as the model organism of choice 
for exploring the fundamentals of plant physiology.  
With the widespread introduction of genome sequencing during the 1990s, traditional 
model organisms became some of the earliest targets for genome sequencing. Yeast 
(Saccharomyces cerevisiae) and E.coli were sequenced alongside the release of the first 
draft of the human genome sequence, with Drosophila and Arabidopsis following soon 
after. It is true to say that the genome sequence will be available for almost all model 
organism employed as proxies for a more complex organisms.  
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 Characteristics of model organisms  
The selection of specific living organisms as experimental models is usually determined 
by the remit of the experimental investigation. With this in mind, the “simpler” model 
organisms, such as E.coli, yeast and fruit flies have been mainly utilised for the 
investigation of fundamental biological phenomena, such as metabolism, eukaryotic cell 
division and embryonic developmental respectively (see for example, Rosenblueth and 
Wiener, 1945). These organisms grow and divide rapidly, and large populations can be 
obtained both rapidly and economically, assuming the relevant laboratory facilities are to 
hand. As the questions become more complex or perhaps more “human”, especially in 
the evaluation of drugs, it is not uncommon to utilise primates for the most critical 
comparative studies. Of course, over the last 20 years in particular, efforts have been 
made to keep the use of animals in research to a minimum on ethical grounds. 
 The use of model organisms in the teaching of Science 
Laboratory classes were popularised by John Dewey at the turn of the 19th century and 
have become embedded in the curriculum of high schools worldwide who teach subjects 
like Chemistry, Physics and Biology. It is primarily in Biology that living organisms have 
been employed for traditional dissection classes, simple microscopy and for 
demonstrations of evolution. However, as part of a project designed to bring a more 
contemporary flavour to school Science: one which captures the existing curriculum and 
introduces genome biology, this Chapter is aimed at developing the darkling beetle, 
Tenebrio molitor for such a purpose. In considering which organism to choose, some of 
the above criteria were incorporated. However, additional criteria were considered and 
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these are discussed below prior to the experimental section, in which the meal worm 
(which will be used interchangeably with T. molitor) is developed as a focus for 
educational experimental biology. One final important point is that this insect should be 
seen not as a fully understood organism, but one for which many questions still remain, 
some of which can be asked in suitably designed, schools-led research projects. 
Schools, unlike professional research laboratories, are generally “closed for business” for 
between 10 and 20 weeks per year, imposing major logistical constraints on the choice of 
a model organism. Plants need regular watering and a regulated light source, bacteria 
require specialised growth, sterilisation and disposal facilities, mice are relatively 
expensive, relatively slow to breed, fish are relatively high maintenance and experimental 
use of both of the latter organisms requires ethical approval. In contrast, insects like 
drosophila and locusts offer many advantages for school science, except that they are 
prone to flying around: making their management more “hands-on”. Flightless insects, 
such as beetles are amongst some of the most diverse species on Earth, and moreover, in 
most Northern Hemisphere countries fishermen use insect larvae as bait. Hence, 
inexpensive supplies of larvae such as the meal worm are readily available from pet shops 
or angling suppliers (angling is the most popular individual sport in the UK) across the UK 
(and the USA, for example). Importantly, meal worm larvae require minimal “life 
support”. A small tray of meal worm will complete the life cycle in around 4 weeks, 
provided simply with bedding and a few pieces of cut fruit or vegetables. Since they are 
flightless, meal worm larvae and adults are extremely low maintenance, and can be kept 
at a wide range of room temperatures with little impact on viability. These features are 
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combined with the more typical, favourable characteristics associated with a model 
organism including small adult size, a relatively short life span, rapid development, 
availability of supply and tractability (Bolker, 1995). 
 The need for another model organism 
Since the completion of the human genome project in 2000, the significantly reduced cost 
and growth in the number of genome sequencing facilities worldwide, has led to a 
significant increase in the number of model organisms, rather than an experimental 
consolidation of existing organisms. The argument made here for developing the meal 
worm (or indeed beetles in general), is primarily made in order to provide access to a 
living organism that straddles school science and frontline research in a manageable, low-
cost way. 
Genetic screening using model organisms has proved to be a powerful and valuable 
approach for over 100 years (in fact the “sanctity” of man possibly influenced the early 
pioneers of experimental anatomy, including Aristotle). Many remarkable studies using 
model organism have helped to understand the fundamental principles of vertebrate 
evolution, which includes resistance to infection (Abnave et al., 2014). Moreover, the 
main recommendation for model organism work, as stated by Jenner and Wills (2007) is 
to broaden phylogenetic sampling, to minimize bias in the sample of characteristics that 
are represented by the chosen models. Our general understanding of phenotypic 
evolution is therefore better served by deliberately choosing new models with traits that 
enable them to provide independent illumination of evolutionary developmental biology 
conceptual themes (Jenner and Wills, 2007).  
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 The yellow mealworm beetle, (Tenebrio molitor), as a model organism 
In considering the development of the mealworm beetle (Tenebrio molitor) as a new 
model organism, it is important to provide some wider contextual information. T. molitor 
is one of the largest known beetles that feeds on plant products and stored food (typically 
in a warehouse setting), causing considerable damage to such produce, in terms of total 
mass, quality and nutritional value. The beetle eats and then contaminates food produce 
with bodily waste and dead larvae (Siemianowska et al., 2013). Each female T. molitor lays 
around 300-500 eggs: each egg hatches in 4- 17 days, growing to a 3mm long larva (Figure 
1.6) that reaches an average full size of (25-35mm long and 200mg in weight). The full 
grown larvae are used in both animal feed and increasingly as a dietary component of the 
human food chain in some parts of the world (Aguilar-Miranda et al., 2002). Mealworm 
larvae have a relatively long life span, compared with other beetles: under optimum 
moisture and temperature, they can survive for up to around six months, followed by 5-
6 days of a dormant pupal stage (Siemianowska et al., 2013). More than 20,000 species 
of Tenebrionidae have been identified and described in different parts of the world (Liu 
and Wang, 2014). The dried, live larvae of the mealworm beetle are most commonly used 
as food for birds and other domestic pets (Barker et al., 1998). However, there is 




Figure 1.6: Tenebrio molitor larvae (Kupferschmidt, 2015). 
 
 Research applications of T. molitor 
A growing number of researchers have used T. molitor as an experimental system for 
studies in biology, biochemistry, evolution, immunology and physiology, owing to its 
relatively large size, ease of handling, and orthodox genetics (Lee et al., 2015). However, 
despite this work, a coherent physiological and genetic “profile” of this beetle is lacking 
(Liu and Wang, 2014), and such information could form the basis of a school-wide 
programme of directed research. 
T. molitor has a particular advantage as a candidate model system for the study of 
pathogens, since the larvae can be maintained at body temperatures between 25 °C and 
37 °C (de Souza et al., 2015). On the other hand, other model organism such as Drosophila 
melanogaster (fruit fly) and Caenorhabditis elegans are unable to tolerate this 
temperature range (Desalermos et al., 2012). Direct inoculation by injecting the pathogen 
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directly into the T. molitor larvae (facilitated by the limited movement of the larvae) make 
this insect much more favourable than C. elegans (Merkx-Jacques et al., 2013). Similar 
arguments can be made for beetles such as the wax worm. It seems clear that beetles 
such as T. molitor offer some distinct experimental advantages in contemporary biological 
research: the area of infectious disease research and antimicrobial screening is one clear 
example. 
1.8.6.1 T. molitor in immunological research 
This thesis provides an introduction to the analysis of those genes involved in the 
transmission of bTB in cattle (Chapters 1-4), Despite the lack of comparative information 
regarding the infected versus uninfected badger transcriptomes, an analysis of the 
immune related genes, reveals a level of complexity that would benefit from investigation 
in a model system. It is the long term aim of this work, that the meal worm may provide 
insights into immune responses to infectious disease that may help us understand events 
in more complex organisms including cattle and man. 
 T. molitor larvae are known to exhibit a population density-dependant immune response, 
where lower mortality rates are observed at higher larval density compared to isolated 
larvae (Barnes and Siva-Jothy, 2000). Studies were also conducted to test the innate 
immunity responses and its “energetic cost” to T. molitor (Moret and Siva-Jothy, 2003) 
and also to examine the adaptive immune response to repeated exposure to pathogens. 
In this work, Moret and Siva-Jothy (2003) showed that larvae were found to produce a 
sustained, antimicrobial response despite that fact that invertebrates do not have 
acquired immunity. The limited availability of genetic data on T. molitor, make it 
 43 
 
extremely difficult to provide a molecular framework for these and similar observations, 
even by drawing on comparative data from Drosophila melanogaster, again arguing in 
favour of the use of a related species such as T. molitor larvae, from which significant 
amounts of haemolymph can be extracted, to help elucidate the mechanisms underlying 
pathogenic microbe recognition (Park et al., 2010). To date this area of research has 
revealed the presence of a number of pattern recognition proteins, serine proteases, 
serpins and antimicrobial peptides and examined how these molecules affect 
innate immunity (Park et al., 2011). 
The difference in gene expression in response to bacterial intoxication by Bacillus 
thuringiensis Cry3Aa Protoxin led to sequencing of T. molitor transcriptome, which 
represents the largest genetic sequence dataset of the organism to date (Oppert et al., 
2012a). Other experiments tested the survival of antimicrobial peptides-resistant 
Staphylococcus aureus in response to T. molitor as an insect model which led to the 
suggestion that increased survival of antimicrobial peptides-resistant bacteria almost 
certainly poses problems to immune-compromised hosts (Dobson et al., 2014). 
1.9 T. molitor genomic DNA sequencing 
The development of efficient, large-scale and relatively inexpensive DNA sequencing 
technology has begun to impact significantly on Biological research in the last decade in 
particular, making DNA sequencing routine in many fields, including forensics, agriculture 
different aspects of medical and non-medical research (Rosenstein, 2014). 
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Obtaining the complete sequence of the T. molitor genome will greatly enhance our 
ability to associate genes and mutations with traits and diseases similarly to the process 
of developing the rat as a model organism and to take full advantage of the wealth of 
physiological variation among strains and mutants using a map of the genetic variation 
(Lindblad-Toh, 2004). 
The recently published T. molitor transcriptome (Oppert et al., 2012b) and mitochondrial 
genome (Liu and Wang, 2014) offer an opportunity for developing the mealworm as a 
model organism. T. molitor is a valuable model host but its full potential and tolerance 
has yet to be studied, and the sequencing of T. molitor genome could allow the production 
of different mutants, and contribute to studies on host response to infection (de Souza et 
al., 2015) just as it has done wlewhere in Biological research. 
 T. Molitor genome sequencing via Illumina platform 
“Illumina" sequencing is dependent on solid phase amplification of random DNA 
fragments followed by sequencing-by-synthesis, by adding fluorescent dNTPs (Fox et al., 
2009) to facilitate detection. All “Illumina” sequencing workflow routines are composed 
of four basic steps that begin with DNA sample preparation, cluster generation, 
sequencing and data analysis. 
1.9.1.1 Sample preparation 
There are number of different procedures available for the preparation of genome 
samples by fragmentation (e.g. nebulization, hydro-shear or sonication). All preparation 
methods incorporate the addition of adaptors to the ends of the DNA or cDNA fragments, 
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through reduced cycle amplification (Figure 1.7), additional motifs are introduced, such 
as the sequence binding site, indices and regions complementary to the flow cell 
oligonucleotide adapters (Mardis and McCombie, 2017). 
 
Figure 1.7: DNA fragments are generated by shearing and joined to a pair of 
oligonucleotides in a forked adapter configuration. The ligated products are amplified 
using two oligonucleotide primers, resulting in double-stranded blunt-ended fragments 
with a different adapter sequence on either end (adapted from Bentley et al., 2008)). 
1.9.1.2 Clustering  
Clustering or cluster generation is a process where each fragment molecule is 
isothermally amplified. The technology involves attachment of a short DNA fragment to a 
solid surface called a flow cell. The flow cell is a glass slide with lanes. Each lane is a 
channel coated with a lawn composed of two types of oligo-nucleotides. Hybridisation is 
enabled by the first of the two types of oligo-nucleotides on the surface where oligo-
nucleotides are complementary to the adapter region on the fragment strands. The 
attached DNA fragments are PCR amplified to create clusters at a very high density (>10 
million DNA clusters per lane) on the surface of the transparent sequencing flow cell. (Fox 
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et al., 2009). A polymerase creates complements of the hybridised fragments then the 
double stranded molecules are denatured and the original templates are washed away. 
The strands are clonally amplified through bridge amplification (Figure 1.8).  
 
Figure 1.8: Formation of clonal single molecule array. DNA fragments are denatured and 
single strands are annealed to complementary oligonucleotides on the flow cell surface. 
A new strand (dotted) is copied from the original strand and the original strand is then 
removed by denaturation. The adapter sequence is annealed to a new surface bound 
complementary oligonucleotide, forming a bridge and generating a new site for synthesis 
of a second strand (shown dotted). (Adapted from Bentley et al., 2008)). 
In this process the strands fold over and the adapter regions hybridise to the second type 
of oligonucleotides on the flow cells. DNA Polymerases generate the complementary 
strands generating double stranded bridges. Each bridge is then denatured resulting in 
two single stranded copies of the molecule that are tethered to the flow cell. The process 
is repeated over and over and occurs simultaneously for millions of clusters resulting in 
clonal amplification of all the fragments. After bridge amplification, the reverse strands 
are cleaved and washed off leaving only the forward strands. The 3” prime ends are 
blocked to prevent unwanted priming. “Solid-phase amplification can produce 100–200 
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million spatially separated template clusters (Illumina/Solexa), providing free ends to 
which a universal sequencing primer can be hybridized to initiate the sequencing reaction 
(Metzker, 2010). 
1.9.1.3 Sequencing 
Sequencing begins with the extension of the first sequencing primer to produce the first 
read. With each cycle fluorescently tagged nucleotides compete for the addition to the 
growing chain (Toh et al., 2017). However, only one nucleotide is incorporated based on 
the sequence of the template. After the addition of each nucleotide, the clusters are 
excited by a light source and a characteristic fluorescent signal is emitted. This proprietary 
process is called “sequencing by synthesis” and the number of cycles determines the 
length of the reads. The emission wave length along with the signal intensity determine 
the base call. For a giving cluster all identical strands are read simultaneously and 
hundreds of millions of clusters are sequenced in a massively parallel process. The 
sequencing process is repeated for multiple cycles. Amplified fragments representing a 
cluster are then sequenced and imaged with each reaction step. The system uses dNTPs 
containing fluorescently labelled 3” reversible terminators, each emitting a different 
fluorescence signal (Fox et al., 2009). 
1.9.1.4 Data analysis 
The sequencing process generates millions of short reads representing all the original 
DNA fragments. Sequences from pooled sample libraries are separated according to the 
unique indices introduced during sample preparation stage. For each sample reads with 
similar stretches of base calls are locally clustered and forward and reversed reads are 
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paired creating contiguous sequences. The contiguous sequences are then either aligned 
back to a reference genome for variant identification or independently assembled into a 
genome.   
1.10 Aims and Objectives 
Understanding the badger’s immunological response to bTB might hold the answer to a 
new treatment or immunisation strategy for cattle and other affected domestic animals 
as well as zoonosis. It might also help in exploring the human disease and help in 
developing more potent vaccine or genetic therapy.  
In that prospect, this research is more of an exploratory nature to delve deeper into the 
immunological components that appear to give the badger a unique tolerance to bTB.  
In that sense, the main aim of the study is to find out the immunological components of 
the badger’s transcriptome and their phylogenetic relations to other mammals, which 
may hold some answers of the evolution of the badger’s immune system.  
The extensive research in immunological responses of mealworm to pathological stress, 
the flexibility of its use and handling in the laboratory and low cost of maintenance, as 
well as the known transcriptome and mitochondrial DNA, have made the mealworm an 
appropriate candidate for genomic DNA sequencing to facilitate its future applications as 
a model organism for schools other educational institutions as well as a candidate for 
studying the basic immunological responses for bacterial infections including bTB.  
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In that prospect, sequencing T. molitor genome will set a platform for expanding the 
current spectrum of model organisms for better understanding of disease and infection 
as well as to reduce the margin of limitations and error. 
The main objectives of this research are:  
 To analyse the badger’s transcriptome and identify its components. 
 To draw a phylogenetic relationship between the badger and other mammals using 
sequence alignment and phylogenetic tree construction tools. 
 To identify the immunity related transcripts involved in bTB pathogenesis using KEGG 
pathway for a tuberculosis as a reference 
 To extract high quality genomic DNA from T. molitor, and from this obtain the 








































2 Materials and Methods 
This chapter is divided into two main sections: the first one describes the bioinformatics 
approaches for badger transcriptome analysis and the second is dedicated to molecular 
biology methods relating to the mealworm genomic DNA extraction. 
2.1 Materials and methods for transcriptome analysis  
The transcriptome data were obtained following isolation of peripheral blood cells at the 
Animal Health and Veterinary Laboratories Agency (AHVLA) in London. The total RNA was 
extracted from healthy bTB free animals. All subsequent RNA-seq work was contracted 
out to the Beijing Genomics Institute (BGI), who also provided a preliminary annotation 
document. Further analysis was performed using the following databases and software: 
 NCBI Basic Local Alignment Search Tool (BLAST+) 
BLAST (Altschul et al., 1997) is one of the more popular software choices for searching 
and aligning biological sequence data. BLAST takes a nucleotide or protein sequence as 
input and compares it with a database of nucleotide or protein sequences respectively. 
BLAST can translate nucleotide sequences as needed; therefore, BLAST can search a 
nucleotide query against a protein database or a protein query against a nucleotide 
database. BLAST uses heuristics to accelerate searches. BLAST also provides statistics that 
estimate the likelihood of a match occurring by chance (Boratyn et al., 2013). BLAST 
search was used in conjunction with other tools and platforms (Clustal omega and Galaxy) 
to draw alignments of several immunity transcripts derived from the badger, and to 





 Galaxy platform 
Galaxy platform is a web-based environment in which users can perform genome related 
computational analyses and importantly, all search details and parameters are 
automatically tracked for later inspection (Cock et al., 2015). Galaxy was used in data 
analysis in order to convert the transcriptome sequence data (FASTA) files into a 
searchable database (makeblastdb), to facilitate the subsequent BLAST+ searches. Galaxy 
utilises BLAST+ command-line applications (Camacho et al., 2009) through a user-friendly 
graphical interface.  
 Kyoto Encyclopaedia of Genes and Genomes (KEGG) 
KEGG is a knowledge base for the systematic analysis of gene function, linking genomic 
information with higher order functional information. The genomic information is stored 
in the GENES database, which is a collection of gene catalogues for all completely 
sequenced genomes, together with some partial genomes with up-to-date annotation of 
gene functions. The higher order functional information is stored in the PATHWAY 
database, which contains graphical representations of cellular processes, such as 
metabolism, membrane transport, signal transduction and cell cycle. The PATHWAY 
database is supplemented by a set of ortholog group tables for the information about 
conserved sub-pathways (pathway motifs), which are often encoded by positionally 
coupled genes on the chromosome and which are especially useful in predicting gene 
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functions (Kanehisa and Goto, 2000). KEGG was use to extract the KEGG pathway for bTB 
and the list of genes involved in tuberculosis pathogenesis. 
 Gene Ontology (GO) 
The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary 
that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells 
is accumulating and changing.  (Ashburner et al., 2000). 
 Clusters of Orthologous Groups database (COG) 
COGs are groups of three or more orthologue genes, which means that  they are direct 
evolutionary counter-parts and are considered to be part of an 'ancient conserved 
domain'.  A COG is defined as three or more proteins from the genomes of distant species 
that are more similar to each other than to any other protein within the individual 
genome. COGs can be used to predict the function of homologous proteins in poorly 
studied species and can also be used to track the evolutionary divergence from a common 
ancestor, hence providing a powerful tool for functional annotation of uncharacterized 
proteins (Tatusov et al., 2000).   
Although they were not directly used in the analysis, GO and COG helped in grouping and 
classification of transcripts involved in immunity and tuberculosis pathway according to 
their GO terms and COG functional groups. 
 Immunome Knowledge Base (IKB) 
IKB is a dedicated resource for immunological information. IKB contains information for 
human immunome genes and proteins, phylogenetic trees and evolutionary information 
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for immunome orthologs, ortholog groups for metazoan immunome, and variation data 
on genomic, transcriptomic and proteomic level. IKB integrates three previous databases, 
Immunome, ImmTree and ImmunomeBase with additional data (Ortutay and Vihinen, 
2009). 
IKB was used as a reference database to extract all the immunity related transcripts form 
the badger transcriptome annotation data files based on the 983 genes classified as 
immunity-related in the IKB database. 
 Clustal Omega 
“Clustal Omega is a multiple sequence alignment tool, which can align (in a virtual sense)  
a large number of protein sequences quickly while delivering accurate and robust 
alignments. The accuracy of the package on smaller test cases is similar to that of the high‐
quality alignment software. Clustal Omega also has powerful features for adding 
sequences to and exploiting information in existing alignments, making use of the vast 
amount of precomputed information in public databases” (Sievers et al., 2011).  Clustal 
Omega was accessed via EMBL-EBI web service interface (McWilliam et al., 2013). Along 
with BLAST+ Clustal Omega was used to align sequences and construct phylogenetic trees. 




In addition to the above databases and platforms, others were used more infrequently to 
address specific features and characteristics (e.g. full sequence) or functions of some 
transcripts e.g. UniProt (2017)    
2.2 Materials and methods for mealworm genomic DNA extraction 
This section describes chemical, enzymes and other materials used in conducting the 
experiments. A description of the protocols and standard molecular biology methods 
used is also included. 
 Chemicals 
All chemicals used were of molecular biology grade 
Material  Provider 
5x DNA Loading Dye QIAGEN 
Agarose Bioline 
DNA Hyperladder I Bioline 
ISOLATE Genomic DNA Mini Kit Bioline 
Table 2.1: Chemicals 
Blast+: 
Database: UniProtKB mammals/ 
Program: blastp/ Matrix: BLOSUM62/ 
Expectation value threshold: 1e-5/ 
Dropoff: 0/ Gap open: -1/ Gap extend: 
-1/ Filter: F/ Sequence range: START-
END/ Gapalign:  true/ Composition-
based statistics: F/ Align views: 0/ 




Program: clustalo/ Version: 1.2.4/ Output guide 
tree: false/ Output distance matrix: false/ 
Dealign input sequences: false/ mBed-like 
clustering guide tree: true/ mBed-like clustering 
iteration: true/ Number of iterations: 0/ 
Maximum guide tree iterations: -1/ Maximum 
HMM iterations: -1/ Output alignment format: 
Clustal/ Output order: aligned/ Sequence Type: 
protein 




  Solutions 
Buffer Composition 
TAE (Tris-Acetate-EDTA) buffer 50X 
stock) 
750 ml of  2.67 M Tris base  
57.1 ml of 17.4 M glacial acetic acid 
100 ml of 0.5 M EDTA (pH 8.0) 
Adjust the solution to a final volume of 1 L 
Ethidium Bromide Stock solution  25.4 mM (10 mg/ml of deionized distilled Water) 
Table 2.2: Solutions  
2.3 Basic Molecular Biology protocols  
 Genomic DNA extraction 
Mealworms were obtained from a pet shop and stored in a -80°C freezer for at least 24 
hours before DNA extraction in order to obtain a more consistent powder when grinded. 
Approximately 50-60 mg of the powdered worm used for the extraction using ISOLATE 
Genomic DNA Mini Kit according to the following steps: 
1- The powdered sample was placed in a 1.5 ml tube and 400μl of lysis buffer and 25 
μl of proteinase were added and mixed immediately by vortexing then incubated 
at 50°C in an incubator fitted with a rocking platform for continuous mixing  for 
about 3.5 to 4 hours until the sample was completely dispersed. 
2- The mixture was centrifuged at 10000x g (12000 rpm) for 1 minute and the 
supernatant was transferred to another 1.5 ml tube. 200 μl of binding buffer were 
added and mixed immediately by vortexing for 15 seconds. 
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3- The sample was then transferred to a spin column with a 2 ml collection tube and 
centrifuged at 10000x g (12000 rpm) for 2 minutes. The filtrate was discarded and 
then column was washed twice with 700 μl Wash buffer with a centrifugation at 
10000x g (12000 rpm) for 1 minutes each time. 
4- To remove all traces of ethanol the sample was centrifuged for 2 minutes at a 
maximum speed and the collection tube was discarded. The column was placed in 
a 1.5 elution tube and 200 μl of Elution buffer were added directly to the spin 
column membrane and incubated at room temperature for 1 minute. The eluted 
DNA was collected by centrifugation at 6000x g (8000 rpm) for 1 minute. 
 Confirmation of the genomic DNA extraction by agarose gel electrophoresis 
 1 g agarose was dissolved in 100 ml TAE buffer by carefully boiling in a microwave oven 
When the solution had cooled down to about 60°C ,  5 μl of ethidium bromide stock (10 
mg/ml) was added to make a final concentration of 0.5 μg/ml. The solution was stirred to 
disperse the ethidium bromide, and then poured into the gel template. The comb was 
placed at one side of the gel (about 5-10 mm from the end of the gel) and the gel left until 
it solidified then it was placed in the tank and TAE buffer was added to just cover the 
agarose. 
After loading the DNA samples and DNA marker electrophoresis was performed at 100 
volts for one hour. Gel-separated DNA was stained with ethidium bromide and visualised 
























3 Transcriptome assembly and annotation 
This chapter explores the transcriptome derived from peripheral blood cells taken from 
live badgers as a first step towards identifying its molecular composition and its coding 
potential. Transcriptome sequencing, assembly and annotation was performed by BGI 
(China) and a description of sequencing platform and assembly pipeline and annotation 
process will be described in addition to a quality control assessment and an analysis of 
the male/female difference in expression and it significance in the light of bTB infection . 
This is the first step in building a platform for future genome sequencing. Here is a 
description of the results of the whole transcriptome assembly and its annotation using 
different databases. 
3.1 Experimental pipeline and Sequencing platform 
 Experimental (mRNA isolation and sequencing) pipeline as described by BGI: 
 
The steps for the experimental pipeline are shown schematically in Figure 3.1. After the 
total RNA extraction and DNase I treatment, magnetic beads coupled to oligo-dT were 
used to enrich for polyA-mRNA from the total RNA. mRNA was then mixed with the 
fragmentation buffer and broken down into short fragments. cDNA was synthesized using 
the mRNA fragments as templates. Short fragments were purified and resolved with EB 
buffer for end reparation and single nucleotide A (adenine) addition. After this, the short 
fragments were connected with adapters. The suitable fragments were selected for PCR 
amplification as templates. During the quality control (QC) steps, Agilent 2100 Bioanaylzer 
and ABI StepOnePlus Real-Time PCR System were used in quantification and qualification 
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of the sample library. Finally, the library was submitted to sequencing via Illumina HiSeq™ 
2000. The steps involved in sequence determination using the Illumina platform will be 
described in more detail in chapter I. 
 
Figure 3.1: Experimental pipeline which mainly involves:  mRNA isolation, cDNA 
synthesis and Illumina sequencing (BGI). 
 
 Assembly pipeline RNA sequencing and de novo assembly 
The fluorescent image data output from Illumina sequencing instruments is transformed 
by base calling into sequence data, which are referred to as raw data or raw reads and 
stored in a text (FASTQ) format. The filtering of raw reads was required, as sequences 
produced from sequencing instruments of this type contain non-clean reads, which 
contain adapters, and sequences of unknown origin or low quality. If left, these data will 
negatively impact on downstream bioinformatics analysis. 
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Therefore, non-clean raw reads were discarded: 
 If they are still attached to adaptors. 
 If the reads have unknown nucleotides in the sequence larger than 5% of the total 
length. 
 If the percentage of low quality bases in the sequence is more than 20% of the 
total length. 
3.1.2.1 Assembly: 
De novo assembly of the Transcriptome was carried out with Trinity, a short reads 
assembling program (Grabherr et al., 2011). Trinity combines three independent software 
modules: Inchworm, Chrysalis, and Butterfly, applied sequentially to process large 
volumes of RNA-seq reads. Trinity partitions the sequence data into many individual de 
Bruijn graphs, each representing the transcriptional complexity at a given gene or locus, 
and then processes each graph independently to extract full-length splicing isoforms and 
to tease apart transcripts derived from paralogous genes. Briefly, the process works as 
follows: 
Inchworm Assembles the RNA-seq data into the unique sequences of transcripts, often 
generating full-length transcripts for a dominant isoform, but then reports only the 
unique portions of alternatively spliced transcripts. 
Chrysalis Clusters the Inchworm Contigs together and constructs complete de Bruijn 
graphs for each cluster. Each cluster represents the full transcriptional complexity for a 
 62 
 
given gene (or sets of genes that share sequences in common). Chrysalis then partitions 
the full read set among these disjoint graphs. 
Butterfly then processes the individual graphs in parallel, tracing the paths that reads and 
pairs of reads take within the graph, ultimately reporting full-length transcripts for 
alternatively spliced isoforms, teasing apart transcripts that correspond to paralogous 
genes. 
 Output statistics and bioinformatics 
Originally, two samples of blood were taken from one male (identifier Q828) and one 
female (identifier Q381) badger. The sequencing process generated over 118 million raw 
reads from each sample. After removing the adaptors and non-clean reads, a total of  
108,193,588 and 105,901,706 high quality,  “clean” reads were obtained for the two 
samples Q828, Q381 respectively ( Table 3.1) 
Samples Total raw reads Total clean reads Total clean 
nucleotides 
GC % 
Q828 121,818,354 108,193,588 9,737,422,920 54.09% 
Q381 118,836,262 105,901,706 9,531,153,540 51.88% 
Table 3.1: Total raw and clean reads generated by sequencing 
After assembly, the total number of sequences produced for annotation was 238,295 
transcripts, with a total nucleotide length of 305,341,024 bp and an average length of 
1281 nucleotides: more than 50% of transcripts are over 2720 nucleotide long (Table 3.2).  
In the table, a contig is defined as any sequence produced by two or more overlapping 
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reads, and a unigene as a hypothetical gene represented by a cluster of similar transcripts 
that are thought to be isoforms in the de novo transcriptome assembly. 
 
Sample Total Number Total Length(nt) Mean 
Length(nt) 
N50 
Contig Q828 320,860 90,046,338 281 382 
 
Q381 433,526 115,082,292 265 334 
Unigene Q828 215,117 247,701,860 1151 2636 
 
Q381 274,052 289,728,809 1057 2625 
 
All 238,295 305,341,024 1281 2720 
Table 3.2: Number of aligned sequences for each sample including contigs, unigenes and 
the mean length of each group 
 
3.2 Distribution of sequence lengths 
The length of transcripts (Figure 3.2) was distributed between a minimum of 300bp and 
3000bp. Over 50% of the transcripts were in the length range of 300bp to 600bp while 




Figure 3.2: The distribution of reads per sequence length. 
 
 
3.3 Transcriptome Similarity, Functional and Pathway annotation 
 Transcriptome annotation 
Sequence similarity, functional annotation and pathway similarity search for the 


























































similarity with their correspondent genes in published-online databases. 38% (90,719) of 
the total transcripts were annotated by sequence similarity using a BLAST search of a  
Non-redundant (nr) database, 27% (65,384) in Swiss-Prot, 29% (69,924) were matched 




Database NR NT Swiss-
Prot 
KEGG COG GO 
Number of genes 
annotated 
90,719 16,330 65,384 69,924 57,098 32,074 
Percentage of genes 
annotated 
38.07% 17.15% 27.44% 29.34% 23.96% 13.45% 
Table 3.3: Number and percentage of transcripts annotated in each database 
 
 NCBI annotation 
In total, 95,245 unigenes were annotated in all databases and 95% (90,719) of all 
annotated unigenes were identified by sequence similarity alignment in the NCBI non-
redundant database. These transcripts were statistically grouped in terms of e-value 
distribution, the similarity of the sequences to their closest match from the database and 
also the top matching hits in terms of organismal similarity. 
 
 
 E-value distribution:  
The E-value threshold was < 1E-5 and according to E-value distribution the alignments 
were divided into: Higher end homology from 0 to <1.0E-100 (39%), moderate 1.0E-100 
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to 1.0E-30 (30%) and lower end homology ranged from 1.0E-30 to 1.0E-5 above which any 
alignment is insignificant. A detailed distribution of the transcripts according to E-value is 
shown in the histogram (Figure. 3.3) 
 
 
Figure 3.3: E-value distribution of the annotated transcripts in NCBI non-redundant 
database 
 Species similarity distribution 
Over 70% of the transcripts matching hits belong to five mammals including Ailuropoda 
melanoleuca (the giant panda) with 25%, Mustela putorius furo (the ferret) 20%, Canis 
lupus familiaris (the dog) 16%, Homo sapiens (human) 4.4%, Sus scrofa (the wild boar) 
2.3% and Bos taurus (the cow) 2.3%. Other species combined represented 29% of the 








































 Sequence similarity distribution 
Over 70% of the alignment achieved similarity greater than 80% between the badger 
blood transcripts and the corresponding genes in the database. Whereas less than 30% 





















Figure 3.5: Sequence similarity distribution in NCBI non-redundant database 
 
 COG Function 
Searching the COG database for domain based alignments led to annotation of 57,089 
reads and revealed their cellular function classification as shown in (Fig. 3.6). After setting 
the E-value threshold at 1.0E-5, the homologically significant matches in the COG 
database were clustered into functional classes, and the cluster (Translation, ribosomal 
structure and biogenesis) has the highest representation with 13.7% of the total 
transcripts and (General function) cluster has 13.3% of the transcripts representation. The 
lowest clusters represented are (Nuclear structure, Extracellular structures and RNA 
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Figure 3.6: COG functional annotation 
 
 Gene Ontology 
According to the sequence alignment and homology, the total number of GO terms that 
correspond to all unigenes is 1,028,340. In general, most of the GO term annotations 
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components represent 37.2% with 382,212 GO terms, and lastly molecular function with 
14.2% with 146,210 GO terms (Figure 3.7). For all GO combined: cell, cell part, binding 
and cellular process have the highest representation with over 70,000 GO term each while 
virion, virion part, protein tag, chemorepellent activity, carbon utilization and nutrient 
reservoir activity have the lowest number of GO terms with less than 10.  
 
 
Figure 3.7: Number of transcripts representing each GO function  
 
The distribution of transcripts according to the three groups of GO terms is shown in 





























Figure 3.8: Distribution of transcripts on different GO terms. 
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 Pathway annotation KEGG 
The mapping of assembled transcripts with pathway annotation to KEGG database 
resulted in assigning those reads to 259 pathways. Among the mostly represented 
pathways Metabolic Pathways have 9.97% (9930), Focal adhesion 7.61% (7582), 
Amoebiasis 7.17% (7136), ECM-receptor interaction 5.94% (5918), Protein digestion and 
absorption 5.65% (5623), RNA transport 4.17% (4158), Regulation of actin cytoskeleton 
4.02% (4001), Pathways in cancer 3.88% (3862) and Herpes simplex infection 3.22% 
(3209). 
In addition to the major pathways represented by the transcripts in the figure 3.9 there 
are other 239 pathways shown in the Appendix including some infectious diseases 




Figure 3.9: Number of transcripts in the main KEGG pathways 
 
In general, there are more transcripts annotated by all four databases combined (9806) 
than transcripts annotated in one or two or three database as shown in Venn diagram  
(Figure 3.10). NR has the majority of transcripts annotated in an independent database 
(8800) whereas COG has the lowest (34).  
The pattern in this is approximately consistent with other Venn diagrams in other 
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Figure 3.10: Venn diagram illustrating shared and unique transcripts annotated in 
databases of Nr, Swiss-Prot, COG and KEGG. 
 
 
3.1 Quality Control using BLAST sequence alignment tool  
In order to check the quality of the acquired transcriptome a BLAST search was performed 
against some of the badgers mRNA sequences available in the NCBI database. To date, 
there are 20-deposited partial sequences of badger’s mRNA in the NCBI database that 




The first comparison was between a transcript which is a partial sequence (399bp) of MHC 
class I antigen and a partial sequence of mRNA of the same gene (975bp) published by 
(Sin et al., 2012). The comparison show that the transcript in hand is 89% identical to that 
of the same organism currently available in public databases (Figure 3.11). The variability 
in the number of class I sequences in M. meles is intermediate compared to other 
carnivores (Sin et al., 2012). 
 
Figure 3.11: Two sequence alignment using online NCBI blastn application: MHC class I 





The second comparison (Figure 3.12) was between a partial sequence (96bp) of MHC class 
II antigen DQ beta chain from the transcriptome and a partial sequence (697bp) of the 
same mRNA from the NCBI public database by (Sin et al., 2011). The two sequences were 




Figure 3.12: Two sequence alignment using online NCBI blastn application: MHC class II 




The last comparison (Figure 3.13) was between a partial sequence (204bp) of interferon 
gamma from the transcriptome and a partial sequence of the same mRNA in NCBI 
database (501bp) submitted by (Zhou et al., 2014) 
 










3.2 Using the transcriptome as a searchable database for MHC genes 
sequences 
MHC are one of the major regulators of cell-mediated adaptive immune response. On 
average, there is a 10% difference between any two unrelated Individuals in the diversity 
of MHC combinations, which provide a protective function against pathogens. For an 
organism, the repertoire of MHC is polygenic, co-dominantly expressed from both sets of 
inherited alleles and highly polymorphic (Janeway, 2005). Moreover, the evidence of 
antigenic peptide splicing which can combine peptides from different proteins resulting 
in increased MHC antigen diversity (Vigneron et al., 2004)and low MHC diversity may pose 
a threat to the organism’s pathogen resistance and on the long term the species survival 
(Zhu et al., 2007). 
Here is an attempt to extract the MHC transcripts from the badger’s transcriptome that 
correspond to 20 RNA-seq sequences in NCBI database and comments on their 
abundance and significance comparing to that of the giant panda and the effect of that 
on the whole immune response to infection. 
The web-based platform Galaxy (Cock et al., 2015) was used in data analysis. Galaxy 
utilises BLAST+ command-line applications (Camacho et al., 2009a) through a user-
friendly graphical interface. The first task performed was the conversion of the badger’s 
transcriptome sequences data (FASTA) files into a searchable database (makeblastdb) 
followed by extraction of the badger’s MCH class I and II RNA-seq genes sequences 
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(FASTA) from NCBI. Both nucleotide and protein sequences were combined into two 
query sequences lists (Figures 3.14 and 3.15) 
 
Figure 3.14: Query nucleotide sequences extracted from NCBI database 
 
Figure 3.15: Query nucleotide sequences extracted from NCBI database 
 
Traditional megablast was used to perform BLAST search to find highly similar sequences 
(Megablast is used for intra-species or closely related species) with e-value cut-off point 
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of 1e-05. Both forward and reverse strands of the query sequences were searched against 
the database with no restriction in the maximum number of hits.  
 Nucleotide BLAST search (tabular format) 
The blast results were first tabulated to obtain a general visualisation of the data in hand. 
The initial observations of this alignment are: 
The total number of achieved alignments between the query sequences and the 
transcriptome database is 195 (Appendix) with an identity percentage range between 
76% and 100%. The e-value range of the alignments was between 0.0 and 4.00e-14. 
From the total alignments 6 query NCBI sequence achieved a 100% identity with 19 
transcripts (Figure 3.16). 49 aligned transcripts with 18 query sequences came up with an 
E-value of 0 (Figure 3.17). 
 
 
Figure 3.16: Nucleotide alignments with a 100% identity score 
Query Seq-id Subject seq-id Identity % Alignment length E-vlue Query seq. length Subject seq. length Sequence classification
JQ425440.1 Unigene117550_All 100 83 2.00E-36 848 171 MHC I
JQ425440.1 Unigene12618_All 100 83 2.00E-36 848 171 MHC I
JQ425440.1 Unigene26995_All 100 73 8.00E-31 848 126 MHC I
JQ425439.1 Unigene117550_All 100 84 7.00E-37 932 171 MHC I
JQ425439.1 Unigene12618_All 100 84 7.00E-37 932 171 MHC I
JQ425439.1 Unigene26995_All 100 73 9.00E-31 932 126 MHC I
JQ425432.1 CL1150.Contig22_All 100 110 3.00E-51 975 360 MHC I
HQ908107.1 Unigene4377_All 100 96 1.00E-43 680 96 MHC II
HQ908107.1 CL4065.Contig4_All 100 96 1.00E-43 680 96 MHC II
HQ908107.1 CL4065.Contig2_All 100 96 1.00E-43 680 96 MHC II
HQ908107.1 CL4065.Contig1_All 100 96 1.00E-43 680 96 MHC II
HQ908098.1 CL10050.Contig2_All 100 582 0 615 582 MHC II
HQ908098.1 CL10050.Contig1_All 100 582 0 615 582 MHC II
HQ908096.1 Unigene4377_All 100 96 1.00E-43 697 96 MHC II
HQ908096.1 CL4065.Contig4_All 100 96 1.00E-43 697 96 MHC II
HQ908096.1 CL4065.Contig2_All 100 96 1.00E-43 697 96 MHC II
HQ908096.1 CL4065.Contig1_All 100 96 1.00E-43 697 96 MHC II
HQ908092.1 CL13896.Contig1_All 100 96 1.00E-43 822 96 MHC II




Figure 3.17: Nucleotide alignments with E-value = 0 
The percentage of identity for the alignments with E-value=0 is in the range between 83% 
and 100%. The alignment lengths were between 506 and 975 bases. 
Query Seq-id Subject seq-id Identity % Alignment length E-vlue Query seq. length Subject seq. length Sequence classification
JQ425440.1 CL1150.Contig16_All 90.12 506 0 848 972 MHC I
JQ425439.1 CL1150.Contig16_All 90.04 562 0 932 972 MHC I
JQ425439.1 CL1150.Contig4_All 89.09 550 0 932 702 MHC I
JQ425438.1 CL1150.Contig16_All 90.8 848 0 900 972 MHC I
JQ425438.1 CL1150.Contig4_All 91.31 587 0 900 702 MHC I
JQ425432.1 CL1150.Contig16_All 92.08 972 0 975 972 MHC I
JQ425432.1 CL1150.Contig4_All 93.28 699 0 975 702 MHC I
JQ425433.1 CL1150.Contig16_All 94.44 972 0 975 972 MHC I
JQ425433.1 CL1150.Contig4_All 98.71 699 0 975 702 MHC I
JQ425431.1 CL1150.Contig16_All 91.98 972 0 975 972 MHC I
JQ425431.1 CL1150.Contig4_All 92.7 699 0 975 702 MHC I
JQ425430.1 CL1150.Contig16_All 93.44 975 0 975 972 MHC I
JQ425430.1 CL1150.Contig4_All 93.87 702 0 975 702 MHC I
JQ425429.1 CL1150.Contig16_All 95.16 972 0 975 972 MHC I
JQ425429.1 CL1150.Contig4_All 98 699 0 975 702 MHC I
JQ425428.1 CL1150.Contig16_All 94.32 546 0 543 972 MHC I
JQ425428.1 CL1150.Contig4_All 92.49 546 0 543 702 MHC I
JQ425427.1 CL1150.Contig4_All 93.59 546 0 543 702 MHC I
JQ425427.1 CL1150.Contig16_All 93.04 546 0 543 972 MHC I
HQ908107.1 Unigene57188_All 97.18 674 0 680 795 MHC II
HQ908107.1 Unigene67843_All 97.23 650 0 680 651 MHC II
HQ908107.1 Unigene75449_All 97.28 551 0 680 774 MHC II
HQ908099.1 CL2981.Contig3_All 99.27 688 0 691 762 MHC II
HQ908099.1 CL2981.Contig1_All 99.27 688 0 691 762 MHC II
HQ908099.1 Unigene42913_All 99.67 603 0 691 603 MHC II
HQ908098.1 CL10050.Contig3_All 99.67 615 0 615 765 MHC II
HQ908098.1 CL10050.Contig2_All 100 582 0 615 582 MHC II
HQ908098.1 CL10050.Contig1_All 100 582 0 615 582 MHC II
HQ908097.1 CL10050.Contig3_All 91.73 617 0 615 765 MHC II
HQ908097.1 CL10050.Contig2_All 91.61 584 0 615 582 MHC II
HQ908097.1 CL10050.Contig1_All 91.61 584 0 615 582 MHC II
HQ908096.1 Unigene57188_All 99.7 674 0 697 795 MHC II
HQ908096.1 Unigene67843_All 99.85 650 0 697 651 MHC II
HQ908096.1 Unigene75449_All 97.28 551 0 697 774 MHC II
HQ908096.1 Unigene75450_All 85.32 654 0 697 774 MHC II
HQ908095.1 Unigene27967_All 94.83 774 0 822 774 MHC II
HQ908095.1 Unigene75450_All 94.6 741 0 822 774 MHC II
HQ908095.1 CL4065.Contig3_All 96.64 684 0 822 693 MHC II
HQ908094.1 Unigene27967_All 99.22 774 0 822 774 MHC II
HQ908094.1 Unigene75450_All 97.17 672 0 822 774 MHC II
HQ908094.1 CL4065.Contig3_All 97.17 672 0 822 693 MHC II
HQ908094.1 Unigene75449_All 84.09 773 0 822 774 MHC II
HQ908093.1 Unigene27967_All 99.48 774 0 822 774 MHC II
HQ908093.1 Unigene75450_All 97.62 672 0 822 774 MHC II
HQ908093.1 CL4065.Contig3_All 97.62 672 0 822 693 MHC II
HQ908093.1 Unigene75449_All 83.44 773 0 822 774 MHC II
HQ908092.1 Unigene27967_All 96.51 774 0 822 774 MHC II
HQ908092.1 Unigene75450_All 92.31 741 0 822 774 MHC II
HQ908092.1 CL4065.Contig3_All 94.79 672 0 822 693 MHC II
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Only one query sequence (ID: HQ908098.1 MHC class II antigen DQ alpha chain) achieved 
both an alignment with 100% identity and E-value=0 with two transcripts (ID: 
CL10050.Contig1_All, CL10050.Contig2_All). 
 Nucleotide alignment (Query-anchored) 
The tabulated alignment was also converted into an alignment (query-anchored format). 
Due to the large data file only one example of the alignment is mentioned below (Figure 
3.18). The reset of the alignments can be viewed in the (Appendix). 
Example: 
Query= JQ425440.1 Meles meles MHC class I antigen (Meme-MHCI) pseudogene mRNA, 
Meme-MHCI*PS03 allele, partial sequence. Length=848bp 
 
Figure 3.18: A section of the nucleotide alignment between a MHC class one (query) and 
the badger transcripts 
On average, 10-17 alignments were achieved between each query sequence and 
transcripts from the badger transcriptome database. Most of the first hits in the 
alignments for each query were with transcripts that have been previously annotated as 
the badger’s own in NCBI blast search (during transcriptome assembly). 
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The remainder alignments were with closely related mammals like the ferret (Mustela 
putorius furo) or extensively studied (for economical or conservational reasons) mammals 
such as panda (Ailuropoda melanoleuca), cow (Bos taurus), horse (Equus caballus), 
Californian sea lion (Zalophus californianus), olive baboon (Papio anubis) and marmoset 
(Callithrix jacchus) as shown in the (Figure 3.19). 
 
Figure 3.19: Aligned transcripts NR annotation during transcriptome assembly and 
annotation (yellow cells indicate sequences previously annotated as MHC genes from the 
badger) 
Subject seq-id NR-annotation
CL10050.Contig1_All MHC class II antigen DQ alpha chain, partial [Meles meles]
CL10050.Contig2_All MHC class II antigen DQ alpha chain, partial [Meles meles]
CL10050.Contig3_All PREDICTED: SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [Ailuropoda melanoleuca]
CL1150.Contig1_All MHC class I antigen, partial [Meles meles]
CL1150.Contig13_All MHC class I antigen, partial [Meles meles]
CL1150.Contig14_All hypothetical protein PANDA_022308 [Ailuropoda melanoleuca]
CL1150.Contig15_All MHC class I antigen, partial [Meles meles]
CL1150.Contig16_All MHC class I antigen, partial [Meles meles]
CL1150.Contig17_All MHC class I antigen, partial [Meles meles]
CL1150.Contig18_All MHC class I antigen [Ailuropoda melanoleuca]
CL1150.Contig2_All MHC class I antigen, partial [Meles meles]
CL1150.Contig22_All PREDICTED: LOW QUALITY PROTEIN: popy Class I histocompatibility antigen, A-1 alpha chain-like [Papio anubis]
CL1150.Contig23_All MHC class I antigen, partial [Meles meles]
CL1150.Contig24_All MHC class I antigen, partial [Meles meles]
CL1150.Contig3_All MHC class I antigen, partial [Meles meles]
CL1150.Contig4_All MHC class I antigen, partial [Meles meles]
CL1150.Contig5_All MHC class I antigen [Bos taurus]
CL1150.Contig7_All MHC class I antigen [Ailuropoda melanoleuca] >gi|163636633|gb|ABY27208.1| MHC class I antigen [Ailuropoda melanoleuca]
CL1150.Contig8_All hypothetical protein PANDA_022308 [Ailuropoda melanoleuca]
CL13896.Contig1_All MHC class II antigen DR beta chain, partial [Meles meles]
CL1793.Contig2_All PREDICTED: MHC class I polypeptide-related sequence B-like [Equus caballus]
CL1793.Contig3_All PREDICTED: MHC class I polypeptide-related sequence B-like [Equus caballus]
CL1793.Contig5_All PREDICTED: MHC class I polypeptide-related sequence B-like [Equus caballus]
CL1793.Contig7_All PREDICTED: MHC class I polypeptide-related sequence B-like [Equus caballus]
CL2981.Contig1_All PREDICTED: HLA class II histocompatibility antigen, DR alpha chain-like [Ailuropoda melanoleuca]
CL2981.Contig3_All PREDICTED: HLA class II histocompatibility antigen, DR alpha chain-like [Ailuropoda melanoleuca]
CL4065.Contig1_All MHC class II antigen DQ beta chain, partial [Meles meles]
CL4065.Contig2_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
CL4065.Contig3_All MHC class II antigen DR beta chain, partial [Meles meles]
CL4065.Contig4_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
CL7631.Contig3_All MHC class I antigen, partial [Meles meles]
Unigene117550_All PREDICTED: patr class I histocompatibility antigen, A-126 alpha chain-like, partial [Callithrix jacchus]
Unigene12618_All PREDICTED: patr class I histocompatibility antigen, A-126 alpha chain-like, partial [Callithrix jacchus]
Unigene26995_All hypothetical protein PANDA_022308 [Ailuropoda melanoleuca]
Unigene27967_All hypothetical protein PANDA_022308 [Ailuropoda melanoleuca]
Unigene42913_All MHC class II antigen DR alpha chain, partial [Meles meles]
Unigene4377_All MHC class II antigen DQ beta chain, partial [Meles meles]
Unigene54563_All interferon gamma [Mustela putorius furo]
Unigene57188_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
Unigene67843_All MHC class II antigen DQ beta chain, partial [Meles meles]
Unigene75449_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
Unigene75450_All MHC class II antigen DR beta chain, partial [Meles meles]




 Protein sequences BLAST search (tabular format) 
Search criteria for protein sequence BLAST included the use of traditional BLASTP to 
compare a protein query to a protein database with e-value cut-off point of 1e-05 and a 
scoring matrix of BLOSUM90 (which is used to compare highly related and less divergent 
sequences). BLOSUM only accepts a mutation in the protein primary structure if it is 
commonly found in conservative substitutions in nature. 
The total number of achieved alignments between query sequences and transcripts is 
248. The Identity percentage observed fell in  a range of between 37% and 100%. The e-
value range was between 0.0 and 8.00e-13.  
Five alignments between two query NCBI sequences and the transcriptome database 
showed a 100% match (Figure 3.20) and only seven alignments with seven query 
sequences produced an e-value of 0 (Figure 3.21) i.e. the probability of the alignments 
arising by chance is zero. 
 
Figure 3.20: Protein alignments with 100% identity score 
 
Query Seq-id Subject seq-id Identity % Alignment length E-vlue Bit score Query seq. length Subject seq. length Sequence classification
AET36874.1 CL10050.Contig2_All 100 194 3.00E-146 423 205 194 MHC II
AET36874.1 CL10050.Contig1_All 100 194 3.00E-146 423 205 194 MHC II
AET36883.1 Unigene42913_All 100 81 8.00E-54 177 81 201 MHC II
AET36883.1 CL2981.Contig3_All 100 81 3.00E-53 178 81 254 MHC II




Figure 3.21: Protein alignments  with an E-value = 0 
  Protein alignment (Query-anchored) 
The tabulated protein alignment was also converted into a query-anchored alignment 
format as in the example (Figure 3.22).   
Database: BLAST Database, 127,401 sequences; 28,354,467 total letters 
Query = AFR54067.1 MHC class I antigen, partial [Meles meles], Length=180 
Query Seq-id Subject seq-id Identity % Alignment length E-vlue Bit score Query seq. length Subject seq. length Sequence classification
AFR54060.1 CL1150.Contig16_All 88.58 324 0 618 325 324 MHC I
AFR54059.1 CL1150.Contig16_All 85.19 324 0 596 325 324 MHC I
AFR54058.1 CL1150.Contig16_All 84.88 324 0 593 325 324 MHC I
AFR54057.1 CL1150.Contig16_All 86.73 324 0 604 325 324 MHC I
AFR54056.1 CL1150.Contig16_All 89.81 324 0 625 325 324 MHC I
AET36870.1 Unigene27967_All 98.84 258 0 554 258 258 MHC II




Figure 3.22: An example of an alignment of a protein query sequence (MHC class I 
antigen) and 10 transcripts from the transcriptome database.  
  
The 25 protein query sequences (NCBI) achieved 248 alignments with 42 transcripts from 
the badger transcriptome database. 10 of the alignments achieved were with transcripts 
previously annotated as badger MHC sequences genes. The remainder alignments were 
with closely related mammals like the ferret (Mustela putorius furo) or extensively studied 
(for economical or conservational reasons) mammals such as panda (Ailuropoda 
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melanoleuca), dog (Canis lupus familiaris), and Californian sea lion (Zalophus 
californianus) as shown in the (Figure 3.23). 
 





CL10050.Contig1_All MHC class II antigen DQ alpha chain, partial [Meles meles]
CL10050.Contig2_All MHC class II antigen DQ alpha chain, partial [Meles meles]
CL10050.Contig3_All PREDICTED: SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [Ailuropoda melanoleuca]
CL1150.Contig13_All MHC class I antigen, partial [Meles meles]
CL1150.Contig15_All MHC class I antigen, partial [Meles meles]
CL1150.Contig16_All MHC class I antigen, partial [Meles meles]
CL1150.Contig17_All MHC class I antigen, partial [Meles meles]
CL1150.Contig18_All MHC class I antigen [Ailuropoda melanoleuca]
CL1150.Contig4_All MHC class I antigen, partial [Meles meles]
CL12484.Contig1_All HLA class II histocompatibility antigen, DO alpha chain precursor [Mustela putorius furo]
CL12484.Contig2_All PREDICTED: HLA class II histocompatibility antigen, DO alpha chain-like [Ailuropoda melanoleuca]
CL12484.Contig3_All MHC class II antigen DO alpha [Canis lupus familiaris]
CL154.Contig1_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig11_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig12_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig13_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig14_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig15_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig16_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig17_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig19_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig2_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig20_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig21_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig23_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig24_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig27_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL154.Contig33_All class I histocompatibility antigen, GOGO-C0203 alpha chain-like protein [Mustela putorius furo]
CL2981.Contig1_All PREDICTED: HLA class II histocompatibility antigen, DR alpha chain-like [Ailuropoda melanoleuca]
CL2981.Contig3_All PREDICTED: HLA class II histocompatibility antigen, DR alpha chain-like [Ailuropoda melanoleuca]
CL5174.Contig1_All hypothetical protein PANDA_002284 [Ailuropoda melanoleuca]
CL6815.Contig2_All PREDICTED: HLA class II histocompatibility antigen, DO beta chain-like [Ailuropoda melanoleuca]
CL6815.Contig3_All PREDICTED: HLA class II histocompatibility antigen, DO beta chain-like [Ailuropoda melanoleuca]
CL6815.Contig4_All major histocompatibility complex, class II, DO beta [Mustela putorius furo]
CL6815.Contig5_All PREDICTED: HLA class II histocompatibility antigen, DO beta chain-like [Ailuropoda melanoleuca]
CL6815.Contig6_All major histocompatibility complex, class II, DO beta [Mustela putorius furo]
Unigene27967_All hypothetical protein PANDA_022308 [Ailuropoda melanoleuca]
Unigene42913_All MHC class II antigen DR alpha chain, partial [Meles meles]
Unigene57188_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
Unigene67843_All MHC class II antigen DQ beta chain, partial [Meles meles]
Unigene75449_All MHC class II antigen [Zalophus californianus] >gi|22023813|gb|AAM89234.1| MHC class II antigen [Zalophus californianus]
Unigene75450_All MHC class II antigen DR beta chain, partial [Meles meles]
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An example of an alignment using Clustal Omega (Sievers et al., 2011) between the first 
query sequence (AFR54067.1, a partial sequence of MHC class I antigen) and two 
transcripts is shown in the (figure 3.24) to visualise the differences in the sequences and 
to show different types of mutations found. 
 
Figure 3.24: An alignment of one query sequence (AFR54067.1) and two transcripts where 
(*) represents conserved sequence, (:) conservative mutations, (.) semi-conservative 










 A comparison between the badger and the giant panda 
A comparison of the most abundant MHC transcripts in the badger and panda 
transcriptomes (Du et al., 2015a) in the (Table 3.4). The comparison is based on the 
abundance of the transcripts despite the annotation of the sequence in terms of the 
closest matching in the public databases, providing it is in the MHC gene family. The data 
are expressed as the total number of fragments (reads) per kilo-base of gene length per 
million reads of the transcriptome (FPKM). The data show that the total abundance of 
badger MHC transcripts is 4936.818 FPKM, which is about 2.5 times more than that of the 
giant panda (1995.43 FPKM). 
Badger 









CL1150.Contig13_All 1363 1467.8917 asmbl_17923 1012 22.47 
CL1150.Contig15_All 1385 1106.5719 asmbl_17924 2228 26.63 
CL1150.Contig16_All 1435 671.4784 asmbl_17925 2257 55.28 
CL1150.Contig4_All 1187 582.748 asmbl_42999 336 14.59 
CL1150.Contig18_All 2627 277.4338 asmbl_43000 1024 16.42 
Unigene27967_All 1466 250.1088 asmbl_43001 1408 4.31 
CL10050.Contig1_All 1750 185.9091 asmbl_43002 1029 15.11 
CL7631.Contig3_All 559 67.2444 asmbl_43007 193 3.16 
Unigene62040_All 269 60.309 asmbl_49924 2383 12.4 
Unigene42913_All 1020 53.2618 asmbl_49925 4142 15.09 
CL4065.Contig2_All 3331 50.9938 asmbl_49929 455 1.96 
CL1150.Contig6_All 251 44.5692 asmbl_55085 320 1744.82 
CL10050.Contig2_All 954 33.539 asmbl_75564 2816 27.39 
CL13896.Contig1_All 508 25.0588 asmbl_77939 2947 1.41 
CL7631.Contig1_All 556 22.8955 asmbl_77940 1870 2.14 
CL4065.Contig1_All 3796 20.1605 asmbl_77941 508 3.55 
CL12484.Contig3_All 627 10.459 asmbl_92419 125 27.35 
CL11221.Contig2_All 492 6.1853 asmbl_92575 104 1.35 
Total  23576 4936.818 Total 25157 1995.43 
Table 3.4: The most abundant MHC transcripts in the badger transcriptome and in the 




3.3 Using the most abundant transcripts to build a phylogenetic tree 
In this section, transcripts with the highest raw reads, highest FPKM value and the longest 
amino acid sequences were used to build three phylogenetic trees using BLAST+ 
(Camacho et al., 2009b) and Clustal Omega (Sievers et al., 2011) from European 
Bioinformatics Institute (EMBL-EBI) web services (McWilliam et al., 2013). 
The nature of the transcripts will be also discussed in terms of the conservative regions 
nature and whether they can be classified as highly conserved sequences.  
The transcript with most abundant raw reads (CL4057.Contig1_All), transcript with 
highest FPKM value (Unigene65050_All) and transcript with the longest amino acid 
sequence (CL3144.Contig26_All) were chosen to build a tree. 
 
 The construction of a phylogenetic tree using the transcript with most abundant 
raw reads 
The query sequence (ID: CL4057.Contig1_All, sequence length: 514 aa) was aligned with 
highest identical blast search results and a phylogenetic tree was drawn using Clustal 





Figure 3.25: A phylogenetic tree model using the most abundant raw read (ID: 
CL4057.Contig1_All) in the badger transcriptome 
 
Sequence (CL4057.Contig1_All) annotation in the BLAST search is the cytochrome c oxidase 
subunit I (COI), a key component in the mitochondrial electron transport chain. The gene 
is used as a “DNA barcode” to identify species. Although the sequence tends to be 
conserved among members of the same species, it has a fast enough mutation rate that 
enables distinction between closely related species where more than 2% sequence 
divergence cab be detected (Hebert et al., 2003). 
The graph shows a degree of distinction within the Mustelidae family among the 
subfamilies such as Mustelinae (ferrets) and Melinae (badgers) and also on the species 
level within the subfamily which tend to be less diverse. This model agrees with multigene 
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phylogeny of the Mustelidae by (Koepfli et al., 2008a). However, it does not reflect the 
chronical evolution and divergence of the species.  
 Construction of a phylogenetic tree using the transcript with the highest FPKM 
value 
Transcript (Unigene65050_All) has the highest FPKM value (38044.2458) in the 
transcriptome annotation data. A phylogenetic tree using this transcript is shown in the 
(Figure 3.27). 
 
Figure 3.26: A phylogenetic tree model using the transcript with the highest FPKM value 
(Unigene65050_All) in the badger transcriptome 
The query sequence (Unigene65050_All) has a length of (141 aa) and is annotated as 
Haemoglobin subunit alpha (HBA). The length of HBA gene in mammals is about 142 aa 
including human, panda, cow and badgers.  
In this example, using a single gene to draw a phylogenetic (gene) tree does not 
necessarily represent the actual evolutionary pathway of a species (whole genome) tree.  
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 Building a phylogenetic tree using the longest transcript sequence 
In the transcriptome data files (FASTA), the query sequence (CL3144.Contig26_All) has 
the longest amino acid sequence with 4719 aa. A BLAST search followed by a Clustal 
Omega alignment and tree formation is in the (figure 3.28). 
 
Figure 3.27: A phylogenetic tree model using the transcript with the longest amino acid 
sequence (CL3144.Contig26_All) in the badger transcriptome 
The query sequence annotation E3 ubiquitin-protein ligase RNF213 suggests a protein 
involved in angiogenesis and vascular development. The function of the sequence is 
predicted in the transcriptome annotation as well as similar sequences from other 
mammals based on the well-known sequence from human genome. 
 
3.4 Discussion  
 General description 
To my knowledge, this is the first attempt to analyse the composition of any 
transcriptome from the European badger. The data appear to be of high quality compared 
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with other published blood transcriptome studies e.g. giant panda blood transcriptome 
(Du et al., 2015b). A large volume of data (about 3.52GB) has been generated using next 
generation (RNA-seq) technology. The quality criteria are discussed below, together with 
the interpretation of the sequencing results in an overall Biological context.  
Although sequence-quality checks are performed at the sequencing service provider (BGI) 
some of the transcripts were aligned to similar single sequences of RNA available on the 
NCBI database in order to provide an independent assessment. From 20 RNA sequences 
of MHC class I and II antigens and interferon gamma, it was found that two of the 
transcripts scored 100% similarity and one achieved 89%. The similarity score is limited 
by the number sequences available on public databases and might not be statistically 
significant. However, still two out of the three aligned transcripts are identical despite 
possible differences in techniques and sequencing bias. 
The annotation generated from different databases provide  different perspectives on the 
sequencing data in terms of similarity to known genes, functionality and the predicted 
roles the sequenced transcripts play  in physiological and pathological pathways. 
After assembly, 95,245 transcripts were found to have significant similarities in six 
databases. In the NCBI non-redundant database, all the significant similarities between 
each two sequences were under the E-value of E≤1.0E-5 and above which the alignments 
considered insignificant. Over 70% of the alignments showed a similarity of ≥ 80% 
between the transcripts and the aligned sequences. More than 70% of the aligned 
sequences match those of genes from six mammals: Ailuropoda melanoleuca (giant 
panda), Mustela putorius furo (ferret), Canis lupus familiaris (Dog), Homo sapiens 
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(human), Sus scrofa (wild boar) and Bos taurus (cow). Other species combined 
represented 29.05% of the total annotation.  
Recent studies suggest that increasing taxon sampling can enhance phylogenetic accuracy 
and resolution (Flynn et al., 2005) and more informative characters are required to 
confidently resolve close species relationships when studying phylogenetic relationships 
(Fulton and Strobeck, 2006). In that sense, even though the transcriptome data places the 
badger under the class “Mammalia” the spectrum of species that emerge as closest 
matches, indicate the need for more similar transcriptome and genome sequencing. 
However, when considering the availability of data at the time of transcriptome 
annotation, the European badger (M. meles) still holds its position within the superfamily 
“Musteloidea” and the family “Mustelidae” which can be attributed to the sequenced 
ferret (Mustela putorius furo) transcriptome (Bruder et al., 2010). 
Similarly, over 45% of the annotated transcripts places the badger under infraorder 
“Arctoidae” of the order “Carnifora” which can be explained by the extensive research on 
the endangered giant panda (Ailuropoda melanoleuca) whose mitogenome (Peng et al., 
2007), genome (Angelia et al., 2010) and transcriptome (Du et al., 2015b) have been 
sequenced. Moreover, the family “Ursidae” has been characterized by rapid radiation 
events, making phylogenetic inference of the species relationships difficult, and thus, 
often contentious (Fulton and Strobeck, 2006) and this may also affect the taxonomic 
relationship between the two families “Mustelidae and Ursidae”.  
A search in Cluster of Orthologous Groups (COG) database was performed In order to 
uncover the homologous relationships of the transcriptome to the well-known conserved 
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domains. Most of the transcripts were matched to the major groups of (Cellular Processes 
and Signalling), (Information Storage and Processing) and (Metabolism). However, there 
were also some transcripts classified as “Poorly Characterized” including 22,329 
transcripts under “General function prediction only” and 11,305 transcripts under 
“Function unknown” categories. 
Transcripts were also mapped against all known GO terms to obtain a consistent 
description of all their corresponding genes and gene products, which may facilitate the 
future update of their characteristics and functions. In total, the 62 GO terms have 
1,028,340 corresponding transcripts and the majority of transcripts (499,918) are 
assigned to “Biological Processes” GO terms, 382,212 transcripts to “Cellular 
components” and 146,210 transcripts to “Molecular functions”. KEGG pathway 
annotation led to the association of 69,924 transcripts to 259 biological pathways 
including those of biomolecules metabolism, drug metabolism and pathological pathways 
such as cancers and infection. 
 Venn diagrams 
The distribution of annotated transcripts among databases and the number of shared 
annotated transcripts appears to be database-dependent rather than a function of the 
nature of the annotated transcripts in a non-target gene study. In another word, a 
database that basically depend on annotation based on simple sequence similarity like NR 
would normally produce more annotations than one that is manually curated (Swiss-
Prot), pathway specific (KEGG) or COG which compare orthologs and paralogs of genes. A 
similar distribution pattern was observed in other transcriptome analysis studies of 
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animals like the panda (Du et al., 2015b) or even trees like Hevea brasiliensis (Para Rubber 
Tree) (Fang et al., 2016).   
 
 Phylogenetic trees  
Three transcripts were used to construct three different phylogenetic trees as shown in 
the results. These transcripts were the most abundant in terms of raw reads, assembled 
transcript and the longest assembled protein sequence in the transcriptome analysis. 
A phylogenetic (evolutionary) tree is a representation of the evolutionary relationships 
among a set of organisms known as taxa. The tips of the tree represent groups of 
descendent taxa (species) and the nodes on the tree represent the common ancestors of 
those descendants. Two descendants that split from the same node are called sister 
groups. 
All three examples showed that the closest relative sequence of the query transcript 
sequence is either from the same animal (M. meles) or a member from the same family 
(Mustelidae).  
Using sequences with highly conserved regions such as haemoglobin alpha subunit and 
cytochrome c oxidase might be useful in comparing deep phylogenies among close 
species. However, caution is required when interpreting the chronological order of 
speciation and divergence. Such an approach might provide satisfactory results in 
distantly related taxa, but suffers from a number of issues when dealing with evolutionary 
relationships at shallow time depths (Nater et al., 2015).  
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It is important to recognise that if the phylogenetic tree is computed from data coming 
from a single gene (gene tree) is sometimes different from a whole-genome tree (species 
tree). One of the important factors that cause this difference is genetic polymorphism in 
the ancestral species (Pamilo and Nei, 1988). Even under standardised alignment 
parameters different genes provide different levels of speciation leading to formation of 
different trees. This could be useful in studying the evolution of a single gene and its 
variants but also could be distracting when studying a whole organism despite the fact 
that the alignments presented here consistently showbadger or ferret is the closest 
because this is in part true but is also a consequence of the sequences deposited and 
searchable in the database.  
It has been shown that a combination fossil record, observation, ecological and biological 
studies in addition to multi-genic phylogeny can describe the classification of a family such 
as Mustelidae and the position of a species such as the European badger in that family 
(Koepfli et al., 2008b). Nevertheless, these data still show a relative degree of similarity in 
accord with the multigene phylogeny of the Mustelidae study (Koepfli et al., 2008b) in 
respect of species divergence. 
 MHC transcripts  
On investigating the abundance of MHC genes in the badger transcriptome, the 
sequences data files for both nucleotide and protein were converted into a searchable 
database. 20 nucleotide sequence and 25 protein sequence achieved respectively 195 and 
248 alignments with nucleotide and protein sequences from the transcriptome database. 
The aligned transcripts were previously annotated (during transcriptome assembly by 
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BGI) as MHC class I, class II and interferon gamma from several mammals including badger 
(Meles meles) and other closely related or more studied mammals. 
MHC genes are highly diverse both within species and among species populations of 
mammals and the confirmation that alignment of the MHC query sequence with 
transcripts that have been previously annotated as MHC transcripts, is a possible indicator 
for both similarity and diversity of badgers MHC transcripts. However, one of the 
limitations of searching a local database (transcriptome) is that it gives an overly 
significant e-value as it is calculated within the local database, in another word, it 
calculates the chances of the alignment occurring by chance with other transcripts. 
The identity range of the first hits in the protein alignment is between 74% and 100% 
which, despite the length of both query and subject sequences, showed regions of highly 
conserved sequences which showed the intra-species similarities and few regions of less 
conserved regions witch may reflect the diversity of MHC genes. However, this would 
require corroboration by sequencing the full length gene of interest. 
Comparing the abundance of MHC transcripts between badger and giant panda blood 
transcriptomes can provide a crude measure of the differences, as the two experiments 
are different to some extent in terms of different living conditions of both animals 
(laboratory controlled vs captivity) which might affect the level of exposure to 
environmental pathogens. Moreover the experimental design (number of samples, 
pipeline, statistical analysis, etc.) may also affect the outcome. Despite this, the use of 
FPKM may overcome some the obstacles in the experimental differences as it not just 
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calculate the crude number of transcripts for a given gene but also gives more statistical 
sense by dividing that number by the actual length (in kilo-base) of that gene then by 
million  fragments mapped.  
In this respect, comparing the highly abundant MHC transcripts from both mammals 
showed that the badger has higher expression levels of both classes of MHC genes. 
Although, this result may require further experimental investigation it may reflect the 
findings of some researches where MHC genes diversity is much lower in this endangered 
species (Zhang et al., 2015) and diversity of MHC genes in the giant panda  was relatively 


































4 A comparison between male and female transcriptome  
Biological differences between males and females can affect susceptibility to 
mycobacterial infection, and these differences may provide valuable insight into the 
components that constitute an effective immune response to this pathogen 
(Nhamoyebonde and Leslie, 2014). Infectious diseases rarely affect males and females 
equally. As a general rule, females present a more-robust immune responses to antigenic 
challenges, such as infection and vaccination, than males (Griesbeck et al., 2015). Sex 
hormones have diverse effects on many immune cell types, including B cells, T cells, 
neutrophils, dendritic cells, macrophages, and natural killer cells (Fish, 2008). In badgers, 
differences in disease prevalence between males and females may affect differences in 
the physiological impact of infection and may also have significant effects on pathogen 
persistence within the host population (Tomlinson et al., 2013). It has been suggested 
that the resilience of female badgers to the negative effects of bTB infection may favour 
its persistence. Females not only exhibited enhanced survival, but also continued to 
reproduce successfully, whilst excreting bacteria. This suggests that infected females may 
play a pivotal role in the maintenance of infection in social groups, particularly through 
transmission to their cubs (Tomlinson et al., 2013). 
In this chapter, the over-arching differences in transcription in terms of a whole 
transcriptome and also for a limited subset of immune/bTB related transcripts, are 
explored. The most significantly affected transcripts are discussed, and a small number of 
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examples of immunologically important pathways with up/down regulated genes were 
also included.  
Fragments per kilo-base per million or FPKM is a normalized count for the sequencing 
depth (million): sequencing runs with greater depth will have more reads mapped to each 
gene. FPKM is also normalized for the length of the original gene (expressed in kilo-bases), 
as longer genes will have more mapped transcripts. The female transcriptome was used 
as a reference for the comparison, i.e. up regulated transcripts means that they are 
expressed at higher levels in male and down regulated transcripts means that they are 
expressed at lower levels in the female badger. The fold change (FC), or difference in 
expression was calculated as a log2, i.e. positive FC for up regulated and negative FC for 
down regulated transcripts. The false discovery rate (FDR) which calculates the expected 
proportion of difference in a comparison (between male and female transcripts counts in 
this case) that is false, thereby ensuring that the differences in expression are statistically 
insignificant.  
4.1 Results 
As mentioned above, male and female FPKM were compared.  2690 transcripts were 
found to be upregulated in the male badger and 18691 transcripts were downregulated 
(Figure 4.1). A lower FC threshold of ± 1.5 was applied to highlight a significant expression 
level difference (Hausen et al., 2015). The FDR (Benjamini and Hochberg, 1995) cutoff 
value was set to ≤ 0.001 as used by most studies of this kind. In (Figure 4.2) the majority 
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of differentially expressed transcripts were in the region of 5 to -5 FC which represents 
log2 of the male FPKM/Female FPKM. 
 
Figure 4.1: Numbers of differentially expressed transcripts (FDR ≤ 0.001) in male badger’s 








Figure 4.2: the expression levels of differentially expressed transcripts in male 
transcriptome compared to the female transcriptome. The expression level was 




 The major differentially regulated transcripts 
Tables 4.1 and 4.2 show top 10 upregulated and down regulated transcripts and their 








 Transcript Nr-annotation FC FDR 
1 Eukaryotic translation initiation factor 2, subunit 3, structural 
gene Y-linked, isoform CRA_c [Mus musculus] 
15.18 2.5E-205 
2 Lysine (K)-specific demethylase 5C [Bos taurus] 14.54 1.3E-97 
3 Probable ubiquitin carboxyl-terminal hydrolase FAF-Y [Bos 
taurus]  
13.97 2.4E-157 
4 PREDICTED: eukaryotic translation initiation factor 1A, Y-
chromosomal-like [Papio anubis] 
13.32 8.9E-29 
5 Lysine -specific demethylase 6A [Mustela putorius furo] 13.28 8.7E-41 
6 Probable ubiquitin carboxyl-terminal hydrolase FAF-Y [Bos 
taurus] 
12.95 2.6E-45 
7 PREDICTED: ATP-dependent RNA helicase DDX3X isoform 3 
[Saimiri boliviensis boliviensis] 
12.93 4.7E-256 
8 Environmental lipopolysaccharide-responding gene protein 
[Macaca fascicularis] 
12.25 7.1E-17 
9 PREDICTED: synaptonemal complex protein 3-like [Sus scrofa] 12.21 2.0E-20 
10 Tetratricopeptide repeat protein [Canis lupus familiaris] 12.21 1.4E-30 
Table 4.1: Table of 10 most upregulated transcripts and their annotation in male badger 
transcriptome compared to the female transcriptome. 
 
 
Transcript Nr-annotation FC FDR 
1 PREDICTED: uncharacterized protein LOC101053426 [Saimiri 
boliviensis boliviensis] 
-14.88 2.5E-99 
2 Immunoglobulin heavy chain variable region subgroup 1 [Felis 
catus] 
-14.61 6.0E-162 
3 Immunoglobulin lambda light chain variable region [Homo 
sapiens] 
-13.78 1.8E-40 
4 Immunoglobulin G heavy chain variable region [Homo 
sapiens] 
-13.58 3.1E-37 
5 Immunoglobulin heavy chain [Homo sapiens] -13.49 3.1E-37 
6 Immunoglobulin heavy chain variable region [Homo sapiens] -13.43 3.4E-30 
7 Immunoglobulin kappa light chain V-J region [Equus caballus] -13.15 1.3E-29 
8 Hypothetical protein [Trypanosoma cruzi strain CL Brener]  -13.02 5.3E-34 
9 Nucleolar RNA-binding protein [Trypanosoma cruzi strain CL 
Brener] 
-12.87 3.8E-28 
10 Hypothetical protein PANDA_022421 [Ailuropoda 
melanoleuca] 
-12.85 9.3E-24 
Table 4.2: Table of most 10 downregulated transcripts and their annotation in male 
badger transcriptome compared to the female transcriptome. 
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 Gene ontology for differentially expressed transcripts 
Gene Ontology (GO) is an international standardized gene functional classification system 
which offers a dynamic, updated and controlled vocabulary, and a strictly defined rule-
set to comprehensively describe the properties of genes and their products in any 
organism. GO has three ontologies: biological process, molecular function and cellular 
component. The basic unit of GO is the GO-term. Every GO-term belongs to a type of 
ontology. GO functional analysis provides a functional classification and annotation for 
differentially expressed genes as well as GO functional enrichment analysis for 
differentially expressed genes. GO functional classification annotation provides a gene list 
and gene numbers for each GO term. 
GO functional enrichment analysis (Figure 4.3) provides GO terms that are significantly 
enriched in differentially expressed genes, showing which differentially expressed genes 
are connected to their respective biological functions. The analysis firstly maps all 
differentially expressed genes to GO terms in the database 
(http://www.geneontology.org/), calculates gene numbers for every term then finds 








Figure 4.3: Gene Ontology annotation of differentially expressed transcripts. GO 
biological process (blue), GO molecular function (red) and GO cellular components 
(green). 
 
1.1.1 KEGG pathways for differentially expressed transcripts   
Individual genes often cooperate with each other to fully express their biological 
functions. Pathway-based analysis helps to further understand the biological functions 
associated with specific genes. KEGG is the major public pathway-related database 
(Kanehisa et al., 2008) operating in this analysis space. Pathway enrichment analysis 
identifies significantly enriched metabolic pathways or signal transduction pathways in 
differentially expressed genes comparing with the whole genome background. A pathway 
with an FDR score of ≤ 0.05 is called significantly enriched in a group of differentially 
expressed genes (Nhamoyebonde and Leslie, 2014). There were 83 significantly enriched 




Figure 4.4: KEGG pathway for differentially expressed transcripts. 
 
 Difference in expression of bTB related transcripts  
There were 117 transcripts that encode candidate genes involved in the bTB pathway, 
with a significant difference in expression levels between male and female badgers. 77 
transcripts were downregulated in the male badger. Immunoglobulin heavy chain variable 
regions annotated as genes from human and cats were the main down regulated 





Nr-annotation log2 (Male RPKM / 
Female RPKM) 
immunoglobulin heavy chain variable region subgroup 1 [Felis catus] -14.6079 
immunoglobulin G heavy chain variable region [Homo sapiens] -13.576 
immunoglobulin heavy chain [Homo sapiens] -13.4881 
immunoglobulin heavy chain variable region [Homo sapiens] -13.4288 
immunoglobulin heavy chain variable region subgroup 3 [Felis catus] -12.589 
immunoglobulin heavy chain variable region [Homo sapiens] -12.4574 
immunoglobulin heavy chain variable region [Homo sapiens] -12.1266 
immunoglobulin heavy chain variable region subgroup 3 [Felis catus] -11.9554 
immunoglobulin heavy chain variable region [Homo sapiens] -11.7744 
immunoglobulin heavy chain variable region subgroup 1 [Felis catus] -11.4248 
Table 4.3: Most downregulated bTB related transcripts in the male badger 
40 transcripts were upregulated in the male badger. The most upregulated transcripts 
(Table 4.4) correspond to TB pathway related genes from different species. 
Nr-annotation log2 (Male 
RPKM / 
Female RPKM) 
PREDICTED: nuclear transcription factor Y subunit gamma isoform 3 [Equus 
caballus] 
2.1209 
PREDICTED: interleukin-23 subunit alpha [Canis lupus familiaris] 2.3726 
PREDICTED: galectin-3-like [Oreochromis niloticus] 2.3844 
PREDICTED: HLA class II histocompatibility antigen, DO alpha chain-like [Ailuropoda 
melanoleuca] 
2.3909 
PREDICTED: bcl2 antagonist of cell death-like [Ailuropoda melanoleuca]  2.6656 
PREDICTED: toll-like receptor 2-like [Ailuropoda melanoleuca]  2.8286 
immunoglobulin mu heavy chain [Pteropus alecto] 3.0128 
PREDICTED: LOW QUALITY PROTEIN: complement receptor type 1-like [Equus 
caballus] 
3.7766 
IgM heavy chain VH1 region precursor [Homo sapiens] 8.7529 
PREDICTED: hypothetical protein LOC467582 [Pan troglodytes] 11.5732 





Differential expression of bTB related transcripts was also illustrated in the KEGG pathway 
of tuberculosis (Figure 4.5), providing a clearer picture of the involvement of differentaily 
expressed transcripts at different stages of disease. The pathway shows transcription 
upregulation in genes involved in the JAK-STAT signalling cascade in the male badger. The 
JAK-STAT cascade is involved in nuclear transcription of genes involved in inflammatory 
response to an infection and antigen processing and presentation. The Figure 4.5 also 
shows a down regulation of transcripts involved in MAPK signalling cascade which affects 
cell proliferation and proinflammatory cytokine production. There was also a 
downregulation of transcripts involved in (NOD)-like receptor signalling cascade which is 
important in the regulation of the host innate immune response (Franchi et al., 2009). 





Figure 4.5: Differential expression of bTB related transcripts for male compared to female badger 




Gene-expression variation may play a significant role in gender-specific health disparities, 
probably through upregulating or downregulating genes within physiological pathways. 
Males and females could have gender-specific transcriptional or translational regulation, 
leading to differential mRNAs or protein products for some genes (Zhang et al., 2009). 
Sex-biased gene expression has been observed in a number of mammals including 
humans, in different tissues that are thought to be phenotypically similar, including the 
brain were it involves about 2.5% of all expressed genes (Trabzuni et al., 2013). Similar 
observations were also recorded in cell lines were gender-specific differential expression 
in lymphoblastoid cell lines in male and female human were studied (Zhang et al., 2007). 
In animal models, genes in the pathway of bone development were shown to be 
differentially expressed between the male and female of mice (Huang et al., 2014). Sexual 
dimorphism is a term used to describe the difference in characteristics - other than sexual 
organs – such as body size, shape and colour between male and female of the same 
species. Transcriptome analysis has showed that sexual dimorphism in gene expression 
was much greater than previously recognized as thousands of genes showed sexual 
dimorphism in liver, adipose, and muscle where the sexually dimorphic genes were also 
found to be highly tissue-specific (Yang et al., 2006). In this chapter, 12.6% of transcripts 
were found upregulated in the male badger and 87.4% transcripts were downregulated 
when compared to the female badger. The highest 10 upregulated transcripts were found 
to be involved in cellular functions such as protein synthesis and folding, vesicular 
trafficking, cytoskeletal assembly and regulation of cell growth and apoptosis which may 
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be attributed to many physiological and environmental factors that can cause this sex-
biased expression such as levels of sex hormones and growth hormones as shown in other 
studies that showed sex-differences in gene expression can be dependent on the 
hormonal status (Jansen et al., 2014). Whereas, the 10 most downregulated transcripts 
in the male badger are of unknown specific function (No. 8 and 9 in table 4.2) or of critical 
regulators of immunity, stress responses, apoptosis differentiation and cell signaling. In 
general, topographical classification of the highest 10 differentially expressed transcripts 
in both tables has showed that upregulated transcripts encode more often, intracellular 
functions, in particular in the cytoplasm; whereas down regulated transcripts generally 
encode integral  membrane proteins, which may reflect the source of the transcriptome 
data:  human peripheral blood cells (Jansen et al., 2014).  
However as stated by (Schurch et al., 2016): “It is worth recalling that identifying a gene 
as significantly differentially expressed does not necessarily equate to identifying it as 
biologically significant and that it is important to consider both the magnitude of the 
measured fold change and existing biological knowledge alongside the statistical 
significance when inferring a biological significance for the results of gene expression 
difference experiments” (Schurch et al., 2016). 
Gender is one variable that influences innate and adaptive immune responses to foreign 
and self-antigens in infections, malignancies and as a response to vaccination. It shows 
distinctions in innate and adaptive immune responses where specific immunological sex-
biased responses are present throughout life and are sex-hormone independent, whereas 
others appear only after the age of puberty which may suggest that both genes and 
 116 
 
hormones are involved (Klein and Flanagan, 2016). In infectious diseases, human males 
tend to be more susceptible to some infections such as Ebola, hepatitis B and tuberculosis 
whereas females are more susceptible to other infections like malaria, influenza and 
toxoplasmosis (Klein and Flanagan, 2016). 
In humans, mycobacterial infection tends to be gender biased and males exhibit a higher 
prevalence of tuberculosis infection even if confounding factors, such as social and 
economic factors, awareness, exposure and are taken into account in epidemiological 
studies (Neyrolles and Quintana-Murci, 2009). In other mammals such as brush-tail 
possums, bTB prevalence is often substantially higher in males than in females (Nugent 
et al., 2015). In cattle, males tended to show higher prevalence rates for bTB (Moiane et 
al., 2014). Female badgers are more resilient to established bTB infection than male 
badgers, with longer survival times following the detection of bacterial excretion 
(Tomlinson et al., 2013).  
The majority of immune cells express specific receptors for sex hormones and are 
responsive to changes in hormone levels. Females pose a more-robust set of immune 
responses to antigenic challenges, such as infection and vaccination, than males. Sex 
hormones have diverse effects on many immune cell types, including dendritic cells, 
macrophages, B cells, T cells, neutrophils and natural killer cells (Figure 4.6)  
(Nhamoyebonde and Leslie, 2014).  
Although it cannot be anticipated whether the observed differential expression between 
male and female badgers is a direct result of the hormonal effect, and despite the fact 
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that these data were from uninfected animals, some of the expression levels difference 
were consistent with the biological differences between the sexes and their susceptibility 




Figure 4.6: The effects of sex hormones on the modulation of immune responses of 
macrophages and dendritic cells to tuberculosis. Adapted from (Nhamoyebonde and 
Leslie, 2014) 
As suggested by the KEGG pathway for tuberculosis infection in macrophages and 
dendritic cells, there was an observed downregulation of the tumour necrosis factor 
superfamily, member 2 (TNFA), Toll-like receptor 4 (TLR4), mitogen-activated protein 
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kinases (MAPK). However, there was a mixed set of expression levels amongst the FC 
receptors, Interleukins and an upregulation of nitric oxide synthase activity (NOS), unlike 
the findings in this figure 4.6. This differences in expression may lead to differences in the 
capability of detection and elimination of mycobacterial cells from the host body through 
phagocytosis, bactericidal action and granuloma formation. 
There was also upregulation of interferon gamma receptor 2 (IFNGR2) and 
downregulation of interferon gamma receptor 1 (IFNGR1) and interleukin 8 (CXCL8) which 
might affect the migration of macrophages and neutrophils to the site of infection.  
In conclusion, the results of the transcriptome analysis and expression difference show 
some consistencies with some aspects of the observed patterns of the body responses to 
tuberculosis, despite the fact that the studied animals are bTB. It is also consistent with 
the epidemiological and observational findings in which males are found to be more 
prone and less resistant to TB and bTB infection. Taking gender and the influence of sex 
hormones into account may help in improving our understanding of the immune response 



































5 Immunity related and bTB specific transcripts 
This chapter describes the immunity related transcripts in terms of numbers and classes 
of the immunity genes they represent. It also illustrates some of the key genes that play 
a potential role in the immune response to infection and the evolutionary relatedness of 
the badger to other mammals as revealed by a bioinformatic analysis. Finally, it also 
describes the key genes in the bTB pathway (as per KEGG) and the matching transcripts 
from the analysis of transcriptome data from the badger. 
5.1 Immunity-related transcripts  
Several search criteria were applied to extract the immuno-components of the badger’s 
transcriptome. After transcriptome assembly and annotation, a basic (crude) search was 
performed using the prefix (immun-) as a search term in the four databases and the 
numbers are shown in the Table 5.1 below. 
Database NR Swiss-Prot COG KEGG 
Number of annotations 358 194 0 266 
Table 5.1: Number of transcripts with (immun-) term in each database annotation 





Figure 5.1: Venn diagram of distribution of the annotations among four databases 
 
From the figure 5.1 Eight transcripts were found annotated only in the NR database 
(suppressive immunomodulating factor, putative [Trypanosoma cruzi marinkellei], 
immunodominant antigen [Trypanosoma cruzi strain CL Brener], PREDICTED: immunity-
related GTPase family M protein 1-like [Canis lupus familiaris], immunoglobulin 
superfamily, DCC subclass, member 4-like [Bos taurus], and leukocyte immunoglobulin-
like receptor B2 [Halichoerus grypus]). A single transcript was found to be annotated only 
in Swiss-Prot database (Immunoglobulin lambda-like polypeptide 5 OS=Homo sapiens 
GN=IGLL5 PE=2 SV=2).  Three transcripts were found to be annotated only in KEGG (as 
human immunodeficiency virus type I enhancer-binding protein and autoimmune 




A more thorough search was performed using the immunity genes list from the IKB 
database (Ortutay and Vihinen, 2009) as search queries. The search has shown the 
number of transcripts in all databases align with each gene of 893 immunity genes. Of the 
11724 annotations found the 20 most abundant are shown in table 5.2, with a 
comprehensive list of annotations for each gene given in the appendix. 
Gene  Full name Number of 
annotations 
WAS Wiskott-Aldrich syndrome protein. 421 
MME membrane metallo-endopeptidase. 295 
CD22 CD22 molecule. 295 
CD2 CD2 molecule. 273 
TMC8 EVIN2. 187 
IL12RB1 interleukin 12 receptor, beta 1 isoform 1 precursor. 171 
TRAF3 TNF receptor-associated factor 3 isoform 1. 151 
LYST lysosomal trafficking regulator. 128 
KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene 
homolog isoform 1 precursor. 
126 
CD19 CD19 antigen. 112 
CD44 CD44 antigen isoform 5 precursor. 109 
CD46 CD46 antigen, complement regulatory protein isoform 12 
precursor. 
107 
ADAM17 ADAM metallopeptidase domain 17 preproprotein. 106 
C4B complement component 4B preproprotein. 97 
RFX1 regulatory factor X1. 97 
ITGA5 integrin alpha 5 precursor. 88 
DKC1 dyskerin. 88 
CD5 CD5 molecule. 87 
BLNK B-cell linker. 86 
STAT3 signal transducer and activator of transcription 3 isoform 2. 84 
Table 5.2: Immunity genes with the most abundant number of annotation found using 
IKB 
5.2 Immunoglobulins 
Members of the immunoglobulin family, an important component of the immune system 
in identifying and tagging foreign antigens for subsequent neutralization, were identified 
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in each database. The number and annotation of immunoglobulins in the badger 
transcriptome are shown in the table 5.3 for three data bases. 
Database NR NT Swiss-Prot 
Number of immunoglobulin related transcripts 289 460 170 
Table 5.3: Number of annotations for immunoglobulin in each database 
 
The most abundant annotations of immunoglobulins and immunoglobulin receptors 
were also extracted and shown in the table 5.4 below.  
Gene  Full name Number of 
annotations 
IGSF8 immunoglobulin superfamily, member 8. 48 
LAIR1 leukocyte-associated immunoglobulin-like receptor 1 isoform a precursor. 11 
LILRB2 leukocyte immunoglobulin-like receptor, subfamily B, member 2 isoform 1. 10 
LILRB3 leukocyte immunoglobulin-like receptor, subfamily B, member 3 isoform 2. 10 
VPREB1 immunoglobulin iota chain preproprotein. 7 
LILRA5 leukocyte immunoglobulin-like receptor subfamily A member 5 isoform 1. 5 
FCGR3B low affinity immunoglobulin gamma Fc region receptor III-B precursor. 4 
IGJ immunoglobulin J chain. 4 
LILRA6 leukocyte immunoglobulin-like receptor, subfamily A, member 6. 4 
IGSF2 immunoglobulin superfamily, member 2. 3 
LILRA2 leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), 
member 2. 
2 
CADM2 immunoglobulin superfamily, member 4D. 1 
PILRA paired immunoglobulin-like type 2 receptor alpha isoform 1 precursor. 1 
KIR2DL4 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic 
tail, 4 isoform a. 
1 
KIR3DL2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic 
tail, 2 precursor. 
1 
IGHG2 immunoglobulin gamma-2 heavy chain. 1 
Table 5.4: most abundant immunoglobulins in the transcriptome  
1.1.2 NCBI Non-redundant database annotation of immunoglobulins 
The figure 5.2 below shows the number of immunoglobulin sequences from different 
mammals that aligned with transcripts from the badger’s RNA-seq data. Sequences from 
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the family Carnivora are the highest in terms of number of alignments and sequence 
similarity.  
 


















































NR annotation of Immunoglobulins
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 Swiss-Prot database annotation of immunoglobulins 
Using SWISS-PROT (Bairoch and Apweiler, 2000) which is a manually curated protein 
sequence database can provide a high level of annotation such as the description of the 
function of a protein with a minimal level of redundancy. In that sense it is naturally that 
most stored sequences are the most studied ones (human and model animals) and the 
similarity shown in the figure 5.3 is mostly driven by function rather than the animal 
source of that sequence   
 






















Swiss-Prot annotation of Immunoglobulins
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5.3 Immunoglobulin variable regions 
Because of the importance of the immunoglobulin variable regions for recognition and 
binding of the antigens, the corresponding sequences of the variable genes from the 
transcriptome data files were extracted, yielding 75 reads that were annotated in 
different databases as follows: 
 NCBI Non-redundant database annotation of variable genes’ transcripts 
Most of the variable genes transcripts of the badger are similar to those of human and 
primates’ figure 5.4 and carnivorous animals with four transcripts unaligned with any 




Figure 5.4: NCBI Non-redundant database annotation of variable genes 
 KEGG annotation of Variable genes 
Most of the badger’s variable genes transcripts were found to be highly similar to 
sequences from dog, rhesus monkey, cow and other mammals with exception of 14 
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Figure 5.5: KEGG annotation of Variable genes. 
 
5.4 Genes involved in the bTB pathway 
Using KEGG pathway for tuberculosis as a reference, 1825 transcripts were extracted from 
the transcriptome sequencing data that correspond to 147 of the 183 genes that are 
involved in the bTB pathway from early infection until cell death. Some of the transcripts 
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themselves. The IKB immunological classification of the transcripts involved in bTB 
pathogenesis is shown in the table 5.5. 
IKB Immunological function Number of transcripts  
Phagocytosis 5 
CD molecules 23 
Chemokines and receptors 30 
Cellular immunity 12 
Humoral Immunity 13 
Antigen processing and presenting 20 
inflammation 25 
Complement system 6 
Transcription factors  6 
Table 5.5: IKB immunological classification of transcripts involved in bTB KEGG pathway.  
However, number of genes that are involved in bTB pathogenesis were found to have no 
matching transcripts in the badger’s RNA-seq. These genes include interleukins, 
interferons and transforming growth factors (table 5.6). 
IL6  interleukin 6 (interferon, beta 
2) 
IFNA13 
 interferon, alpha 13  
IFNA1  interferon, alpha 1 IFNA14  interferon, alpha 14  
IFNA2  interferon, alpha 2  IFNA16  interferon, alpha 16  
IFNA4  interferon, alpha 4  IFNA17  interferon, alpha 17  
IFNA5  interferon, alpha 5  IFNA13  interferon, alpha 13  
IFNA6  interferon, alpha 6  IFNA21  interferon, alpha 21  
IFNA7  interferon, alpha 7  IFNB1  interferon, beta 1, fibroblast 
IFNA8 
 interferon, alpha 8  
TGFB2  transforming growth factor, beta 
2 
IFNA1
0  interferon, alpha 10  
TGFB3  transforming growth factor, beta 
3  
Table 5.6: IKB Genes without matching sequences in the transcriptome. 
1.1.3 NR annotation of TB related transcripts 
NR annotation of bTB related transcripts shows that the most similar sequences are from 




Figure 5.6: NR annotation of TB related transcripts. 
 KEGG pathway  
Host genes involved in KEGG pathway for both M. tuberculosis and M. bovis infection 
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badger’s annotated transcriptome. According to KEGG pathway for tuberculosis 
pathogenesis there are 183 genes involved in encoding cellular and nuclear receptors, 
intracellular signalling molecules and signalling cascades. All the genes involved in bTB 
pathway found matching transcripts with exception of Mincle (Macrophage-inducible C-
type lectin receptor) which has not been detected in the transcriptome. For IL-6 
(Interleukin 6), INFα (Interferon alpha) and INFβ (Interferon beta) only transcripts encode 
cellular receptors were found in the badger’s transcriptome Figure 5.7. 
Tuberculosis pathway can be viewed more clearly on http://www.genome.jp/kegg/ 






Figure 5.7: bTB pathway (KEGG), (*) Genes with no matching transcripts. (#) Genes with 





 Constructing a phylogenetic tree using key transcripts in bTB infection 
“Genetic factors play a major role in determining differential susceptibility to infection 
and disease outcome. Genetic variation in an increasing number of genes (e.g., NRAMP1, 
HLA class II, VDR, DC-SIGN, TLR8) has been found to be associated with complex 
susceptibility to pulmonary TB” (Neyrolles and Quintana-Murci, 2009).  
Natural resistance-associated macrophage protein 1 (NRAMP1) polymorphisms have 
been found to be associated with susceptibility to tuberculosis in cattle (Liu et al., 2017). 
However, a systematic review on HLA class II genes can highly vary in their role against 
tuberculosis infection even within the same species (Oliveira-Cortez et al., 2016). Vitamin 
D receptor (VDR) polymorphisms and vitamin D deficiency are also associated with 
tuberculosis susceptibility in humans (Lee et al., 2016).   DC-sign protein (encoded by 
CD209 gene) is a pathogen-recognition receptor expressed on the surface of immature 
dendritic cells (DCs) and involved in initiation of primary immune response through 
binding mannose containing antigens bacterial cell surface (Tanne and Neyrolles, 2010) 
and thereby considered one of the early systematic responses to tuberculosis. TLR8 
genetic polymorphisms are associated with susceptibility to mycobacterial infection and 
 134 
 
the severity of clinical manifestation by affecting phagocytosis in monocytes (Lai et al., 
2016). 
Here we use BLAST+ and Clustal Omega (through EMBL-EBI) to draw phylogenetic trees 
using transcripts of these genes with standard search criteria of the animal orthologs.  






Database: UniProtKB mammals/ 
Program: blastp/ Matrix: BLOSUM62/ 
Expectation value threshold: 1e-5/ 
Dropoff: 0/ Gap open: -1/ Gap extend: 
-1/ Filter: F/ Sequence range: START-
END/ Gapalign:  true/ Composition-
based statistics: F/ Align views: 0/ 




Program: clustalo/ Version: 1.2.4/ Output guide 
tree: false/ Output distance matrix: false/ 
Dealign input sequences: false/ mBed-like 
clustering guide tree: true/ mBed-like clustering 
iteration: true/ Number of iterations: 0/ 
Maximum guide tree iterations: -1/ Maximum 
HMM iterations: -1/ Output alignment format: 





Figure 5.8: A phylogenetic tree of the VDR gene 
 
Figure 5.8 In this example a Blastp search of the orthologs of VDR gene was performed 
and 50 aligned sequences where then used to build a phylogenetic tree (gene tree) using 
Clustal Omega. The 50 orthologs were from 3 species of birds and 38 species of mammals 
including the badger. These species were originated from 25 families which came from 11 
orders from both classes (birds and Mammals).   
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The "tips" of the tree branches represent the taxa in the study. These taxa include 
taxonomic levels of species, families, orders and classes. 
In the other figure 5.9 DC-sign transcript was used to build a gene phylogeny using 50 





Figure 5.9: A phylogenetic tree of DC-sign gene 
Similar results were obtained for HLA class II, NRAMP1 and TLR8 orthologs Figure 5.10 
where species share the same ancestor gene but with different “adaptive radiation” levels 
which led to speciation (appearance of different species) and different homologs of the 




Figure 5.10: the position of the badger in the order Carnivora from three sections of the 






This chapter provides an in silico characterisation of the coding potential of the badger 
transcriptome, as a platform for characterising and investigating the immune component 
of the assembled transcriptome. A pilot search has shown that 15967 annotations in four 
databases are related to the search term (immun-), however, when a more thorough 
gene-by-gene search was performed using the IKB immunome database as a reference, 
and it showed that 698 genes out of 893 immunity genes in the database have 
corresponding transcripts in the badger transcriptome (11724) annotations. 195 genes 
from IKB show no match in the available data. 
A total of 919 transcripts annotated as immunoglobulins in three databases reveal a 
similarity to immunoglobulin genes from a number of mammals; mainly Ailuropoda 
melanoleuca (Giant panda), Mustela putorius furo (Ferret), Canis lupus familiaris (Dog) 
and Homo sapiens (Human). Swiss-Prot annotation of immunoglobulin transcripts 
showed over 84% similarity of the transcripts to human immunoglobulins, in terms of 
predicted function. 
Venn diagrams are commonly used to visualize the overlap between data sets, including 
differential gene expression data under various condition and genes or transcripts 
annotation in different databases. NR database contains sequences from both, non-
curated and curated databases including non-reviewed sequences submitted from 
individual laboratories and large-scale sequencing projects deposited in GenBank and 
non-reviewed section of Uni-Prot. Thereby NR has the highest number of annotated 
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sequences both independently (8 annotations) or shared with other databases. Swiss-Prot 
is a manually annotated, non-redundant protein sequence database with over 500,000 
manually annotated, curated and reviewed protein sequence. If we  compare the number 
of deposited sequence in Swiss-Prot to that of Genbank alone (200,877,884
 nucleotide sequence on April 2017) we find that the number of annotations in 
GenBank for any given sequence is higher. This can be useful for preliminary investigation 
of a sequence source or closest similar organism. However, in order to obtain a higher 
level of annotation such as description of the function of a protein, its domain structure 
and post-translational modifications then Swiss-Prot will have the advantage over the NR 
database. The COG database is a tool for identifying ortholog and paralog proteins and 
classifying those proteins into identifiable clusters according to protein function i.e. 
protein grouping rather than direct identification of the sequences and thus show less 
independence in annotation. The KEGG pathway is a tool to assign sequences to their 
known or predicted metabolic pathway utilizing genomic and non-genomic data (e.g. drug 
and disease effects) and thereby it is another useful yet less independent database where 
primary annotations are performed through NCBI blast searching. Similar Venn diagram 
distribution patterns were also found in the swamp buffalo transcriptome analysis (Deng 
et al., 2016) and giant panda blood transcriptome analysis (Du et al., 2015) which might 
explain that the difference in number of annotations among databases is more dependent 
on the characteristics of the database itself (such as availability of similar sequences or 
the level of annotation and classification in each database) rather than the significance of 
sequence in question.  
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For the 75 transcripts that match variable genes, NR and NT annotation showed a 
similarity to Mustela putorius furo (Ferret), Canis lupus familiaris (Dog), Files catus (Cat) 
and Homo sapiens (Human). However, KEGG annotation showed that 14 transcripts could 
not be mapped to any known pathway which may indicate a different spectrum of antigen 
binding capabilities of the badger’s immunoglobulins to foreign antigens. Some mapped 
to pathways from Bos taurus (Cow) and Monodelphis domestica (Opossum). Both 
mammals can acquire bTB infection.  
KEGG pathway annotation for both M. bovis and M. tuberculosis infection suggests that 
183 mammalian genes are involved in the pathogenesis of the disease. 1825 transcripts 
were extracted that correspond to 147 of those 183 genes that are involved in bTB 
pathway from early infection until cell death. Some transcripts were found to match 
genes that encode receptors for signalling proteins but not the proteins themselves for 
the remaining 36 genes in bTB pathway. Only subunits of IL-6 receptors (IL6R, IL6ST) and 
INFα and INFβ receptors (IFNAR1, IFNAR2) were found in the annotated transcriptome.  
Production of interferons occurs mainly in response to infection and the inability to detect 
their presence in the transcriptome might be explained by the fact that the animals were 
kept all their lives in a (disease-free) controlled environment. Mincle is essential in 
detection of microbial glycolipids and it has been found that Mincle-dependent 
macrophage activation is regulated by IL-4 which has a strong downregulation of the 
mRNA expression of Mincle (Hupfer et al., 2016). 24 transcripts were annotated as IL-4 
and signal transducer and activator of transcription 6 which might explain the undetected 
presence of Mincle transcripts.  
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A phylogeny is a "tree", which estimates the "historical" connections between species or 
genes that they carry. Five different transcripts were used to construct gene phylogenies 
compared to other fifty animals from different classes and orders.  "Gene" trees represent 
the evolutionary history of the genes included in the study and provide evidence for gene 
duplication events, as well as speciation events by including different homologs in a gene 
tree and clustering orthologs to demonstrate the evolutionary history of the gene 
orthologs. 
The phylogeny was built using only molecular data with no regard to morphological, 
behavioural or any other type of data and only single transcripts were used, which may 
neglect some important inputs drawn by non-coding sequences or the whole genome. 
However, the phylogenetic trees generated by those transcripts managed to some extent 
place the badger in the right position in terms of gene speciation i.e. within the 
Mustelidae family. Although these trees show the approximate speciation process which 
led to the emergence of species, families and orders they do not show the exact 
chronological order for the evolution of these taxa.   
Gene trees showed that phylogenetics can add biological meaning to the data. It is 
important to keep in mind that a single line on the phylogeny is in fact a population, and 
populations can have genetic variation. These gene variations represented as paralogs 
which resulted from duplication of homologs within the genome and orthologs which are 
defined as evolutionary counterparts derived from a single ancestral gene in the last 
common ancestor of the given two species (Koonin and Galperin, 2003). The genetic 
variations within the population can affect the outcome of the phylogeny when single 
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sequence is used to build the tree. Some immunity genes are highly polymorphic and 
different hosts usually have different genotypes and thereby recognize different 
spectrums of pathogens. However, even with such variability it is still possible to produce 





















































6 Mealworm (Tenebrio molitor)  
 “Model organisms have always played a leading role in genetic research, starting with 
Mendel's experimentation with pea plants in the 19th century. Today, geneticists continue 
to rely on these organisms, especially when investigating questions of gene expression, 
function, and mutation. Interestingly, even simple organisms can reveal much about the 
molecular basis of disease; in fact, the simple structure, short life span, and easy 
manipulability of these species make it particularly amenable to ongoing use in the 
research environment.” (Adams, 2008). Thereby, a model organism can be defined as an 
organism appropriate for studying a specific disease or phenomenon owing to its 
relatively short lifetime in addition to characterized genome, well known biology and ease 
of accessibility for laboratory studies (Hedges, 2002).  
“The phylogeny and timescale of life are becoming better understood as the analysis of 
genomic data from model organisms continues to grow. As a result, discoveries are being 
made about the early history of life and the origin and development of complex 
multicellular life” (Hedges, 2002). Insects were among the first animals on land, and the 
diversity and distribution of the current living insects has often been described as 
“astonishing”. Within excess of one million species, insects are the most diverse 
organisms in the history of life, both in the number of species and the variety of structures 
and behaviours (Grimaldi and Engel, 2005). In comparison to the number of insect species 
which is estimated at over 950,000, the diversity of their genome size remains poorly 
understood when compared to all vertebrates and not just mammals  (over 66,000 
species), with sparse and sporadic sampling of a few selected insect orders and with many 
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orders unrepresented or underrepresented in genome databases. The sizes of insect 
genomes are estimated to range from 91 to 7,752 megabase. (Hanrahan and Johnston, 
2011). In terms of genome size, the closest insect to T. molitor is Tribolium castaneum 
(the red flour beetle) from the same family “Tenebrionidae” and it has a genome size of 
160 megabase (Richards et al., 2008). On the other hand, the size of the fully sequenced 
genome of Drosophila melanogaster (the fruit fly) is estimated at 120 megabase (Adams 
et al., 2000).  Understanding the difference in genome sizes between these two species 
provides one justification for widening the genomic pool of model organisms to be 
analysed by sequencing. In the case of the mealworm genome, the availability of the 
mitogenome and transcriptome make the task easier. As previously mentioned, the other 
advantages of using the mealworm beetle as a model organism, include its use in 
immunological research, which will be substantially enhanced with the availability of a 
sequenced genome. On the negative side of course, simple, model organisms are perhaps 
easier to understand, but provide less transferable information, owing to their specialised 
features: and in this respect, the mealworm is not an exception. However, acknowledging 
that all model organisms have limitations, the opportunity to derive the sequence of the 
mealworm genome, seems on balance worthwhile, in particular in respect of its use in a 
wider educational setting, as discussed below. 
The ease of managing the mealworm in teaching and research laboratories, (as has been 
observed with school students at the Liverpool Life Sciences University Technical College 
(UTC)., has provided invaluable support for extending the knowledge base of this 
organism, using genomic technology. Moreover, the significant and experimentally 
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convenient, amounts of protein extraction that can be obtained from a single insect, 
further support the case for making this insect an addition to the list of model organisms. 
Advantages and disadvantages of common animal models are frequently under 
discussion and the two main disadvantages of using models are the evolutionary distance 
from human and the issue of manipulating a small flying insect or its embryo (Wheeler 
and Brandli, 2009). Although not essential for a school-based research organism, simple -
manipulations, the mealworm is much easier to handle, dissect and generally maintain, 
compared with other known insect models such as the fruit fly. The fact that the 
mealworm is evolutionary distant to human more than other mammalian or vertebrate 
models is not a real hindrance when it comes to teaching fundamental aspects of Biology. 
On the contrary it might be easier to use an insect model to avoid conflicts in respect of 
ethics, religion, etc.    
The cost of purchase (around £14 per kg of mealworms) and maintenance, and the level 
of sophistication in mealworm “husbandry” is relatively low. Simple experiments such as 
total protein and DNA extraction and UV light exposure to observe the morphological 
changes such as pigmentation have been performed at Liverpool UTC by students aged 
14-16 years old which provides a promising opportunity for attracting young people to 






6.1 Genomic DNA extraction 
Mealworm larvae were obtained from a local supplier (any general pet shop will suffice) 
and after removal of dead organisms and rinsing in water to remove debris, were dried 
on paper towels before freezing at -80°C and storing for at least 24 hours before DNA 
extraction. This method improved the consistency of extraction compared with grinding 
the larvae directly. Typical  mealworm larvae weigh around 150 mg, and 50 mg of 
homogenised larvae were used for genomic DNA extraction using an ISOLATE Genomic 
DNA Mini Kit (see M and M, give section no.).  
 
Figure 6.1: The analysis of genomic DNA extracted from T molitor, using the Bioline I 
Genomic DNA extraction kit followed by 1% agarose gel electrophoresis. Lane 1 (HL1) DNA 
Hyperladder I (lanes 2-6) X ul Extracted DNA (7) the wash buffer flow-through and lanes 






6.2 Methodology used to determine the nucleotide sequence of genomic 
DNA from T molitor 
In view of the specialised techniques employed, the description of the sequencing 
experiments are included in this Chapter and not Chapter 2. Mealworm DNA samples 
prepared as above, were used to generate three DNA Illumina paired-end libraries with 
different insert sizes for sequencing and downstream genome assembly. The “Illumina” 
method is one of the most common methods used to sequence whole genomes. Genomic 
DNA was sheared using the Covaris S2 sonicator and used as input material for the TruSeq 
Nano DNA LT Sample Prep Kit. The libraries were purified throughout using AMPure XP 
bead clean at a ratio of 1:1.6 sample to beads. Following 6 cycles of amplification libraries 
were purified using AMPure XP beads. Each library was quantified using Qubit. Base-
calling and de-multiplexing of indexed reads was performed by CASAVA version 1.8.2 
(Illumina) to produce sequence data, in FASTQ format. The raw FASTQ files were trimmed 
to remove Illumina adapter sequences using Cutadapt version 1.2.1. The reads were 
further trimmed to remove low quality bases. If both reads from a pair passed this filter, 
each was included in the R1 (forward reads) or R2 (reverse reads) file. If only one of a read 






Library Raw reads Trimmed reads 
(%) 
Paired (R1/ R2) 
reads 
Single (R0) reads 
(%) 
Sample_2_350 153,873,144 153,405,605 
(99.70) 
76,513,117 379,371 (0.25) 
Sample_3_550 136,112,914 135,963,239 
(99.89) 
67,921,367 120,505 (0.09) 
Sample_2_3000 130,794,224 130,180,043 
(99.53) 
64,895,761 388,521 (0.30) 
Table 6.1: summary of the read counts before and after adapter and quality trimming 
for all the samples. Percentage of the reads remaining after adapter and quality 
trimming are is shown in brackets. 
 
6.3 Preliminary sequencing data  
The primary results received to date are the raw reads of the genome (25GB of data) 
which represent sequencing data from three genomic DNA samples. The number of 
sequences produced ranges between 130-153 million short reads each. 
 Data files description 
For paired-end sequence data, there are three sequence file types (Figure 6.2). The files 
labelled R1 and R2 contain the corresponding paired-end sequences. The singlet files 
contain sequences whose pair has been removed due to poor sequence quality or adapter 
contamination. If a sample has been sequenced several times, there will be several sets 




 Sequence size for each sample 
 
Figure 6.2: A graph showing the distribution of trimmed read lengths for the forward 
strand (R1), reverse strand (R2) and singlet (R0) reads. Note that it is common for a small 
number of reads to consist of mostly adapter-derived sequence, so it is expected that the 
distribution will show a long tail. 
 
6.4 Mealworm (T. molitor) extracted genome BLASTN search results 
The received data files incorporated three repeat sequencing experiments on the 
genomic DNA. Each library comprises three raw reads: R1 (Forward reads), R2 (Reverse 
reads) and R0 for single reads, all in FASTQ format. FASTQ files were converted to FASTA 
format using Galaxy platform (Afgan et al., 2016) in order to choose an unbiased selection 
of short reads for a BLASTN search.  
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A 1000 short reads were randomly selected from each file for the three sequencing 
samples making the total short reads around 9000 with a nucleotide length range from 
45 bp to 125 bp per short read. The BLAST? search was optimised for highly similar 
sequences only (megablast) within the class Insecta (taxa ID: 50557) to avoid any 
interference or noise caused by the input sequences, as short input sequences have 
higher chance to align with sequences from organisms other than insects. 
The percentage of short reads that were found to matching sequences are around 10-
20%, i.e. for each 1000 short reads only 100-200 were found to have alignments in the 
public databases. This is probably attributed to the relatively “strict” search parameters 
employed, and the availability of sequences from similar organisms in the database, and 
of course the nature of query sequence themselves. 
55% of the total observed alignments are with sequences from T. molitor with identity 
range between 90-100%. The sequences of T. molitor were from mitogenome, satellite 
repeats and other sequences such as antifreeze protein.  
If we consider species diversity in the observed alignments, we find that over 80% of the 
alignments were with sequences from beetles (Coleoptera) order including mealworm, 
red flour beetle genome (2008) and Asian long-horned beetle genome (McKenna et al., 
2016). The rest of the alignments are from different insect orders including flies (Diptera) 





Order Family Genus  Species  
Coleoptera Tenebrionidae Tenebrio T. Molitor (Mealworm) 
Coleoptera Tenebrionidae Tribolium T. castaneum (Red flour beetle) 
Coleoptera Boridae Synercticus Synercticus spp. 
Coleoptera Cerambycidae Anoplophora A. glabripennis (Asian long-horned beetle) 
Coleoptera Silphidae Nicrophorus N. vespilloides (Burying beetle) 
Coleoptera Eucnemidae Anischia Anischia bicolor  
Coleoptera Cerylonidae Mychocerus Mychocerus spp. 
Coleoptera Scarabaeidae Onthophagus Onthophagus vinctus  
Diptera Tephritidae Bactrocera B. latifrons (Solanum fruit fly) 
Hymenoptera Formicidae Dinoponera D. quadriceps (Ants species) 
Diptera Drosophilidae Drosophila Drosophila busckii (Fruit fly species) 
Lepidoptera Saturniidae Samia Philosamia cynthia ricini (Silkmoth) 
Hemiptera Machaerotidae Pectinariophyes Pectinariophyes reticulata 
Phthiraptera Pediculidae Pediculus Pediculus humanus corporis (Body louse) 
Hymenoptera Formicidae Monomorium M. pharaonic (Pharaoh ant) 
Diptera Drosophilidae Drosophila Drosophila ficusphila (Fruit fly species) 
Diptera Tephritidae Rhagoletis Rhagoletis zephyria 
Hemiptera Cicadellidae Ulopa Ulopa reticulate 
Table 6.2: The most common insect species that were found to have sequence alignment 
with mealworm’s query sequences. Species from the same order (Coleoptera) are 
highlighted in yellow. 
6.5 Using short read to draw a phylogenetic tree 
A short read (HISEQ: 115:C6KP7ANXX/ 18S Ribosomal RNA) was selected after showing 




Figure 6.3: a gene phylogenetic tree for 18S ribosomal RNA sequence from different 
beetles of the order Coleoptera. 
Using a partial sequence of 18S ribosomal RNA gene which has a highly conserved 
function among species can draw a relatively well-ordered species tree which congregate 







 Extracted DNA Quality 
Genomic DNA samples were submitted for sequencing at the Liverpool University 
Genome Centre, and were relatively free from interfering contaminants having been and 
purified as described in Chapter II In order to circumvent the inhibition of downstream, 
enzymatic processing. A gel image of all samples, following analytical agarose gel 
electrophoresis provides a reasonable assessment of sample purity and integrity, and was 
used to “quality control” samples before submitting to sequencing. Genomic DNA was 
visible as a single prominent band >12 Kb (resolution diminishes significantly above 
fragment sizes in excess of 10kb). Samples with significant levels of degraded DNA were 
excluded (If more than one band or a smear was observed, the DNA may be degraded or 
contain components that might impair library preparation.) A low level of RNA usually 
appeared as a smear on gels, despite the use of RNase, however, it did appeared not to 
significantly interfere with sequencing. Purified DNA was dissolved in nuclease-free TE 
buffer for short and long term storage. 
 Quality of the “raw” sequence data 
Although the current sequencing data are still non-assembled, the quality of raw reads 
was interrogated and tested using three adapter trimming programs (by the service 
provider): Sickle, EAUtils and Cutadapt which has been extensively used by sequencing 
providers (Martin, 2011). 
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 Data significance 
To my knowledge this is the first attempt to obtain the nucleotide sequence the 
mealworm genome. Although the data in hand are raw data, theyare suitable for 
submission to  The Sequence Read Archive (SRA) of the NCBI database (Wheeler et al., 
2008) to allow public access,  free annotation and use. The availability of a T. molitor 
genome sequence, will facilitate the wider use of mealworm beetle in immunological 
research and go a long way in developing the insect as a new model organism.  
 Sequence alignment and phylogenetic tree 
Around 9000 short reads from all the sequencing data FASTQ files were used in a 
sequence alignment search. The read lengths was in the range between 90 to 125 
nucleotides. A highly constrained search was performed where BLASTN was limited to 
insects sequences in the database,s and only those  sequences with an identity index of 
95% or more. From each data file around 23% were found to show an alignment via NCBI 
blastn. Around 99% of the alignments were to satellite DNA from T. molitor. Tenebrio 
molitor contains an unusually abundant and homogeneous fraction of satellite DNA, 
which constitutes up to 60% of its genome (Davis and Wyatt, 1989). The remaining aligned 
sequences came from T. molitor mitochondrial DNA and other insects including species 
of beetles and fruit flies. 
The E-value was in the range of 1e-58 to 9e-5 for the observed alignments. Most of the 
aligned sequences with high E-value were those of conserved genes from other insects 
(e.g. Bactrocera latifrons: basic-leucine zipper transcription factor D gene) or T. molitor 
specific sequences (e.g. Tenebrio molitor: antifreeze protein BST1 (BST1) gene). The 
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identity score in both examples were 94% and 100% respectively, which may indicate that 
however the E-value was at the high end, it is still identical to well-known conserved genes 
from other insects or the mealworm’s own gene sequences. The identical alignments (i.e. 
100%) were from T. Molitor mitochondrial genome (Liu and Wang, 2014) and ribosomal 
RNA genes and DNA satellite repeats (Davis and Wyatt, 1989) which may be helpful in a 
school based blastn searches for confirming the identity of the DNA under investigation 
(say by a PCR experiment).  
Although there was considerable difficulty experienced in assembling the data in hand, 
on a genome level a simple NCBI blast search could be used to answer simple questions 
in a school environment, where students can take “ownership” of the project and learn 
about the importance of DNA sequencing and the value of sequence alignments in 
modern biological research. In this case a single or multiple short sequences could be used 
to answer questions such as  “to what organism does this sequences belong?” and “how 
similar is this sequence to others from other organisms?” and the significance of sequence 
similarity in understanding evolution by using a partial sequence as shown in the 
phylogenetic tree of  18S ribosomal RNA sequence. 
The demand for animal protein is expected to rise by 70–80% in the next five decades and 
mealworm is a suggested as a more sustainable source of protein (Adams, 2008). Simple 
lifecycle, protein extraction, DNA sequencing and bioinformatics experiments can help to 










7.1 Analysis of the badger transcriptome  
De novo transcriptome assembly can provide large amounts of data from which it is 
possible to build a preliminary platform for a future, total genome sequencing 
programme. These large data sets have become much easier to generate as a result of 
the simplification and cost reductions in NGS technology. Furthermore, the data we have 
obtained in this study, can be also used in further studies to explore the immune 
components of the badger’s transcriptome, which represents another step in 
understanding the tolerance exhibited by the badger to infectious diseases such as bovine 
tuberculosis. However, in such a scenario it would be desirable to perform a parallel 
programme of sequencing of the blood transcriptome derived from an infected animal. 
Whilst this was an initial aim of this thesis, insurmountable logistical barriers prevented 
this work from being undertaken.  
In comparison with the giant panda (Ailuropoda melanoleuca) transcriptome analysis (Du 
et al., 2015) the Illumina sequencing experiment produced approximately 3.52 Gb of 
“clean” sequence data, which was assembled into 238,295 transcripts using a de novo 
transcriptome assembly without access to a reference genome. This compares with 
92,598 for the panda. The average length of the assembled transcripts was 1281bp with 
N50 over 2720bp long. The mean length of the panda transcripts was 1626 bp with N50 
of 2842 bp. The number of annotated transcripts for the panda was 38,726 whereas 
95,245 of badger’s transcripts were annotated using BLAST searches against public 
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databases. These annotated transcripts will provide a valued resource for improving the 
sequencing and annotation of the badger’s complete genomic DNA. The rationale behind 
the using the giant panda to compare with the badger is that the panda was the closest 
mammal to badger in terms or RNA sequence similarity and sequence function prediction 
in the transcriptome annotation. Moreover, the comparison was between two peripheral 
blood transcriptome analyses data which might eliminating the tissue expression level 
difference bias as it would be difficult to compare two different tissue transcriptomes 
from two animals. Eckalbar et al., (2013) achieved similar improvement through 
reannotation of the genomic DNA of the green anole lizard by transcriptome sequencing. 
E-value distribution in the NR database showed that 39% of the aligned transcripts exhibit 
a highly significant homology (<1.0E-100) whereas for the panda’s transcriptome, about 
44% of the transcripts have similar homology. Over 70% of both badger and panda 
transcripts achieved a similarity of 80% or more. The most important observation in this 
comparison is that, despite the panda’s genome and mitochondrial DNA being sequenced, 
the NR alignment of the panda’s transcripts give only 51% identity to the panda as the 
closest match, whereas for the badger 70% of the transcripts where aligned to five 
mammals with their genome already sequenced. 
The GO annotation was performed to explore the assembled transcriptome and the 
results reflected a functional diversity of the transcripts in the three main categories of 
GO terms. The GO annotation seems consistent with similar results from a GO comparison 
of giant panda and polar bear blood transcriptomes by et al., (2015).  
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The mapping of assembled genes with pathway annotation to the KEGG database resulted 
in assigning those reads to 259 pathways compared to 324 KEGG pathways identified 
from the panda’s transcriptome. Among the highest representation are metabolic 
pathways, at 97% (9930), Focal adhesion 7.61% (7582), Amoebiasis 7.17% (7136), ECM-
receptor interaction 5.94% (5918), Protein digestion and absorption 5.65% (5623), RNA 
transport 4.17% (4158), Regulation of actin cytoskeleton 4.02% (4001), Pathways in 
cancer 3.88% (3862) and Herpes simplex infection 3.22% (3209). In addition to the major 
pathways represented by the transcripts in Chapter III there are other 239 pathways 
shown in the appendix including some infectious diseases pathways like influenza A, 
measles, toxoplasmosis and tuberculosis. 
A search in the Cluster of Orthologous Groups (COG) database was performed, in order 
to uncover the homologous relationships of the transcriptome to well-known conserved 
domains. Most of the transcripts were matched to the major groups of (Cellular Processes 
and Signalling), (Information Storage and Processing) and (Metabolism). However, there 
was also some transcripts classified as (Poorly Characterized) which includes 22,329 
transcripts under (General function prediction only) and 11,305 transcripts under 
(Function unknown) categories. 
A phylogenetic (evolutionary) tree is a representation of the evolutionary relationships 
among a set of organisms known as taxa. It is important to recognise that if the 
phylogenetic tree is computed from data derived from a single gene (gene tree) is 
sometimes different from a whole-genome tree (species tree). One of the important 
factors that cause this difference is genetic polymorphism in the ancestral species (Pamilo 
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and Nei, 1988). Even under standardised alignment parameters different genes provide 
different levels of speciation leading to formation of different trees. This could be useful 
in studying the evolution of a single gene and its variants but also could be misleading 
when studying a whole organism despite the fact that our alignments always show badger 
or ferret is the closest because that’s in part true but is also what is available in the 
database.  
MHC genes are highly diverse both within species and among species. The identity range 
of the first hits in the protein alignment is between 74% and 100% which, despite the 
length of both query and subject sequences showed regions of highly conserved 
sequences which revealed the intra-species similarities and few regions of less conserved 
regions, which may reflect the diversity of MHC genes. However, this can perhaps be more 
easily observed through sequencing the full length of the gene of interest. In a comparison 
of the abundance of MHC transcripts it was found that the badger has higher expression 
levels of both classes of MHC genes. Although, this result may require further 
experimental investigation, it may reflect the findings of other work where MHC genes 
diversity is much lower in this endangered species (Zhang et al., 2015) and the diversity 




7.2 Data from the immune component of the badger’s transcriptome 
The search using the IKB immunome database (Ortutay et al., 2007) as a reference for 
immunity-related  genes, revealed that 698 out of IKB’s 893 immunity genes have 11724 
annotations and 195 have no match to the badger’s transcriptome. 
The total 919 annotations of immunoglobulins in three databases do show a similarity to 
genes from different mammals; mainly: giant panda, ferret, dog and human. Swiss-Prot 
annotation of immunoglobulin-related transcripts showed over 84% similarity of the 
transcripts to human immunoglobulin in terms of predicted function. Immunoglobulin 
heavy and light chains are composed of constant and variable regions and the amino-
terminal variable or V domains of the heavy and light chains together make up the V 
region of the antibody and confer upon it the ability to bind specific antigen(s) (Janeway, 
2001). The 75 transcripts that matches the variable genes by annotation, showed a 
similarity to Mustela putorius furo (Ferret), Canis lupus familiaris (Dog), Files catus (Cat) 
and Homo sapiens (Human). However, KEGG annotation showed that 14 transcripts could 
not be mapped to any known pathological pathway and that some mapped to pathways 
from Bos taurus (Cow) and Monodelphis domestica (Opossum). Both mammals can 
acquire bTB infection.  
KEGG pathway annotation for both M. bovis and M. tuberculosis infection inside their 
hosts showed that 183 mammalian genes are involved in the pathogenesis of the 
diseases. 1825 transcripts from the badger were found to correspond to 147 of those 183 
genes that are involved in bTB pathway from the early infection until cell death.  
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Interestingly, only sequences encoding the subunits of IL-6, INFα and INFβ receptors were 
found in the annotated transcriptome.  Production of interferons occurs mainly in 
response to infection, and the inability to detect their presence in the transcriptome 
might be explained by the fact that the animals had been maintained for their life course 
in a (disease-free) controlled environment. The Mincle receptor is essential for the 
detection of microbial glycolipids, and it has been found that Mincle-dependent 
macrophage activation is regulated by IL-4, which leads to a strong downregulation of 
expression of Mincle mRNA (Hupfer et al., 2016). 24 transcripts were annotated as IL-4 
and signal transducer and activator of transcription 6 which might explain the undetected 
presence of Mincle transcripts.  
A phylogeny is a "tree", which estimates the "historical" connections between species or 
genes that they carry. Five different transcripts were used to construct gene phylogenies 
compared to other fifty animals from different classes and orders.  "Gene" trees represent 
the evolutionary history of the genes included in the study and provide evidence for gene 
duplication events, as well as speciation events by including different homologues in a 
gene tree and clustering orthologues to demonstrate the evolutionary history of the gene 
orthologues. 
7.3 Gender differences in gene expression 
Transcriptome analysis has showed that sexual dimorphism in gene expression was much 
greater than previously recognized, since thousands of genes showed sexual dimorphism 
in liver, adipose, and muscle where the sexually dimorphic genes were also found to be 
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highly tissue-specific (Yang et al., 2006).  Over 12% of transcripts were found upregulated 
in the male badger while 87% of transcripts were downregulated when compared to the 
female badger. 
Although it cannot anticipated whether the observed differential expression between 
male and female badgers is a direct result of the hormonal effect, and despite the fact 
that these data were from uninfected animals, some of the expression levels difference 
were consistent with the biological differences between the sexes and their susceptibility 
to tuberculosis 
7.4 Implications for the evolution of the European Badger 
The phylogenetic gene-trees were constructed using molecular data with no regard to 
morphological, behavioural or any other type of data. In the construction of gene trees 
only transcripts were used, which may neglect some important inputs drawn by non-
coding sequences or the whole genome. However, the phylogenetic trees generated by 
those transcripts managed to some extent place the badger in the appropriate (by 
consensus) position in terms of gene speciation i.e. within the Mustelidae family. 
Although these trees show the approximate speciation process which led to the 
emergence of species, families and orders they do not show the exact chronological order 
for the evolution of these taxa.   
Gene-trees showed that phylogenetics can add biological meaning to the data. It is 
important to keep in mind that a single line on the phylogeny is in fact a population, and 
populations can have genetic variation. These gene variations represented as paralogs 
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which resulted from duplication of homologues within the genome and orthologues 
which are defined as evolutionary counterparts derived from a single ancestral gene in 
the last common ancestor of the given two species (Koonin and Galperin, 2003). The 
genetic variations within the population can affect the outcome of the phylogenetic 
conclusion when single sequence is used to build the tree. Some immunity genes are 
highly polymorphic and different hosts usually have different genotypes and thereby 
recognize different spectrums of pathogens. However, even with such variability it is still 
possible to produce this phylogeny.  
Moreover, the limited availability of sequenced data from other related mammals can 
also contribute to the position of badger in the evolutionary timeline. However, it is still 
possible to make a reasonable, albeit tentative, judgement from such high quality data. 
The anatomical records place the Eurasian badger within the mustelid subfamily where it 
is closely related to the hog badger (Marmi et al., 2006), and this could be either 
sustained, shifted or changed when the whole genome is sequenced. In conclusion, whilst 
the transcriptome data point to the position of the badger, the definitive position must 
await the publication of the badger genome. 
7.5  The data from the mealworm 
The characteristics and the ease of handling of the mealworm make it a suitable choice 
as a model organism in biological and evolutionary research, which in turn made obtaining 
the full genomic data of the organism an experimental priority (Liu and Wang, 2014). 
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To my knowledge this is the first attempt to sequence the mealworm genome. Although 
the data in hand are at this stage “raw” data, they will shortly be submitted to The 
Sequence Read Archive (SRA) of NCBI database (Wheeler et al., 2008) to allow public 
access and free annotation and use. 
As previously mentioned in the introduction, the mealworm has a number of advantages 
that support its selection as another model organism. Phenomena ranging from variable 
temperature tolerance to the ease of induction of infection can be easily investigated and 
combined with a full omics based approach.  The availability of the T. molitor genome will 
facilitate the use of mealworm beetle in immunological research and in developing the 
insect as a new model organism for as yet, undetermined areas of Biology. As a very 
attractive by-product of this work, we have been able to succeed in making this model 
organism a suitable choice as a model organism for introducing school students to 
Systems Biology. This development well also help widening the spectrum of available 
model organisms leading to an increase in experimental variability and a decrease in bias. 
Although there was some difficulty encountered in assembling the data in hand on a 
genome level: a simple NCBI blast search could be used to answer simple question in a 
school environment where students can own the project and learn about the importance 
of DNA sequencing and sequence alignment significance in modern biological research. 
In this case  single or multiple short sequences could be used to answer questions like “to 
what organism does this sequences belong?” and “how similar is this sequence to others 
from other organisms?” and the significance of sequence similarity in understanding 
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evolution by using a partial sequence as shown in the phylogenetic tree of  18S ribosomal 
RNA sequence. 
In addition, the demand for animal protein is expected to rise by 70–80% in the next five 
decades and mealworm is a suggested as a more sustainable source of protein (Adams, 
2008). Simple lifecycle, protein extraction, DNA sequencing and bioinformatics 
experiments can help to draw young people’s attention and acceptance for this possible 
futuristic food. 
 
7.6 Limitations and proposed work  
Current  transcriptome analysis data alone do not provide an explanation for the 
mechanism, by which badgers develop a tolerance to bTB, or indeed what makes them 
effectively transmit the disease to other animals within the badger population or among 
farms. Moreover, the current data do not provide a prevention or treatment strategy for 
both wild and domestic animals. However, it still can be argued that these data can 
contribute to long-term future work such as genome sequencing. Furthermore, the 
available data encourage a further investigation of the badger immunome through a 
transcriptomic comparison between healthy and bTB infected animals.  
The observed similarity between the badger’s bTB-related transcripts that aligned to 
KEGG pathway of both bTB and Human tuberculosis would encourage a prospective study 
of the difference in the key genes in bTB in badgers, cow and human. The available 
transcriptome-immunome would facilitate designing further experiments (e.g. isolation 
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and amplification of specific proteins to study their interaction with the pathogen). 
Moreover, the identification of some variable regions genes with no mention of their 
annotation in the public databases could be a platform for further research to find if they 
play a role that is unique to the badger’s immunoglobulins through specific binding to 
mycobacterial antigens. This can be achieved through a variety of techniques used in 
antibody research including monoclonal and polyclonal antibody production and phage 
display research. 
Simultaneous RNA sequencing (also known as dual RNA-seq) of both mycobacteria and 
badger can be another approach to study the changes in gene expression in both 
organisms along with interactions among the products of those genes during the course 
of infection. However, dual RNA-seq for bTB should be carefully planned in terms of the 
sequencing time and whether a repeated sequencing is required for different stages of 
the disease. Such a procedure could be relatively expensive in an infectious disease that 
exhibits variable manifestation varying from active to latent tuberculosis.  
Single-cell transcriptome analysis which another economical approach that can yield a 
high-throughput, high-resolution transcriptomic analysis of cell states and dynamics (Liu 
and Trapnell, 2016). Single-cell transcriptome analysis has the possibility of shedding the 
light on macrophages behaviour during the course of infection and their possibility to 
override the phagosome/lysosome fusion inhibition effect induced by mycobacteria and 
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8.2 BLASTN output (tabular) 













JQ425440.1 CL1150.Contig16_All 90.12 506 0 848 972 MHC I 
JQ425440.1 CL1150.Contig16_All 87.46 295 2.00E-92 848 972 MHC I 
JQ425440.1 CL1150.Contig4_All 89.33 506 2.00E-180 848 702 MHC I 
JQ425440.1 CL1150.Contig15_All 92.87 421 4.00E-173 848 450 MHC I 
JQ425440.1 CL1150.Contig14_All 95.42 306 5.00E-137 848 540 MHC I 
JQ425440.1 CL1150.Contig14_All 96.19 105 6.00E-42 848 540 MHC I 
JQ425440.1 CL1150.Contig7_All 89.56 297 1.00E-103 848 399 MHC I 
JQ425440.1 CL1150.Contig18_All 88.47 295 2.00E-97 848 417 MHC I 
JQ425440.1 CL1150.Contig17_All 87.46 295 2.00E-92 848 420 MHC I 
JQ425440.1 CL1150.Contig13_All 85.14 296 8.00E-81 848 426 MHC I 
JQ425440.1 CL1150.Contig8_All 94.51 182 1.00E-74 848 507 MHC I 
JQ425440.1 CL1150.Contig8_All 96.19 105 6.00E-42 848 507 MHC I 
JQ425440.1 CL1150.Contig5_All 85.8 162 6.00E-42 848 198 MHC I 
JQ425440.1 Unigene117550_All 100 83 2.00E-36 848 171 MHC I 
JQ425440.1 Unigene12618_All 100 83 2.00E-36 848 171 MHC I 
JQ425440.1 Unigene26995_All 100 73 8.00E-31 848 126 MHC I 
JQ425440.1 CL1793.Contig7_All 85.53 76 4.00E-14 848 297 MHC I 
JQ425440.1 CL1793.Contig5_All 85.53 76 4.00E-14 848 297 MHC I 
JQ425440.1 CL1793.Contig3_All 85.53 76 4.00E-14 848 297 MHC I 
JQ425440.1 CL1793.Contig2_All 85.53 76 4.00E-14 848 297 MHC I 
JQ425439.1 CL1150.Contig16_All 90.04 562 0 932 972 MHC I 
JQ425439.1 CL1150.Contig16_All 87.46 295 2.00E-92 932 972 MHC I 
JQ425439.1 CL1150.Contig4_All 89.09 550 0 932 702 MHC I 
JQ425439.1 CL1150.Contig15_All 91.25 297 8.00E-111 932 450 MHC I 
JQ425439.1 CL1150.Contig15_All 96.85 127 4.00E-54 932 450 MHC I 
JQ425439.1 CL1150.Contig7_All 89.6 298 4.00E-104 932 399 MHC I 
JQ425439.1 CL1150.Contig18_All 88.47 295 2.00E-97 932 417 MHC I 
JQ425439.1 CL1150.Contig17_All 87.46 295 2.00E-92 932 420 MHC I 
JQ425439.1 CL1150.Contig13_All 85.14 296 8.00E-81 932 426 MHC I 
JQ425439.1 CL1150.Contig8_All 94.54 183 3.00E-75 932 507 MHC I 
JQ425439.1 CL1150.Contig8_All 96.19 105 7.00E-42 932 507 MHC I 
JQ425439.1 CL1150.Contig14_All 94.51 182 1.00E-74 932 540 MHC I 
JQ425439.1 CL1150.Contig14_All 96.85 127 4.00E-54 932 540 MHC I 
JQ425439.1 CL1150.Contig14_All 96.19 105 7.00E-42 932 540 MHC I 
JQ425439.1 CL1150.Contig5_All 85.8 162 7.00E-42 932 198 MHC I 
JQ425439.1 Unigene117550_All 100 84 7.00E-37 932 171 MHC I 
JQ425439.1 Unigene12618_All 100 84 7.00E-37 932 171 MHC I 
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JQ425439.1 Unigene26995_All 100 73 9.00E-31 932 126 MHC I 
JQ425439.1 CL1793.Contig7_All 85.53 76 4.00E-14 932 297 MHC I 
JQ425439.1 CL1793.Contig5_All 85.53 76 4.00E-14 932 297 MHC I 
JQ425439.1 CL1793.Contig3_All 85.53 76 4.00E-14 932 297 MHC I 
JQ425439.1 CL1793.Contig2_All 85.53 76 4.00E-14 932 297 MHC I 
JQ425438.1 CL1150.Contig16_All 90.8 848 0 900 972 MHC I 
JQ425438.1 CL1150.Contig4_All 91.31 587 0 900 702 MHC I 
JQ425438.1 CL1150.Contig15_All 96.91 324 1.00E-153 900 450 MHC I 
JQ425438.1 CL1150.Contig17_All 90.17 417 2.00E-152 900 420 MHC I 
JQ425438.1 CL1150.Contig18_All 89.42 416 6.00E-147 900 417 MHC I 
JQ425438.1 CL1150.Contig13_All 87.5 424 7.00E-136 900 426 MHC I 
JQ425438.1 CL1150.Contig7_All 88.89 387 2.00E-132 900 399 MHC I 
JQ425438.1 CL1150.Contig8_All 92.72 261 1.00E-103 900 507 MHC I 
JQ425438.1 CL1150.Contig14_All 93.89 180 6.00E-72 900 540 MHC I 
JQ425438.1 CL1150.Contig24_All 92.26 155 2.00E-56 900 156 MHC I 
JQ425438.1 CL1150.Contig23_All 92.26 155 2.00E-56 900 156 MHC I 
JQ425438.1 CL1150.Contig3_All 92.26 155 2.00E-56 900 156 MHC I 
JQ425438.1 CL1150.Contig1_All 92.26 155 2.00E-56 900 156 MHC I 
JQ425438.1 CL1150.Contig2_All 91.67 156 3.00E-55 900 159 MHC I 
JQ425438.1 CL1150.Contig22_All 99.09 110 1.00E-49 900 360 MHC I 
JQ425432.1 CL1150.Contig16_All 92.08 972 0 975 972 MHC I 
JQ425432.1 CL1150.Contig4_All 93.28 699 0 975 702 MHC I 
JQ425432.1 CL1150.Contig15_All 96.91 324 1.00E-153 975 450 MHC I 
JQ425432.1 CL1150.Contig17_All 89.69 417 4.00E-149 975 420 MHC I 
JQ425432.1 CL1150.Contig18_All 89.42 416 6.00E-147 975 417 MHC I 
JQ425432.1 CL1150.Contig13_All 87.5 424 8.00E-136 975 426 MHC I 
JQ425432.1 CL1150.Contig7_All 88.89 387 2.00E-132 975 399 MHC I 
JQ425432.1 CL1150.Contig8_All 93.1 261 3.00E-105 975 507 MHC I 
JQ425432.1 CL1150.Contig14_All 94.44 180 1.00E-73 975 540 MHC I 
JQ425432.1 CL1150.Contig24_All 92.9 155 5.00E-58 975 156 MHC I 
JQ425432.1 CL1150.Contig23_All 92.9 155 5.00E-58 975 156 MHC I 
JQ425432.1 CL1150.Contig3_All 92.9 155 5.00E-58 975 156 MHC I 
JQ425432.1 CL1150.Contig1_All 92.9 155 5.00E-58 975 156 MHC I 
JQ425432.1 CL1150.Contig2_All 92.31 156 7.00E-57 975 159 MHC I 
JQ425432.1 CL1150.Contig22_All 100 110 3.00E-51 975 360 MHC I 
JQ425433.1 CL1150.Contig16_All 94.44 972 0 975 972 MHC I 
JQ425433.1 CL1150.Contig4_All 98.71 699 0 975 702 MHC I 
JQ425433.1 CL1150.Contig15_All 98.15 324 3.00E-160 975 450 MHC I 
JQ425433.1 CL1150.Contig17_All 89.45 417 2.00E-147 975 420 MHC I 
JQ425433.1 CL1150.Contig18_All 89.18 416 3.00E-145 975 417 MHC I 
JQ425433.1 CL1150.Contig13_All 87.47 423 8.00E-136 975 426 MHC I 
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JQ425433.1 CL1150.Contig7_All 88.37 387 4.00E-129 975 399 MHC I 
JQ425433.1 CL1150.Contig8_All 91.95 261 3.00E-100 975 507 MHC I 
JQ425433.1 CL1150.Contig14_All 92.78 180 1.00E-68 975 540 MHC I 
JQ425433.1 CL1150.Contig2_All 94.23 156 7.00E-62 975 159 MHC I 
JQ425433.1 CL1150.Contig24_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425433.1 CL1150.Contig23_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425433.1 CL1150.Contig3_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425433.1 CL1150.Contig1_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425431.1 CL1150.Contig16_All 91.98 972 0 975 972 MHC I 
JQ425431.1 CL1150.Contig4_All 92.7 699 0 975 702 MHC I 
JQ425431.1 CL1150.Contig15_All 96.91 324 1.00E-153 975 450 MHC I 
JQ425431.1 CL1150.Contig17_All 90.17 417 2.00E-152 975 420 MHC I 
JQ425431.1 CL1150.Contig18_All 89.42 416 6.00E-147 975 417 MHC I 
JQ425431.1 CL1150.Contig13_All 87.5 424 8.00E-136 975 426 MHC I 
JQ425431.1 CL1150.Contig7_All 88.89 387 2.00E-132 975 399 MHC I 
JQ425431.1 CL1150.Contig8_All 92.72 261 1.00E-103 975 507 MHC I 
JQ425431.1 CL1150.Contig14_All 93.89 180 7.00E-72 975 540 MHC I 
JQ425431.1 CL1150.Contig24_All 92.26 155 3.00E-56 975 156 MHC I 
JQ425431.1 CL1150.Contig23_All 92.26 155 3.00E-56 975 156 MHC I 
JQ425431.1 CL1150.Contig3_All 92.26 155 3.00E-56 975 156 MHC I 
JQ425431.1 CL1150.Contig1_All 92.26 155 3.00E-56 975 156 MHC I 
JQ425431.1 CL1150.Contig2_All 91.67 156 3.00E-55 975 159 MHC I 
JQ425431.1 CL1150.Contig22_All 99.09 110 1.00E-49 975 360 MHC I 
JQ425430.1 CL1150.Contig16_All 93.44 975 0 975 972 MHC I 
JQ425430.1 CL1150.Contig4_All 93.87 702 0 975 702 MHC I 
JQ425430.1 CL1150.Contig17_All 90.41 417 4.00E-154 975 420 MHC I 
JQ425430.1 CL1150.Contig18_All 90.14 416 6.00E-152 975 417 MHC I 
JQ425430.1 CL1150.Contig15_All 96.6 324 6.00E-152 975 450 MHC I 
JQ425430.1 CL1150.Contig13_All 88.42 423 2.00E-142 975 426 MHC I 
JQ425430.1 CL1150.Contig7_All 89.41 387 8.00E-136 975 399 MHC I 
JQ425430.1 CL1150.Contig8_All 91.95 261 3.00E-100 975 507 MHC I 
JQ425430.1 CL1150.Contig14_All 92.78 180 1.00E-68 975 540 MHC I 
JQ425430.1 CL1150.Contig2_All 94.23 156 7.00E-62 975 159 MHC I 
JQ425430.1 CL1150.Contig24_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425430.1 CL1150.Contig23_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425430.1 CL1150.Contig3_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425430.1 CL1150.Contig1_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425430.1 CL7631.Contig3_All 91.84 98 3.00E-31 975 108 MHC I 
JQ425430.1 CL1150.Contig22_All 84.68 111 6.00E-23 975 360 MHC I 
JQ425429.1 CL1150.Contig16_All 95.16 972 0 975 972 MHC I 
JQ425429.1 CL1150.Contig4_All 98 699 0 975 702 MHC I 
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JQ425429.1 CL1150.Contig15_All 98.15 324 3.00E-160 975 450 MHC I 
JQ425429.1 CL1150.Contig17_All 89.45 417 2.00E-147 975 420 MHC I 
JQ425429.1 CL1150.Contig18_All 89.18 416 3.00E-145 975 417 MHC I 
JQ425429.1 CL1150.Contig13_All 87.47 423 8.00E-136 975 426 MHC I 
JQ425429.1 CL1150.Contig7_All 88.37 387 4.00E-129 975 399 MHC I 
JQ425429.1 CL1150.Contig8_All 91.95 261 3.00E-100 975 507 MHC I 
JQ425429.1 CL1150.Contig14_All 92.78 180 1.00E-68 975 540 MHC I 
JQ425429.1 CL1150.Contig2_All 94.23 156 7.00E-62 975 159 MHC I 
JQ425429.1 CL1150.Contig24_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425429.1 CL1150.Contig23_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425429.1 CL1150.Contig3_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425429.1 CL1150.Contig1_All 93.55 155 1.00E-59 975 156 MHC I 
JQ425428.1 CL1150.Contig16_All 94.32 546 0 543 972 MHC I 
JQ425428.1 CL1150.Contig4_All 92.49 546 0 543 702 MHC I 
JQ425428.1 CL1150.Contig22_All 85.59 111 7.00E-25 543 360 MHC I 
JQ425427.1 CL1150.Contig4_All 93.59 546 0 543 702 MHC I 
JQ425427.1 CL1150.Contig16_All 93.04 546 0 543 972 MHC I 
JQ425427.1 CL1150.Contig22_All 85.59 111 7.00E-25 543 360 MHC I 
JQ425427.1 CL1150.Contig22_All 97.06 68 2.00E-24 543 360 MHC I 
HQ908107.1 Unigene57188_All 97.18 674 0 680 795 MHC II 
HQ908107.1 Unigene67843_All 97.23 650 0 680 651 MHC II 
HQ908107.1 Unigene75449_All 97.28 551 0 680 774 MHC II 
HQ908107.1 Unigene75450_All 82.72 654 7.00E-160 680 774 MHC II 
HQ908107.1 CL4065.Contig3_All 82.86 566 1.00E-142 680 693 MHC II 
HQ908107.1 Unigene27967_All 80.07 552 3.00E-113 680 774 MHC II 
HQ908107.1 Unigene4377_All 100 96 1.00E-43 680 96 MHC II 
HQ908107.1 CL4065.Contig4_All 100 96 1.00E-43 680 96 MHC II 
HQ908107.1 CL4065.Contig2_All 100 96 1.00E-43 680 96 MHC II 
HQ908107.1 CL4065.Contig1_All 100 96 1.00E-43 680 96 MHC II 
HQ908099.1 CL2981.Contig3_All 99.27 688 0 691 762 MHC II 
HQ908099.1 CL2981.Contig1_All 99.27 688 0 691 762 MHC II 
HQ908099.1 Unigene42913_All 99.67 603 0 691 603 MHC II 
HQ908098.1 CL10050.Contig3_All 99.67 615 0 615 765 MHC II 
HQ908098.1 CL10050.Contig2_All 100 582 0 615 582 MHC II 
HQ908098.1 CL10050.Contig1_All 100 582 0 615 582 MHC II 
HQ908097.1 CL10050.Contig3_All 91.73 617 0 615 765 MHC II 
HQ908097.1 CL10050.Contig2_All 91.61 584 0 615 582 MHC II 
HQ908097.1 CL10050.Contig1_All 91.61 584 0 615 582 MHC II 
HQ908096.1 Unigene57188_All 99.7 674 0 697 795 MHC II 
HQ908096.1 Unigene67843_All 99.85 650 0 697 651 MHC II 
HQ908096.1 Unigene75449_All 97.28 551 0 697 774 MHC II 
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HQ908096.1 Unigene75450_All 85.32 654 0 697 774 MHC II 
HQ908096.1 CL4065.Contig3_All 83.25 573 3.00E-148 697 693 MHC II 
HQ908096.1 Unigene27967_All 80.07 552 4.00E-113 697 774 MHC II 
HQ908096.1 Unigene4377_All 100 96 1.00E-43 697 96 MHC II 
HQ908096.1 CL4065.Contig4_All 100 96 1.00E-43 697 96 MHC II 
HQ908096.1 CL4065.Contig2_All 100 96 1.00E-43 697 96 MHC II 
HQ908096.1 CL4065.Contig1_All 100 96 1.00E-43 697 96 MHC II 
HQ908095.1 Unigene27967_All 94.83 774 0 822 774 MHC II 
HQ908095.1 Unigene75450_All 94.6 741 0 822 774 MHC II 
HQ908095.1 CL4065.Contig3_All 96.64 684 0 822 693 MHC II 
HQ908095.1 Unigene75449_All 80.62 774 1.00E-168 822 774 MHC II 
HQ908095.1 Unigene57188_All 79.89 741 2.00E-151 822 795 MHC II 
HQ908095.1 Unigene67843_All 80.7 596 4.00E-128 822 651 MHC II 
HQ908095.1 Unigene81593_All 93.62 94 6.00E-32 822 93 MHC II 
HQ908094.1 Unigene27967_All 99.22 774 0 822 774 MHC II 
HQ908094.1 Unigene75450_All 97.17 672 0 822 774 MHC II 
HQ908094.1 CL4065.Contig3_All 97.17 672 0 822 693 MHC II 
HQ908094.1 Unigene75449_All 84.09 773 0 822 774 MHC II 
HQ908094.1 Unigene57188_All 79.88 671 5.00E-137 822 795 MHC II 
HQ908094.1 Unigene67843_All 80.8 526 1.00E-113 822 651 MHC II 
HQ908094.1 Unigene81593_All 93.62 94 6.00E-32 822 93 MHC II 
HQ908093.1 Unigene27967_All 99.48 774 0 822 774 MHC II 
HQ908093.1 Unigene75450_All 97.62 672 0 822 774 MHC II 
HQ908093.1 CL4065.Contig3_All 97.62 672 0 822 693 MHC II 
HQ908093.1 Unigene75449_All 83.44 773 0 822 774 MHC II 
HQ908093.1 Unigene57188_All 79.28 671 2.00E-130 822 795 MHC II 
HQ908093.1 Unigene67843_All 80.04 526 5.00E-107 822 651 MHC II 
HQ908092.1 Unigene27967_All 96.51 774 0 822 774 MHC II 
HQ908092.1 Unigene75450_All 92.31 741 0 822 774 MHC II 
HQ908092.1 CL4065.Contig3_All 94.79 672 0 822 693 MHC II 
HQ908092.1 Unigene75449_All 81.57 776 2.00E-180 822 774 MHC II 
HQ908092.1 Unigene57188_All 76.85 743 4.00E-113 822 795 MHC II 
HQ908092.1 Unigene67843_All 77.09 598 2.00E-91 822 651 MHC II 
HQ908092.1 CL13896.Contig1_All 100 96 1.00E-43 822 96 MHC II 













Reference: Zheng Zhang, Scott Schwartz, Lukas Wagner, and Webb 
Miller (2000), "A greedy algorithm for aligning DNA sequences", J 









Query= JQ425440.1 Meles meles MHC class I antigen (Meme-MHCI) pseudogene 
mRNA, Meme-MHCI*PS03 allele, partial sequence 
 
Length=848 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  654     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  632     2e-180 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  608     4e-173 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  488     5e-137 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  377     1e-103 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  357     2e-97  
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  340     2e-92  
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  302     8e-81  
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  281     1e-74  
CL1150.Contig5_All  2 199 minus strand MHC class I antigen [Bos t...  172     6e-42  
Unigene117550_All  775 945 PREDICTED: patr class I histocompatibi...  154     2e-36  
Unigene12618_All  419 589 PREDICTED: patr class I histocompatibil...  154     2e-36  
Unigene26995_All  2 127 minus strand DLA class I histocompatibili...  135     8e-31  
CL1793.Contig7_All  65 361 minus strand PREDICTED: MHC class I po...  80.5    4e-14  
CL1793.Contig5_All  65 361 minus strand PREDICTED: MHC class I po...  80.5    4e-14  
CL1793.Contig3_All  65 361 PREDICTED: MHC class I polypeptide-rel...  80.5    4e-14  




Query_1              25   GGCGGCGAGGAGCCGCGCTTCATCTCCGTCGGCTACGTGGACTTCACGCAGTTCGTGCGG  84 
CL1150.Contig16_All  58   GGCCGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGG  117 
CL1150.Contig4_All   49   GGCCGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGG  108 
 
Query_1              85   TTCGACAGCGACTCTGCCAGTCAGAGAAGGA-GGAGCCGCGGGCGCCGTAAGTGGAGCAG  143 
CL1150.Contig16_All  118  TTCGACAGCGACTCTGCCAGTC-G-G-AGGATGGAGCCGCGGGCGCCGTGGATGGAGCAG  174 
CL1150.Contig4_All   109  TTCGACAGCGACTCTGCCAGTC-G-GA-GGATGGAGCCGCGGGCGCCGTGGATGGAGCAG  165 
 
Query_1              144  GAGGGGCCGGAGTATTGGGACGAGGAGACGCGGATCTGCAAGGAAACCACACAGACTTAC  203 
CL1150.Contig16_All  175  GAGGGGCCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTAC  234 
CL1150.Contig4_All   166  GAGGGGCCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTAC  225 
 
Query_1              204  CGAGGGAGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGAGGCCGGGTCTCACACC  263 
CL1150.Contig16_All  235  CGAGGGAGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACC  294 
CL1150.Contig4_All   226  CGACGGAGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACC  285 
 
Query_1              264  ATCCAGCGCATGTACGGCTGTGACGTGGGGCCCGACGGGCGCCTCCTCCGCGGGTACAGT  323 
CL1150.Contig16_All  295  ATCCAGAACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGT  354 
CL1150.Contig4_All   286  TTCCAGAACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGT  345 
 
Query_1              324  CAGGACGCCTACGACGGCGCGGATTACCTCACCCTGAACGAGGACCTGCGCTCCTGGACC  383 
CL1150.Contig16_All  355  CAGTTCGCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACC  414 
CL1150.Contig4_All   346  CAGTTCGCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACC  405 
 
Query_1              384  GCGGCGGATGCGTCGGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGAGGCAGAG  443 
CL1150.Contig16_All  415  GCGGCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAG  474 
CL1150.Contig4_All   406  GCGGCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAG  465 
CL1150.Contig15_All  1                      CAGATCTCCCGGCGCAAGTGAGAGGACGCGGGTGTGGCAGAG  42 
CL1150.Contig14_All  1                      CAGATCTCCCGGCGCAAGTGAGAGGACGCGGGTGTGGCAGAG  42 
 
Query_1              444  CTTGAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAAC  503 
CL1150.Contig16_All  475  CGCTACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAAC  534 
CL1150.Contig4_All   466  CGCTACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAAC  525 
CL1150.Contig15_All  43   CTTGAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAAC  102 
CL1150.Contig14_All  43   CTTGAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAAC  102 
 
Query_1              504  GGGAAGGAGACGCTACTGCGCACAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  562 
CL1150.Contig16_All  535  GGGAAGGAGTCGCTGCTGCGCGCAGA                                    560 
 199 
 
CL1150.Contig16_All  646                          GAGATCACCCTGACCTGGCAGCGAGATGGA-GAGGA  680 
CL1150.Contig4_All   526  GGGAAGGAGTCGCTGCTGCGCGCAGA                                    551 
CL1150.Contig15_All  103  GGGAAGGAGACGCTACTGCGCACAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  161 
CL1150.Contig14_All  103  GGGAAGGAGACGCTACTGCGCACAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  161 
CL1150.Contig7_All   92                         CAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  128 
CL1150.Contig18_All  91                           GAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  125 
CL1150.Contig17_All  94                           GAGATCACCCTGACCTGGCAGCGAGATGGA-GAGGA  128 
CL1150.Contig13_All  94                           GAGATCACCCTGACCTGGCACCATGA-GGAGGAGGA  128 
CL1150.Contig8_All   92                         CAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  128 
Unigene117550_All    89                         CAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  125 
Unigene12618_All     89                         CAGAGATCACCCTGACCTGGCAGAGGGATGGA-GAGGA  125 
 
Query_1              563  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  622 
CL1150.Contig16_All  681  CCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  740 
CL1150.Contig15_All  162  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  221 
CL1150.Contig14_All  162  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  221 
CL1150.Contig7_All   129  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  188 
CL1150.Contig18_All  126  CCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  185 
CL1150.Contig17_All  129  CCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  188 
CL1150.Contig13_All  129  CCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTACAGGGAATGGAACCTTCCAGAA  188 
CL1150.Contig8_All   129  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGATGGAACCTTCCAGAA  188 
Unigene117550_All    126  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGAT                171 
Unigene12618_All     126  CCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGAGAT                171 
 
Query_1              623  GTGGGTGGCCATGGTGGTGCCTTCTGGACAGGAGCAGAGATACACGTGCCATGTGCAGCA  682 
CL1150.Contig16_All  741  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  800 
CL1150.Contig15_All  222  GTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGATACACATGCTATGTGCAGCA  281 
CL1150.Contig14_All  222  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  281 
CL1150.Contig7_All   189  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  248 
CL1150.Contig18_All  186  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  245 
CL1150.Contig17_All  189  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  248 
CL1150.Contig13_All  189  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  248 
CL1150.Contig8_All   189  GTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATACACATGCCATGTGCAGCA  248 
Unigene26995_All     1                          TCTGGACAGGAGCAGAGATACACGTGCCATGTGCAGCA  38 
 
Query_1              683  TGAGGGACTGTCTGAGCCCATCACCCAGAGATGGGAGCCGCCACATCCTACCATCCCCAT  742 
CL1150.Contig16_All  801  TAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCTCCTCCCACCATCCCCAT  860 
CL1150.Contig15_All  282  TGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCACCTCG-C--ACCATCCCCAT  338 
CL1150.Contig14_All  282  TAAGGGGCTGCCTGAGCCCATCACC                                     306 
CL1150.Contig14_All  436                                    GAGCCACCTCCTCCCACCATCCCCAT  461 
CL1150.Contig7_All   249  TAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCTCCTCCCACCATCCCCAT  308 
CL1150.Contig18_All  246  TAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCTCCTCCCACCATCCCCAT  305 
CL1150.Contig17_All  249  TAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCTCCTCCCACCATCCCCAT  308 
CL1150.Contig13_All  249  TAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCTCCTCCCACCATCCCCAT  308 
CL1150.Contig8_All   249  TAAGGGGCTGCCTGAGCCCATCACC                                     273 
CL1150.Contig8_All   403                                    GAGCCACCTCCTCCCACCATCCCCAT  428 
CL1150.Contig5_All   1     GAGGGACTGTCTGAGCCCATTACCTTGAGATGGGAGCCTCCTCTTCCCATCGTCCTCAT  59 
Unigene26995_All     39   TGAGGGACTGTCTGAGCCCATCACCCAGAGATGGG                           73 
 
Query_1              743  CATGTGGATCATTGCTGGTCTGATTCTCCCCGTGGTCTTTGCAGTGATTAGAGCTGTGAT  802 
CL1150.Contig16_All  861  CATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTGGTGGTTGGAGCTGTGAT  920 
CL1150.Contig15_All  339  CACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATTGCAGTGATTGGAGTTGCAAT  398 
CL1150.Contig14_All  462  CATGTGGATCATTGCTGGTCTGATTCTCCCCGTGGTCTTTGCAGTGATTAGAGCTGTGAT  521 
CL1150.Contig7_All   309  CATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTGGTGGTTGGAGCTGTGAT  368 
CL1150.Contig18_All  306  CATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTGGTGGTTGGAGCTGTGAT  365 
CL1150.Contig17_All  309  CATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTGGTGGTTGGAGCTGTGAT  368 
CL1150.Contig13_All  309  CATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTGGTGGTTGGAGCTGTGAT  368 
CL1150.Contig8_All   429  CATGTGGATCATTGCTGGTCTGATTCTCCCCGTGGTCTTTGCAGTGATTAGAGCTGTGAT  488 
CL1150.Contig5_All   60   CACATGGATCATTGCTGTTCTGGCTCTCCTTGTGGTCGCTGTGGTGGTTGGAGCTGTGAT  119 
CL1793.Contig7_All   1        TGGATCATTGCTGTTCTGGCTCTCCTTGTGGTCGCTGTGGTGGTTGGAGCTGTGAT  56 
CL1793.Contig5_All   1        TGGATCATTGCTGTTCTGGCTCTCCTTGTGGTCGCTGTGGTGGTTGGAGCTGTGAT  56 
CL1793.Contig3_All   1        TGGATCATTGCTGTTCTGGCTCTCCTTGTGGTCGCTGTGGTGGTTGGAGCTGTGAT  56 
CL1793.Contig2_All   1        TGGATCATTGCTGTTCTGGCTCTCCTTGTGGTCGCTGTGGTGGTTGGAGCTGTGAT  56 
 
Query_1              803  CTGGAGGAAGAAGCGCTCAGATGATGACAGTGCCCAGGGCTCT  845 
CL1150.Contig16_All  921  CTGGAGGAGGAAGCGCTCAG                         940 
CL1150.Contig15_All  399  CTGGTGGAAGAAGCGCTCAG                         418 
CL1150.Contig14_All  522  CTGGAGGAAGAAGCGCTCA                          540 
CL1150.Contig7_All   369  CTGGAGGAAGAAGCGCTCAG                         388 
CL1150.Contig18_All  366  CTGGAGGAGGAAGCGCTCAG                         385 
CL1150.Contig17_All  369  CTGGAGGAGGAAGCGCTCAG                         388 
CL1150.Contig13_All  369  CTGGAGGAAGAAGCGCTCAG                         388 
CL1150.Contig8_All   489  CTGGAGGAAGAAGCGCTCA                          507 
CL1150.Contig5_All   120  CTGGAGGAAGAAGCGCTCAGATGATGACAGTGCCCAGGGCTCT  162 
CL1793.Contig7_All   57   CTGGAGGAAGAAGCGCTCAG                         76 
CL1793.Contig5_All   57   CTGGAGGAAGAAGCGCTCAG                         76 
CL1793.Contig3_All   57   CTGGAGGAAGAAGCGCTCAG                         76 
CL1793.Contig2_All   57   CTGGAGGAAGAAGCGCTCAG                         76 
 
 
Lambda      K        H 
 200 
 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 67199301450 
 
 
Query= JQ425439.1 Meles meles MHC class I antigen (Meme-MHCI) pseudogene 
mRNA, Meme-MHCI*PS02 allele, partial sequence 
 
Length=932 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  725     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  680     0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  401     8e-111 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  379     4e-104 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  357     2e-97  
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  340     2e-92  
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  302     8e-81  
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  283     3e-75  
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  281     1e-74  
CL1150.Contig5_All  2 199 minus strand MHC class I antigen [Bos t...  172     7e-42  
Unigene117550_All  775 945 PREDICTED: patr class I histocompatibi...  156     7e-37  
Unigene12618_All  419 589 PREDICTED: patr class I histocompatibil...  156     7e-37  
Unigene26995_All  2 127 minus strand DLA class I histocompatibili...  135     9e-31  
CL1793.Contig7_All  65 361 minus strand PREDICTED: MHC class I po...  80.5    4e-14  
CL1793.Contig5_All  65 361 minus strand PREDICTED: MHC class I po...  80.5    4e-14  
CL1793.Contig3_All  65 361 PREDICTED: MHC class I polypeptide-rel...  80.5    4e-14  




Query_2              17   GAGACCTGGGCGGGCTCCCACTCCCTGAGATATTTCGACACCGCGGTTTCCCCGCCCGGC  76 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_2              77   AGCGAGGAGCCGCGCTTCATCTCCGTCGGCTACGTGGACTTCACGCAGTTCGTGCGGTTC  136 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_2              137  GACAGCGACTCTGCCAGTCAGAGAAGGA-GGAGCCGCGGGCGCCGTAAGTGGAGCAGGAG  195 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTC-G-G-AGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAG  177 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTC-G-GA-GGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAG  168 
 
Query_2              196  GGGCCGGAGTATTGGGACGAGGAGACGCGGATCTGCAAGGAAACCACACAGACTTACCGA  255 
CL1150.Contig16_All  178  GGGCCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGA  237 
CL1150.Contig4_All   169  GGGCCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGA  228 
 
Query_2              256  GGGAGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGAGGCCGGGTCTCACACCATC  315 
CL1150.Contig16_All  238  GGGAGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATC  297 
CL1150.Contig4_All   229  CGGAGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTC  288 
 
Query_2              316  CAGCGCATGTACGGCTGTGACGTGGGGCCCGACGGGCGCCTCCTCCGCGGGTACAGTCAG  375 
CL1150.Contig16_All  298  CAGAACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAG  357 
CL1150.Contig4_All   289  CAGAACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAG  348 
 
Query_2              376  GACGCCTACGACGGCGCGGATTACCTCACCCTGAACGAGGACCTGCGCTCCTGGACCGCG  435 
CL1150.Contig16_All  358  TTCGCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCG  417 
CL1150.Contig4_All   349  TTCGCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCG  408 
 
Query_2              436  GCGGATGCGTCGGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCTT  495 
CL1150.Contig16_All  418  GCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGC  477 
CL1150.Contig4_All   409  GCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGC  468 
CL1150.Contig15_All  1                   CAGATCTCCCGGCGCAAGTGAGAGGACGCGGGTGTGGCAGAGCTT  45 
CL1150.Contig14_All  1                   CAGATCTCCCGGCGCAAGTGAGAGGACGCGGGTGTGGCAGAGCTT  45 
 
Query_2              496  GAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAACGGG  555 
CL1150.Contig16_All  478  TACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGG  537 
CL1150.Contig4_All   469  TACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGG  528 
CL1150.Contig15_All  46   GAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAACGGG  105 
CL1150.Contig14_All  46   GAGAGGGACTACCTGGAGATTACTTGCGTGAAGTGGCTCCACAGGTATCTGGAGAACGGG  105 
 
Query_2              556  AAGGAGACGCTACTGCGCACAGGACAACGGAGGAATCCAGTCTCTCCCAGGAAGCAGAGA  615 
CL1150.Contig16_All  538  AAGGAGTCGCTGCTGCGCGCAG                                        559 
CL1150.Contig16_All  646                                                          GAGA  649 
CL1150.Contig4_All   529  AAGGAGTCGCTGCTGCGCGCAG                                        550 
CL1150.Contig15_All  125                                                        CAGAGA  130 
 201 
 
CL1150.Contig15_All  106  AAGGAGACGCTACTGCGCACAG                                        127 
CL1150.Contig7_All   91                                                        GCAGAGA  97 
CL1150.Contig18_All  91                                                           GAGA  94 
CL1150.Contig17_All  94                                                           GAGA  97 
CL1150.Contig13_All  94                                                           GAGA  97 
CL1150.Contig8_All   91                                                        GCAGAGA  97 
CL1150.Contig14_All  125                                                        CAGAGA  130 
CL1150.Contig14_All  106  AAGGAGACGCTACTGCGCACAG                                        127 
Unigene117550_All    88                                                        GCAGAGA  94 
Unigene12618_All     88                                                        GCAGAGA  94 
 
Query_2              616  TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  674 
CL1150.Contig16_All  650  TCACCCTGACCTGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAG  708 
CL1150.Contig15_All  131  TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  189 
CL1150.Contig7_All   98   TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  156 
CL1150.Contig18_All  95   TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAG  153 
CL1150.Contig17_All  98   TCACCCTGACCTGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAG  156 
CL1150.Contig13_All  98   TCACCCTGACCTGGCACCATGA-GGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGG  156 
CL1150.Contig8_All   98   TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  156 
CL1150.Contig14_All  131  TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  189 
Unigene117550_All    95   TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  153 
Unigene12618_All     95   TCACCCTGACCTGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAG  153 
 
Query_2              675  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGTGGCCATGGTGGTGCCTTCTGGA  734 
CL1150.Contig16_All  709  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  768 
CL1150.Contig15_All  190  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGA  249 
CL1150.Contig7_All   157  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  216 
CL1150.Contig18_All  154  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  213 
CL1150.Contig17_All  157  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  216 
CL1150.Contig13_All  157  ACCAGGCCTACAGGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  216 
CL1150.Contig8_All   157  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  216 
CL1150.Contig14_All  190  ACCAGGCCTGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGA  249 
Unigene117550_All    154  ACCAGGCCTGCAGGAGAT                                            171 
Unigene12618_All     154  ACCAGGCCTGCAGGAGAT                                            171 
Unigene26995_All     1                                                          TCTGGA  6 
 
Query_2              735  CAGGAGCAGAGATACACGTGCCATGTGCAGCATGAGGGACTGTCTGAGCCCATCACCCAG  794 
CL1150.Contig16_All  769  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTG  828 
CL1150.Contig15_All  250  CAGGAGCAGAGATACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGG  309 
CL1150.Contig7_All   217  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTG  276 
CL1150.Contig18_All  214  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTG  273 
CL1150.Contig17_All  217  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTG  276 
CL1150.Contig13_All  217  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTG  276 
CL1150.Contig8_All   217  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC     273 
CL1150.Contig14_All  250  GAGGAGCAGAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC     306 
CL1150.Contig5_All   1                                     GAGGGACTGTCTGAGCCCATTACCTTG  27 
Unigene26995_All     7    CAGGAGCAGAGATACACGTGCCATGTGCAGCATGAGGGACTGTCTGAGCCCATCACCCAG  66 
 
Query_2              795  AGATGGGAGCCGCCACATCCTACCATCCCCATCATGTGGATCATTGCTGGTCTGATTCTC  854 
CL1150.Contig16_All  829  AGTTGGAAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTC  888 
CL1150.Contig15_All  310  AGATGGGAGCCACCTCG-C--ACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTC  366 
CL1150.Contig7_All   277  AGTTGGAAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTC  336 
CL1150.Contig18_All  274  AGTTGGAAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTC  333 
CL1150.Contig17_All  277  AGTTGGAAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTC  336 
CL1150.Contig13_All  277  AGTTGGAAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTC  336 
CL1150.Contig8_All   403        GAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGTCTGATTCTC  456 
CL1150.Contig14_All  436        GAGCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGTCTGATTCTC  489 
CL1150.Contig5_All   28   AGATGGGAGCCTCCTCTTCCCATCGTCCTCATCACATGGATCATTGCTGTTCTGGCTCTC  87 
Unigene26995_All     67   AGATGGG                                                       73 
CL1793.Contig7_All   1                                        TGGATCATTGCTGTTCTGGCTCTC  24 
CL1793.Contig5_All   1                                        TGGATCATTGCTGTTCTGGCTCTC  24 
CL1793.Contig3_All   1                                        TGGATCATTGCTGTTCTGGCTCTC  24 
CL1793.Contig2_All   1                                        TGGATCATTGCTGTTCTGGCTCTC  24 
 
Query_2              855  CCCGTGGTCTTTGCAGTGATTAGAGCTGTGATCTGGAGGAAGAAGCGCTCAGATGATGAC  914 
CL1150.Contig16_All  889  CTGGCAGTCACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAG          940 
CL1150.Contig15_All  367  CTGGTGATCATTGCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAG          418 
CL1150.Contig7_All   337  CTGGCAGTCACTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          388 
CL1150.Contig18_All  334  CTGGCAGTCACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAG          385 
CL1150.Contig17_All  337  CTGGCAGTCACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAG          388 
CL1150.Contig13_All  337  CTGGCAGTCACTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          388 
CL1150.Contig8_All   457  CCCGTGGTCTTTGCAGTGATTAGAGCTGTGATCTGGAGGAAGAAGCGCTCA           507 
CL1150.Contig14_All  490  CCCGTGGTCTTTGCAGTGATTAGAGCTGTGATCTGGAGGAAGAAGCGCTCA           540 
CL1150.Contig5_All   88   CTTGTGGTCGCTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGATGATGAC  147 
CL1793.Contig7_All   25   CTTGTGGTCGCTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          76 
CL1793.Contig5_All   25   CTTGTGGTCGCTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          76 
CL1793.Contig3_All   25   CTTGTGGTCGCTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          76 
CL1793.Contig2_All   25   CTTGTGGTCGCTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAG          76 
 
Query_2              915  AGTGCCCAGGGCTCT  929 





Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 74066383350 
 
 
Query= JQ425438.1 Meles meles MHC class I antigen (Meme-MHCI) pseudogene 
mRNA, Meme-MHCI*PS01 allele, partial sequence 
 
Length=900 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1131    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  802     0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  544     1e-153 
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  540     2e-152 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  521     6e-147 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  484     7e-136 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  473     2e-132 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  377     1e-103 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  272     6e-72  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  220     2e-56  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  220     2e-56  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  220     2e-56  
CL1150.Contig1_All  1600 1755 MHC class I antigen, partial [Meles...  220     2e-56  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  217     3e-55  




Query_3              29   GCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGG  88 
CL1150.Contig16_All  125  GCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGG  184 
CL1150.Contig4_All   116  GCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGG  175 
CL1150.Contig22_All  1                                                      GAGGGGCCGG  10 
 
Query_3              89   AGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTGAACC  148 
CL1150.Contig16_All  185  AGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGGAGCC  244 
CL1150.Contig4_All   176  AGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGGAGCC  235 
CL1150.Contig22_All  11   AGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTGAACC  70 
 
Query_3              149  TGAACACCCTGCGGGACTACTATAACCAGAGCGCGGCCGGGTCTCACACCATCCAGCGCA  208 
CL1150.Contig16_All  245  TGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAGAACT  304 
CL1150.Contig4_All   236  TGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAGAACA  295 
CL1150.Contig22_All  71   TGAACACCCTGCGGGACTACTACAACCAGAGCGCGGCCGG                      110 
 
Query_3              209  TGTACGGCTGTGACGTGGGGCCCGACGGCCGCCTCCTCCGCGGGTACAGTCAGGTGGCCT  268 
CL1150.Contig16_All  305  TGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCT  364 
CL1150.Contig4_All   296  TGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCT  355 
 
Query_3              269  ACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACGGTGGCGGACG  328 
CL1150.Contig16_All  365  ACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACA  424 
CL1150.Contig4_All   356  ACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACA  415 
 
Query_3              329  CCACAGCGCAGATCTCCCGGCGCAAGTGGGAGGCGGCGGATGAGGCGGAGCATGAGAGGA  388 
CL1150.Contig16_All  425  CGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGA  484 
CL1150.Contig4_All   416  CGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGA  475 
 
Query_3              389  ACTACCTGGAGGTGACATGCCTGGAGTGGCTCCACAGGTACCTGGAGAACGGGAAGGAGT  448 
CL1150.Contig16_All  485  ACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGT  544 
CL1150.Contig4_All   476  ACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGT  535 
 
Query_3              449  CGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGACCGTG  508 
CL1150.Contig16_All  545  CGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGACCGTG  604 
CL1150.Contig4_All   536  CGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGACCGTG  595 
CL1150.Contig17_All  4               GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGACCATG  52 
CL1150.Contig18_All  2                CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGACCATG  49 
CL1150.Contig13_All  4               GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGACCATG  52 
CL1150.Contig7_All   13                       CCCAACACACACGTGACCCACCACCCCATCTCTGACCATG  52 
CL1150.Contig8_All   13                       CCCAACACACACGTGACCCACCACCCCATCTCTGACCATG  52 
CL1150.Contig24_All  2                CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAACAATG  49 
CL1150.Contig23_All  2                CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAACAATG  49 
CL1150.Contig3_All   2                CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAACAATG  49 
CL1150.Contig1_All   2                CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAACAATG  49 




Query_3              509  ATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGC  568 
CL1150.Contig16_All  605  ATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGC  664 
CL1150.Contig4_All   596  ATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  655 
CL1150.Contig15_All  127                                           GAGATCACCCTGACCTGGC  145 
CL1150.Contig17_All  53   CTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGC  112 
CL1150.Contig18_All  50   CTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGC  109 
CL1150.Contig13_All  53   CTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGC  112 
CL1150.Contig7_All   53   CTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACCTGGC  112 
CL1150.Contig8_All   53   CTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACCTGGC  112 
CL1150.Contig14_All  127                                           GAGATCACCCTGACCTGGC  145 
CL1150.Contig24_All  50   ATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  109 
CL1150.Contig23_All  50   ATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  109 
CL1150.Contig3_All   50   ATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  109 
CL1150.Contig1_All   50   ATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  109 
CL1150.Contig2_All   53   CTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACCTGGA  112 
 
Query_3              569  AGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGA  627 
CL1150.Contig16_All  665  AGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGA  723 
CL1150.Contig4_All   656  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              702 
CL1150.Contig15_All  146  AGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGA  204 
CL1150.Contig17_All  113  AGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGA  171 
CL1150.Contig18_All  110  AGAGGGATGGA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCAGGA  168 
CL1150.Contig13_All  113  ACCATGA-GGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTACAGGG  171 
CL1150.Contig7_All   113  AGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGA  171 
CL1150.Contig8_All   113  AGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGA  171 
CL1150.Contig14_All  146  AGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCAGGA  204 
CL1150.Contig24_All  110  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              156 
CL1150.Contig23_All  110  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              156 
CL1150.Contig3_All   110  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              156 
CL1150.Contig1_All   110  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              156 
CL1150.Contig2_All   113  AGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC              159 
 
Query_3              628  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGATAC  687 
CL1150.Contig16_All  724  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  783 
CL1150.Contig15_All  205  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGATAC  264 
CL1150.Contig17_All  172  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  231 
CL1150.Contig18_All  169  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  228 
CL1150.Contig13_All  172  AATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  231 
CL1150.Contig7_All   172  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  231 
CL1150.Contig8_All   172  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  231 
CL1150.Contig14_All  205  GATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGATAC  264 
 
Query_3              688  ACATGCCATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCACCT  747 
CL1150.Contig16_All  784  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCT  843 
CL1150.Contig15_All  265  ACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCACCT  324 
CL1150.Contig17_All  232  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCT  291 
CL1150.Contig18_All  229  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCT  288 
CL1150.Contig13_All  232  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCT  291 
CL1150.Contig7_All   232  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCACCT  291 
CL1150.Contig8_All   232  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                    273 
CL1150.Contig14_All  265  ACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                    306 
 
Query_3              748  CG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGGTCATTGCA  804 
CL1150.Contig16_All  844  CCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTG  903 
CL1150.Contig15_All  325  CG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATTGCA  381 
CL1150.Contig17_All  292  CCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTG  351 
CL1150.Contig18_All  289  CCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTG  348 
CL1150.Contig13_All  292  CCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTG  351 
CL1150.Contig7_All   292  CCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACTGTG  351 
 
Query_3              805  GTGATTGGAGTTGCGATCTGGTGGAAGAAGCACTCAGGAGAGAAAGGACCAGGCTACTCT  864 
CL1150.Contig16_All  904  GTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTACTCT  963 
CL1150.Contig15_All  382  GTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTACTCT  441 
CL1150.Contig17_All  352  GTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTACTCT  411 
CL1150.Contig18_All  349  GTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTACTCT  408 
CL1150.Contig13_All  352  GTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGGCTACTCT  411 
CL1150.Contig7_All   352  GTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA              399 
 
Query_3              865  CATGCTGCACGCGAT  879 
CL1150.Contig16_All  964  CATGCTGCA        972 
CL1150.Contig15_All  442  CATGCTGCA        450 
CL1150.Contig17_All  412  CATGCTGCA        420 
CL1150.Contig18_All  409  CATGCTGCA        417 
CL1150.Contig13_All  412  CATGCTGCACGCGAT  426 
 
 
Lambda      K        H 





Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 71450352150 
 
 
Query= JQ425432.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*06 allele, partial cds 
 
Length=975 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1365    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  1031    0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  544     1e-153 
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  529     4e-149 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  521     6e-147 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  484     8e-136 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  473     2e-132 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  383     3e-105 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  278     1e-73  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  226     5e-58  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  226     5e-58  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  226     5e-58  
CL1150.Contig1_All  1600 1755 MHC class I antigen, partial [Meles...  226     5e-58  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  222     7e-57  




Query_4              1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_4              61   CGCGGGGAACCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTT  120 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_4              121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGGTGGAGCAGGAGGGG  180 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  171 
CL1150.Contig22_All  1                                                          GAGGGG  6 
 
Query_4              181  CCGGAGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTG  240 
CL1150.Contig16_All  181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGG  240 
CL1150.Contig4_All   172  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  231 
CL1150.Contig22_All  7    CCGGAGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTG  66 
 
Query_4              241  AACCTGAACACCCTGCGGGACTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig16_All  241  AGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig4_All   232  AGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAG  291 
CL1150.Contig22_All  67   AACCTGAACACCCTGCGGGACTACTACAACCAGAGCGCGGCCGG                  110 
 
Query_4              301  CGCATGTACGGCTGTGATATGGGGCCCGATGGGCGCCTCCTCCGCGGGTACAGTCAGGTG  360 
CL1150.Contig16_All  301  AACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  360 
CL1150.Contig4_All   292  AACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  351 
 
Query_4              361  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACGGTGGCG  420 
CL1150.Contig16_All  361  GCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig4_All   352  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  411 
 
Query_4              421  GACGCCACAGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGATGAGGCGGAGCATGAG  480 
CL1150.Contig16_All  421  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  480 
CL1150.Contig4_All   412  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  471 
 
Query_4              481  AGGAACTACCTGGAGGTCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig16_All  481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig4_All   472  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  531 
 
Query_4              541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig16_All  541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig4_All   532  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  591 
CL1150.Contig17_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig18_All  2                    CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  45 
CL1150.Contig13_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig7_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig8_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig24_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig23_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig3_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
 205 
 
CL1150.Contig1_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig2_All   4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
 
Query_4              601  CGTGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig16_All  601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig4_All   592  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  651 
CL1150.Contig15_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig17_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig18_All  46   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig13_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig7_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig8_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig14_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig24_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig23_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig3_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig1_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig2_All   49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
 
Query_4              661  TGGCAGCGAGATGGA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  719 
CL1150.Contig16_All  661  TGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  719 
CL1150.Contig4_All   652  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          702 
CL1150.Contig15_All  142  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  200 
CL1150.Contig17_All  109  TGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  167 
CL1150.Contig18_All  106  TGGCAGAGGGATGGA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  164 
CL1150.Contig13_All  109  TGGCACCATGA-GGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTAC  167 
CL1150.Contig7_All   109  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  167 
CL1150.Contig8_All   109  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  167 
CL1150.Contig14_All  142  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  200 
CL1150.Contig24_All  106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig23_All  106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig3_All   106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig1_All   106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig2_All   109  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          159 
 
Query_4              720  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAG  779 
CL1150.Contig16_All  720  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  779 
CL1150.Contig15_All  201  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAG  260 
CL1150.Contig17_All  168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig18_All  165  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  224 
CL1150.Contig13_All  168  AGGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig7_All   168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig8_All   168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig14_All  201  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  260 
 
Query_4              780  ATACACATGCCATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCC  839 
CL1150.Contig16_All  780  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  839 
CL1150.Contig15_All  261  ATACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCC  320 
CL1150.Contig17_All  228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig18_All  225  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  284 
CL1150.Contig13_All  228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig7_All   228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig8_All   228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                273 
CL1150.Contig14_All  261  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                306 
 
Query_4              840  ACCTCG---CACCATCCCCATCACATGGATCATTGCTGGTGTGGTTCTCCTGGTGGTCAT  896 
CL1150.Contig16_All  840  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  899 
CL1150.Contig15_All  321  ACCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCAT  377 
CL1150.Contig17_All  288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
CL1150.Contig18_All  285  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  344 
CL1150.Contig13_All  288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
CL1150.Contig7_All   288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
 
Query_4              897  TGCAGTGACTGGAGTTGCGATCTGGTGGAAGAAGCGCTCAGGAGAGAAAGGACCAGGCTA  956 
CL1150.Contig16_All  900  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  959 
CL1150.Contig15_All  378  TGCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTA  437 
CL1150.Contig17_All  348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  407 
CL1150.Contig18_All  345  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  404 
CL1150.Contig13_All  348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  407 
CL1150.Contig7_All   348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA          399 
 
Query_4              957  CTCTCATGCTGCACGCGAT  975 
CL1150.Contig16_All  960  CTCTCATGCTGCA        972 
CL1150.Contig15_All  438  CTCTCATGCTGCA        450 
CL1150.Contig17_All  408  CTCTCATGCTGCA        420 
CL1150.Contig18_All  405  CTCTCATGCTGCA        417 
CL1150.Contig13_All  408  CTCTCATGCTGCACGCGAT  426 
 
 
Lambda      K        H 





Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 77581675275 
 
 
Query= JQ425433.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*07 allele, partial cds 
 
Length=975 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1493    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  1242    0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  566     3e-160 
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  523     2e-147 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  516     3e-145 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  484     8e-136 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  462     4e-129 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  366     3e-100 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  261     1e-68  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  239     7e-62  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  231     1e-59  




Query_5              1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_5              61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_5              121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  171 
 
Query_5              181  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  240 
CL1150.Contig16_All  181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGG  240 
CL1150.Contig4_All   172  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  231 
 
Query_5              241  AGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAG  300 
CL1150.Contig16_All  241  AGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig4_All   232  AGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAG  291 
 
Query_5              301  AACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACAGTCAGCAC  360 
CL1150.Contig16_All  301  AACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  360 
CL1150.Contig4_All   292  AACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  351 
 
Query_5              361  TCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig16_All  361  GCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig4_All   352  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  411 
 
Query_5              421  GACACGGCGGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTGG  480 
CL1150.Contig16_All  421  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  480 
CL1150.Contig4_All   412  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  471 
 
Query_5              481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig16_All  481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig4_All   472  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  531 
 
Query_5              541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig16_All  541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig4_All   532  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  591 
CL1150.Contig17_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig18_All  2                    CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  45 
CL1150.Contig13_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig7_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig8_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig2_All   4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig24_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig23_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig3_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 




Query_5              601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig16_All  601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig4_All   592  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  651 
CL1150.Contig15_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig17_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig18_All  46   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig13_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig7_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig8_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig14_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig2_All   49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig24_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig23_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig3_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig1_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
 
Query_5              661  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  720 
CL1150.Contig16_All  661  TGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  720 
CL1150.Contig4_All   652  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           702 
CL1150.Contig15_All  142  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  201 
CL1150.Contig17_All  109  TGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  168 
CL1150.Contig18_All  106  TGGCAGAGGGATGGAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  165 
CL1150.Contig13_All  109  TGGCACCATGAGGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTACA  168 
CL1150.Contig7_All   109  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  168 
CL1150.Contig8_All   109  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  168 
CL1150.Contig14_All  142  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  201 
CL1150.Contig2_All   109  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           159 
CL1150.Contig24_All  106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig23_All  106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig3_All   106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig1_All   106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
 
Query_5              721  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGA  780 
CL1150.Contig16_All  721  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  780 
CL1150.Contig15_All  202  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGA  261 
CL1150.Contig17_All  169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig18_All  166  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  225 
CL1150.Contig13_All  169  GGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig7_All   169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig8_All   169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig14_All  202  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  261 
 
Query_5              781  TACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCA  840 
CL1150.Contig16_All  781  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  840 
CL1150.Contig15_All  262  TACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCA  321 
CL1150.Contig17_All  229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig18_All  226  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  285 
CL1150.Contig13_All  229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig7_All   229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig8_All   229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                 273 
CL1150.Contig14_All  262  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                 306 
 
Query_5              841  CCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATT  897 
CL1150.Contig16_All  841  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  900 
CL1150.Contig15_All  322  CCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATT  378 
CL1150.Contig17_All  289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
CL1150.Contig18_All  286  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  345 
CL1150.Contig13_All  289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
CL1150.Contig7_All   289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
 
Query_5              898  GCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTAC  957 
CL1150.Contig16_All  901  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  960 
CL1150.Contig15_All  379  GCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTAC  438 
CL1150.Contig17_All  349  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  408 
CL1150.Contig18_All  346  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  405 
CL1150.Contig13_All  349  GTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  408 
CL1150.Contig7_All   349  GTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA           399 
 
Query_5              958  TCTCATGCTGCACGCGAT  975 
CL1150.Contig16_All  961  TCTCATGCTGCA        972 
CL1150.Contig15_All  439  TCTCATGCTGCA        450 
CL1150.Contig17_All  409  TCTCATGCTGCA        420 
CL1150.Contig18_All  406  TCTCATGCTGCA        417 
CL1150.Contig13_All  409  TCTCATGCTGCACGCGAT  426 
 
 
Lambda      K        H 





Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 77581675275 
 
 
Query= JQ425431.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*05 allele, partial cds 
 
Length=975 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1360    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  1009    0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  544     1e-153 
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  540     2e-152 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  521     6e-147 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  484     8e-136 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  473     2e-132 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  377     1e-103 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  272     7e-72  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  220     3e-56  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  220     3e-56  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  220     3e-56  
CL1150.Contig1_All  1600 1755 MHC class I antigen, partial [Meles...  220     3e-56  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  217     3e-55  




Query_6              1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_6              61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_6              121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  171 
CL1150.Contig22_All  1                                                          GAGGGG  6 
 
Query_6              181  CCGGAGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTG  240 
CL1150.Contig16_All  181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGG  240 
CL1150.Contig4_All   172  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  231 
CL1150.Contig22_All  7    CCGGAGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTG  66 
 
Query_6              241  AACCTGAACACCCTGCGGGACTACTATAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig16_All  241  AGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig4_All   232  AGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAG  291 
CL1150.Contig22_All  67   AACCTGAACACCCTGCGGGACTACTACAACCAGAGCGCGGCCGG                  110 
 
Query_6              301  CGCATGTACGGCTGTGACGTGGGGCCCGACGGCCGCCTCCTCCGCGGGTACAGTCAGGTG  360 
CL1150.Contig16_All  301  AACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  360 
CL1150.Contig4_All   292  AACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  351 
 
Query_6              361  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACGGTGGCG  420 
CL1150.Contig16_All  361  GCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig4_All   352  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  411 
 
Query_6              421  GACGCCACAGCGCAGATCTCCCGGCGCAAGTGGGAGGCGGCGGATGAGGCGGAGCATGAG  480 
CL1150.Contig16_All  421  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  480 
CL1150.Contig4_All   412  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  471 
 
Query_6              481  AGGAACTACCTGGAGGTGACATGCCTGGAGTGGCTCCACAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig16_All  481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig4_All   472  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  531 
 
Query_6              541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig16_All  541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig4_All   532  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  591 
CL1150.Contig17_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig18_All  2                    CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  45 
CL1150.Contig13_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig7_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig8_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig24_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig23_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig3_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
 209 
 
CL1150.Contig1_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig2_All   4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
 
Query_6              601  CGTGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig16_All  601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig4_All   592  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  651 
CL1150.Contig15_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig17_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig18_All  46   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig13_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig7_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig8_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig14_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig24_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig23_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig3_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig1_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig2_All   49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
 
Query_6              661  TGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  719 
CL1150.Contig16_All  661  TGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  719 
CL1150.Contig4_All   652  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          702 
CL1150.Contig15_All  142  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  200 
CL1150.Contig17_All  109  TGGCAGCGAGATGGA-GAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  167 
CL1150.Contig18_All  106  TGGCAGAGGGATGGA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGC  164 
CL1150.Contig13_All  109  TGGCACCATGA-GGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTAC  167 
CL1150.Contig7_All   109  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  167 
CL1150.Contig8_All   109  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  167 
CL1150.Contig14_All  142  TGGCAGAGGGATGGA-GAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGC  200 
CL1150.Contig24_All  106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig23_All  106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig3_All   106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig1_All   106  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          156 
CL1150.Contig2_All   109  TGGAAGCGAGATGAA-GAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC          159 
 
Query_6              720  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAG  779 
CL1150.Contig16_All  720  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  779 
CL1150.Contig15_All  201  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAG  260 
CL1150.Contig17_All  168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig18_All  165  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  224 
CL1150.Contig13_All  168  AGGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig7_All   168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig8_All   168  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  227 
CL1150.Contig14_All  201  AGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAG  260 
 
Query_6              780  ATACACATGCCATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCC  839 
CL1150.Contig16_All  780  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  839 
CL1150.Contig15_All  261  ATACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCC  320 
CL1150.Contig17_All  228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig18_All  225  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  284 
CL1150.Contig13_All  228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig7_All   228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCC  287 
CL1150.Contig8_All   228  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                273 
CL1150.Contig14_All  261  ATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                306 
 
Query_6              840  ACCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGGTCAT  896 
CL1150.Contig16_All  840  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  899 
CL1150.Contig15_All  321  ACCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCAT  377 
CL1150.Contig17_All  288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
CL1150.Contig18_All  285  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  344 
CL1150.Contig13_All  288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
CL1150.Contig7_All   288  ACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCAC  347 
 
Query_6              897  TGCAGTGATTGGAGTTGCGATCTGGTGGAAGAAGCACTCAGGAGAGAAAGGACCAGGCTA  956 
CL1150.Contig16_All  900  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  959 
CL1150.Contig15_All  378  TGCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTA  437 
CL1150.Contig17_All  348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  407 
CL1150.Contig18_All  345  TGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  404 
CL1150.Contig13_All  348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGGCTA  407 
CL1150.Contig7_All   348  TGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA          399 
 
Query_6              957  CTCTCATGCTGCACGCGAT  975 
CL1150.Contig16_All  960  CTCTCATGCTGCA        972 
CL1150.Contig15_All  438  CTCTCATGCTGCA        450 
CL1150.Contig17_All  408  CTCTCATGCTGCA        420 
CL1150.Contig18_All  405  CTCTCATGCTGCA        417 
CL1150.Contig13_All  408  CTCTCATGCTGCACGCGAT  426 
 
 
Lambda      K        H 





Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 77581675275 
 
 
Query= JQ425430.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*04 allele, partial cds 
 
Length=975 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1437    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  1053    0.0    
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  545     4e-154 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  538     6e-152 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  538     6e-152 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  507     2e-142 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  484     8e-136 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  366     3e-100 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  261     1e-68  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  239     7e-62  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  231     1e-59  
CL1150.Contig1_All  1600 1755 MHC class I antigen, partial [Meles...  231     1e-59  
CL7631.Contig3_All  2 109 minus strand MHC class I antigen, parti...  137     3e-31  




Query_7              1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTCCACCGCGGTGTCCCGGCCCGGC  60 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_7              61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_7              121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGGTGGAGCAGGAGGGG  180 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  171 
CL1150.Contig22_All  1                                                          GAGGGG  6 
 
Query_7              181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGACGCCGCACAGACTTACCGAGGG  240 
CL1150.Contig16_All  181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGG  240 
CL1150.Contig4_All   172  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  231 
CL1150.Contig22_All  7    CCGGAGTATTGGGACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTG  66 
 
Query_7              241  AACCTGCAGACCGCACT-C--CG-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCAT  296 
CL1150.Contig16_All  241  AGCCTG-A-ACATC-CTGCGGGG-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCAT  296 
CL1150.Contig4_All   232  AGCCTG-A-ACAAC-CTGCGGGG-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCTT  287 
CL1150.Contig22_All  67   AACCTGAACACC-CTGC-G--GGACTACTACAACCAGAGCGCGGCCGG              110 
 
Query_7              297  CCAGAACGTGTACGGCTGTGATGTGGGGCGCGACGGGCGTCTCCTCCGCGGATACAGTCA  356 
CL1150.Contig16_All  297  CCAGAACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCA  356 
CL1150.Contig4_All   288  CCAGAACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCA  347 
 
Query_7              357  GGACTCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGC  416 
CL1150.Contig16_All  357  GTTCGCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGC  416 
CL1150.Contig4_All   348  GTTCGCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGC  407 
 
Query_7              417  GGCGGACACGGCGGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGCGGCAGAGCG  476 
CL1150.Contig16_All  417  GGCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCG  476 
CL1150.Contig4_All   408  GGCGGACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCG  467 
 
Query_7              477  CTGGAGGAACTACCTGGAGGTCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGG  536 
CL1150.Contig16_All  477  CTACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGG  536 
CL1150.Contig4_All   468  CTACAGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGG  527 
 
Query_7              537  GAAGGAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTC  596 
CL1150.Contig16_All  537  GAAGGAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTC  596 
CL1150.Contig4_All   528  GAAGGAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTC  587 
CL1150.Contig17_All  4                       GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTC  44 
CL1150.Contig18_All  2                        CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTC  41 
CL1150.Contig13_All  4                       GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTC  44 
CL1150.Contig7_All   13                               CCCAACACACACGTGACCCACCACCCCATCTC  44 
CL1150.Contig8_All   13                               CCCAACACACACGTGACCCACCACCCCATCTC  44 
 211 
 
CL1150.Contig2_All   4                       GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTC  44 
CL1150.Contig24_All  2                        CAGAACCCTCCAACACACACGTGACACACCACCCGATCTC  41 
CL1150.Contig23_All  2                        CAGAACCCTCCAACACACACGTGACACACCACCCGATCTC  41 
CL1150.Contig3_All   2                        CAGAACCCTCCAACACACACGTGACACACCACCCGATCTC  41 
CL1150.Contig1_All   2                        CAGAACCCTCCAACACACACGTGACACACCACCCGATCTC  41 
 
Query_7              597  TGACCGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  656 
CL1150.Contig16_All  597  TGACCGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  656 
CL1150.Contig4_All   588  TGACCGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  647 
CL1150.Contig17_All  45   TGACCATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  104 
CL1150.Contig18_All  42   TGACCATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  101 
CL1150.Contig15_All  127                                                   GAGATCACCCT  137 
CL1150.Contig13_All  45   TGACCATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  104 
CL1150.Contig7_All   45   TGACCATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCT  104 
CL1150.Contig8_All   45   TGACCATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCT  104 
CL1150.Contig14_All  127                                                   GAGATCACCCT  137 
CL1150.Contig2_All   45   TGACCATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  104 
CL1150.Contig24_All  42   TAACAATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  101 
CL1150.Contig23_All  42   TAACAATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  101 
CL1150.Contig3_All   42   TAACAATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  101 
CL1150.Contig1_All   42   TAACAATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCT  101 
 
Query_7              657  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCC  716 
CL1150.Contig16_All  657  GACCTGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCC  716 
CL1150.Contig4_All   648  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       702 
CL1150.Contig17_All  105  GACCTGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCC  164 
CL1150.Contig18_All  102  GACCTGGCAGAGGGATGGAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCC  161 
CL1150.Contig15_All  138  GACCTGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCC  197 
CL1150.Contig13_All  105  GACCTGGCACCATGAGGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCC  164 
CL1150.Contig7_All   105  GACCTGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCC  164 
CL1150.Contig8_All   105  GACCTGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCC  164 
CL1150.Contig14_All  138  GACCTGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCC  197 
CL1150.Contig2_All   105  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       159 
CL1150.Contig24_All  102  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       156 
CL1150.Contig23_All  102  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       156 
CL1150.Contig3_All   102  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       156 
CL1150.Contig1_All   102  GACCTGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC       156 
 
Query_7              717  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCA  776 
CL1150.Contig16_All  717  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  776 
CL1150.Contig17_All  165  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  224 
CL1150.Contig18_All  162  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  221 
CL1150.Contig15_All  198  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCA  257 
CL1150.Contig13_All  165  TACAGGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  224 
CL1150.Contig7_All   165  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  224 
CL1150.Contig8_All   165  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  224 
CL1150.Contig14_All  198  TGCAGGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCA  257 
 
Query_7              777  GAGATACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGA  836 
CL1150.Contig16_All  777  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAA  836 
CL1150.Contig17_All  225  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAA  284 
CL1150.Contig18_All  222  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAA  281 
CL1150.Contig15_All  258  GAGATACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGA  317 
CL1150.Contig13_All  225  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAA  284 
CL1150.Contig7_All   225  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAA  284 
CL1150.Contig8_All   225  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC             273 
CL1150.Contig14_All  258  GAGATACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC             306 
 
Query_7              837  GCCACCTCA---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGGT  893 
CL1150.Contig16_All  837  GCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGT  896 
CL1150.Contig17_All  285  GCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGT  344 
CL1150.Contig18_All  282  GCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGT  341 
CL1150.Contig15_All  318  GCCACCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGAT  374 
CL1150.Contig13_All  285  GCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGT  344 
CL1150.Contig7_All   285  GCCACCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGT  344 
CL7631.Contig3_All   4        CCTCC---CACCATCCCCATCACTTGGATGATTGCTGGCCTGGCTCTCCTGGTGGT  56 
 
Query_7              894  CATTGCAGTGATTGGAGCTGTGATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGG  953 
CL1150.Contig16_All  897  CACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGG  956 
CL1150.Contig17_All  345  CACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGG  404 
CL1150.Contig18_All  342  CACTGTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGG  401 
CL1150.Contig15_All  375  CATTGCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGG  434 
CL1150.Contig13_All  345  CACTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGG  404 
CL1150.Contig7_All   345  CACTGTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA       399 
CL7631.Contig3_All   57   CACTGTGGTGATTGGAGCTGTGATCTGGTGGAAGAAGCGCTCAGG                 101 
 
Query_7              954  CTACTCTCATGCTGCACGCGAT  975 
CL1150.Contig16_All  957  CTACTCTCATGCTGCA        972 
CL1150.Contig17_All  405  CTACTCTCATGCTGCA        420 
CL1150.Contig18_All  402  CTACTCTCATGCTGCA        417 
CL1150.Contig15_All  435  CTACTCTCATGCTGCA        450 
 212 
 
CL1150.Contig13_All  405  CTACTCTCATGCTGCACGCGAT  426 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 77581675275 
 
 
Query= JQ425429.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*03 allele, partial cds 
 
Length=975 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  1531    0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  1214    0.0    
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  566     3e-160 
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  523     2e-147 
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  516     3e-145 
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  484     8e-136 
CL1150.Contig7_All  20 418 minus strand MHC class I antigen [Ailu...  462     4e-129 
CL1150.Contig8_All  20 526 hypothetical protein PANDA_022308 [Ail...  366     3e-100 
CL1150.Contig14_All  3 542 minus strand hypothetical protein PAND...  261     1e-68  
CL1150.Contig2_All  970 1128 MHC class I antigen, partial [Meles ...  239     7e-62  
CL1150.Contig24_All  1312 1467 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig23_All  1371 1526 MHC class I antigen, partial [Mele...  231     1e-59  
CL1150.Contig3_All  1659 1814 MHC class I antigen, partial [Meles...  231     1e-59  




Query_8              1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig16_All  1    GAGACCTGGGCGGGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  60 
CL1150.Contig4_All   4                GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGC  51 
 
Query_8              61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACGCGCAGTTCGTGCGGTTC  120 
CL1150.Contig16_All  61   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  120 
CL1150.Contig4_All   52   CGCGGGGAGCCCCGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTC  111 
 
Query_8              121  GACAGCGACTCTGCCAGTCTGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig16_All  121  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  180 
CL1150.Contig4_All   112  GACAGCGACTCTGCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGG  171 
 
Query_8              181  CCGGAGTATTGGGACCGGGAGACCCGGAACCTCAAGGAAACCACACAGACTTACCGAGTG  240 
CL1150.Contig16_All  181  CCGGAGTATTGGGACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGG  240 
CL1150.Contig4_All   172  CCGGAGTATTGGGACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGG  231 
 
Query_8              241  AACCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig16_All  241  AGCCTGAACATCCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAG  300 
CL1150.Contig4_All   232  AGCCTGAACAACCTGCGGGGCTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAG  291 
 
Query_8              301  AACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  360 
CL1150.Contig16_All  301  AACTTGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  360 
CL1150.Contig4_All   292  AACATGTACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTC  351 
 
Query_8              361  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig16_All  361  GCCTACGACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  420 
CL1150.Contig4_All   352  GCCTACGACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCG  411 
 
Query_8              421  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  480 
CL1150.Contig16_All  421  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  480 
CL1150.Contig4_All   412  GACACGGCGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTAC  471 
 
Query_8              481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig16_All  481  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  540 
CL1150.Contig4_All   472  AGGAACTATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAG  531 
 
Query_8              541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig16_All  541  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  600 
CL1150.Contig4_All   532  GAGTCGCTGCTGCGCGCAGAAACCCCCAATACACACGTGACCCGCCACCCCATCTCTGAC  591 
CL1150.Contig17_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig18_All  2                    CAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  45 
CL1150.Contig13_All  4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig7_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
CL1150.Contig8_All   13                           CCCAACACACACGTGACCCACCACCCCATCTCTGAC  48 
 213 
 
CL1150.Contig2_All   4                   GCAGAACCGCCCAACACACGCATGACCCACCACCCTATCTCTGAC  48 
CL1150.Contig24_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig23_All  2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig3_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
CL1150.Contig1_All   2                    CAGAACCCTCCAACACACACGTGACACACCACCCGATCTCTAAC  45 
 
Query_8              601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig16_All  601  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  660 
CL1150.Contig4_All   592  CGTGATGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  651 
CL1150.Contig15_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig17_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig18_All  46   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig13_All  49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig7_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig8_All   49   CATGCTAACACCCTGAGGTGATGGGCCCTGGACTTCTACCCTGCAGAGATCACCCTGACC  108 
CL1150.Contig14_All  127                                               GAGATCACCCTGACC  141 
CL1150.Contig2_All   49   CATGCTGTCACCCTGAGGTGCTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  108 
CL1150.Contig24_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig23_All  46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig3_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
CL1150.Contig1_All   46   AATGATGTCACCCTGAGGTGTTGGGCCCTGGACTTCTACCCTGCGGAGATCACCCTGACC  105 
 
Query_8              661  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  720 
CL1150.Contig16_All  661  TGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  720 
CL1150.Contig4_All   652  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           702 
CL1150.Contig15_All  142  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  201 
CL1150.Contig17_All  109  TGGCAGCGAGATGGAGAGGACCTAACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  168 
CL1150.Contig18_All  106  TGGCAGAGGGATGGAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACCAGGCCTGCA  165 
CL1150.Contig13_All  109  TGGCACCATGAGGAGGAGGACCTGACCCAGGACACAGAACTTGTAGGGACCAGGCCTACA  168 
CL1150.Contig7_All   109  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  168 
CL1150.Contig8_All   109  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  168 
CL1150.Contig14_All  142  TGGCAGAGGGATGGAGAGGACCAGACCCAGGACACAGAGCTTGTGGAGACCAGGCCTGCA  201 
CL1150.Contig2_All   109  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           159 
CL1150.Contig24_All  106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig23_All  106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig3_All   106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
CL1150.Contig1_All   106  TGGAAGCGAGATGAAGAGGACCTGACCCAGGACACAGAGCTCGTGGAGACC           156 
 
Query_8              721  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGA  780 
CL1150.Contig16_All  721  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  780 
CL1150.Contig15_All  202  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTGGTGCCTTCTGGACAGGAGCAGAGA  261 
CL1150.Contig17_All  169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig18_All  166  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  225 
CL1150.Contig13_All  169  GGGAATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig7_All   169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig8_All   169  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  228 
CL1150.Contig14_All  202  GGAGATGGAACCTTCCAGAAGTGGGCGGCTGTGGTTGTGCCCTCTGGAGAGGAGCAGAGA  261 
 
Query_8              781  TACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCA  840 
CL1150.Contig16_All  781  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  840 
CL1150.Contig15_All  262  TACACATGCTATGTGCAGCATGAGGGGCTGTCTGAACCCATCACCCGGAGATGGGAGCCA  321 
CL1150.Contig17_All  229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig18_All  226  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  285 
CL1150.Contig13_All  229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig7_All   229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACCTTGAGTTGGAAGCCA  288 
CL1150.Contig8_All   229  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                 273 
CL1150.Contig14_All  262  TACACATGCCATGTGCAGCATAAGGGGCTGCCTGAGCCCATCACC                 306 
 
Query_8              841  CCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATT  897 
CL1150.Contig16_All  841  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  900 
CL1150.Contig15_All  322  CCTCG---CACCATCCCCATCACATGGATCATTGCTGGTCTGGTTCTCCTGGTGATCATT  378 
CL1150.Contig17_All  289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
CL1150.Contig18_All  286  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  345 
CL1150.Contig13_All  289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
CL1150.Contig7_All   289  CCTCCTCCCACCATCCCCATCATGTGGATCATTGCTGGCCTGGCTCTCCTGGCAGTCACT  348 
 
Query_8              898  GCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTAC  957 
CL1150.Contig16_All  901  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  960 
CL1150.Contig15_All  379  GCAGTGATTGGAGTTGCAATCTGGTGGAAGAAGCGCTCAGGAGAAAAAGGACCAGGCTAC  438 
CL1150.Contig17_All  349  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  408 
CL1150.Contig18_All  346  GTGGTGGTTGGAGCTGTGATCTGGAGGAGGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  405 
CL1150.Contig13_All  349  GTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGACCAGGCTAC  408 
CL1150.Contig7_All   349  GTGGTGGTTGGAGCTGTGATCTGGAGGAAGAAGCGCTCAGGAGGAAAAGGA           399 
 
Query_8              958  TCTCATGCTGCACGCGAT  975 
CL1150.Contig16_All  961  TCTCATGCTGCA        972 
CL1150.Contig15_All  439  TCTCATGCTGCA        450 
CL1150.Contig17_All  409  TCTCATGCTGCA        420 
CL1150.Contig18_All  406  TCTCATGCTGCA        417 





Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 77581675275 
 
 
Query= JQ425428.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 
Meme-MHCI*02 allele, partial cds 
 
Length=543 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  832     0.0   
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  776     0.0   




Query_9              1    GGCTCCCACTCCCTGAGGTATTTCTCCACCGCGGTGTCCCGGCCCGGCCGCGGGGAGCCC  60 
CL1150.Contig16_All  13   GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGCCGCGGGGAGCCC  72 
CL1150.Contig4_All   4    GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGCCGCGGGGAGCCC  63 
 
Query_9              61   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  120 
CL1150.Contig16_All  73   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  132 
CL1150.Contig4_All   64   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  123 
 
Query_9              121  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGGTGGAGCAGGAGGGGCCGGAGTATTGG  180 
CL1150.Contig16_All  133  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGGAGTATTGG  192 
CL1150.Contig4_All   124  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGGAGTATTGG  183 
CL1150.Contig22_All  1                                              GAGGGGCCGGAGTATTGG  18 
 
Query_9              181  GACCGGCAGACGCAGATCTGCAAGGACGCCGCACAGACTTTCCGAGGGAACCTGCAGACC  240 
CL1150.Contig16_All  193  GACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGGAGCCTG-A-ACA  250 
CL1150.Contig4_All   184  GACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGGAGCCTG-A-ACA  241 
CL1150.Contig22_All  19   GACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTGAACCTGAACACC  78 
 
Query_9              241  GCACTCC---G-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAGAACGTGTA  296 
CL1150.Contig16_All  251  TC-CTGCGGGG-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCATCCAGAACTTGTA  308 
CL1150.Contig4_All   242  AC-CTGCGGGG-CTACTACAACCAGAGCGCGGCCGGGTCTCACACCTTCCAGAACATGTA  299 
CL1150.Contig22_All  79   -CTGCGG---GACTACTACAACCAGAGCGCGGCCGG                          110 
 
Query_9              297  CGGCTGTGACGTGGGGCCCGACGGGCGTTTCCTCCGCGGGTACCGTCAGGACTCCTACGA  356 
CL1150.Contig16_All  309  CGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCTACGA  368 
CL1150.Contig4_All   300  CGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCTACGA  359 
 
Query_9              357  CGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGGC  416 
CL1150.Contig16_All  369  CGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGGC  428 
CL1150.Contig4_All   360  CGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGGC  419 
 
Query_9              417  GGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGCGGCAGAGCGCTGGAGGAACTA  476 
CL1150.Contig16_All  429  GGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGAACTA  488 
CL1150.Contig4_All   420  GGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGAACTA  479 
 
Query_9              477  CCTGGAGGTCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGCT  536 
CL1150.Contig16_All  489  TGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGCT  548 
CL1150.Contig4_All   480  TGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGCT  539 
 
Query_9              537  GCTGCGC  543 
CL1150.Contig16_All  549  GCTGCGC  555 
CL1150.Contig4_All   540  GCTGCGC  546 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 42412998768 
 
 
Query= JQ425427.1 Meles meles MHC class I antigen (Meme-MHCI) mRNA, 





                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  809     0.0   
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  793     0.0   




Query_10             1    GGCTCCCACTCCCTGAGGTATTTCTCCACCGCGGTGTCCCGGCCCGGCCGCGGGGAGCCC  60 
CL1150.Contig4_All   4    GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGCCGCGGGGAGCCC  63 
CL1150.Contig16_All  13   GGCTCCCACTCCCTGAGGTATTTCTACACCGGCGTGTCCCGGCCCGGCCGCGGGGAGCCC  72 
 
Query_10             61   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  120 
CL1150.Contig4_All   64   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  123 
CL1150.Contig16_All  73   CGCTTCATCGCCGTCGGCTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACTCT  132 
 
Query_10             121  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGGTGGAGCAGGAGGGGCCGGAGTATTGG  180 
CL1150.Contig4_All   124  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGGAGTATTGG  183 
CL1150.Contig16_All  133  GCCAGTCGGAGGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCGGAGTATTGG  192 
CL1150.Contig22_All  1                                              GAGGGGCCGGAGTATTGG  18 
 
Query_10             181  GACCGGCAGACGCGGGGGATCAAGGACGCCGCACAGACTTTCCGAGGGAACCTGCAGACC  240 
CL1150.Contig4_All   184  GACCAGCAGACGCGGGGGATCAAGGAAACCACACAGACTTACCGACGGAGCCTG-A-ACA  241 
CL1150.Contig16_All  193  GACCGGCAGACGCAGATCTGCAAGGAAACCACACAGACTTACCGAGGGAGCCTG-A-ACA  250 
CL1150.Contig22_All  19   GACCGGCAGACGCGGAACCTCAAGGACGCCGCACACGCTTTCCGAGTGAACCTGAACACC  78 
 
Query_10             241  GCACTCC---G-CTACTACAACCAGAGCGCGGCC-GGGTCTCACACCATCCAGAGCATGT  295 
CL1150.Contig4_All   242  AC-CTGCGGGG-CTACTACAACCAGAGCGCGGCC-GGGTCTCACACCTTCCAGAACATGT  298 
CL1150.Contig16_All  251  TC-CTGCGGGG-CTACTACAACCAGAGCGCGGCC-GGGTCTCACACCATCCAGAACTTGT  307 
CL1150.Contig22_All  79   -CTGCGG---GACTACTACAACCAGAGCGCGGCC-GG                         110 
CL1150.Contig22_All  293                                GGCCAGGGTCTCACACCATCCAGAGCATGT  322 
 
Query_10             296  ACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACAGTCAGGACTCCTACG  355 
CL1150.Contig4_All   299  ACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCTACG  358 
CL1150.Contig16_All  308  ACGGCTGTGACGTGGGGCCCGACGGGCGTCTCCTCCGCGGGTACCGTCAGTTCGCCTACG  367 
CL1150.Contig22_All  323  ACGGCTGTGACGTGGAGCCCGACGGGCGTCTCCTCCGC                        360 
 
Query_10             356  ACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGG  415 
CL1150.Contig4_All   359  ACGGCGCGGATTACCTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGG  418 
CL1150.Contig16_All  368  ACGGCGCGGATTACATCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGG  427 
 
Query_10             416  CGGCGCAGATCACCCAGCGCAAGTGGGAGGACGCGGGTGTGGCAGAGCGCTGGAGGAACT  475 
CL1150.Contig4_All   419  CGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGAACT  478 
CL1150.Contig16_All  428  CGGCGCAGATCTCCCGGCGCAAGTGGGAGGACGCGGGTGAGGCAGAGCGCTACAGGAACT  487 
 
Query_10             476  ACCTGGAGGTCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGC  535 
CL1150.Contig4_All   479  ATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGC  538 
CL1150.Contig16_All  488  ATGTGGAGGGCACGTGCGTGGAGTGGCTCGGCAGGTACCTGGAGAACGGGAAGGAGTCGC  547 
 
Query_10             536  TGCTGCGC  543 
CL1150.Contig4_All   539  TGCTGCGC  546 
CL1150.Contig16_All  548  TGCTGCGC  555 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 42412998768 
 
 
Query= HQ908107.1 Meles meles nonfunctional MHC class II antigen (Meme-DQB) 
pseudogene mRNA, Meme-DQB*PS01 allele, partial sequence 
 
Length=680 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  1123    0.0    
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  1085    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  935     0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  564     7e-160 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  507     1e-142 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  409     3e-113 
Unigene4377_All  98 193 minus strand MHC class II antigen DQ beta...  178     1e-43  
CL4065.Contig4_All  98 193 minus strand MHC class II antigen [Zal...  178     1e-43  
 216 
 
CL4065.Contig2_All  98 193 minus strand MHC class II antigen [Zal...  178     1e-43  




Query_11            24   ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  83 
Unigene57188_All    1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
Unigene67843_All    1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
Unigene75450_All    1                         GGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  39 
Unigene4377_All     1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig4_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig2_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig1_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
 
Query_11            84   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAA-----------------TTTAAG  126 
Unigene57188_All    61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  120 
Unigene67843_All    61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  120 
Unigene75450_All    40   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  99 
CL4065.Contig3_All  8                                    TCCAG-----------------TTTAAG  18 
Unigene4377_All     61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig4_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig2_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig1_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
 
Query_11            127  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  186 
Unigene57188_All    121  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  180 
Unigene67843_All    121  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  180 
Unigene75449_All    103     GAGTGCCACTTCACCAACGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTAT  159 
Unigene75450_All    100  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  159 
CL4065.Contig3_All  19   GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  78 
Unigene27967_All    103     GAGTGCCACTTCACCAACGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTAT  159 
 
Query_11            187  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  246 
Unigene57188_All    181  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  240 
Unigene67843_All    181  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  240 
Unigene75449_All    160  AACGGCGAGGAGTACGTGCGCTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  219 
Unigene75450_All    160  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  219 
CL4065.Contig3_All  79   AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  138 
Unigene27967_All    160  AACGGCGAGGAGTACGTGCGCTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  219 
 
Query_11            247  CTGGGGCGGCCGGACGCTGAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  306 
Unigene57188_All    241  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  300 
Unigene67843_All    241  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  300 
Unigene75449_All    220  CTGGGGCGGCCGGACGCTGAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  279 
Unigene75450_All    220  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  279 
CL4065.Contig3_All  139  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  198 
Unigene27967_All    220  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  279 
 
Query_11            307  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  366 
Unigene57188_All    301  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  360 
Unigene67843_All    301  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  360 
Unigene75449_All    280  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  339 
Unigene75450_All    280  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  339 
CL4065.Contig3_All  199  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  258 
Unigene27967_All    280  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  339 
 
Query_11            367  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  426 
Unigene57188_All    361  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  420 
Unigene67843_All    361  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  420 
Unigene75449_All    340  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  399 
Unigene75450_All    340  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  399 
CL4065.Contig3_All  259  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  318 
Unigene27967_All    340  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  399 
 
Query_11            427  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  486 
Unigene57188_All    421  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  480 
Unigene67843_All    421  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  480 
Unigene75449_All    400  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  459 
Unigene75450_All    400  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  459 
CL4065.Contig3_All  319  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  378 
Unigene27967_All    400  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  459 
 
Query_11            487  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  546 
Unigene57188_All    481  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  540 
Unigene67843_All    481  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  540 
Unigene75449_All    460  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  519 
Unigene75450_All    460  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  519 
CL4065.Contig3_All  379  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  438 
Unigene27967_All    460  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  519 
 
Query_11            547  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  605 
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Unigene57188_All    541  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  599 
Unigene67843_All    541  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  599 
Unigene75449_All    520  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  578 
Unigene75450_All    520  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  578 
CL4065.Contig3_All  439  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  497 
Unigene27967_All    520  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  578 
 
Query_11            606  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  665 
Unigene57188_All    600  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  659 
Unigene67843_All    600  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCG           650 
Unigene75449_All    579  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  638 
Unigene75450_All    579  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  638 
CL4065.Contig3_All  498  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  557 
Unigene27967_All    579  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  638 
 
Query_11            666  TGAATCTGCCCAGAG  680 
Unigene57188_All    660  GGAATCTGCCCAGAG  674 
Unigene75449_All    639  GGAATCTGCCCAGAG  653 
Unigene75450_All    639  TGGGTCTGCACAGAG  653 
CL4065.Contig3_All  558  TGGGTCTGCACAGAG  572 
Unigene27967_All    639  TGGGTCTGCACAGAG  653 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 53465137650 
 
 
Query= HQ908099.1 Meles meles MHC class II antigen DR alpha chain 
(Meme-DRA) mRNA, Meme-DRA*02 allele, partial cds 
 
Length=691 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL2981.Contig3_All  111 872 minus strand PREDICTED: HLA class II ...  1243    0.0   
CL2981.Contig1_All  111 872 minus strand PREDICTED: HLA class II ...  1243    0.0   




Query_12            1    CATAAGTGGAGTCCCTGTGCTAGGATTTTTCATCATGACTTTACTGATGGGTCCCCAAGA  60 
CL2981.Contig3_All  6    CATAAATGGAGTCCCAGTGCTAGGATTTTTCATCATGACTTTACTGATGGGTCCCCAAGA  65 
CL2981.Contig1_All  6    CATAAATGGAGTCCCAGTGCTAGGATTTTTCATCATGACTTTACTGATGGGTCCCCAAGA  65 
Unigene42913_All    1     ATAAATGGAGTCCCAGTGCTAGGATTTTTCATCATGACTTTACTGATGGGTCCCCAAGA  59 
 
Query_12            61   ATCACAGGCTATCAAAGAGGACCATGTGATCATCCAGGCTGAGTTTTATCTGACCCCTGA  120 
CL2981.Contig3_All  66   ATCACAGGCTATCAAAGAGGACCATGTGATCATCCAGGCTGAGTTTTATCTGACCCCTGA  125 
CL2981.Contig1_All  66   ATCACAGGCTATCAAAGAGGACCATGTGATCATCCAGGCTGAGTTTTATCTGACCCCTGA  125 
Unigene42913_All    60   ATCACAGGCTATCAAAGAGGACCATGTGATCATCCAGGCTGAGTTTTATCTGACCCCTGA  119 
 
Query_12            121  CCCGTCAGGCGAGTTTATGTTTGACTTCGATGGTGATGAGATTTTCCACGTGGATATGGA  180 
CL2981.Contig3_All  126  CCCGTCAGGCGAGTTTATGTTTGACTTCGATGGTGATGAGATTTTCCACGTGGATATGGA  185 
CL2981.Contig1_All  126  CCCGTCAGGCGAGTTTATGTTTGACTTCGATGGTGATGAGATTTTCCACGTGGATATGGA  185 
Unigene42913_All    120  CCCGTCAGGCGAGTTTATGTTTGACTTCGATGGTGATGAGATTTTCCACGTGGATATGGA  179 
 
Query_12            181  AAAGAAGGAGACAGTGTGGCGGCTGGAAGAATTTGGACGCTTTGCCAGCTTTGAGGCACA  240 
CL2981.Contig3_All  186  AAAGAAGGAGACAGTGTGGCGGCTGGAAGAATTTGGACGCTTTGCCAGCTTTGAGGCACA  245 
CL2981.Contig1_All  186  AAAGAAGGAGACAGTGTGGCGGCTGGAAGAATTTGGACGCTTTGCCAGCTTTGAGGCACA  245 
Unigene42913_All    180  AAAGAAGGAGACAGTGTGGCGGCTGGAAGAATTTGGACGCTTTGCCAGCTTTGAGGCACA  239 
 
Query_12            241  GGGTGCCTTGGCCAACATAGCTGTGGACAAAGCTAACCTGGACATCATGATAAAGCGCTC  300 
CL2981.Contig3_All  246  GGGTGCCTTGGCCAACATAGCTGTGGACAAAGCTAACCTGGACATCATGATAAAGCGCTC  305 
CL2981.Contig1_All  246  GGGTGCCTTGGCCAACATAGCTGTGGACAAAGCTAACCTGGACATCATGATAAAGCGCTC  305 
Unigene42913_All    240  GGGTGCCTTGGCCAACATAGCTGTGGACAAAGCTAACCTGGACATCATGATAAAGCGCTC  299 
 
Query_12            301  CAACCACACCCCAAACACCAATGTACCTCCAGAGGTGACCGTGCTCTCAAACACCCCTGT  360 
CL2981.Contig3_All  306  CAACCACACCCCAAACACCAATGTACCTCCAGAGGTGACCGTGCTCTCAAACACCCCTGT  365 
CL2981.Contig1_All  306  CAACCACACCCCAAACACCAATGTACCTCCAGAGGTGACCGTGCTCTCAAACACCCCTGT  365 
Unigene42913_All    300  CAACCACACCCCAAACACCAATGTACCTCCAGAGGTGACCGTGCTCTCAAACACCCCTGT  359 
 
Query_12            361  GGAACTGGGAGAGCCCAACACCCTCATCTGCTTCATCGACAAGTTCTCCCCACCAGTGAT  420 
CL2981.Contig3_All  366  GGAACTGGGAGAGCCCAACACCCTCATCTGCTTCATCGACAAGTTCTCCCCACCAGTGAT  425 
CL2981.Contig1_All  366  GGAACTGGGAGAGCCCAACACCCTCATCTGCTTCATCGACAAGTTCTCCCCACCAGTGAT  425 




Query_12            421  CAATGTCACGTGGCTTCGAAATGGAAACCCTGTCACCACAGGAGTGTCCGAGACAGTCTT  480 
CL2981.Contig3_All  426  CAATGTCACGTGGCTTCGAAATGGAAACCCTGTCACCACAGGAGTGTCCGAGACAGTCTT  485 
CL2981.Contig1_All  426  CAATGTCACGTGGCTTCGAAATGGAAACCCTGTCACCACAGGAGTGTCCGAGACAGTCTT  485 
Unigene42913_All    420  CAATGTCACGTGGCTTCGAAATGGAAACCCTGTCACCACAGGAGTGTCCGAGACAGTCTT  479 
 
Query_12            481  CCTGCCCAGGGAAGACCACCTTTTCCGCAAGTTCCACTATCTCCCCTTCCTGCCCTCAGC  540 
CL2981.Contig3_All  486  CCTGCCCAGGGAAGACCACCTTTTCCGCAAGTTCCACTATCTCCCCTTCCTGCCCTCAGC  545 
CL2981.Contig1_All  486  CCTGCCCAGGGAAGACCACCTTTTCCGCAAGTTCCACTATCTCCCCTTCCTGCCCTCAGC  545 
Unigene42913_All    480  CCTGCCCAGGGAAGACCACCTTTTCCGCAAGTTCCACTATCTCCCCTTCCTGCCCTCAGC  539 
 
Query_12            541  CAACGATGTCTATGACTGCAAGGTGGAGCACTGGGGTCTGGATGAGCCTCTTCTCAAGCA  600 
CL2981.Contig3_All  546  CAACGATGTCTATGACTGCAAGGTGGAGCACTGGGGTCTGGATGAGCCTCTTCTCAAGCA  605 
CL2981.Contig1_All  546  CAACGATGTCTATGACTGCAAGGTGGAGCACTGGGGTCTGGATGAGCCTCTTCTCAAGCA  605 
Unigene42913_All    540  CAACGATGTCTATGACTGCAAGGTGGAGCACTGGGGTCTGGATGAGCCTCTTCTCAAGCA  599 
 
Query_12            601  CTGGGAGTTTGAACCACCAACTCCTCTCCCAGAGACAACCGAGAATGTGGTGTGTGCCCT  660 
CL2981.Contig3_All  606  CTGGGAGTTTGAACCACCAACTCCTCTCCCAGAGACAACCGAGAATGTGGTGTGTGCCCT  665 
CL2981.Contig1_All  606  CTGGGAGTTTGAACCACCAACTCCTCTCCCAGAGACAACCGAGAATGTGGTGTGTGCCCT  665 
Unigene42913_All    600  CTGG                                                          603 
 
Query_12            661  GGGCCTGGTTGTGGGTCTGGTTGGCATC  688 
CL2981.Contig3_All  666  GGGCCTGGTTGTGGGTTTGGTGGGTATC  693 
CL2981.Contig1_All  666  GGGCCTGGTTGTGGGTTTGGTGGGTATC  693 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 54364398375 
 
 
Query= HQ908098.1 Meles meles MHC class II antigen DQ alpha chain 
(Meme-DQA) mRNA, Meme-DQA*02 allele, partial cds 
 
Length=615 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  1125    0.0   
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  1075    0.0   




Query_13             1    ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  60 
CL10050.Contig3_All  31   ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  90 
CL10050.Contig2_All  1    ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  60 
CL10050.Contig1_All  1    ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  60 
 
Query_13             61   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  120 
CL10050.Contig3_All  91   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  150 
CL10050.Contig2_All  61   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  120 
CL10050.Contig1_All  61   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  120 
 
Query_13             121  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  180 
CL10050.Contig3_All  151  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  210 
CL10050.Contig2_All  121  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  180 
CL10050.Contig1_All  121  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  180 
 
Query_13             181  CTGCCTGTGTTTAGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAGCT  240 
CL10050.Contig3_All  211  CTGCCTGTGTTTAGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAGCT  270 
CL10050.Contig2_All  181  CTGCCTGTGTTTAGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAGCT  240 
CL10050.Contig1_All  181  CTGCCTGTGTTTAGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAGCT  240 
 
Query_13             241  ACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCAAT  300 
CL10050.Contig3_All  271  ACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCAAT  330 
CL10050.Contig2_All  241  ACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCAAT  300 
CL10050.Contig1_All  241  ACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCAAT  300 
 
Query_13             301  GAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACACC  360 
CL10050.Contig3_All  331  GAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACACC  390 
CL10050.Contig2_All  301  GAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACACC  360 
CL10050.Contig1_All  301  GAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACACC  360 
 
Query_13             361  CTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGAAC  420 
CL10050.Contig3_All  391  CTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGAAC  450 
CL10050.Contig2_All  361  CTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGAAC  420 
 219 
 
CL10050.Contig1_All  361  CTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGAAC  420 
 
Query_13             421  AGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATTCC  480 
CL10050.Contig3_All  451  AGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATTCC  510 
CL10050.Contig2_All  421  AGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATTCC  480 
CL10050.Contig1_All  421  AGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATTCC  480 
 
Query_13             481  TTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCAAG  540 
CL10050.Contig3_All  511  TTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCAAG  570 
CL10050.Contig2_All  481  TTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCAAG  540 
CL10050.Contig1_All  481  TTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCAAG  540 
 
Query_13             541  GTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGGGAACCTGAAATTCCAACC  600 
CL10050.Contig3_All  571  GTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGGGAACCTGAAATTCCATCC  630 
CL10050.Contig2_All  541  GTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGG                    582 
CL10050.Contig1_All  541  GTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGG                    582 
 
Query_13             601  CCTATGTCAGAGCTG  615 
CL10050.Contig3_All  631  CCCATGTCAGAGCTG  645 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 48308241840 
 
 
Query= HQ908097.1 Meles meles MHC class II antigen DQ alpha chain 
(Meme-DQA) mRNA, Meme-DQA*01 allele, partial cds 
 
Length=615 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  854     0.0   
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  804     0.0   




Query_14             1    ACTCTTGCCCTGACCACCATAATGAGCCTTGGTGGCAGTGAAGACATTGTGGCTGATCAT  60 
CL10050.Contig3_All  31   ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  90 
CL10050.Contig2_All  1    ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  60 
CL10050.Contig1_All  1    ACTCTTGCCCTGACCACCATGATGAGCCCTGGTGGCAGTGAAGACATTGTGGCTGACCAT  60 
 
Query_14             61   GTTGCTTCCTATGGCATAAGTGTCTACCAGTCTTATGGTCCCTCTGGCCAGTACACCCGT  120 
CL10050.Contig3_All  91   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  150 
CL10050.Contig2_All  61   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  120 
CL10050.Contig1_All  61   GTTGGTGCCTATGGCGTAGAAGTCTACCAGTCTTATGGTCCCTCTGGCCAATACACTCAA  120 
 
Query_14             121  GAATTTGATGGTGATGAGGAATTCTACGTGGACTTGGAGAAGAAGGAGACAGTCTGGCAG  180 
CL10050.Contig3_All  151  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  210 
CL10050.Contig2_All  121  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  180 
CL10050.Contig1_All  121  GAATTTGATGGAGATGAGTTGTTCTATGTGGACCTGGAGAAGAAGGAAACTGTCTGGCGG  180 
 
Query_14             181  CTGCCCATGTTTCAAGCAC-TTAG-ACGTTTTGACCCACAAGGTGCACTGAGAAACTTGG  238 
CL10050.Contig3_All  211  CTGCCTGTGTTT--AGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAG  268 
CL10050.Contig2_All  181  CTGCCTGTGTTT--AGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAG  238 
CL10050.Contig1_All  181  CTGCCTGTGTTT--AGCACATTTGCAGGTTTTGACCCACAAGGTGCACTGAGCGAAATAG  238 
 
Query_14             239  CAATAGCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCA  298 
CL10050.Contig3_All  269  CTACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCA  328 
CL10050.Contig2_All  239  CTACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCA  298 
CL10050.Contig1_All  239  CTACATCAAAACAAAACTTGAACATCCTGACTAAACGCTCCAACTATACCGCTGCTACCA  298 
 
Query_14             299  ATGAGGTTCCTGAGGTGACGCTGTTTCTAAAGACTCCTGTGATGCTGGGTCAGCCCAACA  358 
CL10050.Contig3_All  329  ATGAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACA  388 
CL10050.Contig2_All  299  ATGAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACA  358 
CL10050.Contig1_All  299  ATGAGGTTCCTGAGGTGACGCTGTTTCCCAAGTCTCCTGTGATGCTGGGTCAGCCCAACA  358 
 
Query_14             359  CCCTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGA  418 
CL10050.Contig3_All  389  CCCTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGA  448 
CL10050.Contig2_All  359  CCCTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGA  418 
CL10050.Contig1_All  359  CCCTCATCTGTCTTGTGGACAACATCTTTCCTCCTGTGATCAATGTCACGTGGTTGAAGA  418 
 
Query_14             419  ACAGGCATTCAGTCACAGAAGGTGTTTCTGAAACCCACTTCCTTATCAAAAAGGATTATT  478 
CL10050.Contig3_All  449  ACAGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATT  508 
 220 
 
CL10050.Contig2_All  419  ACAGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATT  478 
CL10050.Contig1_All  419  ACAGGCACTCAGTCACAGAAGGTGTTTCTGAAACCAGCTTCCTTGCCAAGAAGGATCATT  478 
 
Query_14             479  CCTTCTTAAAGTTCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCA  538 
CL10050.Contig3_All  509  CCTTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCA  568 
CL10050.Contig2_All  479  CCTTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCA  538 
CL10050.Contig1_All  479  CCTTCTTAAAGATCAGTTACCTCACCTTCCTCCCTTCTGCTGATGATATTTATGACTGCA  538 
 
Query_14             539  AGGTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGGGAACCTGAAATTCCAA  598 
CL10050.Contig3_All  569  AGGTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGGGAACCTGAAATTCCAT  628 
CL10050.Contig2_All  539  AGGTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGG                  582 
CL10050.Contig1_All  539  AGGTGGAGCACTGGGGCCTGGATGAACCACTTCTGAAACACTGG                  582 
 
Query_14             599  CCCCTATGTCAGAGCTG  615 
CL10050.Contig3_All  629  CCCCCATGTCAGAGCTG  645 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 48308241840 
 
 
Query= HQ908096.1 Meles meles MHC class II antigen DQ beta chain (Meme-DQB) 
mRNA, Meme-DQB*02 allele, partial cds 
 
Length=697 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  1234    0.0    
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  1195    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  935     0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  675     0.0    
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  525     3e-148 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  409     4e-113 
Unigene4377_All  98 193 minus strand MHC class II antigen DQ beta...  178     1e-43  
CL4065.Contig4_All  98 193 minus strand MHC class II antigen [Zal...  178     1e-43  
CL4065.Contig2_All  98 193 minus strand MHC class II antigen [Zal...  178     1e-43  




Query_15            24   ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  83 
Unigene57188_All    1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
Unigene67843_All    1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
Unigene75450_All    1                         GGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  39 
Unigene4377_All     1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig4_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig2_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
CL4065.Contig1_All  1    ATGGCACTGTGGATCCCCAGAGGCCTCTGGACAGCAGCTGTGATGGCGATCTTGGTGGTG  60 
 
Query_15            84   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  143 
Unigene57188_All    61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  120 
Unigene67843_All    61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  120 
Unigene75450_All    40   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAG  99 
CL4065.Contig3_All  1                                              TTCGTGTTCCAGTTTAAG  18 
Unigene4377_All     61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig4_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig2_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
CL4065.Contig1_All  61   CTGAGCGTCCCAGTGGCTGAGGGCAGAGACTCTCCA                          96 
 
Query_15            144  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  203 
Unigene57188_All    121  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  180 
Unigene67843_All    121  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  180 
Unigene75449_All    103     GAGTGCCACTTCACCAACGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTAT  159 
Unigene75450_All    100  GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  159 
CL4065.Contig3_All  19   GGCGAGTGCTACTTCACCAACGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTAT  78 
Unigene27967_All    103     GAGTGCCACTTCACCAACGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTAT  159 
 
Query_15            204  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  263 
Unigene57188_All    181  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  240 
Unigene67843_All    181  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  240 
Unigene75449_All    160  AACGGCGAGGAGTACGTGCGCTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  219 
Unigene75450_All    160  AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  219 
CL4065.Contig3_All  79   AACCGGGAGGAGTTCGTGCGCTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAG  138 




Query_15            264  CTGGGGCGGCCGGACGCTGAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  323 
Unigene57188_All    241  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  300 
Unigene67843_All    241  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  300 
Unigene75449_All    220  CTGGGGCGGCCGGACGCTGAGTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAG  279 
Unigene75450_All    220  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  279 
CL4065.Contig3_All  139  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  198 
Unigene27967_All    220  CTGGGGCGGCCGGACGCTCAGTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGG  279 
 
Query_15            324  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  383 
Unigene57188_All    301  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  360 
Unigene67843_All    301  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  360 
Unigene75449_All    280  GCCGAGACAGACACGGTGTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAG  339 
Unigene75450_All    280  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  339 
CL4065.Contig3_All  199  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  258 
Unigene27967_All    280  GCCGCGGTGGACACATACTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAG  339 
 
Query_15            384  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  443 
Unigene57188_All    361  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  420 
Unigene67843_All    361  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  420 
Unigene75449_All    340  AGGCGAGTGGAACCTACAGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCAC  399 
Unigene75450_All    340  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  399 
CL4065.Contig3_All  259  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  318 
Unigene27967_All    340  CGGCGAGTGGAGCCTACAGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCAC  399 
 
Query_15            444  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  503 
Unigene57188_All    421  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  480 
Unigene67843_All    421  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  480 
Unigene75449_All    400  AACATGCTGGTCTGCTCGGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTT  459 
Unigene75450_All    400  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  459 
CL4065.Contig3_All  319  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  378 
Unigene27967_All    400  AACCTCCTGGTCTGCTCTGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTC  459 
 
Query_15            504  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  563 
Unigene57188_All    481  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  540 
Unigene67843_All    481  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  540 
Unigene75449_All    460  CGGAATGACCAGGAGGAGAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGAC  519 
Unigene75450_All    460  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  519 
CL4065.Contig3_All  379  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  438 
Unigene27967_All    460  CGGAATGGCCAGGAAGAGGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGAC  519 
 
Query_15            564  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  622 
Unigene57188_All    541  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  599 
Unigene67843_All    541  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  599 
Unigene75449_All    520  TGGACCTTCCAGATCCTTGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACAC  578 
Unigene75450_All    520  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  578 
CL4065.Contig3_All  439  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  497 
Unigene27967_All    520  TGGACCTTCCAGACCCTGGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACAC  578 
 
Query_15            623  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  682 
Unigene57188_All    600  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  659 
Unigene67843_All    600  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCG           650 
Unigene75449_All    579  CTGCCATGTGGAGCACCCCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTC  638 
Unigene75450_All    579  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  638 
CL4065.Contig3_All  498  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  557 
Unigene27967_All    579  CTGCCAAGTGGAGCACCCCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTC  638 
 
Query_15            683  TGAATCTGCCCAGAG  697 
Unigene57188_All    660  GGAATCTGCCCAGAG  674 
Unigene75449_All    639  GGAATCTGCCCAGAG  653 
Unigene75450_All    639  TGGGTCTGCACAGAG  653 
CL4065.Contig3_All  558  TGGGTCTGCACAGAG  572 
Unigene27967_All    639  TGGGTCTGCACAGAG  653 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 54854904225 
 
 
Query= HQ908095.1 Meles meles MHC class II antigen DR beta chain (Meme-DRB) 
mRNA, Meme-DRB*04 allele, partial cds 
 
Length=822 
                                                                      Score     E 




Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  1208    0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  1146    0.0    
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  1136    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  593     1e-168 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  536     2e-151 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  459     4e-128 




Query_16            3    GGCTCCTGGATGACAGCTTTGACACTGATACTGATGGTGCTGAGCCCTCCC-TTGGCTTG  61 
Unigene27967_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCC-TTGGCTTG  59 
Unigene75450_All    35                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  59 
Unigene75449_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCC-TTGGCTTG  59 
Unigene57188_All    56                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  80 
Unigene67843_All    56                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  80 
 
Query_16            62   GGCCAGGGACACCCCACGACATTTCCTGATGCAGTTTAAGGGCGAGTGCTACTTCACCAA  121 
Unigene27967_All    60   GGCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAA  119 
Unigene75450_All    60   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  119 
CL4065.Contig3_All  10                                  CAGTTTAAGGGCGAGTGCTACTTCACCAA  38 
Unigene75449_All    60   GGCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAA  119 
Unigene57188_All    81   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  140 
Unigene67843_All    81   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  140 
 
Query_16            122  TGGGACGGAGCGGGTGCGGCTCCTGGTCAGACACATCTATAACCGGGAGGAGTTCGTGCG  181 
Unigene27967_All    120  CGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCG  179 
Unigene75450_All    120  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  179 
CL4065.Contig3_All  39   CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  98 
Unigene75449_All    120  CGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCG  179 
Unigene57188_All    141  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  200 
Unigene67843_All    141  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  200 
 
Query_16            182  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCCATCGCTCA  241 
Unigene27967_All    180  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  239 
Unigene75450_All    180  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  239 
CL4065.Contig3_All  99   CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  158 
Unigene75449_All    180  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTGA  239 
Unigene57188_All    201  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  260 
Unigene67843_All    201  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  260 
 
Query_16            242  GGGCTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGAGGTGGACACCGTGTG  301 
Unigene27967_All    240  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTG  299 
Unigene75450_All    240  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTG  299 
CL4065.Contig3_All  159  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTG  218 
Unigene75449_All    240  GTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTG  299 
Unigene57188_All    261  GTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTG  320 
Unigene67843_All    261  GTACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTG  320 
Unigene81593_All    1                 CAGAAGGACATCATGGAGCGGAAGAGGTCCGAGGTGGACACCGTGTG  47 
 
Query_16            302  CAGACACAACTACGGGGTGGTTGAGAGCTTCACGGTGCAGCGGCGAGTGGAGCCTACAGT  361 
Unigene27967_All    300  CAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGT  359 
Unigene75450_All    300  CAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGT  359 
CL4065.Contig3_All  219  CAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGT  278 
Unigene75449_All    300  CAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGT  359 
Unigene57188_All    321  CAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGT  380 
Unigene67843_All    321  CAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGT  380 
Unigene81593_All    48   CAGACACAACCACGGGGTGTTTGAGAGCTTC-CGGTGCAGCGGCGAG               93 
 
Query_16            362  GACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGT  421 
Unigene27967_All    360  GACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGT  419 
Unigene75450_All    360  GACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGT  419 
CL4065.Contig3_All  279  GACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGT  338 
Unigene75449_All    360  GACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGT  419 
Unigene57188_All    381  GACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGT  440 
Unigene67843_All    381  GACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGT  440 
 
Query_16            422  GAATGGTTTCTATCCAGGCCACATTGAAGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGA  481 
Unigene27967_All    420  GAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGA  479 
Unigene75450_All    420  GAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGA  479 
CL4065.Contig3_All  339  GAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGA  398 
Unigene75449_All    420  GACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAA  479 
Unigene57188_All    441  GACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAA  500 
Unigene67843_All    441  GACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAA  500 
 
Query_16            482  GTCTGGGGTCGTGTCCACAGG-CTTGATCCCTAATGGAGACTGGACCTTCCAGACCCTGG  540 
Unigene27967_All    480  GTCTGGGGTCGTGTCCACAGG-CCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGG  538 
Unigene75450_All    480  GTCTGGGGTCGTGTCCACAGG-CCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGG  538 
CL4065.Contig3_All  399  GTCTGGGGTCGTGTCCACAGG-CCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGG  457 
Unigene75449_All    480  AGCTGGTGTGGTGTCCACTCCACTT-ATTAGGAATGGGGACTGGACCTTCCAGATCCTTG  538 
 223 
 
Unigene57188_All    501  AGCTGGTGTGGTGTCCACTCCACTT-ATTAGGAATGGGGACTGGACCTTCCAGATCCTTG  559 
Unigene67843_All    501  AGCTGGTGTGGTGTCCACTCCACTT-ATTAGGAATGGGGACTGGACCTTCCAGATCCTTG  559 
 
Query_16            541  TGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCC  599 
Unigene27967_All    539  TGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCC  597 
Unigene75450_All    539  TGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCC  597 
CL4065.Contig3_All  458  TGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCC  516 
Unigene75449_All    539  TGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCC  597 
Unigene57188_All    560  TGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCC  618 
Unigene67843_All    560  TGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCC  618 
 
Query_16            600  AGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAG  659 
Unigene27967_All    598  AGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAG  657 
Unigene75450_All    598  AGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAG  657 
CL4065.Contig3_All  517  AGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAG  576 
Unigene75449_All    598  AGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAG  657 
Unigene57188_All    619  AGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAG  678 
Unigene67843_All    619  AGCCTCCAGAGCCCCATCACAGTGGAGTGG                                648 
 
Query_16            660  ATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTC  719 
Unigene27967_All    658  ATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTC  717 
Unigene75450_All    658  ATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTC  717 
CL4065.Contig3_All  577  ATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTC  636 
Unigene75449_All    658  ATGCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATC  717 
Unigene57188_All    679  ATGCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATC  738 
 
Query_16            720  ATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  776 
Unigene27967_All    718  ATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
Unigene75450_All    718  ATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
CL4065.Contig3_All  637  ATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  693 
Unigene75449_All    718  GTCCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     771 
Unigene57188_All    739  GTCCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     792 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 65073776100 
 
 
Query= HQ908094.1 Meles meles MHC class II antigen DR beta chain (Meme-DRB) 
mRNA, Meme-DRB*03 allele, partial cds 
 
Length=822 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  1397    0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  1136    0.0    
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  1136    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  743     0.0    
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  488     5e-137 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  411     1e-113 




Query_17            3    GGCTCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  62 
Unigene27967_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  60 
Unigene75449_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  60 
 
Query_17            63   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  122 
Unigene27967_All    61   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  120 
Unigene75450_All    103                                            GAGTGCTACTTCACCAAC  120 
CL4065.Contig3_All  22                                             GAGTGCTACTTCACCAAC  39 
Unigene75449_All    61   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  120 
Unigene57188_All    124                                            GAGTGCTACTTCACCAAC  141 
Unigene67843_All    124                                            GAGTGCTACTTCACCAAC  141 
 
Query_17            123  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  182 
Unigene27967_All    121  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  180 
Unigene75450_All    121  GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  180 
CL4065.Contig3_All  40   GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  99 
Unigene75449_All    121  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  180 
Unigene57188_All    142  GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  201 




Query_17            183  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  242 
Unigene27967_All    181  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  240 
Unigene75450_All    181  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  240 
CL4065.Contig3_All  100  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  159 
Unigene75449_All    181  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTGAG  240 
Unigene57188_All    202  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  261 
Unigene67843_All    202  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  261 
 
Query_17            243  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGAGGTGGACACCGTGTGC  302 
Unigene27967_All    241  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  300 
Unigene75450_All    241  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  300 
CL4065.Contig3_All  160  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  219 
Unigene75449_All    241  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  300 
Unigene57188_All    262  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  321 
Unigene67843_All    262  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  321 
Unigene81593_All    1                CAGAAGGACATCATGGAGCGGAAGAGGTCCGAGGTGGACACCGTGTGC  48 
 
Query_17            303  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  362 
Unigene27967_All    301  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  360 
Unigene75450_All    301  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  360 
CL4065.Contig3_All  220  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  279 
Unigene75449_All    301  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  360 
Unigene57188_All    322  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  381 
Unigene67843_All    322  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  381 
Unigene81593_All    49   AGACACAACCACGGGGTGTTTGAGAGCTTCC-GGTGCAGCGGCGAG                93 
 
Query_17            363  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  422 
Unigene27967_All    361  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  420 
Unigene75450_All    361  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  420 
CL4065.Contig3_All  280  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  339 
Unigene75449_All    361  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  420 
Unigene57188_All    382  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  441 
Unigene67843_All    382  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  441 
 
Query_17            423  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  482 
Unigene27967_All    421  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  480 
Unigene75450_All    421  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  480 
CL4065.Contig3_All  340  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  399 
Unigene75449_All    421  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  480 
Unigene57188_All    442  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  501 
Unigene67843_All    442  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  501 
 
Query_17            483  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  542 
Unigene27967_All    481  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  540 
Unigene75450_All    481  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  540 
CL4065.Contig3_All  400  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  459 
Unigene75449_All    481  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  540 
Unigene57188_All    502  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  561 
Unigene67843_All    502  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  561 
 
Query_17            543  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  601 
Unigene27967_All    541  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  599 
Unigene75450_All    541  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  599 
CL4065.Contig3_All  460  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  518 
Unigene75449_All    541  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  599 
Unigene57188_All    562  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  620 
Unigene67843_All    562  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  620 
 
Query_17            602  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  661 
Unigene27967_All    600  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  659 
Unigene75450_All    600  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  659 
CL4065.Contig3_All  519  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  578 
Unigene75449_All    600  CCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAGAT  659 
Unigene57188_All    621  CCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAGAT  680 
Unigene67843_All    621  CCTCCAGAGCCCCATCACAGTGGAGTGG                                  648 
 
Query_17            662  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  721 
Unigene27967_All    660  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  719 
Unigene75450_All    660  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  719 
CL4065.Contig3_All  579  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  638 
Unigene75449_All    660  GCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATCGT  719 
Unigene57188_All    681  GCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATCGT  740 
 
Query_17            722  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  776 
Unigene27967_All    720  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
Unigene75450_All    720  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
CL4065.Contig3_All  639  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  693 
Unigene75449_All    720  CCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     771 





Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 65073776100 
 
 
Query= HQ908093.1 Meles meles MHC class II antigen DR beta chain (Meme-DRB) 
mRNA, Meme-DRB*02 allele, partial cds 
 
Length=822 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  1408    0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  1153    0.0    
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  1153    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  715     0.0    
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  466     2e-130 




Query_18            3    GGCTCCTGGATGACAGCTTTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  62 
Unigene27967_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  60 
Unigene75449_All    1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCTTGGCTTGG  60 
 
Query_18            63   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  122 
Unigene27967_All    61   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  120 
Unigene75450_All    103                                            GAGTGCTACTTCACCAAC  120 
CL4065.Contig3_All  22                                             GAGTGCTACTTCACCAAC  39 
Unigene75449_All    61   GCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAAC  120 
Unigene57188_All    124                                            GAGTGCTACTTCACCAAC  141 
Unigene67843_All    124                                            GAGTGCTACTTCACCAAC  141 
 
Query_18            123  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  182 
Unigene27967_All    121  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  180 
Unigene75450_All    121  GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  180 
CL4065.Contig3_All  40   GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  99 
Unigene75449_All    121  GGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCGC  180 
Unigene57188_All    142  GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  201 
Unigene67843_All    142  GGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCGC  201 
 
Query_18            183  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  242 
Unigene27967_All    181  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  240 
Unigene75450_All    181  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  240 
CL4065.Contig3_All  100  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  159 
Unigene75449_All    181  TTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTGAG  240 
Unigene57188_All    202  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  261 
Unigene67843_All    202  TACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCAG  261 
 
Query_18            243  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  302 
Unigene27967_All    241  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  300 
Unigene75450_All    241  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  300 
CL4065.Contig3_All  160  TACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGGCCGCGGTGGACACATACTGC  219 
Unigene75449_All    241  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  300 
Unigene57188_All    262  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  321 
Unigene67843_All    262  TACTGGAACAGCCAGAAGGACATCCTGGAGAGAACGGAGGCCGAGACAGACACGGTGTGC  321 
 
Query_18            303  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  362 
Unigene27967_All    301  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  360 
Unigene75450_All    301  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  360 
CL4065.Contig3_All  220  AGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTACAGTG  279 
Unigene75449_All    301  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  360 
Unigene57188_All    322  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  381 
Unigene67843_All    322  AGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTACAGTG  381 
 
Query_18            363  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  422 
Unigene27967_All    361  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  420 
Unigene75450_All    361  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  420 
CL4065.Contig3_All  280  ACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTCTGTG  339 
Unigene75449_All    361  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  420 
Unigene57188_All    382  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  441 
Unigene67843_All    382  ACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTCGGTG  441 
 
Query_18            423  AATGGTTTCTATCCAGGCCACATTGAAGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  482 
Unigene27967_All    421  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  480 
Unigene75450_All    421  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  480 
 226 
 
CL4065.Contig3_All  340  AATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGAGGAG  399 
Unigene75449_All    421  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  480 
Unigene57188_All    442  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  501 
Unigene67843_All    442  ACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGAGAAA  501 
 
Query_18            483  TCTGGGGTCGTGTCCACAGGCCTGATCCCTAATGGAGACTGGACCTTCCAGACCCTGGTG  542 
Unigene27967_All    481  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  540 
Unigene75450_All    481  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  540 
CL4065.Contig3_All  400  TCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCTGGTG  459 
Unigene75449_All    481  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  540 
Unigene57188_All    502  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  561 
Unigene67843_All    502  GCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCTTGTG  561 
 
Query_18            543  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  601 
Unigene27967_All    541  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  599 
Unigene75450_All    541  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  599 
CL4065.Contig3_All  460  ATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACCCCAG  518 
Unigene75449_All    541  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  599 
Unigene57188_All    562  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  620 
Unigene67843_All    562  ATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACCCCAG  620 
 
Query_18            602  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  661 
Unigene27967_All    600  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  659 
Unigene75450_All    600  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  659 
CL4065.Contig3_All  519  TTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCAAGAT  578 
Unigene75449_All    600  CCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAGAT  659 
Unigene57188_All    621  CCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCAAGAT  680 
Unigene67843_All    621  CCTCCAGAGCCCCATCACAGTGGAGTGG                                  648 
 
Query_18            662  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  721 
Unigene27967_All    660  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  719 
Unigene75450_All    660  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  719 
CL4065.Contig3_All  579  TCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGTTCAT  638 
Unigene75449_All    660  GCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATCGT  719 
Unigene57188_All    681  GCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTATCGT  740 
 
Query_18            722  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  776 
Unigene27967_All    720  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
Unigene75450_All    720  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
CL4065.Contig3_All  639  CTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  693 
Unigene75449_All    720  CCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     771 
Unigene57188_All    741  CCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     792 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 65073776100 
 
 
Query= HQ908092.1 Meles meles MHC class II antigen DR beta chain (Meme-DRB) 
mRNA, Meme-DRB*01 allele, partial cds 
 
Length=822 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  1280    0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  1051    0.0    
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  1048    0.0    
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  632     2e-180 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  409     4e-113 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  337     2e-91  




Query_19             3    GGCTCCTGGATGACAGCTTTGACCGTGATACTGATGGTGCTGAGCCCTCCCA-TGGCTTG  61 
Unigene27967_All     1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCT-TGGCTTG  59 
Unigene75450_All     35                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  59 
Unigene75449_All     1    GGCGCCTGGATGACAGCTCTGACACTGATACTGATGGTGCTGAGCCCTCCCT-TGGCTTG  59 
Unigene57188_All     56                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  80 
Unigene67843_All     56                                     TGGTGCTGAG-CGTCCCAGTGGCTGA  80 
 
Query_19             62   GGCCAGGGACACCCCACCACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAA  121 
Unigene27967_All     60   GGCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAA  119 
Unigene75450_All     60   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  119 
 227 
 
CL4065.Contig3_All   22                                              GAGTGCTACTTCACCAA  38 
Unigene75449_All     60   GGCCAGGGACACCCCACGACATTTCCTGTTCCTGACGACGTCGGAGTGCCACTTCACCAA  119 
Unigene57188_All     81   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  140 
Unigene67843_All     81   GGGCAGAGACTCTCCAAAGGATTTCGTGTTCCAGTTTAAGGGCGAGTGCTACTTCACCAA  140 
 
Query_19             122  CGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCG  181 
Unigene27967_All     120  CGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCG  179 
Unigene75450_All     120  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  179 
CL4065.Contig3_All   39   CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  98 
Unigene75449_All     120  CGGCACGGAGCGGGTGCGGTTCCTGGATAGGTATTTCTATAACGGCGAGGAGTACGTGCG  179 
Unigene57188_All     141  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  200 
Unigene67843_All     141  CGGGACGGAGCGGGTGCGGAGCGTGAACAGATACATCTATAACCGGGAGGAGTTCGTGCG  200 
 
Query_19             182  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCCATCGCTCA  241 
Unigene27967_All     180  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  239 
Unigene75450_All     180  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  239 
CL4065.Contig3_All   99   CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  158 
Unigene75449_All     180  CTTCGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTGA  239 
Unigene57188_All     201  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  260 
Unigene67843_All     201  CTACGACAGCGACGTGGGGGAGTACCGGCCGGTGACCGAGCTGGGGCGGCCGGACGCTCA  260 
 
Query_19             242  GGGCTGGAACAGCCAGAAGGACATCATGGAGCAGAAGCGCG-CC-A-ACGTGGACACATA  298 
Unigene27967_All     240  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGG-CC-G-CGGTGGACACATA  296 
Unigene75450_All     240  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGG-CC-G-CGGTGGACACATA  296 
CL4065.Contig3_All   159  GTACTGGAACAGCCAGAAGGACATCATGGAGCGGAGGCGGG-CC-G-CGGTGGACACATA  215 
Unigene75449_All     240  GTACTGGAACAGCCAGAAGGACATCCTGGAG-AGAACGGAGGCCGAGACA-G-ACACGGT  296 
Unigene57188_All     261  GTACTGGAACAGCCAGAAGGACATCCTGGAG-AGAACGGAGGCCGAGACA-G-ACACGGT  317 
Unigene67843_All     261  GTACTGGAACAGCCAGAAGGACATCCTGGAG-AGAACGGAGGCCGAGACA-G-ACACGGT  317 
CL13896.Contig1_All  1              AGCCAGAAGGACATCATGGAGCAGAAGCGCG-CC-A-ACGTGGACACATA  47 
 
Query_19             299  CTGCAGGCACAACTACGGGGTGGGTGAGAGCTTCACGGTGCAGCGGCGAGTGGAGCCTAC  358 
Unigene27967_All     297  CTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTAC  356 
Unigene75450_All     297  CTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTAC  356 
CL4065.Contig3_All   216  CTGCAGACACAACTACGGGGTGGTTGAGAGCTTCCTGGTGCAGCGGCGAGTGGAGCCTAC  275 
Unigene75449_All     297  GTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTAC  356 
Unigene57188_All     318  GTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTAC  377 
Unigene67843_All     318  GTGCAGACACAACTACCTGACTGATGAGAGCTTCACGGTGCAGAGGCGAGTGGAACCTAC  377 
CL13896.Contig1_All  48   CTGCAGGCACAACTACGGGGTGGGTGAGAGCTTCACGGTGCAGCGGCGA             96 
 
Query_19             359  AGTGACTGTGTATCCCGCGAAGAACCAGCCCTTGCAGCACCACAGCCTCCTGGTCTGCTC  418 
Unigene27967_All     357  AGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTC  416 
Unigene75450_All     357  AGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTC  416 
CL4065.Contig3_All   276  AGTGACTGTGTATCCCGCGAAGAACCAGCCCCTGCAGCACCACAACCTCCTGGTCTGCTC  335 
Unigene75449_All     357  AGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTC  416 
Unigene57188_All     378  AGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTC  437 
Unigene67843_All     378  AGTGACCATCTCCCCATCCAGGACGGAGGTTCTGAACCACCACAACATGCTGGTCTGCTC  437 
 
Query_19             419  TGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTACCAGAATGGCCAGGAAGA  478 
Unigene27967_All     417  TGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGA  476 
Unigene75450_All     417  TGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGA  476 
CL4065.Contig3_All   336  TGTGAATGGTTTCTATCCAGGCCACATTGAGGTCAGGTGGTTCCGGAATGGCCAGGAAGA  395 
Unigene75449_All     417  GGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGA  476 
Unigene57188_All     438  GGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGA  497 
Unigene67843_All     438  GGTGACAGATTTCTACCCAGGCCAGATCAAAGTTCGGTGGTTTCGGAATGACCAGGAGGA  497 
 
Query_19             479  GGAGTCTGGGGTCGTGTCCACAGGCCTGATCCATAATGGAGACTGGACCTTCCAGACCCT  538 
Unigene27967_All     477  GGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCT  536 
Unigene75450_All     477  GGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCT  536 
CL4065.Contig3_All   396  GGAGTCTGGGGTCGTGTCCACAGGCCTGATCCGTAATGGAGACTGGACCTTCCAGACCCT  455 
Unigene75449_All     477  GAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCT  536 
Unigene57188_All     498  GAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCT  557 
Unigene67843_All     498  GAAAGCTGGTGTGGTGTCCACTCCACTTATTAGGAATGGGGACTGGACCTTCCAGATCCT  557 
 
Query_19             539  GGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACC  597 
Unigene27967_All     537  GGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACC  595 
Unigene75450_All     537  GGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACC  595 
CL4065.Contig3_All   456  GGTGATGCTGGAGACTGT-TCCTCAGAGTGGAGAGGTCTACACCTGCCAAGTGGAGCACC  514 
Unigene75449_All     537  TGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACC  595 
Unigene57188_All     558  TGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACC  616 
Unigene67843_All     558  TGTGATGCTGGAAA-TGACTCCCCAGCGAGGAGATGTCTACACCTGCCATGTGGAGCACC  616 
 
Query_19             598  CCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCA  657 
Unigene27967_All     596  CCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCA  655 
Unigene75450_All     596  CCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCA  655 
CL4065.Contig3_All   515  CCAGTTTGACGAGCCCTGTCACCGTGGAATGGAGGGCACAGTCTGGGTCTGCACAGAGCA  574 
Unigene75449_All     596  CCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCA  655 
Unigene57188_All     617  CCAGCCTCCAGAGCCCCATCACAGTGGAGTGGCGGGCACAGTCGGAATCTGCCCAGAGCA  676 
Unigene67843_All     617  CCAGCCTCCAGAGCCCCATCACAGTGGAGTGG                              648 
 
Query_19             658  AGATTCTTAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGT  717 
Unigene27967_All     656  AGATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGT  715 
 228 
 
Unigene75450_All     656  AGATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGT  715 
CL4065.Contig3_All   575  AGATTCTGAGTGGAACTGGAGGCTTTGTTCTGGGTCTGCTCTTCCTCGTGGTGGGGCTGT  634 
Unigene75449_All     656  AGATGCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTA  715 
Unigene57188_All     677  AGATGCTGAGTGGCATCGGAGGCTTTGTGCTGGGGCTGATCTTCCTCGGGCTGGGCCTTA  736 
 
Query_19             718  TCATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  776 
Unigene27967_All     716  TCATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
Unigene75450_All     716  TCATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  774 
CL4065.Contig3_All   635  TCATCTACTTCAGGAATCAGAAGGGACACTC-TGGACTTCAGCCAACAGGTCTCCTGAGC  693 
Unigene75449_All     716  TCGTCCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     771 
Unigene57188_All     737  TCGTCCGTCACAGGAGCCAGAAAGGAC-CTCGTGGGTCTCCGCCAGCAGGGCTCCTG     792 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 65073776100 
 
 
Query= Y11647.2 M.meles mRNA for interferon gamma, partial 
 
Length=501 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 




Query_20          184  GAGAGTGACAAAACAATCATTCAAAGCCAAATTGTCTCCTTCTACTTGAAACTGTTTGAA  243 
Unigene54563_All  1    GAGAGTGACAAAACAATCATTCAAAGCCAAATTGTCTCCTTCTACTTGAAACTGTTTGAA  60 
 
Query_20          244  AACTTTAAAGATAACCAGATCATTCAAAGGAGCATGGATACCATCAAGGAAGACATGCTT  303 
Unigene54563_All  61   AACTTTAAAGATAACCAGATCATTCAAAGGAGCATGGATACCATCAAGGAAGACATGCTT  120 
 
Query_20          304  GTCAGGTTCTTCAATAGCAGCAGCAGTAAGCGGGAGGACTTTCTTAAGCTGATTCGAATT  363 
Unigene54563_All  121  GTCAGGTTCTTCAATAGCAGCAGCAGTAAGCGGGAGGACTTTCTTAAGCTGATTCGAATT  180 
 
Query_20          364  CCCGTGAATGATCTGCAGGTCCAG  387 
Unigene54563_All  181  CCCGTGAATGATCTGCAGGTCCAG  204 
 
 
Lambda      K        H 
    1.33    0.621     1.12  
 
Gapped 
Lambda      K        H 
    1.28    0.460    0.850  
 
Effective search space used: 38974106976 
 
 
  Database: badgernt 
    Posted date:  Feb 23, 2017  11:56 AM 
  Number of letters in database: 85,063,401 




Matrix: blastn matrix 1 -2 
Gap Penalties: Existence: 0, Extension: 2.5 
 
 
8.4 BLASTP output (tabular) 
Query Seq-id Subject seq-id Identity % Alignment length  E-vlue Query seq. length Subject seq. length 
AFR54067.1 CL1150.Contig4_All 96.11 180 7.00E-128 180 234 
AFR54067.1 CL1150.Contig16_All 92.22 180 1.00E-118 180 324 
AFR54067.1 CL154.Contig12_All 38.12 181 4.00E-31 180 306 
 229 
 
AFR54067.1 CL154.Contig11_All 38.12 181 4.00E-31 180 306 
AFR54067.1 CL154.Contig24_All 38.12 181 7.00E-31 180 358 
AFR54067.1 CL154.Contig19_All 38.12 181 7.00E-31 180 358 
AFR54067.1 CL154.Contig27_All 38.12 181 8.00E-31 180 345 
AFR54067.1 CL154.Contig23_All 38.12 181 8.00E-31 180 345 
AFR54067.1 CL154.Contig2_All 38.12 181 8.00E-31 180 345 
AFR54067.1 CL154.Contig1_All 38.12 181 8.00E-31 180 345 
AFR54066.1 CL1150.Contig4_All 85 180 6.00E-111 180 234 
AFR54066.1 CL1150.Contig16_All 84.44 180 5.00E-108 180 324 
AFR54066.1 CL154.Contig12_All 38.67 181 2.00E-32 180 306 
AFR54066.1 CL154.Contig11_All 38.67 181 2.00E-32 180 306 
AFR54066.1 CL154.Contig27_All 38.67 181 4.00E-32 180 345 
AFR54066.1 CL154.Contig23_All 38.67 181 4.00E-32 180 345 
AFR54066.1 CL154.Contig2_All 38.67 181 4.00E-32 180 345 
AFR54066.1 CL154.Contig1_All 38.67 181 4.00E-32 180 345 
AFR54066.1 CL154.Contig24_All 38.67 181 4.00E-32 180 358 
AFR54066.1 CL154.Contig19_All 38.67 181 4.00E-32 180 358 
AFR54065.1 CL1150.Contig4_All 84.44 180 9.00E-110 180 234 
AFR54065.1 CL1150.Contig16_All 83.89 180 7.00E-107 180 324 
AFR54065.1 CL154.Contig12_All 39.78 181 6.00E-34 180 306 
AFR54065.1 CL154.Contig11_All 39.78 181 6.00E-34 180 306 
AFR54065.1 CL154.Contig27_All 39.78 181 1.00E-33 180 345 
AFR54065.1 CL154.Contig23_All 39.78 181 1.00E-33 180 345 
AFR54065.1 CL154.Contig2_All 39.78 181 1.00E-33 180 345 
AFR54065.1 CL154.Contig1_All 39.78 181 1.00E-33 180 345 
AFR54065.1 CL154.Contig24_All 39.78 181 1.00E-33 180 358 
AFR54065.1 CL154.Contig19_All 39.78 181 1.00E-33 180 358 
AFR54064.1 CL1150.Contig16_All 87.22 180 4.00E-111 180 324 
AFR54064.1 CL1150.Contig4_All 83.33 180 1.00E-106 180 234 
AFR54064.1 CL154.Contig12_All 38.12 181 2.00E-29 180 306 
AFR54064.1 CL154.Contig11_All 38.12 181 2.00E-29 180 306 
AFR54064.1 CL154.Contig24_All 38.12 181 3.00E-29 180 358 
AFR54064.1 CL154.Contig19_All 38.12 181 3.00E-29 180 358 
AFR54064.1 CL154.Contig27_All 38.12 181 3.00E-29 180 345 
AFR54064.1 CL154.Contig23_All 38.12 181 3.00E-29 180 345 
AFR54064.1 CL154.Contig2_All 38.12 181 3.00E-29 180 345 
AFR54064.1 CL154.Contig1_All 38.12 181 3.00E-29 180 345 
AFR54063.1 CL1150.Contig4_All 94.44 180 7.00E-125 180 234 
AFR54063.1 CL1150.Contig16_All 94.44 180 1.00E-121 180 324 
AFR54063.1 CL154.Contig12_All 39.23 181 2.00E-34 180 306 
AFR54063.1 CL154.Contig11_All 39.23 181 2.00E-34 180 306 
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AFR54063.1 CL154.Contig27_All 39.23 181 4.00E-34 180 345 
AFR54063.1 CL154.Contig23_All 39.23 181 4.00E-34 180 345 
AFR54063.1 CL154.Contig2_All 39.23 181 4.00E-34 180 345 
AFR54063.1 CL154.Contig1_All 39.23 181 4.00E-34 180 345 
AFR54063.1 CL154.Contig24_All 39.23 181 4.00E-34 180 358 
AFR54063.1 CL154.Contig19_All 39.23 181 4.00E-34 180 358 
AFR54062.1 CL1150.Contig4_All 88.89 90 3.00E-53 90 234 
AFR54062.1 CL1150.Contig16_All 86.67 90 7.00E-50 90 324 
AFR54062.1 CL154.Contig16_All 38.64 88 2.00E-15 90 88 
AFR54062.1 CL154.Contig15_All 38.64 88 2.00E-15 90 88 
AFR54062.1 CL154.Contig14_All 38.64 88 2.00E-15 90 88 
AFR54062.1 CL154.Contig13_All 38.64 88 2.00E-15 90 88 
AFR54062.1 CL154.Contig33_All 38.64 88 4.00E-15 90 127 
AFR54062.1 CL154.Contig21_All 38.64 88 4.00E-15 90 127 
AFR54062.1 CL154.Contig20_All 38.64 88 4.00E-15 90 127 
AFR54062.1 CL154.Contig17_All 38.64 88 4.00E-15 90 127 
AFR54061.1 CL1150.Contig4_All 74.44 90 1.00E-40 90 234 
AFR54061.1 CL1150.Contig16_All 72.22 90 6.00E-38 90 324 
AFR54061.1 CL154.Contig16_All 37.5 88 4.00E-13 90 88 
AFR54061.1 CL154.Contig15_All 37.5 88 4.00E-13 90 88 
AFR54061.1 CL154.Contig14_All 37.5 88 4.00E-13 90 88 
AFR54061.1 CL154.Contig13_All 37.5 88 4.00E-13 90 88 
AFR54061.1 CL154.Contig33_All 37.5 88 8.00E-13 90 127 
AFR54061.1 CL154.Contig21_All 37.5 88 8.00E-13 90 127 
AFR54061.1 CL154.Contig20_All 37.5 88 8.00E-13 90 127 
AFR54061.1 CL154.Contig17_All 37.5 88 8.00E-13 90 127 
AFR54060.1 CL1150.Contig16_All 88.58 324 0 325 324 
AFR54060.1 CL1150.Contig4_All 97.01 234 1.00E-169 325 234 
AFR54060.1 CL1150.Contig15_All 74.86 179 3.00E-83 325 150 
AFR54060.1 CL1150.Contig17_All 79.29 140 4.00E-73 325 140 
AFR54060.1 CL154.Contig12_All 42.31 312 6.00E-73 325 306 
AFR54060.1 CL154.Contig11_All 42.31 312 6.00E-73 325 306 
AFR54060.1 CL1150.Contig13_All 77.46 142 1.00E-72 325 142 
AFR54060.1 CL154.Contig27_All 42.31 312 3.00E-72 325 345 
AFR54060.1 CL154.Contig23_All 42.31 312 3.00E-72 325 345 
AFR54060.1 CL154.Contig2_All 42.31 312 3.00E-72 325 345 
AFR54059.1 CL1150.Contig16_All 85.19 324 0 325 324 
AFR54059.1 CL1150.Contig4_All 87.61 234 1.00E-150 325 234 
AFR54059.1 CL1150.Contig15_All 75.42 179 3.00E-86 325 150 
AFR54059.1 CL1150.Contig17_All 81.43 140 6.00E-75 325 140 
AFR54059.1 CL154.Contig12_All 42.95 312 1.00E-74 325 306 
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AFR54059.1 CL154.Contig11_All 42.95 312 1.00E-74 325 306 
AFR54059.1 CL154.Contig27_All 42.95 312 6.00E-74 325 345 
AFR54059.1 CL154.Contig23_All 42.95 312 6.00E-74 325 345 
AFR54059.1 CL154.Contig2_All 42.95 312 6.00E-74 325 345 
AFR54059.1 CL154.Contig1_All 42.95 312 6.00E-74 325 345 
AFR54058.1 CL1150.Contig16_All 84.88 324 0 325 324 
AFR54058.1 CL1150.Contig4_All 87.18 234 3.00E-149 325 234 
AFR54058.1 CL1150.Contig15_All 75.42 179 2.00E-86 325 150 
AFR54058.1 CL154.Contig12_All 43.27 312 3.00E-76 325 306 
AFR54058.1 CL154.Contig11_All 43.27 312 3.00E-76 325 306 
AFR54058.1 CL154.Contig24_All 43.27 312 2.00E-75 325 358 
AFR54058.1 CL154.Contig19_All 43.27 312 2.00E-75 325 358 
AFR54058.1 CL154.Contig27_All 43.27 312 2.00E-75 325 345 
AFR54058.1 CL154.Contig23_All 43.27 312 2.00E-75 325 345 
AFR54058.1 CL154.Contig2_All 43.27 312 2.00E-75 325 345 
AFR54057.1 CL1150.Contig16_All 86.73 324 0 325 324 
AFR54057.1 CL1150.Contig4_All 87.18 234 2.00E-148 325 234 
AFR54057.1 CL1150.Contig15_All 73.18 179 9.00E-83 325 150 
AFR54057.1 CL1150.Contig17_All 81.43 140 7.00E-75 325 140 
AFR54057.1 CL1150.Contig13_All 79.58 142 2.00E-74 325 142 
AFR54057.1 CL1150.Contig18_All 80.58 139 1.00E-73 325 139 
AFR54057.1 CL154.Contig12_All 41.99 312 1.00E-70 325 306 
AFR54057.1 CL154.Contig11_All 41.99 312 1.00E-70 325 306 
AFR54057.1 CL154.Contig27_All 41.99 312 5.00E-70 325 345 
AFR54057.1 CL154.Contig23_All 41.99 312 5.00E-70 325 345 
AFR54056.1 CL1150.Contig16_All 89.81 324 0 325 324 
AFR54056.1 CL1150.Contig4_All 95.73 234 3.00E-166 325 234 
AFR54056.1 CL1150.Contig15_All 75.98 179 8.00E-85 325 150 
AFR54056.1 CL154.Contig12_All 42.95 312 3.00E-76 325 306 
AFR54056.1 CL154.Contig11_All 42.95 312 3.00E-76 325 306 
AFR54056.1 CL154.Contig27_All 42.95 312 1.00E-75 325 345 
AFR54056.1 CL154.Contig23_All 42.95 312 1.00E-75 325 345 
AFR54056.1 CL154.Contig2_All 42.95 312 1.00E-75 325 345 
AFR54056.1 CL154.Contig1_All 42.95 312 1.00E-75 325 345 
AFR54056.1 CL154.Contig24_All 42.95 312 2.00E-75 325 358 
AFR54055.1 CL1150.Contig16_All 87.29 181 5.00E-113 181 324 
AFR54055.1 CL1150.Contig4_All 83.43 181 2.00E-108 181 234 
AFR54055.1 CL154.Contig12_All 38.46 182 5.00E-30 181 306 
AFR54055.1 CL154.Contig11_All 38.46 182 5.00E-30 181 306 
AFR54055.1 CL154.Contig24_All 38.46 182 7.00E-30 181 358 
AFR54055.1 CL154.Contig19_All 38.46 182 7.00E-30 181 358 
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AFR54055.1 CL154.Contig27_All 38.46 182 8.00E-30 181 345 
AFR54055.1 CL154.Contig23_All 38.46 182 8.00E-30 181 345 
AFR54055.1 CL154.Contig2_All 38.46 182 8.00E-30 181 345 
AFR54055.1 CL154.Contig1_All 38.46 182 8.00E-30 181 345 
AFR54054.1 CL1150.Contig4_All 85.08 181 6.00E-111 181 234 
AFR54054.1 CL1150.Contig16_All 85.08 181 2.00E-108 181 324 
AFR54054.1 CL154.Contig12_All 38.46 182 3.00E-30 181 306 
AFR54054.1 CL154.Contig11_All 38.46 182 3.00E-30 181 306 
AFR54054.1 CL154.Contig24_All 38.46 182 5.00E-30 181 358 
AFR54054.1 CL154.Contig19_All 38.46 182 5.00E-30 181 358 
AFR54054.1 CL154.Contig27_All 38.46 182 6.00E-30 181 345 
AFR54054.1 CL154.Contig23_All 38.46 182 6.00E-30 181 345 
AFR54054.1 CL154.Contig2_All 38.46 182 6.00E-30 181 345 
AFR54054.1 CL154.Contig1_All 38.46 182 6.00E-30 181 345 
AET36883.1 Unigene42913_All 100 81 8.00E-54 81 201 
AET36883.1 CL2981.Contig3_All 100 81 3.00E-53 81 254 
AET36883.1 CL2981.Contig1_All 100 81 3.00E-53 81 254 
AET36883.1 CL10050.Contig3_All 56.1 82 1.00E-28 81 255 
AET36883.1 CL10050.Contig2_All 56.1 82 9.00E-25 81 194 
AET36883.1 CL10050.Contig1_All 56.1 82 9.00E-25 81 194 
AET36883.1 CL12484.Contig1_All 52.05 73 3.00E-22 81 109 
AET36883.1 CL12484.Contig3_All 52.05 73 2.00E-21 81 193 
AET36881.1 Unigene67843_All 75.28 89 2.00E-43 89 217 
AET36881.1 Unigene57188_All 75.28 89 3.00E-43 89 265 
AET36881.1 Unigene75449_All 69.32 88 4.00E-38 89 258 
AET36881.1 Unigene75450_All 69.66 89 8.00E-38 89 258 
AET36881.1 CL4065.Contig3_All 69.32 88 7.00E-37 89 231 
AET36881.1 CL6815.Contig5_All 58.23 79 7.00E-35 89 273 
AET36881.1 Unigene27967_All 64.77 88 3.00E-33 89 258 
AET36881.1 CL6815.Contig6_All 53.93 89 9.00E-31 89 215 
AET36881.1 CL6815.Contig1_All 53.93 89 9.00E-31 89 215 
AET36881.1 CL6815.Contig3_All 53.93 89 9.00E-31 89 252 
AET36880.1 Unigene27967_All 77.38 84 5.00E-41 89 258 
AET36880.1 Unigene75449_All 72.62 84 2.00E-37 89 258 
AET36880.1 CL4065.Contig3_All 69.88 83 7.00E-36 89 231 
AET36880.1 Unigene75450_All 69.88 83 8.00E-36 89 258 
AET36880.1 Unigene67843_All 66.27 83 6.00E-33 89 217 
AET36880.1 Unigene57188_All 66.27 83 9.00E-33 89 265 
AET36880.1 CL6815.Contig4_All 44.58 83 8.00E-22 89 218 
AET36880.1 CL6815.Contig6_All 44.58 83 8.00E-22 89 215 
AET36880.1 CL6815.Contig1_All 44.58 83 8.00E-22 89 215 
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AET36880.1 CL6815.Contig3_All 44.58 83 1.00E-21 89 252 
AET36875.1 CL2981.Contig3_All 99.13 230 7.00E-171 230 254 
AET36875.1 CL2981.Contig1_All 99.13 230 7.00E-171 230 254 
AET36875.1 Unigene42913_All 99.5 201 1.00E-149 230 201 
AET36875.1 CL10050.Contig3_All 60.53 228 7.00E-94 230 255 
AET36875.1 CL10050.Contig2_All 60.21 191 9.00E-78 230 194 
AET36875.1 CL10050.Contig1_All 60.21 191 9.00E-78 230 194 
AET36875.1 CL12484.Contig3_All 55.5 191 2.00E-70 230 193 
AET36875.1 CL12484.Contig2_All 65.06 83 6.00E-32 230 83 
AET36875.1 CL12484.Contig1_All 48.15 108 3.00E-28 230 109 
AET36875.1 CL5174.Contig1_All 63.38 71 2.00E-23 230 79 
AET36874.1 CL10050.Contig3_All 99.51 205 7.00E-154 205 255 
AET36874.1 CL10050.Contig2_All 100 194 3.00E-146 205 194 
AET36874.1 CL10050.Contig1_All 100 194 3.00E-146 205 194 
AET36874.1 CL2981.Contig3_All 60.2 201 5.00E-81 205 254 
AET36874.1 CL2981.Contig1_All 60.2 201 5.00E-81 205 254 
AET36874.1 Unigene42913_All 60.21 191 6.00E-78 205 201 
AET36874.1 CL12484.Contig3_All 59.44 180 2.00E-74 205 193 
AET36874.1 CL12484.Contig2_All 66.67 81 2.00E-34 205 83 
AET36874.1 CL12484.Contig1_All 54.64 97 8.00E-30 205 109 
AET36874.1 CL5174.Contig1_All 60.76 79 1.00E-25 205 79 
AET36873.1 CL10050.Contig3_All 86.83 205 3.00E-133 205 255 
AET36873.1 CL10050.Contig2_All 86.6 194 2.00E-125 205 194 
AET36873.1 CL10050.Contig1_All 86.6 194 2.00E-125 205 194 
AET36873.1 CL2981.Contig3_All 58.21 201 8.00E-76 205 254 
AET36873.1 CL2981.Contig1_All 58.21 201 8.00E-76 205 254 
AET36873.1 Unigene42913_All 58.12 191 9.00E-73 205 201 
AET36873.1 CL12484.Contig3_All 56.45 186 3.00E-69 205 193 
AET36873.1 CL12484.Contig2_All 64.2 81 1.00E-31 205 83 
AET36873.1 CL12484.Contig1_All 51.96 102 1.00E-27 205 109 
AET36873.1 CL5174.Contig1_All 63.38 71 3.00E-24 205 79 
AET36872.1 Unigene57188_All 99.55 224 4.00E-170 224 265 
AET36872.1 Unigene67843_All 99.54 217 2.00E-165 224 217 
AET36872.1 Unigene75449_All 87.56 217 6.00E-142 224 258 
AET36872.1 Unigene75450_All 82.95 217 4.00E-134 224 258 
AET36872.1 CL4065.Contig3_All 80.53 190 2.00E-112 224 231 
AET36872.1 Unigene27967_All 70.51 217 1.00E-111 224 258 
AET36872.1 CL6815.Contig3_All 57.6 217 8.00E-91 224 252 
AET36872.1 CL6815.Contig2_All 57.6 217 1.00E-90 224 265 
AET36872.1 CL6815.Contig5_All 57.6 217 2.00E-90 224 273 
AET36872.1 CL6815.Contig6_All 57.01 214 7.00E-89 224 215 
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AET36871.1 Unigene27967_All 92.64 258 2.00E-164 258 258 
AET36871.1 Unigene75450_All 89.53 258 4.00E-158 258 258 
AET36871.1 CL4065.Contig3_All 94.37 231 8.00E-148 258 231 
AET36871.1 Unigene75449_All 74.71 257 1.00E-133 258 258 
AET36871.1 Unigene57188_All 71.98 257 4.00E-127 258 265 
AET36871.1 Unigene67843_All 73.33 210 8.00E-112 258 217 
AET36871.1 CL6815.Contig2_All 53.36 253 1.00E-95 258 265 
AET36871.1 CL6815.Contig5_All 53.36 253 2.00E-95 258 273 
AET36871.1 CL6815.Contig3_All 54.69 245 5.00E-95 258 252 
AET36871.1 CL6815.Contig6_All 55.77 208 4.00E-81 258 215 
AET36870.1 Unigene27967_All 98.84 258 0 258 258 
AET36870.1 Unigene75450_All 88.76 258 9.00E-158 258 258 
AET36870.1 Unigene75449_All 80.16 257 8.00E-148 258 258 
AET36870.1 CL4065.Contig3_All 93.51 231 2.00E-147 258 231 
AET36870.1 Unigene57188_All 70.43 257 3.00E-125 258 265 
AET36870.1 Unigene67843_All 71.43 210 2.00E-109 258 217 
AET36870.1 CL6815.Contig2_All 52.57 253 5.00E-95 258 265 
AET36870.1 CL6815.Contig5_All 52.57 253 1.00E-94 258 273 
AET36870.1 CL6815.Contig3_All 53.88 245 2.00E-94 258 252 
AET36870.1 CL6815.Contig6_All 54.81 208 2.00E-80 258 215 
AET36869.1 Unigene27967_All 99.22 258 0 258 258 
AET36869.1 Unigene75450_All 89.15 258 7.00E-159 258 258 
AET36869.1 CL4065.Contig3_All 93.94 231 2.00E-148 258 231 
AET36869.1 Unigene75449_All 78.99 257 6.00E-145 258 258 
AET36869.1 Unigene57188_All 69.26 257 2.00E-122 258 265 
AET36869.1 Unigene67843_All 70 210 1.00E-106 258 217 
AET36869.1 CL6815.Contig2_All 52.17 253 5.00E-94 258 265 
AET36869.1 CL6815.Contig5_All 52.17 253 8.00E-94 258 273 
AET36869.1 CL6815.Contig3_All 53.47 245 2.00E-93 258 252 
AET36869.1 CL6815.Contig6_All 54.33 208 2.00E-79 258 215 
AET36868.1 Unigene27967_All 94.19 258 2.00E-170 258 258 
AET36868.1 Unigene75450_All 85.27 258 1.00E-149 258 258 
AET36868.1 CL4065.Contig3_All 89.61 231 2.00E-139 258 231 
AET36868.1 Unigene75449_All 75.88 257 2.00E-139 258 258 
AET36868.1 Unigene57188_All 67.32 257 2.00E-118 258 265 
AET36868.1 Unigene67843_All 67.62 210 8.00E-103 258 217 
AET36868.1 CL6815.Contig2_All 52.17 253 1.00E-94 258 265 
AET36868.1 CL6815.Contig5_All 52.17 253 3.00E-94 258 273 
AET36868.1 CL6815.Contig3_All 53.47 245 6.00E-94 258 252 








Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro A. 
Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. 
Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of 
protein database search programs", Nucleic Acids Res. 25:3389-3402. 
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Database: BLAST Database 




Query= AFR54067.1 MHC class I antigen, partial [Meles meles] 
 
Length=180 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  377     7e-128 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  359     1e-118 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  124     4e-31  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  124     4e-31  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  124     7e-31  
CL154.Contig19_All  122 1195 class I histocompatibility antigen, ...  124     7e-31  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  124     8e-31  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  124     8e-31  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  124     8e-31  




Query_1              1    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  60 
CL1150.Contig4_All   3    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  62 
CL1150.Contig16_All  6    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  65 
CL154.Contig12_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig11_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig24_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig19_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig27_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig23_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig2_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig1_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
 
Query_1              61   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYSQHSYDGA  
120 
CL1150.Contig4_All   63   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDGA  
122 
CL1150.Contig16_All  66   RQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
125 
CL154.Contig12_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 




CL154.Contig24_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig19_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig27_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig23_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig2_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig1_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
 
Query_1              121  DYIALNEDLRSWTAADTAAQITQRKWE-DAGEAERWRNYVEGTCVEWLGRYLENGKESLL  
179 
CL1150.Contig4_All   123  DYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
181 
CL1150.Contig16_All  126  DYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
184 
CL154.Contig12_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig11_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig24_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig19_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig27_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig23_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig2_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig1_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
 
Query_1              180  R  180 
CL1150.Contig4_All   182  R  182 
CL1150.Contig16_All  185  R  185 
CL154.Contig12_All   178  R  178 
CL154.Contig11_All   178  R  178 
CL154.Contig24_All   230  R  230 
CL154.Contig19_All   230  R  230 
CL154.Contig27_All   217  R  217 
CL154.Contig23_All   217  R  217 
CL154.Contig2_All    217  R  217 
CL154.Contig1_All    217  R  217 
 
 
Lambda      K        H        a         alpha 
   0.335    0.191    0.791    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2743481178 
 
 
Query= AFR54066.1 MHC class I antigen, partial [Meles meles] 
 
Length=180 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  334     6e-111 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  332     5e-108 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  127     2e-32  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  127     2e-32  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  127     4e-32  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  127     4e-32  
 237 
 
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  127     4e-32  
CL154.Contig1_All  294 1328 minus strand class I histocompatibili...  127     4e-32  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  127     4e-32  




Query_2              1    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEGPEYWD  60 
CL1150.Contig4_All   3    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  62 
CL1150.Contig16_All  6    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  65 
CL154.Contig12_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig11_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig27_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig23_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig2_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig1_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig24_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig19_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
 
Query_2              61   RQTRNLKDAAHAFRVNLNTLRDYYNQSAAGSHTIQRMYGCDMGPDGRLLRGYSQVAYDGA  
120 
CL1150.Contig4_All   63   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDGA  
122 
CL1150.Contig16_All  66   RQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
125 
CL154.Contig12_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig11_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig27_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig23_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig2_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig1_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig24_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig19_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
 
Query_2              121  DYLALNEDLRSWTVADATAQISRRKWE-DADEAEHERNYLEVTCVEWLGRYLENGKESLL  
179 
CL1150.Contig4_All   123  DYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
181 
CL1150.Contig16_All  126  DYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
184 
CL154.Contig12_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig11_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig27_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig23_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig2_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig1_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig24_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig19_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
 
Query_2              180  R  180 
CL1150.Contig4_All   182  R  182 
CL1150.Contig16_All  185  R  185 
CL154.Contig12_All   178  R  178 
 238 
 
CL154.Contig11_All   178  R  178 
CL154.Contig27_All   217  R  217 
CL154.Contig23_All   217  R  217 
CL154.Contig2_All    217  R  217 
CL154.Contig1_All    217  R  217 
CL154.Contig24_All   230  R  230 
CL154.Contig19_All   230  R  230 
 
 
Lambda      K        H        a         alpha 
   0.336    0.192    0.788    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2743481178 
 
 
Query= AFR54065.1 MHC class I antigen, partial [Meles meles] 
 
Length=180 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  331     9e-110 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  329     7e-107 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  132     6e-34  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  132     6e-34  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  132     1e-33  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  132     1e-33  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  132     1e-33  
CL154.Contig1_All  294 1328 minus strand class I histocompatibili...  132     1e-33  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  132     1e-33  




Query_3              1    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  60 
CL1150.Contig4_All   3    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  62 
CL1150.Contig16_All  6    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  65 
CL154.Contig12_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig11_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  59 
CL154.Contig27_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig23_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig2_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig1_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig24_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig19_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
 
Query_3              61   RQTRNLKDAAHAFRVNLNTLRDYYNQSAAGSHTIQRMYGCDVGPDGRLLRGYSQVAYDGA  
120 
CL1150.Contig4_All   63   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDGA  
122 
CL1150.Contig16_All  66   RQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
125 
CL154.Contig12_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig11_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig27_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig23_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig2_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 




CL154.Contig24_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig19_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
 
Query_3              121  DYLALNEDLRSWTVADATAQISRRKWEAA-DEAEHERNYLEVTCLEWLHRYLENGKESLL  
179 
CL1150.Contig4_All   123  DYLALNEDLRSWTAADTAAQISRRKWEDA-GEAERYRNYVEGTCVEWLGRYLENGKESLL  
181 
CL1150.Contig16_All  126  DYIALNEDLRSWTAADTAAQISRRKWEDA-GEAERYRNYVEGTCVEWLGRYLENGKESLL  
184 
CL154.Contig12_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig11_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig27_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig23_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig2_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig1_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig24_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig19_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
 
Query_3              180  R  180 
CL1150.Contig4_All   182  R  182 
CL1150.Contig16_All  185  R  185 
CL154.Contig12_All   178  R  178 
CL154.Contig11_All   178  R  178 
CL154.Contig27_All   217  R  217 
CL154.Contig23_All   217  R  217 
CL154.Contig2_All    217  R  217 
CL154.Contig1_All    217  R  217 
CL154.Contig24_All   230  R  230 
CL154.Contig19_All   230  R  230 
 
 
Lambda      K        H        a         alpha 
   0.336    0.191    0.785    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2743481178 
 
 
Query= AFR54064.1 MHC class I antigen, partial [Meles meles] 
 
Length=180 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  340     4e-111 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  323     1e-106 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  119     2e-29  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  119     2e-29  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  119     3e-29  
CL154.Contig19_All  122 1195 class I histocompatibility antigen, ...  119     3e-29  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  119     3e-29  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  119     3e-29  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  119     3e-29  




Query_4              1    SHSLRYFSTAVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEGPEYWD  60 
 240 
 
CL1150.Contig16_All  6    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  65 
CL1150.Contig4_All   3    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  62 
CL154.Contig12_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYWE  59 
CL154.Contig11_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYWE  59 
CL154.Contig24_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig19_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  
111 
CL154.Contig27_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig23_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig2_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
CL154.Contig1_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYWE  98 
 
Query_4              61   RQTQICKDAAQTYRGNLQTALRYYNQSAAGSHTIQNVYGCDVGRDGRLLRGYSQDSYDGA  
120 
CL1150.Contig16_All  66   RQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
125 
CL1150.Contig4_All   63   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDGA  
122 
CL154.Contig12_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig11_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig24_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig19_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig27_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig23_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig2_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig1_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
 
Query_4              121  DYIALNEDLRSWTAADTAAQITQRKWEDAGA-AERWRNYLEVTCVEWLGRYLENGKESLL  
179 
CL1150.Contig16_All  126  DYIALNEDLRSWTAADTAAQISRRKWEDAGE-AERYRNYVEGTCVEWLGRYLENGKESLL  
184 
CL1150.Contig4_All   123  DYLALNEDLRSWTAADTAAQISRRKWEDAGE-AERYRNYVEGTCVEWLGRYLENGKESLL  
181 
CL154.Contig12_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig11_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig24_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig19_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig27_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig23_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig2_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig1_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
 
Query_4              180  R  180 
CL1150.Contig16_All  185  R  185 
CL1150.Contig4_All   182  R  182 
CL154.Contig12_All   178  R  178 
CL154.Contig11_All   178  R  178 
CL154.Contig24_All   230  R  230 
CL154.Contig19_All   230  R  230 
CL154.Contig27_All   217  R  217 
CL154.Contig23_All   217  R  217 
CL154.Contig2_All    217  R  217 





Lambda      K        H        a         alpha 
   0.334    0.190    0.776    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2743481178 
 
 
Query= AFR54063.1 MHC class I antigen, partial [Meles meles] 
 
Length=180 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  369     7e-125 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  367     1e-121 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  133     2e-34  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  133     2e-34  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  133     4e-34  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  133     4e-34  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  133     4e-34  
CL154.Contig1_All  294 1328 minus strand class I histocompatibili...  133     4e-34  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  133     4e-34  




Query_5              1    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDAQFVRFDSDSASLRMEPRAPWMEQEGPEYWD  60 
CL1150.Contig4_All   3    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  62 
CL1150.Contig16_All  6    SHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYWD  65 
CL154.Contig12_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  59 
CL154.Contig11_All   2    THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  59 
CL154.Contig27_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  98 
CL154.Contig23_All   41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  98 
CL154.Contig2_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  98 
CL154.Contig1_All    41   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  98 
CL154.Contig24_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  
111 
CL154.Contig19_All   54   THSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYWE  
111 
 
Query_5              61   RETRNLKETTQTYRVNLNNLRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
120 
CL1150.Contig4_All   63   QQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDGA  
122 
CL1150.Contig16_All  66   RQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDGA  
125 
CL154.Contig12_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig11_All   60   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
117 
CL154.Contig27_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig23_All   99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig2_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig1_All    99   TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
156 
CL154.Contig24_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
CL154.Contig19_All   112  TETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDGQ  
169 
 
Query_5              121  DYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
179 




CL1150.Contig16_All  126  DYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESLL  
184 
CL154.Contig12_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig11_All   118  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
177 
CL154.Contig27_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig23_All   157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig2_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig1_All    157  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
216 
CL154.Contig24_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
CL154.Contig19_All   170  DHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSLT  
229 
 
Query_5              180  R  180 
CL1150.Contig4_All   182  R  182 
CL1150.Contig16_All  185  R  185 
CL154.Contig12_All   178  R  178 
CL154.Contig11_All   178  R  178 
CL154.Contig27_All   217  R  217 
CL154.Contig23_All   217  R  217 
CL154.Contig2_All    217  R  217 
CL154.Contig1_All    217  R  217 
CL154.Contig24_All   230  R  230 
CL154.Contig19_All   230  R  230 
 
 
Lambda      K        H        a         alpha 
   0.335    0.193    0.791    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2743481178 
 
 
Query= AFR54062.1 MHC class I antigen, partial [Meles meles] 
 
Length=90 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  178     3e-53 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  171     7e-50 
CL154.Contig16_All  217 480 class I histocompatibility antigen, G...  70.7    2e-15 
CL154.Contig15_All  215 478 minus strand class I histocompatibili...  70.7    2e-15 
CL154.Contig14_All  217 480 class I histocompatibility antigen, G...  70.7    2e-15 
CL154.Contig13_All  215 478 minus strand class I histocompatibili...  70.7    2e-15 
CL154.Contig33_All  343 723 class I histocompatibility antigen, G...  70.7    4e-15 
CL154.Contig21_All  339 719 class I histocompatibility antigen, G...  70.7    4e-15 
CL154.Contig20_All  339 719 class I histocompatibility antigen, G...  70.7    4e-15 




Query_6              1    GSHSLRYFYTGVSRPGRAEPRFIAVGYVDDAQFVRFDSDSASRRMEPRAPWMEQEGPEYW  60 
CL1150.Contig4_All   2    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  61 
CL1150.Contig16_All  5    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  64 
CL154.Contig16_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig15_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig14_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig13_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig33_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig21_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig20_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
 243 
 
CL154.Contig17_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
 
Query_6              61   DRQTRNLKDAAQTYRRSLNNLRDYYNQSEA  90 
CL1150.Contig4_All   62   DQQTRGIKETTQTYRRSLNNLRGYYNQSAA  91 
CL1150.Contig16_All  65   DRQTQICKETTQTYRGSLNILRGYYNQSAA  94 
CL154.Contig16_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig15_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig14_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig13_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig33_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig21_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig20_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig17_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
 
 
Lambda      K        H        a         alpha 
   0.332    0.189    0.769    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 906584538 
 
 
Query= AFR54061.1 MHC class I antigen, partial [Meles meles] 
 
Length=90 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  144     1e-40 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  138     6e-38 
CL154.Contig16_All  217 480 class I histocompatibility antigen, G...  64.4    4e-13 
CL154.Contig15_All  215 478 minus strand class I histocompatibili...  64.4    4e-13 
CL154.Contig14_All  217 480 class I histocompatibility antigen, G...  64.4    4e-13 
CL154.Contig13_All  215 478 minus strand class I histocompatibili...  64.4    4e-13 
CL154.Contig33_All  343 723 class I histocompatibility antigen, G...  64.4    8e-13 
CL154.Contig21_All  339 719 class I histocompatibility antigen, G...  64.4    8e-13 
CL154.Contig20_All  339 719 class I histocompatibility antigen, G...  64.4    8e-13 




Query_7              1    GSHSLRYFSTAVSRPGRGEARYWEVGYVDDTQFARFDSDSASPRMEPRAPWVEQAGPEYW  60 
CL1150.Contig4_All   2    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  61 
CL1150.Contig16_All  5    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  64 
CL154.Contig16_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig15_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig14_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig13_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig33_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYW  97 
CL154.Contig21_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYW  97 
CL154.Contig20_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYW  97 
CL154.Contig17_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVDAQYW  97 
 
Query_7              61   DRETRGIKDAAQTYRVDLQTALGCYNQSEA  90 
CL1150.Contig4_All   62   DQQTRGIKETTQTYRRSLNNLRGYYNQSAA  91 
CL1150.Contig16_All  65   DRQTQICKETTQTYRGSLNILRGYYNQSAA  94 
CL154.Contig16_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig15_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig14_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig13_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS    86 
CL154.Contig33_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig21_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig20_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
CL154.Contig17_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS    125 
 
 
Lambda      K        H        a         alpha 





Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 906584538 
 
 
Query= AFR54060.1 MHC class I antigen, partial [Meles meles] 
 
Length=325 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  618     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  494     1e-169 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  266     3e-83  
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  239     4e-73  
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  248     6e-73  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  248     6e-73  
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  238     1e-72  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  248     3e-72  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  248     3e-72  




Query_8              1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig16_All  1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig4_All   1       AGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  57 
CL154.Contig12_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig11_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig27_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig23_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig2_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
 
Query_8              61   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYSQH  
120 
CL1150.Contig16_All  61   PEYWDRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig4_All   58   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQF  
117 
CL154.Contig12_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig11_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig27_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig23_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig2_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
 
Query_8              121  SYDGADYIALNEDLRSWTAADTAAQITQRKWE-DAGEAERWRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig16_All  121  AYDGADYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig4_All   118  AYDGADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
176 
CL1150.Contig15_All  1                            QISRRKUE-DAGVAELERDYLEITCVKWLHRYLENG  35 
CL154.Contig12_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig11_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig27_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig23_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 





Query_8              180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVETRP  
239 
CL1150.Contig16_All  180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig4_All   177  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVET    
234 
CL1150.Contig15_All  36   KETLLR-----------------------------TEITLTWQRDGEDQTQDTELVETRP  66 
CL1150.Contig17_All  1         RAEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  55 
CL154.Contig12_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig11_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL1150.Contig13_All  1         RAEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWHHEEEDLTQDTELVGTRP  55 
CL154.Contig27_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig23_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig2_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
 
Query_8              240  AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
298 
CL1150.Contig16_All  240  AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
299 
CL1150.Contig15_All  67   AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
125 
CL1150.Contig17_All  56   AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
115 
CL154.Contig12_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig11_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL1150.Contig13_All  56   TGNGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
115 
CL154.Contig27_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig23_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig2_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
 
Query_8              299  IAVI---GVAIWWKKRSGEKGPGYSHAARD  325 
CL1150.Contig16_All  300  TVVV---GAVIWRRKRSGGKGPGYSHAA    324 
CL1150.Contig15_All  126  IAVI---GVAIWWKKRSGEKGPGYSHAA    150 
CL1150.Contig17_All  116  TVVV---GAVIWRRKRSGGKGPGYSHAA    140 
CL154.Contig12_All   289  IFLLLTAGVLIFIKQYS               305 
CL154.Contig11_All   289  IFLLLTAGVLIFIKQYS               305 
CL1150.Contig13_All  116  TVVV---GAVIWRKKRSGGKGPGYSHAARD  142 
CL154.Contig27_All   328  IFLLLTAGVLIFIKQYS               344 
CL154.Contig23_All   328  IFLLLTAGVLIFIKQYS               344 
CL154.Contig2_All    328  IFLLLTAGVLIFIKQYS               344 
 
 
Lambda      K        H        a         alpha 
   0.335    0.191    0.801    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 5708182959 
 
 
Query= AFR54059.1 MHC class I antigen, partial [Meles meles] 
 
Length=325 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  596     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  446     1e-150 
 246 
 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  274     3e-86  
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  244     6e-75  
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  253     1e-74  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  253     1e-74  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  253     6e-74  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  253     6e-74  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  253     6e-74  




Query_9              1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEG  60 
CL1150.Contig16_All  1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig4_All   1       AGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  57 
CL154.Contig12_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig11_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig27_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig23_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig2_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig1_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
 
Query_9              61   PEYWDRQTRNLKDAAHAFRVNLNTLRDYYNQSAAGSHTIQRMYGCDMGPDGRLLRGYSQV  
120 
CL1150.Contig16_All  61   PEYWDRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig4_All   58   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQF  
117 
CL154.Contig12_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig11_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig27_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig23_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig2_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig1_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
 
Query_9              121  AYDGADYLALNEDLRSWTVADATAQISRRKWE-DADEAEHERNYLEVTCVEWLGRYLENG  
179 
CL1150.Contig16_All  121  AYDGADYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig4_All   118  AYDGADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
176 
CL1150.Contig15_All  1                            QISRRKUE-DAGVAELERDYLEITCVKWLHRYLENG  35 
CL154.Contig12_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig11_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig27_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig23_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig2_All    152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig1_All    152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
 
Query_9              180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig16_All  180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig4_All   177  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVET    
234 
CL1150.Contig15_All  36   KETLLR-----------------------------TEITLTWQRDGEDQTQDTELVETRP  66 
CL1150.Contig17_All  1         RAEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  55 




CL154.Contig11_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig27_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig23_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig2_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig1_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
 
Query_9              240  AGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLSEPITRRWE-PPRTIPITWIIAGVV---L  
295 
CL1150.Contig16_All  240  AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLA---L  
296 
CL1150.Contig15_All  67   AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLV---L  
122 
CL1150.Contig17_All  56   AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLA---L  
112 
CL154.Contig12_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig11_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig27_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig23_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig2_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig1_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
 
Query_9              296  LVVIAVTGVAIWWKKRSGEKGPGYSHAA  323 
CL1150.Contig16_All  297  LAVTVVVGAVIWRRKRSGGKGPGYSHAA  324 
CL1150.Contig15_All  123  LVIIAVIGVAIWWKKRSGEKGPGYSHAA  150 
CL1150.Contig17_All  113  LAVTVVVGAVIWRRKRSGGKGPGYSHAA  140 
CL154.Contig12_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig11_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig27_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig23_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig2_All    328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig1_All    328  IFLLLTAGVLIFIKQYS             344 
 
 
Lambda      K        H        a         alpha 
   0.336    0.191    0.798    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 5708182959 
 
 
Query= AFR54058.1 MHC class I antigen, partial [Meles meles] 
 
Length=325 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  593     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  443     3e-149 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  274     2e-86  
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  257     3e-76  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  257     3e-76  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  258     2e-75  
CL154.Contig19_All  122 1195 class I histocompatibility antigen, ...  258     2e-75  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  257     2e-75  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  257     2e-75  






Query_10             1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig16_All  1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig4_All   1       AGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  57 
CL154.Contig12_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig11_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig24_All   53       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  
106 
CL154.Contig19_All   53       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  
106 
CL154.Contig27_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig23_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig2_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
 
Query_10             61   PEYWDRQTRNLKDAAHAFRVNLNTLRDYYNQSAAGSHTIQRMYGCDVGPDGRLLRGYSQV  
120 
CL1150.Contig16_All  61   PEYWDRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig4_All   58   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQF  
117 
CL154.Contig12_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig11_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig24_All   107  AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
164 
CL154.Contig19_All   107  AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
164 
CL154.Contig27_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig23_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig2_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
 
Query_10             121  AYDGADYLALNEDLRSWTVADATAQISRRKWEAAD-EAEHERNYLEVTCLEWLHRYLENG  
179 
CL1150.Contig16_All  121  AYDGADYIALNEDLRSWTAADTAAQISRRKWEDAG-EAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig4_All   118  AYDGADYLALNEDLRSWTAADTAAQISRRKWEDAG-EAERYRNYVEGTCVEWLGRYLENG  
176 
CL1150.Contig15_All  1                            QISRRKUEDAG-VAELERDYLEITCVKWLHRYLENG  35 
CL154.Contig12_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig11_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig24_All   165  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
224 
CL154.Contig19_All   165  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
224 
CL154.Contig27_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig23_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig2_All    152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
 
Query_10             180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig16_All  180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig4_All   177  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVET    
234 
CL1150.Contig15_All  36   KETLLR-----------------------------TEITLTWQRDGEDQTQDTELVETRP  66 
CL154.Contig12_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig11_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 




CL154.Contig19_All   225  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
284 
CL154.Contig27_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig23_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig2_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
 
Query_10             240  AGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVV  
298 
CL1150.Contig16_All  240  AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
299 
CL1150.Contig15_All  67   AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
125 
CL154.Contig12_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig11_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig24_All   285  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
340 
CL154.Contig19_All   285  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
340 
CL154.Contig27_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig23_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig2_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
 
Query_10             299  IAVI---GVAIWWKKHSGEKGPGYSHAA  323 
CL1150.Contig16_All  300  TVVV---GAVIWRRKRSGGKGPGYSHAA  324 
CL1150.Contig15_All  126  IAVI---GVAIWWKKRSGEKGPGYSHAA  150 
CL154.Contig12_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig11_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig24_All   341  IFLLLTAGVLIFIKQYS             357 
CL154.Contig19_All   341  IFLLLTAGVLIFIKQYS             357 
CL154.Contig27_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig23_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig2_All    328  IFLLLTAGVLIFIKQYS             344 
 
 
Lambda      K        H        a         alpha 
   0.336    0.191    0.799    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 5708182959 
 
 
Query= AFR54057.1 MHC class I antigen, partial [Meles meles] 
 
Length=325 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  604     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  440     2e-148 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  265     9e-83  
CL1150.Contig17_All  682 1101 minus strand MHC class I antigen, p...  243     7e-75  
CL1150.Contig13_All  621 1046 minus strand MHC class I antigen, p...  243     2e-74  
CL1150.Contig18_All  1278 1694 minus strand MHC class I antigen [...  240     1e-73  
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  242     1e-70  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  242     1e-70  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  242     5e-70  






Query_11             1    ETWAGSHSLRYFSTAVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEG  60 
CL1150.Contig16_All  1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig4_All   1       AGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  57 
CL154.Contig12_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig11_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDS--RVDRAKPQALWMATVD  54 
CL154.Contig27_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
CL154.Contig23_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRV--DRAKPQALWMATVD  93 
 
Query_11             61   PEYWDRQTQICKDAAQTYRGNLQTALRYYNQSAAGSHTIQNVYGCDVGRDGRLLRGYSQD  
120 
CL1150.Contig16_All  61   PEYWDRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig4_All   58   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQF  
117 
CL154.Contig12_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig11_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig27_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig23_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
 
Query_11             121  SYDGADYIALNEDLRSWTAADTAAQITQRKWE-DAGAAERWRNYLEVTCVEWLGRYLENG  
179 
CL1150.Contig16_All  121  AYDGADYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig4_All   118  AYDGADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
176 
CL1150.Contig15_All  1                            QISRRKUE-DAGVAELERDYLEITCVKWLHRYLENG  35 
CL154.Contig12_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig11_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig27_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig23_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
 
Query_11             180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVETRP  
239 
CL1150.Contig16_All  180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig4_All   177  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVET    
234 
CL1150.Contig15_All  36   KETLLR-----------------------------TEITLTWQRDGEDQTQDTELVETRP  66 
CL1150.Contig17_All  1         RAEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  55 
CL1150.Contig13_All  1         RAEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWHHEEEDLTQDTELVGTRP  55 
CL1150.Contig18_All  1          SEPPNTRMTHHPISDHAVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  54 
CL154.Contig12_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig11_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig27_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig23_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
 
Query_11             240  AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPHTIPITWIIAGLVLLVV  
298 
CL1150.Contig16_All  240  AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
299 
CL1150.Contig15_All  67   AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
125 
CL1150.Contig17_All  56   AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
115 
CL1150.Contig13_All  56   TGNGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
115 




CL154.Contig12_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig11_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig27_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig23_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
 
Query_11             299  IAVI---GAVIWWKKRSGEKGPGYSHAARD  325 
CL1150.Contig16_All  300  TVVV---GAVIWRRKRSGGKGPGYSHAA    324 
CL1150.Contig15_All  126  IAVI---GVAIWWKKRSGEKGPGYSHAA    150 
CL1150.Contig17_All  116  TVVV---GAVIWRRKRSGGKGPGYSHAA    140 
CL1150.Contig13_All  116  TVVV---GAVIWRKKRSGGKGPGYSHAARD  142 
CL1150.Contig18_All  115  TVVV---GAVIWRRKRSGGKGPGYSHAA    139 
CL154.Contig12_All   289  IFLLLTAGVLIFIKQYS               305 
CL154.Contig11_All   289  IFLLLTAGVLIFIKQYS               305 
CL154.Contig27_All   328  IFLLLTAGVLIFIKQYS               344 
CL154.Contig23_All   328  IFLLLTAGVLIFIKQYS               344 
 
 
Lambda      K        H        a         alpha 
   0.335    0.190    0.793    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 5708182959 
 
 
Query= AFR54056.1 MHC class I antigen, partial [Meles meles] 
 
Length=325 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  625     0.0    
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  486     3e-166 
CL1150.Contig15_All  3 452 minus strand MHC class I antigen, part...  270     8e-85  
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  257     3e-76  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  257     3e-76  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  258     1e-75  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  258     1e-75  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  258     1e-75  
CL154.Contig1_All  294 1328 minus strand class I histocompatibili...  258     1e-75  




Query_12             1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDAQFVRFDSDSASLRMEPRAPWMEQEG  60 
CL1150.Contig16_All  1    ETWAGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  60 
CL1150.Contig4_All   1       AGSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEG  57 
CL154.Contig12_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  54 
CL154.Contig11_All   1        GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  54 
CL154.Contig27_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  93 
CL154.Contig23_All   40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  93 
CL154.Contig2_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  93 
CL154.Contig1_All    40       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  93 
CL154.Contig24_All   53       GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSRVD--RAKPQALWMATVD  
106 
 
Query_12             61   PEYWDRETRNLKETTQTYRVNLNNLRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig16_All  61   PEYWDRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQF  
120 
CL1150.Contig4_All   58   PEYWDQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQF  
117 




CL154.Contig11_All   55   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
112 
CL154.Contig27_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig23_All   94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig2_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig1_All    94   AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
151 
CL154.Contig24_All   107  AQYWETETQKQRAWAKVQQVETWTVMGYHNQST-GMHSTQRMFGCEIREDGHT-HSFWQF  
164 
 
Query_12             121  AYDGADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig16_All  121  AYDGADYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
179 
CL1150.Contig4_All   118  AYDGADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENG  
176 
CL1150.Contig15_All  1                            QISRRKUE-DAGVAELERDYLEITCVKWLHRYLENG  35 
CL154.Contig12_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig11_All   113  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
172 
CL154.Contig27_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig23_All   152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig2_All    152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig1_All    152  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
211 
CL154.Contig24_All   165  GFDGQDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELG  
224 
 
Query_12             180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVETRP  
239 
CL1150.Contig16_All  180  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWQRDGEDLTQDTELVETRP  
239 
CL1150.Contig4_All   177  KESLLRAETPNTHVTRHPISDRDVTLRCWALDFYPAEITLTWKRDEEDLTQDTELVET    
234 
CL1150.Contig15_All  36   KETLLR-----------------------------TEITLTWQRDGEDQTQDTELVETRP  66 
CL154.Contig12_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig11_All   173  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
232 
CL154.Contig27_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig23_All   212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig2_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig1_All    212  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
271 
CL154.Contig24_All   225  GQSLTRKEPPTVQVTRHTARDGSITLKCWARGFYPRDISLSWWLGEEELVLETEYVETRP  
284 
 
Query_12             240  AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
298 
CL1150.Contig16_All  240  AGDGTFQKWAAVVVPSGEEQRYTCHVQHKGLPEPITLSWKPPPPTIPIMWIIAGLALLAV  
299 
CL1150.Contig15_All  67   AGDGTFQKWAAVVVPSGQEQRYTCYVQHEGLSEPITRRWE-PPRTIPITWIIAGLVLLVI  
125 
CL154.Contig12_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig11_All   233  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
288 
CL154.Contig27_All   272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 




CL154.Contig2_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig1_All    272  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
327 
CL154.Contig24_All   285  SGDGTYQTWAAVQVPARTEDRYICHVQHSGLNHTLTVTWE-AP---PRQWITSAVVIPML  
340 
 
Query_12             299  IAVI---GVAIWWKKRSGEKGPGYSHAA  323 
CL1150.Contig16_All  300  TVVV---GAVIWRRKRSGGKGPGYSHAA  324 
CL1150.Contig15_All  126  IAVI---GVAIWWKKRSGEKGPGYSHAA  150 
CL154.Contig12_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig11_All   289  IFLLLTAGVLIFIKQYS             305 
CL154.Contig27_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig23_All   328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig2_All    328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig1_All    328  IFLLLTAGVLIFIKQYS             344 
CL154.Contig24_All   341  IFLLLTAGVLIFIKQYS             357 
 
 
Lambda      K        H        a         alpha 
   0.335    0.192    0.801    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 5708182959 
 
 
Query= AFR54055.1 MHC class I antigen, partial [Meles meles] 
 
Length=181 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  345     5e-113 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  328     2e-108 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  121     5e-30  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  121     5e-30  
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  121     7e-30  
CL154.Contig19_All  122 1195 class I histocompatibility antigen, ...  121     7e-30  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  121     8e-30  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  121     8e-30  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  121     8e-30  




Query_13             1    GSHSLRYFSTAVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEGPEYW  60 
CL1150.Contig16_All  5    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  64 
CL1150.Contig4_All   2    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  61 
CL154.Contig12_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig11_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig24_All   53   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  
110 
CL154.Contig19_All   53   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  
110 
CL154.Contig27_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig23_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig2_All    40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig1_All    40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
 
Query_13             61   DRQTQICKDAAQTFRGNLQTALRYYNQSAAGSHTIQNVYGCDVGPDGRFLRGYRQDSYDG  
120 
CL1150.Contig16_All  65   DRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDG  
124 
CL1150.Contig4_All   62   DQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDG  
121 




CL154.Contig11_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
116 
CL154.Contig24_All   111  ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
168 
CL154.Contig19_All   111  ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
168 
CL154.Contig27_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig23_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig2_All    98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig1_All    98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
 
Query_13             121  ADYIALNEDLRSWTAADTAAQITQRKWEDAGA-AERWRNYLEVTCVEWLGRYLENGKESL  
179 
CL1150.Contig16_All  125  ADYIALNEDLRSWTAADTAAQISRRKWEDAGE-AERYRNYVEGTCVEWLGRYLENGKESL  
183 
CL1150.Contig4_All   122  ADYLALNEDLRSWTAADTAAQISRRKWEDAGE-AERYRNYVEGTCVEWLGRYLENGKESL  
180 
CL154.Contig12_All   117  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
176 
CL154.Contig11_All   117  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
176 
CL154.Contig24_All   169  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
228 
CL154.Contig19_All   169  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
228 
CL154.Contig27_All   156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig23_All   156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig2_All    156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig1_All    156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
 
Query_13             180  LR  181 
CL1150.Contig16_All  184  LR  185 
CL1150.Contig4_All   181  LR  182 
CL154.Contig12_All   177  TR  178 
CL154.Contig11_All   177  TR  178 
CL154.Contig24_All   229  TR  230 
CL154.Contig19_All   229  TR  230 
CL154.Contig27_All   216  TR  217 
CL154.Contig23_All   216  TR  217 
CL154.Contig2_All    216  TR  217 
CL154.Contig1_All    216  TR  217 
 
 
Lambda      K        H        a         alpha 
   0.334    0.191    0.785    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2765083392 
 
 
Query= AFR54054.1 MHC class I antigen, partial [Meles meles] 
 
Length=181 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL1150.Contig4_All  486 1187 MHC class I antigen, partial [Meles ...  334     6e-111 
CL1150.Contig16_All  189 1160 minus strand MHC class I antigen, p...  333     2e-108 
CL154.Contig12_All  217 1134 class I histocompatibility antigen, ...  121     3e-30  
CL154.Contig11_All  215 1132 minus strand class I histocompatibil...  121     3e-30  
 255 
 
CL154.Contig24_All  126 1199 class I histocompatibility antigen, ...  121     5e-30  
CL154.Contig19_All  122 1195 class I histocompatibility antigen, ...  121     5e-30  
CL154.Contig27_All  343 1377 class I histocompatibility antigen, ...  121     6e-30  
CL154.Contig23_All  339 1373 class I histocompatibility antigen, ...  121     6e-30  
CL154.Contig2_All  362 1396 class I histocompatibility antigen, G...  121     6e-30  




Query_14             1    GSHSLRYFSTAVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWVEQEGPEYW  60 
CL1150.Contig4_All   2    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  61 
CL1150.Contig16_All  5    GSHSLRYFYTGVSRPGRGEPRFIAVGYVDDTQFVRFDSDSASRRMEPRAPWMEQEGPEYW  64 
CL154.Contig12_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig11_All   1    GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHY--DSRVDRAKPQALWMATVDAQYW  58 
CL154.Contig24_All   53   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  
110 
CL154.Contig19_All   53   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  
110 
CL154.Contig27_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig23_All   40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig2_All    40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
CL154.Contig1_All    40   GTHSLHYHYLALSEPGPDLPQFLAVGYVDDQPFIHYDSR--VDRAKPQALWMATVDAQYW  97 
 
Query_14             61   DRQTRGIKDAAQTFRGNLQTALRYYNQSAAGSHTIQSMYGCDVGPDGRLLRGYSQDSYDG  
120 
CL1150.Contig4_All   62   DQQTRGIKETTQTYRRSLNNLRGYYNQSAAGSHTFQNMYGCDVGPDGRLLRGYRQFAYDG  
121 
CL1150.Contig16_All  65   DRQTQICKETTQTYRGSLNILRGYYNQSAAGSHTIQNLYGCDVGPDGRLLRGYRQFAYDG  
124 
CL154.Contig12_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
116 
CL154.Contig11_All   59   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
116 
CL154.Contig24_All   111  ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
168 
CL154.Contig19_All   111  ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
168 
CL154.Contig27_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig23_All   98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig2_All    98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
CL154.Contig1_All    98   ETETQKQRAWAKVQQVETWTVMGYHNQS-TGMHSTQRMFGCEIREDGH-THSFWQFGFDG  
155 
 
Query_14             121  ADYIALNEDLRSWTAADTAAQITQRKWE-DAGVAERWRNYLEVTCVEWLGRYLENGKESL  
179 
CL1150.Contig4_All   122  ADYLALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESL  
180 
CL1150.Contig16_All  125  ADYIALNEDLRSWTAADTAAQISRRKWE-DAGEAERYRNYVEGTCVEWLGRYLENGKESL  
183 
CL154.Contig12_All   117  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
176 
CL154.Contig11_All   117  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
176 
CL154.Contig24_All   169  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
228 
CL154.Contig19_All   169  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
228 
CL154.Contig27_All   156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig23_All   156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig2_All    156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
CL154.Contig1_All    156  QDHLSLDLETLSWVSAKPAATRTKSWWETERCYAEYDKAYLEGLCLVSLRRYLELGGQSL  
215 
 
Query_14             180  LR  181 
CL1150.Contig4_All   181  LR  182 
 256 
 
CL1150.Contig16_All  184  LR  185 
CL154.Contig12_All   177  TR  178 
CL154.Contig11_All   177  TR  178 
CL154.Contig24_All   229  TR  230 
CL154.Contig19_All   229  TR  230 
CL154.Contig27_All   216  TR  217 
CL154.Contig23_All   216  TR  217 
CL154.Contig2_All    216  TR  217 
CL154.Contig1_All    216  TR  217 
 
 
Lambda      K        H        a         alpha 
   0.335    0.191    0.779    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 2765083392 
 
 
Query= AET36883.1 MHC class II antigen, partial [Meles meles] 
 
Length=81 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene42913_All  108 710 MHC class II antigen DR alpha chain, pa...  177     8e-54 
CL2981.Contig3_All  111 872 minus strand PREDICTED: HLA class II ...  178     3e-53 
CL2981.Contig1_All  111 872 minus strand PREDICTED: HLA class II ...  178     3e-53 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  110     1e-28 
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  98.7    9e-25 
CL10050.Contig1_All  105 686 minus strand MHC class II antigen DQ...  98.7    9e-25 
CL12484.Contig1_All  50 376 minus strand HLA class II histocompat...  90.3    3e-22 




Query_15             1    DHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWRLEEFGRFASFEAQGALAN  59 
Unigene42913_All     27   DHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWRLEEFGRFASFEAQGALAN  85 
CL2981.Contig3_All   29   DHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWRLEEFGRFASFEAQGALAN  87 
CL2981.Contig1_All   29   DHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWRLEEFGRFASFEAQGALAN  87 
CL10050.Contig3_All  29   DHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWRLPVFSTFAGFDPQGALSE  88 
CL10050.Contig2_All  19   DHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWRLPVFSTFAGFDPQGALSE  78 
CL10050.Contig1_All  19   DHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWRLPVFSTFAGFDPQGALSE  78 
CL12484.Contig1_All  37            FYQSYGASGQFAYEFDGEQLFSVELKKKEAVWRLPEFGNLAHFDPQNGLAS  87 
CL12484.Contig3_All  38            FYQSYGASGQFAYEFDGEQLFSVELKKKEAVWRLPEFGNLAHFDPQNGLAS  88 
 
Query_15             60   IAVDKANLDIMIKRSNHTPNTN  81 
Unigene42913_All     86   IAVDKANLDIMIKRSNHTPNTN  107 
CL2981.Contig3_All   88   IAVDKANLDIMIKRSNHTPNTN  109 
CL2981.Contig1_All   88   IAVDKANLDIMIKRSNHTPNTN  109 
CL10050.Contig3_All  89   IATSKQNLNILTKRSNYTAATN  110 
CL10050.Contig2_All  79   IATSKQNLNILTKRSNYTAATN  100 
CL10050.Contig1_All  79   IATSKQNLNILTKRSNYTAATN  100 
CL12484.Contig1_All  88   IAVIKAHLDVLVERSNRTRATN  109 
CL12484.Contig3_All  89   IAVIKAHLDVLVERSNRTRATN  110 
 
 
Lambda      K        H        a         alpha 
   0.336    0.192    0.769    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 733894227 
 
 





                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  151     2e-43 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  151     3e-43 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  137     4e-38 
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  136     8e-38 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  133     7e-37 
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  128     7e-35 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  123     3e-33 
CL6815.Contig6_All  88 732 minus strand major histocompatibility ...  116     9e-31 
CL6815.Contig1_All  88 732 minus strand major histocompatibility ...  116     9e-31 




Query_16            1    DFVFQFMGQCYFTNGTERVRYLTRYIYNREEYARFDSDLGKYVAVTELGRPSAQYWNSQK  60 
Unigene67843_All    34   DFVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  93 
Unigene57188_All    34   DFVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  93 
Unigene75449_All    28    FLFLTTSECHFTNGTERVRFLDRYFYNGEEYVRFDSDVGEYRPVTELGRPDAEYWNSQK  86 
Unigene75450_All    27   DFVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  86 
CL4065.Contig3_All  1     FVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  59 
CL6815.Contig5_All  32   DFVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
Unigene27967_All    28    FLFLTTSECHFTNGTERVRFLDRYFYNGEEYVRFDSDVGEYRPVTELGRPDAQYWNSQK  86 
CL6815.Contig6_All  32   DFVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
CL6815.Contig1_All  32   DFVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
CL6815.Contig3_All  32   DFVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
 
Query_16            61   DIVDRTEAERDTVCRHNYKNEERTTLQRR  89 
Unigene67843_All    94   DILERTEAETDTVCRHNYLTDESFTVQRR  122 
Unigene57188_All    94   DILERTEAETDTVCRHNYLTDESFTVQRR  122 
Unigene75449_All    87   DILERTEAETDTVCRHNYLTDESFTVQRR  115 
Unigene75450_All    87   DIMERRRAAVDTYCRHNYGVVESFLVQRR  115 
CL4065.Contig3_All  60   DIMERRRAAVDTYCRHNYGVVESFLVQRR  88 
CL6815.Contig5_All  92   DILERSRASVDALCRHNYK            110 
Unigene27967_All    87   DIMERRRAAVDTYCRHNYGVVESFLVQRR  115 
CL6815.Contig6_All  92   DILERSRASVDALCRHNYKLGAPFTVGRK  120 
CL6815.Contig1_All  92   DILERSRASVDALCRHNYKLGAPFTVGRK  120 
CL6815.Contig3_All  92   DILERSRASVDALCRHNYKLGAPFTVGRK  120 
 
 
Lambda      K        H        a         alpha 
   0.336    0.192    0.778    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 884472720 
 
 
Query= AET36880.1 MHC class II antigen, partial [Meles meles] 
 
Length=89 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  145     5e-41 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  135     2e-37 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  130     7e-36 
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  131     8e-36 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  122     6e-33 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  122     9e-33 
CL6815.Contig4_All  88 741 minus strand major histocompatibility ...  91.6    8e-22 
CL6815.Contig6_All  88 732 minus strand major histocompatibility ...  91.6    8e-22 
CL6815.Contig1_All  88 732 minus strand major histocompatibility ...  91.6    8e-22 






Query_17            1    HFLLPVKPECHYCNGTERVRLLDRYFYNSEEYVHFNSDVGEYRPVTELGRPIAQGWNSQK  60 
Unigene27967_All    27   HFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVRFDSDVGEYRPVTELGRPDAQYWNSQK  86 
Unigene75449_All    27   HFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVRFDSDVGEYRPVTELGRPDAEYWNSQK  86 
CL4065.Contig3_All  1     FVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  59 
Unigene75450_All    28    FVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  86 
Unigene67843_All    35    FVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  93 
Unigene57188_All    35    FVFQFKGECYFTNGTERVRSVNRYIYNREEFVRYDSDVGEYRPVTELGRPDAQYWNSQK  93 
CL6815.Contig4_All  33    FVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
CL6815.Contig6_All  33    FVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
CL6815.Contig1_All  33    FVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
CL6815.Contig3_All  33    FVIQAKADCYFINGTEKVQFVVRFIFNLEEYARFDSHVGKFVALTELGKPDAELWNHRP  91 
 
Query_17            61   DIMERKRSEVDTVCRHNHGVFESF  84 
Unigene27967_All    87   DIMERRRAAVDTYCRHNYGVVESF  110 
Unigene75449_All    87   DILERTEAETDTVCRHNYLTDESF  110 
CL4065.Contig3_All  60   DIMERRRAAVDTYCRHNYGVVESF  83 
Unigene75450_All    87   DIMERRRAAVDTYCRHNYGVVESF  110 
Unigene67843_All    94   DILERTEAETDTVCRHNYLTDESF  117 
Unigene57188_All    94   DILERTEAETDTVCRHNYLTDESF  117 
CL6815.Contig4_All  92   DILERSRASVDALCRHNYKLGAPF  115 
CL6815.Contig6_All  92   DILERSRASVDALCRHNYKLGAPF  115 
CL6815.Contig1_All  92   DILERSRASVDALCRHNYKLGAPF  115 
CL6815.Contig3_All  92   DILERSRASVDALCRHNYKLGAPF  115 
 
 
Lambda      K        H        a         alpha 
   0.343    0.198    0.854    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 884472720 
 
 




                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL2981.Contig3_All  111 872 minus strand PREDICTED: HLA class II ...  492     7e-171 
CL2981.Contig1_All  111 872 minus strand PREDICTED: HLA class II ...  492     7e-171 
Unigene42913_All  108 710 MHC class II antigen DR alpha chain, pa...  434     1e-149 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  295     7e-94  
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  250     9e-78  
CL10050.Contig1_All  105 686 minus strand MHC class II antigen DQ...  250     9e-78  
CL12484.Contig3_All  47 625 minus strand MHC class II antigen DO ...  230     2e-70  
CL12484.Contig2_All  651 899 minus strand PREDICTED: HLA class II...  120     6e-32  
CL12484.Contig1_All  50 376 minus strand HLA class II histocompat...  112     3e-28  




Query_18             1    ISGVPVLGFFIMTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDM  59 
CL2981.Contig3_All   3    INGVPVLGFFIMTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDM  61 
CL2981.Contig1_All   3    INGVPVLGFFIMTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDM  61 
Unigene42913_All     1    INGVPVLGFFIMTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDM  59 
CL10050.Contig3_All  6       VLILGTLALTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDL  62 
CL10050.Contig2_All  4               LTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDL  52 
CL10050.Contig1_All  4               LTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDL  52 
CL12484.Contig3_All  3    LSGGLVLGLYTLMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVEL  62 
CL12484.Contig1_All  2    LSGGLVLGLYTLMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVEL  61 
 
Query_18             60   EKKETVWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTP  
119 
CL2981.Contig3_All   62   EKKETVWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTP  
121 




Unigene42913_All     60   EKKETVWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTP  
119 
CL10050.Contig3_All  63   EKKETVWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSP  
122 
CL10050.Contig2_All  53   EKKETVWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSP  
112 
CL10050.Contig1_All  53   EKKETVWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSP  
112 
CL12484.Contig3_All  63   KKKEAVWRLPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATNVPPRVTVLPRFR  
122 
CL12484.Contig2_All  1                                                    VPPRVTVLPRFR  12 
CL12484.Contig1_All  62   KKKEAVWRLPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATN              
109 
CL5174.Contig1_All   9                     FDAWRGIGDIVVAKKNLNNLIQRSNHTRATNEPPEVTVFPKEP  51 
 
Query_18             120  VELGEPNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPS  
179 
CL2981.Contig3_All   122  VELGEPNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPS  
181 
CL2981.Contig1_All   122  VELGEPNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPS  
181 
Unigene42913_All     120  VELGEPNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPS  
179 
CL10050.Contig3_All  123  VMLGQPNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPS  
182 
CL10050.Contig2_All  113  VMLGQPNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPS  
172 
CL10050.Contig1_All  113  VMLGQPNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPS  
172 
CL12484.Contig3_All  123  VELGQPNVLICMVDNIFPPVINITWLRNGQIVSEGVAQTSFYSQPDHLFRKFCYLTFVPS  
182 
CL12484.Contig2_All  13   VELGQPNVLICMVDNIFPPVINITWLRNGQIVSEGVAQTSFYSQPDHLFRKFCYLTFVPS  72 
CL5174.Contig1_All   52   VELGQPNTLICHVDKFFPPVLNVTWLRN                                  79 
 
Query_18             180  ANDVYDCKVEHWGLDEPLLKHWEFEPPTPLPETTENVVCALGLVVGLVGII  230 
CL2981.Contig3_All   182  ANDVYDCKVEHWGLDEPLLKHWEFEPPTPLPETTENVVCALGLVVGLVGIV  232 
CL2981.Contig1_All   182  ANDVYDCKVEHWGLDEPLLKHWEFEPPTPLPETTENVVCALGLVVGLVGIV  232 
Unigene42913_All     180  ANDVYDCKVEHWGLDEPLLKHW                               201 
CL10050.Contig3_All  183  ADDIYDCKVEHWGLDEPLLKHWEPEIPSPMSELTETVVCALGLAVGLVGIV  233 
CL10050.Contig2_All  173  ADDIYDCKVEHWGLDEPLLKHW                               194 
CL10050.Contig1_All  173  ADDIYDCKVEHWGLDEPLLKHW                               194 
CL12484.Contig3_All  183  ADDMYDCKVEH                                          193 
CL12484.Contig2_All  73   ADDMYDCKVEH                                          83 
 
 
Lambda      K        H        a         alpha 
   0.337    0.196    0.813    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 3779567088 
 
 




                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  447     7e-154 
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  423     3e-146 
CL10050.Contig1_All  105 686 minus strand MHC class II antigen DQ...  423     3e-146 
CL2981.Contig3_All  111 872 minus strand PREDICTED: HLA class II ...  260     5e-81  
CL2981.Contig1_All  111 872 minus strand PREDICTED: HLA class II ...  260     5e-81  
Unigene42913_All  108 710 MHC class II antigen DR alpha chain, pa...  249     6e-78  
CL12484.Contig3_All  47 625 minus strand MHC class II antigen DO ...  239     2e-74  
CL12484.Contig2_All  651 899 minus strand PREDICTED: HLA class II...  127     2e-34  
CL12484.Contig1_All  50 376 minus strand HLA class II histocompat...  115     8e-30  
 260 
 




Query_19             1    TLALTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWR  60 
CL10050.Contig3_All  11   TLALTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWR  70 
CL10050.Contig2_All  1    TLALTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWR  60 
CL10050.Contig1_All  1    TLALTTMMSPGGSEDIVADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKETVWR  60 
CL2981.Contig3_All   14      MTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWR  69 
CL2981.Contig1_All   14      MTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWR  69 
Unigene42913_All     12      MTLLMGPQESQAIKEDHV-IIQAEFYLTPDPSGEFMFDFDGDEIFHVDMEKKETVWR  67 
CL12484.Contig3_All  14      LMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVELKKKEAVWR  70 
CL12484.Contig1_All  13      LMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVELKKKEAVWR  69 
 
Query_19             61   LPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQPNT  
120 
CL10050.Contig3_All  71   LPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQPNT  
130 
CL10050.Contig2_All  61   LPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQPNT  
120 
CL10050.Contig1_All  61   LPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQPNT  
120 
CL2981.Contig3_All   70   LEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGEPNT  
129 
CL2981.Contig1_All   70   LEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGEPNT  
129 
Unigene42913_All     68   LEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGEPNT  
127 
CL12484.Contig3_All  71   LPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATNVPPRVTVLPRFRVELGQPNV  
130 
CL12484.Contig2_All  3                                              PRVTVLPRFRVELGQPNV  20 
CL12484.Contig1_All  70   LPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATN                      
109 
CL5174.Contig1_All   1     PDFIHAFDFDAWRGIGDIVVAKKNLNNLIQRSNHTRATNEPPEVTVFPKEPVELGQPNT  59 
 
Query_19             121  LICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIYDCK  
180 
CL10050.Contig3_All  131  LICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIYDCK  
190 
CL10050.Contig2_All  121  LICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIYDCK  
180 
CL10050.Contig1_All  121  LICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIYDCK  
180 
CL2981.Contig3_All   130  LICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVYDCK  
189 
CL2981.Contig1_All   130  LICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVYDCK  
189 
Unigene42913_All     128  LICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVYDCK  
187 
CL12484.Contig3_All  131  LICMVDNIFPPVINITWLRNGQIVSEGVAQTSFYSQPDHLFRKFCYLTFVPSADDMYDCK  
190 
CL12484.Contig2_All  21   LICMVDNIFPPVINITWLRNGQIVSEGVAQTSFYSQPDHLFRKFCYLTFVPSADDMYDCK  80 
CL5174.Contig1_All   60   LICHVDKFFPPVLNVTWLRN                                          79 
 
Query_19             181  VEHWGLDEPLLKHWEPEIPTPMSEL  205 
CL10050.Contig3_All  191  VEHWGLDEPLLKHWEPEIPSPMSEL  215 
CL10050.Contig2_All  181  VEHWGLDEPLLKHW             194 
CL10050.Contig1_All  181  VEHWGLDEPLLKHW             194 
CL2981.Contig3_All   190  VEHWGLDEPLLKHWEFEPPTPLPE   213 
CL2981.Contig1_All   190  VEHWGLDEPLLKHWEFEPPTPLPE   213 
Unigene42913_All     188  VEHWGLDEPLLKHW             201 
CL12484.Contig3_All  191  VEH                        193 
CL12484.Contig2_All  81   VEH                        83 
 
 
Lambda      K        H        a         alpha 
   0.333    0.190    0.770    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 




Effective search space used: 3242696763 
 
 




                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
CL10050.Contig3_All  75 839 minus strand PREDICTED: SLA class II ...  394     3e-133 
CL10050.Contig2_All  105 686 minus strand MHC class II antigen DQ...  370     2e-125 
CL10050.Contig1_All  105 686 minus strand MHC class II antigen DQ...  370     2e-125 
CL2981.Contig3_All  111 872 minus strand PREDICTED: HLA class II ...  246     8e-76  
CL2981.Contig1_All  111 872 minus strand PREDICTED: HLA class II ...  246     8e-76  
Unigene42913_All  108 710 MHC class II antigen DR alpha chain, pa...  235     9e-73  
CL12484.Contig3_All  47 625 minus strand MHC class II antigen DO ...  226     3e-69  
CL12484.Contig2_All  651 899 minus strand PREDICTED: HLA class II...  119     1e-31  
CL12484.Contig1_All  50 376 minus strand HLA class II histocompat...  109     1e-27  




Query_20             1    TLALTTIMSLGGSEDI---VADHVASYGISVYQSYGPSGQYTREFDGDEEFYVDLEKKET  57 
CL10050.Contig3_All  11   TLALTTMMSPGGSEDI---VADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKET  67 
CL10050.Contig2_All  1    TLALTTMMSPGGSEDI---VADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKET  57 
CL10050.Contig1_All  1    TLALTTMMSPGGSEDI---VADHVGAYGVEVYQSYGPSGQYTQEFDGDELFYVDLEKKET  57 
CL2981.Contig3_All   14      MTLLMGPQESQAI---KEDHVIIQA-EFYLTPDPSGEFMFDFDGDEIFHVDMEKKET  66 
CL2981.Contig1_All   14      MTLLMGPQESQAI---KEDHVIIQA-EFYLTPDPSGEFMFDFDGDEIFHVDMEKKET  66 
Unigene42913_All     12      MTLLMGPQESQAI---KEDHVIIQA-EFYLTPDPSGEFMFDFDGDEIFHVDMEKKET  64 
CL12484.Contig3_All  8    VLGLYTLMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVELKKKEA  67 
CL12484.Contig1_All  8     LGLYTLMSLLSPQEIGAIKADHMGSYGPAFYQSYGASGQFAYEFDGEQLFSVELKKKEA  66 
 
Query_20             58   VWQLPMFQALRRFDPQGALRNLAIAKQNLNILTKRSNYTAATNEVPEVTLFLKTPVMLGQ  
117 
CL10050.Contig3_All  68   VWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQ  
127 
CL10050.Contig2_All  58   VWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQ  
117 
CL10050.Contig1_All  58   VWRLPVFSTFAGFDPQGALSEIATSKQNLNILTKRSNYTAATNEVPEVTLFPKSPVMLGQ  
117 
CL2981.Contig3_All   67   VWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGE  
126 
CL2981.Contig1_All   67   VWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGE  
126 
Unigene42913_All     65   VWRLEEFGRFASFEAQGALANIAVDKANLDIMIKRSNHTPNTNVPPEVTVLSNTPVELGE  
124 
CL12484.Contig3_All  68   VWRLPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATNVPPRVTVLPRFRVELGQ  
127 
CL12484.Contig2_All  3                                                 PRVTVLPRFRVELGQ  17 
CL12484.Contig1_All  67   VWRLPEFGNLAHFDPQNGLASIAVIKAHLDVLVERSNRTRATN                   
109 
CL5174.Contig1_All   9                FDAWRGIGDIVVAKKNLNNLIQRSNHTRATNEPPEVTVFPKEPVELGQ  56 
 
Query_20             118  PNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETHFLIKKDYSFLKFSYLTFLPSADDIY  
177 
CL10050.Contig3_All  128  PNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIY  
187 
CL10050.Contig2_All  118  PNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIY  
177 
CL10050.Contig1_All  118  PNTLICLVDNIFPPVINVTWLKNRHSVTEGVSETSFLAKKDHSFLKISYLTFLPSADDIY  
177 
CL2981.Contig3_All   127  PNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVY  
186 
CL2981.Contig1_All   127  PNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVY  
186 
Unigene42913_All     125  PNTLICFIDKFSPPVINVTWLRNGNPVTTGVSETVFLPREDHLFRKFHYLPFLPSANDVY  
184 




CL12484.Contig2_All  18   PNVLICMVDNIFPPVINITWLRNGQIVSEGVAQTSFYSQPDHLFRKFCYLTFVPSADDMY  77 
CL5174.Contig1_All   57   PNTLICHVDKFFPPVLNVTWLRN                                       79 
 
Query_20             178  DCKVEHWGLDEPLLKHWEPEIPTPMSEL  205 
CL10050.Contig3_All  188  DCKVEHWGLDEPLLKHWEPEIPSPMSEL  215 
CL10050.Contig2_All  178  DCKVEHWGLDEPLLKHW             194 
CL10050.Contig1_All  178  DCKVEHWGLDEPLLKHW             194 
CL2981.Contig3_All   187  DCKVEHWGLDEPLLKHWEFEPPTPLPE   213 
CL2981.Contig1_All   187  DCKVEHWGLDEPLLKHWEFEPPTPLPE   213 
Unigene42913_All     185  DCKVEHWGLDEPLLKHW             201 
CL12484.Contig3_All  188  DCKVEH                        193 
CL12484.Contig2_All  78   DCKVEH                        83 
 
 
Lambda      K        H        a         alpha 
   0.334    0.192    0.775    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 3242696763 
 
 
Query= AET36872.1 MHC class II antigen DQ beta chain, partial [Meles meles] 
 
Length=224 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  490     4e-170 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  475     2e-165 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  418     6e-142 
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  398     4e-134 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  341     2e-112 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  341     1e-111 
CL6815.Contig3_All  88 843 minus strand PREDICTED: HLA class II h...  286     8e-91  
CL6815.Contig2_All  88 882 minus strand PREDICTED: HLA class II h...  287     1e-90  
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  287     2e-90  




Query_21            1    MALWIPRGLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIY  60 
Unigene57188_All    1    MALWIPRGLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIY  60 
Unigene67843_All    1    MALWIPRGLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIY  60 
Unigene75449_All    1           GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFY  53 
Unigene75450_All    1           GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIY  53 
CL4065.Contig3_All  1                                      FVFQFKGECYFTNGTERVRSVNRYIY  26 
Unigene27967_All    1           GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFY  53 
CL6815.Contig3_All  5       WVP---WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIF  58 
CL6815.Contig2_All  5       WVP---WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIF  58 
CL6815.Contig5_All  5       WVP---WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIF  58 
CL6815.Contig6_All  5       WVP---WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIF  58 
 
Query_21            61   NREEFVRYDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQ  120 
Unigene57188_All    61   NREEFVRYDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQ  120 
Unigene67843_All    61   NREEFVRYDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQ  120 
Unigene75449_All    54   NGEEYVRFDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQ  113 
Unigene75450_All    54   NREEFVRYDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQ  113 
CL4065.Contig3_All  27   NREEFVRYDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQ  86 
Unigene27967_All    54   NGEEYVRFDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQ  113 
CL6815.Contig3_All  59   NLEEYARFDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVG  118 
CL6815.Contig2_All  59   NLEEYARFDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVG  118 
CL6815.Contig5_All  59   NLEEYARFDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVG  118 
CL6815.Contig6_All  59   NLEEYARFDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVG  118 
 
Query_21            121  RRVEPTVTISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGD  180 
Unigene57188_All    121  RRVEPTVTISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGD  180 
Unigene67843_All    121  RRVEPTVTISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGD  180 
Unigene75449_All    114  RRVEPTVTISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGD  173 
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Unigene75450_All    114  RRVEPTVTVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGD  173 
CL4065.Contig3_All  87   RRVEPTVTVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGD  146 
Unigene27967_All    114  RRVEPTVTVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGD  173 
CL6815.Contig3_All  119  RKVQPEVAVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGD  178 
CL6815.Contig2_All  119  RKVQPEVAVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGD  178 
CL6815.Contig5_All  119  RKVQPEVAVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGD  178 
CL6815.Contig6_All  119  RKVQPEVAVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGD  178 
 
Query_21            181  WTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQ  224 
Unigene57188_All    181  WTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQ  224 
Unigene67843_All    181  WTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWR         217 
Unigene75449_All    174  WTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQ  217 
Unigene75450_All    174  WTFQTLVMLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQ  217 
CL4065.Contig3_All  147  WTFQTLVMLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQ  190 
Unigene27967_All    174  WTFQTLVMLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQ  217 
CL6815.Contig3_All  179  WTFQTMVMLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQS      218 
CL6815.Contig2_All  179  WTFQTMVMLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQS      218 
CL6815.Contig5_All  179  WTFQTMVMLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQS      218 
CL6815.Contig6_All  179  WTFQTMVMLEMTPALGDVYTCLVNHVSLLSPVSVEWR         215 
 
 
Lambda      K        H        a         alpha 
   0.336    0.191    0.786    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 3650718210 
 
 
Query= AET36871.1 MHC class II antigen DR beta chain, partial [Meles meles] 
 
Length=258 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  478     2e-164 
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  462     4e-158 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  434     8e-148 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  399     1e-133 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  383     4e-127 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  341     8e-112 
CL6815.Contig2_All  88 882 minus strand PREDICTED: HLA class II h...  302     1e-95  
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  302     2e-95  
CL6815.Contig3_All  88 843 minus strand PREDICTED: HLA class II h...  300     5e-95  




Query_22            1    GSWMTALTLILMVLSPPLAWARDTPRHFLMQFKGECYFTNGTERVRLLVRHIYNREEFVR  60 
Unigene27967_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene75450_All    1    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  60 
CL4065.Contig3_All  1                               FVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  33 
Unigene75449_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene57188_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
Unigene67843_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
CL6815.Contig2_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig5_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig3_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig6_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
 
Query_22            61   FDSDVGEYRPVTELGRPIAQGWNSQKDIMERRRAEVDTVCRHNYGVVESFTVQRRVEPTV  120 
Unigene27967_All    61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene75450_All    61   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
CL4065.Contig3_All  34   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  93 
Unigene75449_All    61   FDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  120 
Unigene57188_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
Unigene67843_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
CL6815.Contig2_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig5_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
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CL6815.Contig3_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig6_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
 
Query_22            121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIPNGDWTFQTLV  180 
Unigene27967_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene75450_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
CL4065.Contig3_All  94   TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  153 
Unigene75449_All    121  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  180 
Unigene57188_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
Unigene67843_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
CL6815.Contig2_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig5_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig3_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig6_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
 
Query_22            181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene27967_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene75450_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
CL4065.Contig3_All  154  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  213 
Unigene75449_All    181  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  240 
Unigene57188_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  247 
Unigene67843_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWR                                217 
CL6815.Contig2_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig5_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig3_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig6_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWR                                215 
 
Query_22            241  YFRNQKGHSGLQPTGLLS  258 
Unigene27967_All    241  YFRNQKGHSGLQPTGLLS  258 
Unigene75450_All    241  YFRNQKGHSGLQPTGLLS  258 
CL4065.Contig3_All  214  YFRNQKGHSGLQPTGLLS  231 
Unigene75449_All    241  RHRSQKGPRGSPPAGLL   257 
Unigene57188_All    248  RHRSQKGPRGSPPAGLL   264 
CL6815.Contig2_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig5_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig3_All  246  CLRAQKG             252 
 
 
Lambda      K        H        a         alpha 
   0.339    0.194    0.800    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 4333524636 
 
 
Query= AET36870.1 MHC class II antigen DR beta chain, partial [Meles meles] 
 
Length=258 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  554     0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  461     9e-158 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  436     8e-148 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  433     2e-147 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  379     3e-125 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  335     2e-109 
CL6815.Contig2_All  88 882 minus strand PREDICTED: HLA class II h...  301     5e-95  
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  300     1e-94  
CL6815.Contig3_All  88 843 minus strand PREDICTED: HLA class II h...  298     2e-94  




Query_23            1    GSWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene27967_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene75450_All    1    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  60 
Unigene75449_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
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CL4065.Contig3_All  1                               FVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  33 
Unigene57188_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
Unigene67843_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
CL6815.Contig2_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig5_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig3_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig6_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
 
Query_23            61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAEVDTVCRHNYGVVESFLVQRRVEPTV  120 
Unigene27967_All    61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene75450_All    61   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene75449_All    61   FDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  120 
CL4065.Contig3_All  34   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  93 
Unigene57188_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
Unigene67843_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
CL6815.Contig2_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig5_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig3_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig6_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
 
Query_23            121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene27967_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene75450_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene75449_All    121  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  180 
CL4065.Contig3_All  94   TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  153 
Unigene57188_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
Unigene67843_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
CL6815.Contig2_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig5_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig3_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig6_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
 
Query_23            181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene27967_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene75450_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene75449_All    181  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  240 
CL4065.Contig3_All  154  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  213 
Unigene57188_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  247 
Unigene67843_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWR                                217 
CL6815.Contig2_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig5_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig3_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig6_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWR                                215 
 
Query_23            241  YFRNQKGHSGLQPTGLLS  258 
Unigene27967_All    241  YFRNQKGHSGLQPTGLLS  258 
Unigene75450_All    241  YFRNQKGHSGLQPTGLLS  258 
Unigene75449_All    241  RHRSQKGPRGSPPAGLL   257 
CL4065.Contig3_All  214  YFRNQKGHSGLQPTGLLS  231 
Unigene57188_All    248  RHRSQKGPRGSPPAGLL   264 
CL6815.Contig2_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig5_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig3_All  246  CLRAQKG             252 
 
 
Lambda      K        H        a         alpha 
   0.339    0.195    0.804    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 4333524636 
 
 
Query= AET36869.1 MHC class II antigen DR beta chain, partial [Meles meles] 
 
Length=258 
                                                                      Score     E 




Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  557     0.0    
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  464     7e-159 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  435     2e-148 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  428     6e-145 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  371     2e-122 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  327     1e-106 
CL6815.Contig2_All  88 882 minus strand PREDICTED: HLA class II h...  298     5e-94  
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  298     8e-94  
CL6815.Contig3_All  88 843 minus strand PREDICTED: HLA class II h...  296     2e-93  




Query_24            1    GSWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene27967_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene75450_All    1    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  60 
CL4065.Contig3_All  1                               FVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  33 
Unigene75449_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene57188_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
Unigene67843_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
CL6815.Contig2_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig5_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig3_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig6_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
 
Query_24            61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene27967_All    61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene75450_All    61   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
CL4065.Contig3_All  34   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  93 
Unigene75449_All    61   FDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  120 
Unigene57188_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
Unigene67843_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
CL6815.Contig2_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig5_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig3_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig6_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
 
Query_24            121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIPNGDWTFQTLV  180 
Unigene27967_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene75450_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
CL4065.Contig3_All  94   TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  153 
Unigene75449_All    121  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  180 
Unigene57188_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
Unigene67843_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
CL6815.Contig2_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig5_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig3_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig6_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
 
Query_24            181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene27967_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene75450_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
CL4065.Contig3_All  154  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  213 
Unigene75449_All    181  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  240 
Unigene57188_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  247 
Unigene67843_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWR                                217 
CL6815.Contig2_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig5_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig3_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig6_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWR                                215 
 
Query_24            241  YFRNQKGHSGLQPTGLLS  258 
Unigene27967_All    241  YFRNQKGHSGLQPTGLLS  258 
Unigene75450_All    241  YFRNQKGHSGLQPTGLLS  258 
CL4065.Contig3_All  214  YFRNQKGHSGLQPTGLLS  231 
Unigene75449_All    241  RHRSQKGPRGSPPAGLL   257 
Unigene57188_All    248  RHRSQKGPRGSPPAGLL   264 
CL6815.Contig2_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig5_All  246  CLRAQKGYAETRLSG     260 





Lambda      K        H        a         alpha 
   0.338    0.194    0.805    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 4333524636 
 
 
Query= AET36868.1 MHC class II antigen DR beta chain, partial [Meles meles] 
 
Length=258 
                                                                      Score     E 
Sequences producing significant alignments:                          (Bits)  Value 
 
Unigene27967_All  155 928 minus strand MHC class II antigen DR be...  493     2e-170 
Unigene75450_All  119 892 minus strand MHC class II antigen DR be...  440     1e-149 
CL4065.Contig3_All  1603 2295 minus strand MHC class II antigen D...  412     2e-139 
Unigene75449_All  155 928 minus strand MHC class II antigen [Zalo...  414     2e-139 
Unigene57188_All  98 892 minus strand MHC class II antigen [Zalop...  361     2e-118 
Unigene67843_All  95 745 minus strand MHC class II antigen DQ bet...  317     8e-103 
CL6815.Contig2_All  88 882 minus strand PREDICTED: HLA class II h...  299     1e-94  
CL6815.Contig5_All  88 906 minus strand PREDICTED: HLA class II h...  299     3e-94  
CL6815.Contig3_All  88 843 minus strand PREDICTED: HLA class II h...  297     6e-94  




Query_25            1    GSWMTALTVILMVLSPPMAWARDTPPHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene27967_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene75450_All    1    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  60 
CL4065.Contig3_All  1                               FVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  33 
Unigene75449_All    1    GAWMTALTLILMVLSPPLAWARDTPRHFLFLTTSECHFTNGTERVRFLDRYFYNGEEYVR  60 
Unigene57188_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
Unigene67843_All    8    GLWTAAVMAILVVLSVPVAEGRDSPKDFVFQFKGECYFTNGTERVRSVNRYIYNREEFVR  67 
CL6815.Contig2_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig5_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig3_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
CL6815.Contig6_All  8      WTVVLLVSVIRLDSSRTQGRDSPEDFVIQAKADCYFINGTEKVQFVVRFIFNLEEYAR  65 
 
Query_25            61   FDSDVGEYRPVTELGRPIAQGWNSQKDIMEQKRANVDTYCRHNYGVGESFTVQRRVEPTV  120 
Unigene27967_All    61   FDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
Unigene75450_All    61   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  120 
CL4065.Contig3_All  34   YDSDVGEYRPVTELGRPDAQYWNSQKDIMERRRAAVDTYCRHNYGVVESFLVQRRVEPTV  93 
Unigene75449_All    61   FDSDVGEYRPVTELGRPDAEYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  120 
Unigene57188_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
Unigene67843_All    68   YDSDVGEYRPVTELGRPDAQYWNSQKDILERTEAETDTVCRHNYLTDESFTVQRRVEPTV  127 
CL6815.Contig2_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig5_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig3_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
CL6815.Contig6_All  66   FDSHVGKFVALTELGKPDAELWNHRPDILERSRASVDALCRHNYKLGAPFTVGRKVQPEV  125 
 
Query_25            121  TVYPAKNQPLQHHSLLVCSVNGFYPGHIEVRWYQNGQEEESGVVSTGLIHNGDWTFQTLV  180 
Unigene27967_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
Unigene75450_All    121  TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  180 
CL4065.Contig3_All  94   TVYPAKNQPLQHHNLLVCSVNGFYPGHIEVRWFRNGQEEESGVVSTGLIRNGDWTFQTLV  153 
Unigene75449_All    121  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  180 
Unigene57188_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
Unigene67843_All    128  TISPSRTEVLNHHNMLVCSVTDFYPGQIKVRWFRNDQEEKAGVVSTPLIRNGDWTFQILV  187 
CL6815.Contig2_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig5_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig3_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
CL6815.Contig6_All  126  AVHPERTPSLQHRSLLFCSVTGFYPGDIKIRWFRNGQEQRVGVLSTGLVRNGDWTFQTMV  185 
 
Query_25            181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene27967_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
Unigene75450_All    181  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  240 
CL4065.Contig3_All  154  MLETVPQSGEVYTCQVEHPSLTSPVTVEWRAQSGSAQSKILSGTGGFVLGLLFLVVGLFI  213 
Unigene75449_All    181  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  240 
 268 
 
Unigene57188_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIV  247 
Unigene67843_All    188  MLEMTPQRGDVYTCHVEHPSLQSPITVEWR                                217 
CL6815.Contig2_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig5_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig3_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWRAQSAYSWRKMLSGIAAFLIGLIFVLVGTVI  245 
CL6815.Contig6_All  186  MLEMTPALGDVYTCLVNHVSLLSPVSVEWR                                215 
 
Query_25            241  YFRNQKGHSGLQPTGLLS  258 
Unigene27967_All    241  YFRNQKGHSGLQPTGLLS  258 
Unigene75450_All    241  YFRNQKGHSGLQPTGLLS  258 
CL4065.Contig3_All  214  YFRNQKGHSGLQPTGLLS  231 
Unigene75449_All    241  RHRSQKGPRGSPPAGLL   257 
Unigene57188_All    248  RHRSQKGPRGSPPAGLL   264 
CL6815.Contig2_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig5_All  246  CLRAQKGYAETRLSG     260 
CL6815.Contig3_All  246  CLRAQKG             252 
 
 
Lambda      K        H        a         alpha 
   0.338    0.193    0.800    0.443     1.38  
 
Gapped 
Lambda      K        H        a         alpha    sigma 
   0.290   0.0750    0.280     1.04     11.5     12.3  
 
Effective search space used: 4333524636 
 
 
  Database: BLAST Database 
    Posted date:  Feb 23, 2017  2:08 PM 
  Number of letters in database: 28,354,467 





Gap Penalties: Existence: 10, Extension: 1 
Neighboring words threshold: 11 












1 WAS Wiskott-Aldrich syndrome protein. 421 
2 MME membrane metallo-endopeptidase. 295 
3 CD22 CD22 molecule. 295 
4 CD2 CD2 molecule. 273 
5 TMC8 EVIN2. 187 
6 IL12RB1 interleukin 12 receptor, beta 1 isoform 1 precursor. 171 
7 TRAF3 TNF receptor-associated factor 3 isoform 1. 151 




v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 
isoform 1 precursor. 
126 
10 CD19 CD19 antigen. 112 
11 CD44 CD44 antigen isoform 5 precursor. 109 
12 CD46 CD46 antigen, complement regulatory protein isoform 12 precursor. 107 
13 ADAM17 ADAM metallopeptidase domain 17 preproprotein. 106 
14 C4B complement component 4B preproprotein. 97 
15 RFX1 regulatory factor X1. 97 
16 ITGA5 integrin alpha 5 precursor. 88 
17 DKC1 dyskerin. 88 
18 CD5 CD5 molecule. 87 
19 BLNK B-cell linker. 86 
20 STAT3 signal transducer and activator of transcription 3 isoform 2. 84 
21 STAT4 signal transducer and activator of transcription 4. 82 
22 FGFR1 fibroblast growth factor receptor 1 isoform 2 precursor. 80 
23 NFATC1 nuclear factor of activated T-cells, cytosolic component 1 isoform B. 77 
24 NCF1C neutrophil cytosolic factor 1 isoform 1. 76 
25 STAT6 signal transducer and activator of transcription 6. 76 
26 UNC13D unc-13 homolog D. 74 
27 MR1 major histocompatibility complex, class I-related. 69 
28 TCIRG1 T-cell, immune regulator 1 isoform a. 67 
29 TCF7 transcription factor 7 (T-cell specific, HMG-box) isoform 1. 64 
30 CD4 CD4 antigen precursor. 63 
31 JAK3 Janus kinase 3. 59 
32 CD69 CD69 molecule. 58 
33 TCF3 transcription factor 3. 58 
34 IKBKE IKK-related kinase epsilon. 58 
35 CLCN7 chloride channel 7. 55 
36 CD2BP2 CD2 antigen (cytoplasmic tail) binding protein 2. 53 
37 CD300A leukocyte membrane antigen. 53 
38 TNFRSF14 tumor necrosis factor receptor superfamily, member 14 precursor. 53 
39 HAMP hepcidin antimicrobial peptide. 53 
40 CD80 CD80 antigen precursor. 52 
41 CD226 CD226 molecule. 52 
42 IL21R interleukin 21 receptor precursor. 52 
43 CD151 CD151 antigen. 51 
44 CCR1 chemokine (C-C motif) receptor 1. 51 
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45 CIITA class II transactivator. 51 
46 CD40 CD40 antigen isoform 2 precursor. 50 
47 TMC6 EVIN1. 50 
48 SP110 SP110 nuclear body protein isoform a. 49 
49 MVK mevalonate kinase. 49 
50 IGSF8 immunoglobulin superfamily, member 8. 48 
51 CCR2 chemokine (C-C motif) receptor 2 isoform A. 48 
52 NCF2 neutrophil cytosolic factor 2. 48 
53 WIPF1 WAS/WASL interacting protein family, member 1. 48 
54 CD1C CD1C antigen precursor. 47 
55 ITGA6 integrin alpha chain, alpha 6 isoform b precursor. 47 
56 CD97 CD97 antigen isoform 3 precursor. 47 
57 CD33 CD33 antigen (gp67) isoform 1 precursor. 45 
58 TRAF5 TNF receptor-associated factor 5. 45 
59 CASP8 caspase 8 isoform A precursor. 44 
60 CRLF3 cytokine receptor-like factor 3. 44 
61 IL3RA interleukin 3 receptor, alpha precursor. 44 
62 TAP1 transporter 1, ATP-binding cassette, sub-family B. 43 
63 TBX21 T-box 21. 43 
64 ABCF1 ATP-binding cassette, sub-family F, member 1 isoform a. 43 
65 IGF2R insulin-like growth factor 2 receptor precursor. 42 
66 PPP3CC 
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma 
isoform (calcineurin A gamma). 
42 
67 IRF5 interferon regulatory factor 5 isoform a. 41 
68 IFNGR1 interferon gamma receptor 1. 40 
69 IKBKB 
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase 
beta. 
40 
70 SIGIRR single Ig IL-1R-related molecule. 39 
71 CD7 CD7 antigen precursor. 38 
72 JAK2 Janus kinase 2. 38 
73 CEACAM1 
carcinoembryonic antigen-related cell adhesion molecule 1 isoform 1 
precursor. 
37 
74 CD86 CD86 antigen isoform 2 precursor. 37 
75 FYN protein-tyrosine kinase fyn isoform a. 37 
76 PSIP1 PC4 and SFRS1 interacting protein 1 isoform 1. 37 
77 LAX1 lymphocyte transmembrane adaptor 1. 37 
78 STAT2 signal transducer and activator of transcription 2. 36 
79 LPIN2 lipin 2. 36 
80 CD48 CD48 molecule. 35 
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81 IRF2 interferon regulatory factor 2. 34 
82 FOXK2 forkhead box K2. 34 
83 PLK3 polo-like kinase 3. 34 
84 SEMA7A semaphorin 7A. 33 
85 TNFRSF4 tumor necrosis factor receptor superfamily, member 4 precursor. 33 
86 PPIA peptidylprolyl isomerase A. 33 
87 HPS3 Hermansky-Pudlak syndrome 3 protein. 33 
88 MYO5A myosin VA (heavy polypeptide 12, myoxin). 33 
89 FAS 
tumor necrosis factor receptor superfamily, member 6 isoform 1 
precursor. 
32 
90 DCLRE1C artemis protein isoform a. 32 
91 DOCK2 dedicator of cytokinesis 2. 32 
92 STAT5B signal transducer and activator of transcription 5B. 32 
93 SEMA4D semaphorin 4D. 31 
94 CD163 CD163 antigen isoform a. 31 
95 LY9 lymphocyte antigen 9 isoform b. 31 
96 FOXP3 forkhead box P3. 31 
97 IL12RB2 interleukin 12 receptor, beta 2 precursor. 31 
98 IRAK1 interleukin-1 receptor-associated kinase 1 isoform 2. 30 
99 SH2B2 SH2B adaptor protein 2. 30 
100 RELB reticuloendotheliosis viral oncogene homolog B. 30 
101 TNFRSF1A tumor necrosis factor receptor 1 precursor. 29 
102 IL6R interleukin 6 receptor isoform 1 precursor. 29 
103 JMJD6 jumonji domain containing 6 isoform 2. 29 
104 TYK2 tyrosine kinase 2. 29 
105 RIPK1 receptor (TNFRSF)-interacting serine-threonine kinase 1. 29 
106 ZAP70 zeta-chain associated protein kinase 70kDa isoform 1. 29 
107 IRAK3 interleukin-1 receptor-associated kinase 3. 29 
108 DDR1 discoidin domain receptor family, member 1 isoform b. 28 
109 IRF8 interferon regulatory factor 8. 28 
110 CD27 tumor necrosis factor receptor superfamily, member 7 precursor. 27 
111 FLT3 fms-related tyrosine kinase 3. 27 
112 STAT1 signal transducer and activator of transcription 1 isoform alpha. 27 
113 MX1 myxovirus resistance protein 1. 27 
114 ITGAV integrin alpha-V precursor. 26 
115 PLAUR plasminogen activator, urokinase receptor isoform 1 precursor. 26 
116 CCR5 chemokine (C-C motif) receptor 5. 26 
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117 CD200 CD200 antigen isoform b. 26 
118 C1QBP 
complement component 1, q subcomponent binding protein 
precursor. 
26 
119 IL18 interleukin 18 proprotein. 26 
120 ITGAX PREDICTED: similar to integrin alpha X precursor. 25 
121 CD83 CD83 antigen isoform b. 25 
122 CD99 CD99 molecule. 25 
123 ALCAM activated leukocyte cell adhesion molecule. 25 
124 PRNP prion protein preproprotein. 25 
125 CLIP1 restin isoform a. 25 
126 PAFAH1B1 




protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform 
(calcineurin A beta). 
25 
128 TRAF2 TNF receptor-associated factor 2. 25 
129 FANCD2 Fanconi anemia complementation group D2 isoform b. 25 
130 NRAS neuroblastoma RAS viral (v-ras) oncogene homolog. 25 
131 CSF2RB 
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-
macrophage). 
24 
132 SDC1 syndecan 1 precursor. 24 
133 ATM ataxia telangiectasia mutated protein isoform 1. 24 
134 MAPK14 mitogen-activated protein kinase 14 isoform 1. 24 
135 CD1A CD1A antigen precursor. 23 
136 ICAM3 intercellular adhesion molecule 3 precursor. 23 
137 PTPRJ protein tyrosine phosphatase, receptor type, J isoform 1 precursor. 23 
138 IL17RA interleukin 17A receptor precursor. 23 
139 CLIP2 CAP-GLY domain containing linker protein 2 isoform 1. 23 
140 IL16 interleukin 16 isoform 1 precursor. 23 
141 PSME1 proteasome activator subunit 1 isoform 1. 23 
142 TRAF4 TNF receptor-associated factor 4. 23 
143 CD53 CD53 antigen. 22 
144 XRCC5 ATP-dependent DNA helicase II. 22 
145 CSF1 colony stimulating factor 1 isoform a precursor. 22 
146 FGFR3 fibroblast growth factor receptor 3 isoform 1 precursor. 22 
147 IL28RA interleukin 28 receptor, alpha isoform 1. 22 
148 NFATC2 
nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 2 isoform B. 
21 
149 CASP10 caspase 10 isoform a preproprotein. 21 
150 BANK1 B-cell scaffold protein with ankyrin repeats 1 isoform 1. 21 
151 CLU clusterin isoform 1. 21 
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152 CSF2RA colony stimulating factor 2 receptor alpha chain isoform a precursor. 21 
153 IL15RA interleukin 15 receptor, alpha isoform 1 precursor. 21 
154 TNFRSF18 
tumor necrosis factor receptor superfamily, member 18 isoform 1 
precursor. 
21 
155 CD1E CD1E antigen isoform a precursor. 20 
156 CD6 CD6 molecule. 20 
157 CD36 CD36 antigen. 20 
158 CD37 CD37 antigen isoform B. 20 
159 CD47 CD47 antigen isoform 1 precursor. 20 
160 IL1R1 interleukin 1 receptor, type I precursor. 20 
161 CD244 CD244 natural killer cell receptor 2B4. 20 
162 TLR2 toll-like receptor 2. 20 
163 PLAA phospholipase A2-activating protein isoform 1. 20 
164 LIG1 DNA ligase I. 20 
165 CHUK conserved helix-loop-helix ubiquitous kinase. 20 
166 ILF3 interleukin enhancer binding factor 3 isoform b. 20 
167 ZEB1 zinc finger E-box binding homeobox 1. 20 
168 TLR3 toll-like receptor 3. 20 
169 MLPH melanophilin isoform 1. 20 
170 CD28 CD28 antigen. 19 
171 ICAM2 intercellular adhesion molecule 2 precursor. 19 
172 CD300C CD300C antigen. 19 
173 MRE11A meiotic recombination 11 homolog A isoform 2. 19 
174 MYD88 myeloid differentiation primary response gene (88). 19 
175 GFI1 growth factor independent 1. 19 
176 CD1B CD1B antigen precursor. 18 
177 ST6GAL1 sialyltransferase 1 isoform a. 18 
178 CD84 CD84 molecule. 18 
179 IGF1R insulin-like growth factor 1 receptor precursor. 18 
180 EMR3 egf-like module-containing mucin-like receptor 3. 18 
181 RFXANK regulatory factor X-associated ankyrin-containing protein isoform a. 18 
182 FCRL5 Fc receptor-like 5. 18 
183 FANCA Fanconi anemia, complementation group A isoform a. 18 
184 PTPN22 
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) 
isoform 2. 
17 
185 ITGA1 integrin, alpha 1 precursor. 17 
186 CD9 CD9 antigen. 16 
187 ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 isoform 1. 16 
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188 NT5E 5` nucleotidase, ecto. 16 
189 TNFRSF1B tumor necrosis factor receptor 2 precursor. 16 
190 MUC1 mucin 1 isoform 2 precursor. 16 
191 CXCL16 chemokine (C-X-C motif) ligand 16. 16 
192 PSMB8 proteasome beta 8 subunit isoform E1 proprotein. 16 
193 RAG1 recombination activating gene 1. 16 
194 PAFAH2 platelet-activating factor acetylhydrolase 2. 16 
195 ANP32B acidic (leucine-rich) nuclear phosphoprotein 32 family, member B. 16 
196 LCK lymphocyte-specific protein tyrosine kinase precursor. 16 
197 PIK3CG phosphoinositide-3-kinase, catalytic, gamma polypeptide. 16 
198 SLAMF6 activating NK receptor precursor. 16 
199 PSMF1 proteasome inhibitor subunit 1. 16 
200 HAX1 HCLS1 associated protein X-1 isoform b. 16 
201 CD1D CD1D antigen precursor. 15 
202 SIGLEC5 sialic acid binding Ig-like lectin 5. 15 
203 SPN sialophorin. 15 
204 LY75 lymphocyte antigen 75. 15 
205 CCR6 chemokine (C-C motif) receptor 6. 15 
206 TRADD TNFRSF1A-associated via death domain. 15 
207 IRF9 interferon-stimulated transcription factor 3, gamma 48kDa. 15 
208 IL1B interleukin 1, beta proprotein. 15 
209 IL1F10 interleukin 1 family, member 10. 15 
210 ITGAD integrin, alpha D precursor. 15 
211 CD8A CD8 antigen alpha polypeptide isoform 1 precursor. 14 
212 FCER2 Fc fragment of IgE, low affinity II, receptor for (CD23A). 14 
213 IL2RA interleukin 2 receptor, alpha chain precursor. 14 
214 ITGA2 integrin alpha 2 precursor. 14 
215 SELP selectin P precursor. 14 
216 CD72 CD72 molecule. 14 
217 CD81 CD81 antigen. 14 
218 CSF1R colony stimulating factor 1 receptor precursor. 14 
219 C2 complement component 2 precursor. 14 
220 SIRPA signal-regulatory protein alpha precursor. 14 
221 NFATC3 cytoplasmic nuclear factor of activated T-cells 3 isoform 2. 14 
222 EBF1 early B-cell factor. 14 




inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase 
gamma. 
14 
225 PARP1 poly (ADP-ribose) polymerase family, member 1. 14 
226 IL17RB interleukin 17B receptor precursor. 14 
227 LITAF lipopolysaccharide-induced TNF factor. 14 
228 SOCS7 suppressor of cytokine signaling 7. 14 
229 TRAF7 ring finger and WD repeat domain 1. 14 
230 TSPYL2 TSPY-like 2. 14 
231 MEFV Mediterranean fever protein. 14 
232 UNC93B1 unc-93 homolog B1. 14 
233 SIGLEC6 sialic acid binding Ig-like lectin 6 isoform 1 precursor. 13 
234 CD164 CD164 molecule, sialomucin. 13 
235 MASP2 mannan-binding lectin serine protease 2 isoform 1 precursor. 13 
236 LTB lymphotoxin-beta isoform a. 13 
237 ADA adenosine deaminase. 13 
238 G6PD glucose-6-phosphate dehydrogenase isoform a. 13 
239 TNFRSF13C BAFF receptor. 13 
240 MICB MHC class I polypeptide-related sequence B. 13 
241 LIG4 DNA ligase IV. 13 
242 C1R complement component 1, r subcomponent. 13 
243 PSMB7 proteasome beta 7 subunit proprotein. 13 
244 IL27RA class I cytokine receptor. 13 
245 ADAM10 ADAM metallopeptidase domain 10. 13 
246 BTLA B and T lymphocyte associated isoform 1. 13 
247 CASP1 caspase 1 isoform beta precursor. 13 
248 CD2AP CD2-associated protein. 13 
249 CKLF chemokine-like factor isoform e. 13 
250 IL1RAP interleukin 1 receptor accessory protein isoform 1. 13 
251 TRAF1 TNF receptor-associated factor 1. 13 
252 TAZ tafazzin isoform 1. 13 
253 TFRC transferrin receptor. 12 
254 KLRD1 killer cell lectin-like receptor subfamily D, member 1 isoform 1. 12 
255 TNFRSF13B tumor necrosis factor receptor 13B. 12 
256 RFX5 regulatory factor X, 5. 12 
257 UNG uracil-DNA glycosylase isoform UNG1 precursor. 12 
258 HLA-DMB major histocompatibility complex, class II, DM beta precursor. 12 
259 CD248 tumor endothelial marker 1 precursor. 12 
 276 
 
260 ERGIC2 PTX1 protein. 12 
261 IL17RD interleukin 17 receptor D isoform hSef-b. 12 
262 MRC2 mannose receptor, C type 2. 12 
263 DNMT3B DNA cytosine-5 methyltransferase 3 beta isoform 1. 12 
264 CD55 decay accelerating factor for complement. 11 
265 CD96 CD96 antigen isoform 2 precursor. 11 
266 IL4R interleukin 4 receptor alpha chain isoform a precursor. 11 
267 SMARCAL1 
SWI/SNF-related matrix-associated actin-dependent regulator of 
chromatin a-like 1. 
11 
268 CLEC12A myeloid inhibitory C-type lectin-like receptor isoform alpha. 11 
269 SH2D1A SH2 domain protein 1A. 11 
270 LAIR1 
leukocyte-associated immunoglobulin-like receptor 1 isoform a 
precursor. 
11 
271 AP3B1 adaptor-related protein complex 3, beta 1 subunit. 11 
272 CR1 complement receptor 1 isoform S precursor. 10 
273 ITGB3 integrin beta chain, beta 3 precursor. 10 
274 CD79A CD79A antigen isoform 2 precursor. 10 
275 CD82 CD82 antigen isoform 2. 10 
276 SLC44A1 CDW92 antigen. 10 
277 ITGB4 integrin beta 4 isoform 1 precursor. 10 
278 LAMP2 lysosomal-associated membrane protein 2 precursor. 10 
279 IL7R interleukin 7 receptor precursor. 10 
280 IL6ST interleukin 6 signal transducer isoform 1 precursor. 10 
281 PDGFRB platelet-derived growth factor receptor beta precursor. 10 
282 BLM Bloom syndrome protein. 10 
283 LILRB2 
leukocyte immunoglobulin-like receptor, subfamily B, member 2 
isoform 1. 
10 
284 CAMP cathelicidin antimicrobial peptide. 10 
285 TLR1 toll-like receptor 1. 10 
286 LTF lactotransferrin. 10 
287 IFI27 interferon, alpha-inducible protein 27. 10 
288 NFKBIA 
nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor, alpha. 
10 
289 TOLLIP toll interacting protein. 10 
290 CD99L2 CD99 antigen-like 2 isoform E3`-E4`-E3-E4. 10 
291 IL18RAP interleukin 18 receptor accessory protein precursor. 10 
292 IL32 interleukin 32 isoform B. 10 
293 ILF2 interleukin enhancer binding factor 2. 10 
294 LILRB3 





295 NCR3 natural cytotoxicity triggering receptor 3. 10 
296 CD8B CD8b antigen isoform 5 precursor. 9 
297 MS4A1 membrane-spanning 4-domains, subfamily A, member 1. 9 
298 CD68 CD68 antigen isoform B. 9 
299 CD74 CD74 antigen isoform a. 9 
300 IKBKAP 
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase 
complex-associated protein. 
9 
301 CTSS cathepsin S preproprotein. 9 
302 A2M alpha-2-macroglobulin precursor. 9 
303 ICOS inducible T-cell co-stimulator precursor. 9 
304 ULBP1 UL16 binding protein 1. 9 
305 NOD2 nucleotide-binding oligomerization domain containing 2. 9 
306 CD24 CD24 antigen precursor. 9 
307 CD276 CD276 antigen isoform a. 9 
308 CD302 CD302 molecule. 9 
309 CLCF1 cardiotrophin-like cytokine factor 1. 9 
310 IL17RE interleukin 17 receptor E isoform 1. 9 
311 ISG20 interferon stimulated exonuclease gene 20kDa. 9 
312 NFIL3 nuclear factor, interleukin 3 regulated. 9 
313 RAB27A Ras-related protein Rab-27A. 9 
314 SBDS Shwachman-Bodian-Diamond syndrome protein. 9 
315 NLRP3 NLR family, pyrin domain containing 3 isoform a. 9 
316 ITGAM integrin alpha M precursor. 8 
317 PTPRC protein tyrosine phosphatase, receptor type, C isoform 4. 8 
318 SELL selectin L precursor. 8 
319 CD63 CD63 antigen isoform B. 8 
320 ITGAE integrin, alpha E precursor. 8 
321 ENG endoglin precursor. 8 
322 CSF3R colony stimulating factor 3 receptor isoform a precursor. 8 
323 SLAMF1 signaling lymphocytic activation molecule family member 1. 8 
324 MFI2 melanoma-associated antigen p97 isoform 1, precursor. 8 
325 CCR3 CC chemokine receptor 3. 8 
326 WASF1 Wiskott-Aldrich syndrome protein family member 1. 8 
327 JAK1 janus kinase 1. 8 
328 NDUFS3 
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-
coenzyme Q reductase). 
8 
329 SDF2 stromal cell-derived factor 2 precursor. 8 
330 CCR4 chemokine (C-C motif) receptor 4. 8 
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331 HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 precursor. 8 
332 IFIT1 
interferon-induced protein with tetratricopeptide repeats 1 isoform 
2. 
8 
333 IRF1 interferon regulatory factor 1. 8 
334 PSMB6 proteasome beta 6 subunit. 8 
335 CD300LG CD300 molecule-like family member g. 8 
336 CD320 8D6 antigen. 8 
337 SCARB1 scavenger receptor class B, member 1 isoform 1. 7 
338 CD40LG CD40 ligand. 7 
339 LRP1 low density lipoprotein-related protein 1. 7 
340 IL2RB interleukin 2 receptor beta precursor. 7 
341 ACE angiotensin I converting enzyme isoform 1 precursor. 7 
342 CTLA4 cytotoxic T-lymphocyte-associated protein 4 isoform b precursor. 7 
343 CD160 CD160 antigen. 7 
344 L1CAM L1 cell adhesion molecule isoform 1 precursor. 7 
345 VPREB1 immunoglobulin iota chain preproprotein. 7 
346 MSR1 macrophage scavenger receptor 1 isoform type 2. 7 
347 ABCB1 ATP-binding cassette sub-family B member 1. 7 
348 CCRN4L CCR4 carbon catabolite repression 4-like. 7 
349 IL10 interleukin 10 precursor. 7 
350 NP purine nucleoside phosphorylase. 7 
351 C8G complement component 8, gamma polypeptide. 7 
352 RAC2 ras-related C3 botulinum toxin substrate 2. 7 
353 CFH complement factor H isoform a precursor. 7 
354 HLA-DOA major histocompatibility complex, class II, DO alpha precursor. 7 
355 IFI35 interferon-induced protein 35. 7 
356 IL1A interleukin 1, alpha proprotein. 7 
357 IL15 interleukin 15 preproprotein. 7 
358 IL18R1 interleukin 18 receptor 1 precursor. 7 
359 BATF basic leucine zipper transcription factor, ATF-like. 7 
360 IFI44L histocompatibility 28. 7 
361 TAP2 transporter 2, ATP-binding cassette, sub-family B isoform 1. 7 
362 C6 Complement component 6 precursor. 7 
363 CCRL2 chemokine (C-C motif) receptor-like 2. 7 
364 CD200R1 CD200 receptor 1 isoform a. 7 
365 CD300E CD300e molecule. 7 
366 CD300LF NK inhibitory receptor precursor. 7 
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367 CX3CR1 chemokine (C-X3-C motif) receptor 1. 7 
368 IL17D interleukin 17D precursor. 7 
369 SOCS2 suppressor of cytokine signaling-2. 7 
370 SOCS4 suppressor of cytokine signaling 4. 7 
371 CD3E CD3E antigen, epsilon polypeptide (TiT3 complex). 6 
372 PTGFRN prostaglandin F2 receptor negative regulator. 6 
373 ITGAL integrin alpha L precursor. 6 
374 CD70 tumor necrosis factor ligand superfamily, member 7. 6 
375 TNFSF8 tumor necrosis factor (ligand) superfamily, member 8. 6 
376 PECAM1 platelet/endothelial cell adhesion molecule (CD31 antigen). 6 
377 ITGA4 integrin alpha 4 precursor. 6 
378 ICAM1 intercellular adhesion molecule 1 precursor. 6 
379 CD59 CD59 antigen p18-20. 6 
380 SLC7A5 
solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 5. 
6 
381 PVRL2 poliovirus receptor related 2 isoform alpha precursor. 6 
382 IL5RA interleukin 5 receptor, alpha isoform 1 precursor. 6 
383 MST1R macrophage stimulating 1 receptor. 6 
384 CD180 CD180 molecule. 6 
385 CD209 CD209 molecule. 6 
386 INSR insulin receptor isoform Long precursor. 6 
387 PLXNC1 plexin C1. 6 
388 GYPA glycophorin A precursor. 6 
389 CXCL1 chemokine (C-X-C motif) ligand 1. 6 
390 IL8 interleukin 8 precursor. 6 
391 KLRK1 NKG2-D type II integral membrane protein. 6 
392 IFNAR2 interferon alpha/beta receptor 2 isoform b precursor. 6 
393 ICOSLG inducible T-cell co-stimulator ligand. 6 
394 NPTN neuroplastin isoform b precursor. 6 
395 EBI2 EBV-induced G protein-coupled receptor 2. 6 
396 HLA-DOB major histocompatibility complex, class II, DO beta precursor. 6 
397 HRH2 histamine receptor H2. 6 
398 IL19 interleukin 19 isoform 2 precursor. 6 
399 IL20 interleukin 20 precursor. 6 
400 HSP90B1 tumor rejection antigen (gp96) 1. 6 
401 FCRLA Fc receptor-like and mucin-like 1. 6 
402 IL11RA interleukin 11 receptor, alpha isoform 1 precursor. 6 
 280 
 
403 IL18BP interleukin 18 binding protein precursor. 6 
404 SOCS6 suppressor of cytokine signaling 6. 6 
405 TNFSF10 tumor necrosis factor (ligand) superfamily, member 10. 6 
406 TRAF3IP1 TNF receptor-associated factor 3 interacting protein 1. 6 
407 CD5L CD5 molecule-like. 5 
408 CD14 CD14 antigen precursor. 5 
409 ITGB2 integrin, beta 2 precursor. 5 
410 CD34 CD34 antigen isoform a. 5 
411 SCARB2 scavenger receptor class B, member 2. 5 
412 CEACAM8 carcinoembryonic antigen-related cell adhesion molecule 8. 5 
413 CD93 CD93 antigen precursor. 5 
414 FASLG fas ligand. 5 
415 HMMR hyaluronan-mediated motility receptor isoform a. 5 
416 CXCR4 chemokine (C-X-C motif) receptor 4 isoform a. 5 
417 CCR9 chemokine (C-C motif) receptor 9 isoform B. 5 
418 CCL3 chemokine (C-C motif) ligand 3. 5 
419 ENC1 ectodermal-neural cortex (with BTB-like domain). 5 
420 CFB complement factor B preproprotein. 5 
421 CASP2 caspase 2 isoform 1 preproprotein. 5 
422 CASP7 caspase 7 isoform alpha precursor. 5 
423 TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b. 5 
424 PSMB9 proteasome beta 9 subunit isoform 1 proprotein. 5 
425 C1QB complement component 1, q subcomponent, B chain precursor. 5 
426 AICDA activation-induced cytidine deaminase. 5 
427 PLA2R1 phospholipase A2 receptor 1 isoform 2 precursor. 5 
428 PAFAH1B2 
platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 
30kDa. 
5 
429 CFP complement factor properdin. 5 
430 CYSLTR1 cysteinyl leukotriene receptor 1. 5 
431 GUSB glucuronidase, beta. 5 
432 FCER1G 
Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide 
precursor. 
5 
433 IFIT2 interferon-induced protein with tetratricopeptide repeats 2. 5 
434 PSME3 proteasome activator subunit 3 isoform 1. 5 
435 CLEC5A C-type lectin, superfamily member 5. 5 
436 IL12A interleukin 12A precursor. 5 
437 PSME2 proteasome activator subunit 2. 5 
438 TAL1 T-cell acute lymphocytic leukemia 1. 5 
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439 C1RL complement component 1, r subcomponent-like precursor. 5 
440 CCRL1 chemokine (C-C motif) receptor-like 1. 5 
441 CXCR6 G protein-coupled receptor TYMSTR. 5 
442 IL17C interleukin 17C. 5 
443 IRAK1BP1 interleukin-1 receptor-associated kinase 1 binding protein 1. 5 
444 IRAK2 interleukin-1 receptor-associated kinase 2. 5 
445 LILRA5 
leukocyte immunoglobulin-like receptor subfamily A member 5 
isoform 1. 
5 
446 SLAMF7 SLAM family member 7. 5 
447 TICAM2 toll-like receptor adaptor molecule 2. 5 
448 TLR4 toll-like receptor 4 precursor. 5 
449 TLR5 toll-like receptor 5. 5 
450 TNFSF11 tumor necrosis factor ligand superfamily, member 11 isoform 1. 5 
451 CTSC cathepsin C isoform a preproprotein. 5 
452 FANCG Fanconi anemia, complementation group G. 5 
453 IFNGR2 interferon-gamma receptor beta chain precursor. 5 
454 FCGR3B 
low affinity immunoglobulin gamma Fc region receptor III-B 
precursor. 
4 
455 CR2 complement component (3d/Epstein Barr virus) receptor 2 isoform 2. 4 
456 ITGB1 integrin beta 1 isoform 1B precursor. 4 
457 GP1BA platelet glycoprotein Ib alpha polypeptide precursor. 4 
458 NCAM1 neural cell adhesion molecule 1 isoform 1. 4 
459 CD58 CD58 molecule. 4 
460 CD109 CD109. 4 
461 MPL myeloproliferative leukemia virus oncogene. 4 
462 PVRL1 poliovirus receptor-related 1 isoform 1. 4 
463 IL2RG interleukin 2 receptor, gamma precursor. 4 
464 KLRB1 killer cell lectin-like receptor subfamily B, member 1. 4 
465 SIGLEC1 sialoadhesin precursor. 4 
466 LAMP3 lysosomal-associated membrane protein 3. 4 
467 IL13RA1 interleukin 13 receptor, alpha 1 precursor. 4 
468 KEL Kell blood group, metallo-endopeptidase. 4 
469 CCL4 chemokine C-C motif ligand 4 isoform 1 precursor. 4 
470 CCL27 small inducible cytokine A27 precursor. 4 
471 CCL28 chemokine (C-C motif) ligand 28 precursor. 4 
472 IL9 interleukin 9 precursor. 4 
473 CASP3 caspase 3 preproprotein. 4 




tyrosine 3/tryptophan 5 -monooxygenase activation protein, zeta 
polypeptide. 
4 
476 CFI complement factor I. 4 
477 MYLK myosin light chain kinase isoform 1. 4 
478 TCN2 transcobalamin II precursor. 4 
479 PDGFB platelet-derived growth factor beta isoform 1, preproprotein. 4 
480 SOD3 superoxide dismutase 3, extracellular precursor. 4 
481 TNF tumor necrosis factor alpha. 4 
482 RELA 
v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor 
of kappa light polypeptide gene enhancer in B-cells 3, p65. 
4 
483 PPP3CA 
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform 
(calcineurin A alpha). 
4 
484 IGJ immunoglobulin J chain. 4 
485 LCP2 lymphocyte cytosolic protein 2. 4 
486 PTAFR platelet-activating factor receptor. 4 
487 IL24 interleukin 24 isoform 1 precursor. 4 
488 IL1RN interleukin 1 receptor antagonist isoform 3. 4 
489 POU2AF1 POU domain, class 2, associating factor 1. 4 
490 LY86 MD-1, RP105-associated. 4 
491 C4BPB 
complement component 4 binding protein, beta chain isoform 1 
precursor. 
4 
492 CISH cytokine-inducible SH2-containing protein. 4 
493 CMTM7 CKLF-like MARVEL transmembrane domain containing 7 isoform a. 4 
494 IL10RA interleukin 10 receptor, alpha precursor. 4 
495 IL9R interleukin 9 receptor isoform 1 precursor. 4 
496 IRAK4 interleukin-1 receptor-associated kinase 4. 4 
497 ITFG1 integrin alpha FG-GAP repeat containing 1. 4 
498 LILRA6 leukocyte immunoglobulin-like receptor, subfamily A, member 6. 4 
499 SOCS1 suppressor of cytokine signaling 1. 4 
500 SOCS3 suppressor of cytokine signaling 3. 4 
501 SOCS5 suppressor of cytokine signaling 5. 4 
502 MAPBPIP mitogen-activated protein-binding protein-interacting protein. 4 
503 ANPEP membrane alanine aminopeptidase precursor. 3 
504 CD79B CD79B antigen isoform 1 precursor. 3 
505 IGSF2 immunoglobulin superfamily, member 2. 3 
506 THBD thrombomodulin precursor. 3 
507 CDH5 cadherin 5, type 2 preproprotein. 3 
508 BSG basigin isoform 1. 3 
509 TSPAN7 tetraspanin 7. 3 
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510 GYPC glycophorin C isoform 1. 3 
511 PF4 platelet factor 4 (chemokine (C-X-C motif) ligand 4). 3 
512 PRF1 perforin 1 precursor. 3 
513 GZMB granzyme B precursor. 3 
514 FADD Fas-associated via death domain. 3 
515 NBN nibrin isoform 2. 3 
516 C1QA complement component 1, q subcomponent, A chain precursor. 3 
517 NCR1 natural cytotoxicity triggering receptor 1. 3 
518 PAFAH1B3 
platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 
29kDa. 
3 
519 C3 complement component 3 precursor. 3 
520 HLA-B major histocompatibility complex, class I, B. 3 
521 HLA-DRA major histocompatibility complex, class II, DR alpha precursor. 3 
522 IFI16 interferon, gamma-inducible protein 16. 3 
523 IFIT3 interferon-induced protein with tetratricopeptide repeats 3. 3 
524 MIF 
macrophage migration inhibitory factor (glycosylation-inhibiting 
factor). 
3 
525 IL1F5 interleukin 1 family, member 5. 3 
526 IL1F8 interleukin 1 family, member 8 isoform 1. 3 
527 IL1F6 interleukin 1 family, member 6 (epsilon). 3 
528 CLEC4D C-type lectin domain family 4, member D. 3 
529 IL1F9 interleukin 1 family, member 9. 3 
530 CLEC7A dendritic cell-associated C-type lectin 1 isoform b. 3 
531 C1QL1 complement component 1, q subcomponent-like 1. 3 
532 C1QTNF6 C1q and tumor necrosis factor related protein 6. 3 
533 CMKLR1 chemokine-like receptor 1. 3 
534 CMTM6 CKLF-like MARVEL transmembrane domain containing 6. 3 
535 IFITM1 interferon induced transmembrane protein 1 (9-27). 3 
536 IL1F7 interleukin 1 family, member 7 isoform 1 proprotein. 3 
537 IL20RA interleukin 20 receptor, alpha. 3 
538 IL23A interleukin 23, alpha subunit p19 precursor. 3 
539 IL27 interleukin 27. 3 
540 IL4I1 interleukin 4 induced 1 isoform 1 precursor. 3 
541 PDCD1 programmed cell death 1 precursor. 3 
542 TLR9 toll-like receptor 9 isoform A precursor. 3 
543 TNFSF12 tumor necrosis factor (ligand) superfamily, member 12 precursor. 3 
544 FANCC Fanconi anemia, complementation group C. 3 
545 FANCE Fanconi anemia, complementation group E. 3 
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546 STX11 syntaxin 11. 3 
547 NHEJ1 nonhomologous end-joining factor 1. 3 
548 PSTPIP1 proline-serine-threonine phosphatase interacting protein 1. 2 
549 CD3D CD3D antigen, delta polypeptide isoform A precursor. 2 
550 CD3G CD3G gamma precursor. 2 
551 LTBR lymphotoxin beta receptor. 2 
552 TNFRSF8 tumor necrosis factor receptor superfamily, member 8 isoform 2. 2 
553 FCGR2B Fc fragment of IgG, low affinity IIb, receptor for (CD32) isoform 3. 2 
554 ITGA2B integrin alpha 2b preproprotein. 2 
555 GP9 glycoprotein IX (platelet). 2 
556 PTPRCAP protein tyrosine phosphatase, receptor type, C-associated protein. 2 
557 CD52 CD52 antigen. 2 
558 SELE selectin E precursor. 2 
559 FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64). 2 
560 CEACAM6 
carcinoembryonic antigen-related cell adhesion molecule 6 (non-
specific cross reacting antigen). 
2 
561 FCAR Fc alpha receptor isoform a precursor. 2 
562 LAMP1 lysosomal-associated membrane protein 1. 2 
563 IL1R2 interleukin 1 receptor, type II precursor. 2 
564 TNFSF4 tumor necrosis factor (ligand) superfamily, member 4. 2 
565 ADAM8 ADAM metallopeptidase domain 8 precursor. 2 
566 BST1 bone marrow stromal cell antigen 1 precursor. 2 
567 SELPLG selectin P ligand. 2 
568 CXCR3 chemokine (C-X-C motif) receptor 3. 2 
569 TEK TEK tyrosine kinase, endothelial precursor. 2 
570 SLC4A1 solute carrier family 4, anion exchanger, member 1. 2 
571 RHCE Rhesus blood group, CcEe antigens isoform 1. 2 
572 RHD Rh blood group D antigen. 2 
573 BLR1 Burkitt lymphoma receptor 1 isoform 1. 2 
574 CCR10 CC chemokine receptor 10. 2 
575 CCL5 small inducible cytokine A5 precursor. 2 
576 CCL14 chemokine (C-C motif) ligand 14 isoform 1 precursor. 2 
577 CCL23 small inducible cytokine A23 isoform CKbeta8-1 precursor. 2 
578 XCL1 chemokine (C motif) ligand 1. 2 
579 SCYE1 small inducible cytokine subfamily E, member 1. 2 
580 LIF leukemia inhibitory factor (cholinergic differentiation factor). 2 
581 CASP6 caspase 6 isoform alpha preproprotein. 2 
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582 GZMK granzyme K precursor. 2 
583 PSMB10 proteasome beta 10 subunit proprotein. 2 
584 PSMB5 proteasome beta 5 subunit. 2 
585 CANX calnexin precursor. 2 
586 TRAF6 TNF receptor-associated factor 6. 2 
587 LY96 MD-2 protein. 2 
588 HRH4 histamine H4 receptor. 2 
589 RFXAP regulatory factor X-associated protein. 2 
590 C4A complement component 4A preproprotein. 2 
591 MPO myeloperoxidase. 2 
592 TIMP1 tissue inhibitor of metalloproteinase 1 precursor. 2 
593 CEBPE CCAAT/enhancer binding protein epsilon. 2 
594 HLA-DMA major histocompatibility complex, class II, DM alpha precursor. 2 
595 SOD1 superoxide dismutase 1, soluble. 2 
596 TNFSF14 
tumor necrosis factor ligand superfamily, member 14 isoform 1 
precursor. 
2 
597 C1QC complement component 1, q subcomponent, gamma polypeptide. 2 
598 FCER1A 
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide 
precursor. 
2 
599 HLA-DPB1 major histocompatibility complex, class II, DP beta 1 precursor. 2 
600 BCAP31 B-cell receptor-associated protein 31. 2 
601 NCF4 neutrophil cytosolic factor 4 (40kD) isoform 1. 2 
602 B2M beta-2-microglobulin precursor. 2 
603 FCAMR Fc receptor, IgA, IgM, high affinity. 2 
604 PRDX6 peroxiredoxin 6. 2 
605 BST2 bone marrow stromal cell antigen 2. 2 
606 C1QL3 complement component 1, q subcomponent-like 3. 2 
607 C1QL4 complement component 1, q subcomponent-like 4. 2 
608 C1QTNF4 C1q and tumor necrosis factor related protein 4. 2 
609 C7 complement component 7 precursor. 2 
610 CD274 CD274 molecule. 2 
611 CD3EAP CD3E antigen, epsilon polypeptide associated protein. 2 
612 CXCR7 chemokine orphan receptor 1. 2 
613 CMTM3 chemokine-like factor superfamily 3. 2 
614 IL10RB interleukin 10 receptor, beta precursor. 2 
615 IL17RC interleukin 17 receptor C isoform 3 precursor. 2 
616 IL1RAPL1 interleukin 1 receptor accessory protein-like 1. 2 




leukocyte immunoglobulin-like receptor, subfamily A (with TM 
domain), member 2. 
2 
619 LTB4R leukotriene B4 receptor. 2 
620 PDCD1LG2 programmed cell death 1 ligand 2. 2 
621 SIVA1 CD27-binding (Siva) protein isoform 1. 2 
622 TNFRSF12A tumor necrosis factor receptor superfamily, member 12A. 2 
623 TNFSF15 tumor necrosis factor (ligand) superfamily, member 15. 2 
624 TTRAP TRAF and TNF receptor-associated protein. 2 
625 FANCB Fanconi anemia complementation group B. 2 
626 SPINK5 serine peptidase inhibitor, Kazal type 5 precursor. 2 
627 SLC35C1 solute carrier family 35, member C1. 2 
628 ORAI1 hypothetical protein LOC84876. 2 
629 FCGR3A Fc fragment of IgG, low affinity IIIa, receptor for (CD16). 1 
630 DPP4 dipeptidylpeptidase IV. 1 
631 ITGA3 integrin alpha 3 isoform b, precursor. 1 
632 C5AR1 complement component 5 receptor 1 (C5a ligand). 1 
633 SLC3A2 
solute carrier family 3 (activators of dibasic and neutral amino acid 
transport), member 2 isoform a. 
1 
634 IL8RB interleukin 8 receptor beta. 1 
635 PVR poliovirus receptor. 1 
636 KLRC1 killer cell lectin-like receptor subfamily C, member 1 isoform NKG2-A. 1 
637 CCR7 chemokine (C-C motif) receptor 7 precursor. 1 
638 PROCR endothelial protein C receptor precursor. 1 
639 MRC1 mannose receptor C type 1 precursor. 1 
640 LAG3 lymphocyte-activation protein 3 precursor. 1 
641 DARC Duffy blood group. 1 
642 ICAM4 intercellular adhesion molecule 4 isoform 3 precursor. 1 
643 CD247 T-cell receptor zeta chain isoform 2 precursor. 1 
644 CCR8 chemokine (C-C motif) receptor 8. 1 
645 CXCL2 chemokine (C-X-C motif) ligand 2. 1 
646 CXCL3 chemokine (C-X-C motif) ligand 3. 1 
647 PPBP pro-platelet basic protein precursor. 1 
648 CXCL12 
chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 
isoform beta. 
1 
649 CX3CL1 chemokine (C-X3-C motif) ligand 1. 1 
650 MBL2 soluble mannose-binding lectin precursor. 1 
651 IL4 interleukin 4 isoform 1 precursor. 1 




tumor necrosis factor ligand superfamily, member 13 isoform alpha 
proprotein. 
1 
654 TAPBP tapasin isoform 1 precursor. 1 
655 TIRAP 
Toll-interleukin 1 receptor domain-containing adaptor protein 
isoform a. 
1 
656 PGLYRP1 peptidoglycan recognition protein 1. 1 
657 TNFRSF17 tumor necrosis factor receptor superfamily, member 17. 1 
658 RAG2 recombination activating gene 2. 1 
659 BTK Bruton agammaglobulinemia tyrosine kinase. 1 
660 WASF3 WAS protein family, member 3. 1 
661 AIRE autoimmune regulator isoform 1. 1 
662 CYBB 
cytochrome b-245, beta polypeptide (chronic granulomatous 
disease). 
1 
663 CYBA cytochrome b, alpha polypeptide. 1 
664 C8A complement component 8, alpha polypeptide precursor. 1 
665 SERPING1 complement component 1 inhibitor precursor. 1 
666 LYZ lysozyme precursor. 1 
667 MARCO macrophage receptor with collagenous structure. 1 
668 CFD complement factor D preproprotein. 1 
669 IFNG interferon, gamma. 1 
670 LTB4R2 leukotriene B4 receptor 2. 1 
671 SDF2L1 stromal cell-derived factor 2-like 1 precursor. 1 
672 PPP3R1 protein phosphatase 3, regulatory subunit B, alpha isoform 1. 1 
673 PPP3R2 protein phosphatase 3 regulatory subunit B, beta isoform. 1 
674 FCGRT Fc fragment of IgG, receptor, transporter, alpha. 1 
675 HLA-A major histocompatibility complex, class I, A precursor. 1 
676 HLA-C major histocompatibility complex, class I, C precursor. 1 
677 HLA-DPA1 major histocompatibility complex, class II, DP alpha 1 precursor. 1 
678 HLA-F major histocompatibility complex, class I, F isoform 2 precursor. 1 
679 PRSS16 protease, serine, 16. 1 
680 A2ML1 alpha-2-macroglobulin-like 1. 1 
681 IL23R interleukin 23 receptor precursor. 1 
682 CADM2 immunoglobulin superfamily, member 4D. 1 
683 PILRA 
paired immunoglobulin-like type 2 receptor alpha isoform 1 
precursor. 
1 
684 S100A8 S100 calcium-binding protein A8. 1 
685 C5 complement component 5. 1 
686 C9 complement component 9. 1 
687 COLEC12 collectin sub-family member 12. 1 
 288 
 
688 C4BPA complement component 4 binding protein, alpha chain precursor. 1 
689 CR1L complement component (3b/4b) receptor 1-like. 1 
690 CRLF1 cytokine receptor-like factor 1. 1 
691 KIR2DL4 
killer cell immunoglobulin-like receptor, two domains, long 
cytoplasmic tail, 4 isoform a. 
1 
692 KIR3DL2 
killer cell immunoglobulin-like receptor, three domains, long 
cytoplasmic tail, 2 precursor. 
1 
693 TNFRSF11A tumor necrosis factor receptor superfamily, member 11a precursor. 1 
694 XCR1 XC chemokine receptor 1. 1 
695 FANCF Fanconi anemia, complementation group F. 1 
696 IGHG2 immunoglobulin gamma-2 heavy chain. 1 
697 OSTM1 osteopetrosis associated transmembrane protein 1. 1 
698 FANCL Fanconi anemia, complementation group L. 1 
699 MS4A3 membrane-spanning 4-domains, subfamily A, member 3 isoform c. 0 
700 MS4A5 membrane-spanning 4-domains, subfamily A, member 5. 0 
701 FCGR2A 
PREDICTED: similar to Low affinity immunoglobulin gamma Fc region 
receptor II-a precursor (Fc-gamma RII-a) (FcRII-a) (IgG Fc receptor II-a) 
(Fc-gamma-RIIa) (CD32 antigen) (CDw32). 
0 
702 CD38 CD38 antigen. 0 
703 GP1BB glycoprotein Ib, beta polypeptide precursor. 0 
704 GP5 glycoprotein V (platelet). 0 
705 CEACAM3 carcinoembryonic antigen-related cell adhesion molecule 3 precursor. 0 
706 CEACAM5 
carcinoembryonic antigen-related cell adhesion molecule 5 
preproprotein. 
0 
707 PSG1 pregnancy specific beta-1-glycoprotein 1. 0 
708 LILRB1 
leukocyte immunoglobulin-like receptor, subfamily B, member 1 
isoform 1. 
0 
709 THY1 Thy-1 cell surface antigen. 0 
710 VCAM1 vascular cell adhesion molecule 1 isoform a precursor. 0 
711 IL8RA interleukin 8 receptor alpha. 0 
712 PROM1 prominin 1. 0 
713 TNFRSF9 tumor necrosis factor receptor superfamily, member 9 precursor. 0 
714 PDGFRA platelet-derived growth factor receptor alpha precursor. 0 
715 F3 coagulation factor III precursor. 0 
716 MCAM melanoma cell adhesion molecule. 0 
717 FUT3 fucosyltransferase 3. 0 
718 CD177 CD177 molecule. 0 
719 IGLL1 immunoglobulin lambda-like polypeptide 1 isoform a precursor. 0 
720 CD207 CD207 antigen, langerin. 0 
721 CLEC4M C-type lectin domain family 4, member M isoform 1. 0 
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722 IL13RA2 interleukin 13 receptor, alpha 2 precursor. 0 
723 GYPB glycophorin B precursor. 0 
724 BCAM basal cell adhesion molecule isoform 2 precursor. 0 
725 RHAG Rh-associated glycoprotein. 0 
726 ALK anaplastic lymphoma kinase Ki-1. 0 
727 CCBP2 chemokine binding protein 2. 0 
728 CCL1 small inducible cytokine A1 precursor. 0 
729 CCL2 small inducible cytokine A2 precursor. 0 
730 CCL7 chemokine (C-C motif) ligand 7 precursor. 0 
731 CCL8 small inducible cytokine A8 precursor. 0 
732 CCL11 small inducible cytokine A11 precursor. 0 
733 CCL13 small inducible cytokine A13 precursor. 0 
734 CCL15 chemokine (C-C motif) ligand 15 precursor. 0 
735 CCL16 small inducible cytokine A16 precursor. 0 
736 CCL17 small inducible cytokine A17 precursor. 0 
737 CCL18 small inducible cytokine A18 precursor. 0 
738 CCL19 small inducible cytokine A19 precursor. 0 
739 CCL20 chemokine (C-C motif) ligand 20. 0 
740 CCL21 small inducible cytokine A21 precursor. 0 
741 CCL22 small inducible cytokine A22 precursor. 0 
742 CCL24 small inducible cytokine A24 precursor. 0 
743 CCL25 small inducible cytokine A25 precursor. 0 
744 CCL26 chemokine (C-C motif) ligand 26 precursor. 0 
745 CXCL5 chemokine (C-X-C motif) ligand 5 precursor. 0 
746 CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2). 0 
747 CXCL9 small inducible cytokine B9 precursor. 0 
748 CXCL10 small inducible cytokine B10 precursor. 0 
749 CXCL11 small inducible cytokine B11 precursor. 0 
750 CXCL13 chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant). 0 
751 XCL2 chemokine (C motif) ligand 2. 0 
752 CXCL14 small inducible cytokine B14 precursor. 0 
753 MASP1 mannan-binding lectin serine protease 1 isoform 3. 0 
754 IL2 interleukin 2 precursor. 0 
755 IL3 interleukin 3 precursor. 0 
756 IL11 interleukin 11 precursor. 0 
757 CSF3 colony stimulating factor 3 isoform a precursor. 0 
758 NOS2A nitric oxide synthase 2A. 0 
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759 LTA lymphotoxin alpha precursor. 0 
760 GZMM granzyme M precursor. 0 
761 LPO lactoperoxidase. 0 
762 DEFA3 defensin, alpha 3 preproprotein. 0 
763 DEFA5 defensin, alpha 5 preproprotein. 0 
764 DEFA6 defensin, alpha 6 preproprotein. 0 
765 POMC proopiomelanocortin preproprotein. 0 
766 PGLYRP2 peptidoglycan recognition protein 2 precursor. 0 
767 IL12B interleukin 12B precursor. 0 
768 C8B complement component 8, beta polypeptide preproprotein. 0 
769 LILRB4 
leukocyte immunoglobulin-like receptor, subfamily B, member 4 
isoform 1. 
0 
770 GYPE glycophorin E precursor. 0 
771 GNLY granulysin isoform NKG5. 0 
772 EPO erythropoietin precursor. 0 
773 EPX eosinophil peroxidase. 0 
774 MICA MHC class I chain-related gene A protein. 0 
775 PLA2G7 phospholipase A2, group VII. 0 
776 NFATC4 cytoplasmic nuclear factor of activated T-cells 4. 0 
777 CHL1 cell adhesion molecule with homology to L1CAM precursor. 0 
778 IFNB1 interferon, beta 1, fibroblast. 0 
779 CTSG cathepsin G preproprotein. 0 
780 PRG2 proteoglycan 2 preproprotein. 0 
781 EBF2 early B-cell factor 2. 0 
782 CSF2 colony stimulating factor 2 precursor. 0 
783 HRB HIV-1 Rev binding protein. 0 
784 DEFB4 defensin, beta 4 precursor. 0 
785 HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 precursor. 0 
786 HLA-DQB2 major histocompatibility complex, class II, DQ beta 2. 0 
787 HLA-DRB3 major histocompatibility complex, class II, DR beta 3 precursor. 0 
788 HLA-DRB4 major histocompatibility complex, class II, DR beta 4 precursor. 0 
789 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 precursor. 0 
790 HLA-E major histocompatibility complex, class I, E precursor. 0 
791 IL5 interleukin 5 precursor. 0 
792 IL13 interleukin 13 precursor. 0 
793 IL17A interleukin 17A precursor. 0 
794 KIR2DL1 
killer cell immunoglobulin-like receptor, two domains, long 





killer cell immunoglobulin-like receptor, two domains, long 
cytoplasmic tail, 3 isoform 1. 
0 
796 KIR2DS1 
killer cell immunoglobulin-like receptor, two domains, short 
cytoplasmic tail, 1 precursor. 
0 
797 KIR2DS2 
killer cell immunoglobulin-like receptor, two domains, short 
cytoplasmic tail, 2 precursor. 
0 
798 KIR2DS5 
killer cell immunoglobulin-like receptor, two domains, short 
cytoplasmic tail, 5. 
0 
799 KIR3DL1 
killer cell immunoglobulin-like receptor, three domains, long 
cytoplasmic tail, 1 precursor. 
0 
800 IL17B interleukin 17B precursor. 0 
801 CLEC10A C-type lectin, superfamily member 14 isoform 2. 0 
802 PGLYRP3 peptidoglycan recognition protein 3 precursor. 0 
803 LEAP2 liver-expressed antimicrobial peptide 2 precursor. 0 
804 DCD dermcidin preproprotein. 0 
805 WFDC12 WAP four-disulfide core domain 12 precursor. 0 
806 CRP C-reactive protein, pentraxin-related. 0 
807 DEFA1 defensin, alpha 1 preproprotein. 0 
808 DEFA4 defensin, alpha 4 preproprotein. 0 
809 DEFB1 defensin, beta 1 preproprotein. 0 
810 DEFB105A defensin, beta 105A precursor. 0 
811 DEFB106A defensin, beta 106A precursor. 0 
812 DEFB119 defensin, beta 119 isoform a precursor. 0 
813 DEFB123 beta defensin 123 precursor. 0 
814 LYG2 lysozyme G-like 2. 0 
815 CLEC4E C-type lectin domain family 4, member E. 0 
816 HTN3 histatin 3. 0 
817 IL6 interleukin 6 (interferon, beta 2). 0 
818 IL7 interleukin 7 precursor. 0 
819 INDO indoleamine-pyrrole 2,3 dioxygenase. 0 
820 IFIT1L interferon-induced protein with tetratricopeptide repeats 1-like. 0 
821 IL22 interleukin 22. 0 
822 CLEC4A C-type lectin, superfamily member 6 isoform 1. 0 
823 DEFB103A defensin, beta 103B precursor. 0 
824 CCL3L1 chemokine (C-C motif) ligand 3-like 1 precursor. 0 
825 IL25 interleukin 25 isoform 1 precursor. 0 
826 FOXN1 forkhead box N1. 0 
827 RNASE7 ribonuclease, RNase A family, 7. 0 
828 CLEC6A dectin-2. 0 
829 C1QL2 complement component 1, q subcomponent-like 2. 0 
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830 C1QTNF2 C1q and tumor necrosis factor related protein 2. 0 
831 C1QTNF3 C1q and tumor necrosis factor related protein 3 isoform a. 0 
832 C1QTNF5 C1q and tumor necrosis factor related protein 5. 0 
833 C1QTNF7 C1q and tumor necrosis factor related protein 7. 0 
834 C1S complement component 1, s subcomponent. 0 
835 C3AR1 complement component 3a receptor 1. 0 
836 CCL3L3 chemokine (C-C motif) ligand 3-like 3 precursor. 0 
837 CCL4L1 chemokine (C-C motif) ligand 4-like 1 precursor. 0 
838 CCL4L2 chemokine (C-C motif) ligand 4-like 2 precursor. 0 
839 CD164L2 CD164 sialomucin-like 2. 0 
840 CD200R2 CD200 cell surface glycoprotein receptor isoform 2. 0 
841 CD300LB CD300 molecule-like family member b. 0 
842 SIGLEC15 sialic acid binding Ig-like lectin 15. 0 
843 CFHR1 complement factor H-related 1. 0 
844 CFHR2 H factor (complement)-like 3. 0 
845 CFHR3 complement factor H-related 3. 0 
846 CFHR4 complement factor H-related 4. 0 
847 CFHR5 complement factor H-related 5. 0 
848 CLEC4C C-type lectin domain family 4, member C isoform 1. 0 
849 CMTM1 chemokine-like factor superfamily 1 isoform 13. 0 
850 CMTM2 chemokine-like factor superfamily 2. 0 
851 CMTM4 chemokine-like factor superfamily 4 isoform 1. 0 
852 CMTM5 chemokine-like factor superfamily 5 isoform c. 0 
853 CMTM8 CKLF-like MARVEL transmembrane domain containing 8. 0 
854 CRLF2 cytokine receptor-like factor 2 isoform 2. 0 
855 CYTL1 cytokine-like 1. 0 
856 FCGR2C Fc fragment of IgG, low affinity IIc, receptor for isoform 2. 0 
857 FGFR2 fibroblast growth factor receptor 2 isoform 1 precursor. 0 
858 FGFR4 fibroblast growth factor receptor 4 isoform 1 precursor. 0 
859 IL17F interleukin 17F precursor. 0 
860 IL1RL1 interleukin 1 receptor-like 1 isoform 2 precursor. 0 
861 IL1RL2 interleukin 1 receptor-like 2 precursor. 0 
862 IL21 interleukin 21. 0 
863 IL22RA1 interleukin 22 receptor, alpha 1. 0 
864 IL22RA2 interleukin 22-binding protein isoform 1. 0 
865 IL26 interleukin 26 precursor. 0 
866 IL28A interleukin 28A. 0 
 293 
 
867 IL28B interleukin 28B. 0 
868 IL29 interleukin 29. 0 
869 IL31 interleukin 31. 0 
870 IL31RA gp130-like monocyte receptor. 0 
871 KDR kinase insert domain receptor (a type III receptor tyrosine kinase). 0 
872 KIR2DL2 
killer cell immunoglobulin-like receptor, two domains, long 
cytoplasmic tail, 2 precursor. 
0 
873 KIR2DL5A 
killer cell immunoglobulin-like receptor, two domains, long 
cytoplasmic tail, 5A. 
0 
874 KIR2DS4 
killer cell immunoglobulin-like receptor, two domains, short 
cytoplasmic tail, 4. 
0 
875 KIR3DL3 
killer cell immunoglobulin-like receptor, three domains, long 
cytoplasmic tail, 3. 
0 
876 KLRC2 killer cell lectin-like receptor subfamily C, member 2. 0 
877 LAIR2 leukocyte-associated immunoglobulin-like receptor 2 isoform a. 0 
878 LIFR leukemia inhibitory factor receptor precursor. 0 
879 LILRA1 
leukocyte immunoglobulin-like receptor, subfamily A (with TM 
domain), member 1. 
0 
880 LILRA3 
leukocyte immunoglobulin-like receptor, subfamily A (without TM 
domain), member 3. 
0 
881 LILRA4 leukocyte immunoglobulin-like receptor subfamily A member 4. 0 
882 LILRB5 
leukocyte immunoglobulin-like receptor, subfamily B, member 5 
isoform 2. 
0 
883 NCR2 natural cytotoxicity triggering receptor 2. 0 
884 SCGB3A1 secretoglobin, family 3A, member 1. 0 
885 TNFRSF10A tumor necrosis factor receptor superfamily, member 10a. 0 
886 TNFRSF10B 
tumor necrosis factor receptor superfamily, member 10b isoform 1 
precursor. 
0 
887 TNFRSF10C tumor necrosis factor receptor superfamily, member 10c precursor. 0 
888 TNFRSF10D tumor necrosis factor receptor superfamily, member 10d precursor. 0 
889 CA2 carbonic anhydrase II. 0 
890 ELA2 elastase 2, neutrophil preproprotein. 0 
891 F12 coagulation factor XII precursor. 0 
892 IGHM FLJ00385 protein. 0 
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